TWI804514B - Pyrimidinium compounds and their mixtures for combating animal pests - Google Patents

Pyrimidinium compounds and their mixtures for combating animal pests Download PDF

Info

Publication number
TWI804514B
TWI804514B TW107134558A TW107134558A TWI804514B TW I804514 B TWI804514 B TW I804514B TW 107134558 A TW107134558 A TW 107134558A TW 107134558 A TW107134558 A TW 107134558A TW I804514 B TWI804514 B TW I804514B
Authority
TW
Taiwan
Prior art keywords
methyl
phenyl
rice
compound
spp
Prior art date
Application number
TW107134558A
Other languages
Chinese (zh)
Other versions
TW202012418A (en
Inventor
裘秦 迪克豪特
阿夏克庫瑪 阿迪賽辰
格柏 克瑞喜納 達塔
歐雷雅 庫茲密那
猶庚 藍傑沃德
Original Assignee
德商巴地斯顏料化工廠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 德商巴地斯顏料化工廠 filed Critical 德商巴地斯顏料化工廠
Priority to TW107134558A priority Critical patent/TWI804514B/en
Publication of TW202012418A publication Critical patent/TW202012418A/en
Application granted granted Critical
Publication of TWI804514B publication Critical patent/TWI804514B/en

Links

Abstract

The present invention relates to pyrimidinium compounds of formula (I), to the stereoisomers, salts, tautomers and N-oxides thereof, their mixtures and to compositions comprising such compounds or mixtures. The invention also relates to methods and uses of these pyrimidinium compounds and of compositions thereof, for combating and controlling animal pests. Furthermore, the invention relates also to pesticidal methods of applying such substituted pyrimidinium compounds. The pyrimidinium compounds of the present invention are defined by the following general formula (I):
Figure 107134558-A0101-11-0001-1
wherein R1 , R2 and Het are defined as in the description.

Description

用於對抗動物有害生物之嘧啶鎓化合物及其混合物Pyrimidinium compounds and mixtures thereof for use against animal pests

本發明係關於用於對抗無脊椎有害生物之殺昆蟲嘧啶鎓化合物及/或包含此類化合物之組合物。本發明進一步關於此等化合物與其他具有協同增強作用之活性成分的混合物。本發明亦關於殺有害生物方法,關於本發明所述之嘧啶鎓化合物及其立體異構體、鹽、互變異構體及N-氧化物以及其混合物及包含其之組合物的用途及應用。The present invention relates to insecticidal pyrimidinium compounds and/or compositions comprising such compounds for use against invertebrate pests. The invention further relates to mixtures of these compounds with other active ingredients having a synergistically potentiating effect. The present invention also relates to methods of killing pests, and to the uses and applications of the pyrimidinium compounds described in the present invention and their stereoisomers, salts, tautomers and N-oxides, mixtures thereof and compositions containing them.

無脊椎有害生物,特別是昆蟲、節肢動物及線蟲會破壞生長及收穫的作物且侵襲木質住宅及商業結構,從而對食物供應及財產造成巨大的經濟損失。雖然已知大量殺有害生物劑,但由於目標有害生物對該等試劑產生抗性之能力,因此一直需要用於對抗無脊椎有害生物諸如昆蟲、蛛形綱動物及線蟲的新試劑。因此,本發明之一個目的為提供具有良好殺有害生物活性且顯示針對大量不同的無脊椎有害生物,尤其針對難以控制的昆蟲、蛛形綱動物及線蟲之廣泛活性譜的化合物。Invertebrate pests, especially insects, arthropods and nematodes, can damage growing and harvested crops and attack wooden residential and commercial structures, causing huge economic losses to food supplies and property. Although a large number of pesticidal agents are known, there is a continuing need for new agents for combating invertebrate pests such as insects, arachnids and nematodes due to the ability of target pests to develop resistance to such agents. It was therefore an object of the present invention to provide compounds which have good pesticidal activity and which exhibit a broad spectrum of activity against a large number of different invertebrate pests, especially against difficult-to-control insects, arachnids and nematodes.

已發現,此等目的可藉由如下文所定義之通式(I)之嘧啶鎓化合物,包括其立體異構體,其鹽,特別是其農業上或獸醫學上可接受之鹽,其互變異構體及其N-氧化物來達成。It has been found that these objects can be achieved by pyrimidinium compounds of general formula (I) as defined below, including their stereoisomers, their salts, especially their agriculturally or veterinarily acceptable salts, their mutual isomers and their N-oxides.

本發明係關於式(I)之嘧啶鎓化合物

Figure 02_image005
其中 R1 為C1 -C4 烷基、C3 -C6 環烷基、C2 -C4 烯基或苯甲基,該等基團可經鹵素或C1 -C4 烷基部分或完全取代; R2 為五員或六員碳環或雜環,該環可未經取代、經R2a 部分或完全取代; Het係選自D-1、D-2及D-3:
Figure 02_image007
其中 Ra 為鹵素、C1 -C4 鹵烷基、C1 -C4 烷氧基或C1 -C4 烷硫基或苯基, n為0、1或2,及 #表示式(I)中之鍵; R2a 為鹵素、C1 -C6 鹵烷基、C1 -C6 鹵烷氧基、ORc 、C(=O)ORc 、C(=O)NRb Rc 、苯基或吡啶基,其可經鹵素、C1 -C6 鹵烷基或C1 -C6 鹵烷氧基取代; Rb 各自獨立地為氫、C1 -C6 烷基、C1 -C6 鹵烷基、C1 -C6 烷氧基、C1 -C6 鹵烷氧基; Rc 各自獨立地為氫、C1 -C4 烷基、C1 -C4 鹵烷基、C1 -C6 環烷基; 其中兩個偕鍵結之基團Rb Rb 、Rc Rb 或Rc Rc 與其所鍵結原子一起可形成3員、4員、5員、6員或7員飽和、部分不飽和或芳族碳環或雜環; 或其立體異構體、互變異構體、鹽或N-氧化物。The present invention relates to pyrimidinium compounds of formula (I)
Figure 02_image005
wherein R 1 is C 1 -C 4 alkyl, C 3 -C 6 cycloalkyl, C 2 -C 4 alkenyl or benzyl, these groups can be modified by halogen or C 1 -C 4 alkyl moiety or Fully substituted; R 2 is a five-membered or six-membered carbocyclic or heterocyclic ring, which can be unsubstituted, partially or completely substituted by R 2a ; Het is selected from D-1, D-2 and D-3:
Figure 02_image007
Wherein R a is halogen, C 1 -C 4 haloalkyl, C 1 -C 4 alkoxy or C 1 -C 4 alkylthio or phenyl, n is 0, 1 or 2, and # represents the formula (I ) in the bond; R 2a is halogen, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, OR c , C(=O)OR c , C(=O)NR b R c , Phenyl or pyridyl, which may be substituted by halogen, C 1 -C 6 haloalkyl or C 1 -C 6 haloalkoxy; R b is each independently hydrogen, C 1 -C 6 alkyl, C 1 - C 6 haloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy; R c each independently hydrogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, C 1 -C 6 cycloalkyl group; where the two gem-bonded groups R b R b , R c R b or R c R c can form 3-membered, 4-membered, 5-membered, 6-membered groups together with the atoms to which they are bonded or 7-membered saturated, partially unsaturated or aromatic carbocyclic or heterocyclic rings; or stereoisomers, tautomers, salts or N-oxides thereof.

WO2014/167084描述用於對抗無脊椎有害生物之某些經取代之嘧啶鎓化合物。WO2014/167084 describes certain substituted pyrimidinium compounds for use against invertebrate pests.

本發明亦關於非外消旋式(I)化合物,其中變數Het、R1 及R2 如式(I)化合物中所定義;The invention also relates to non-racemic compounds of formula (I), wherein the variables Het, R and R are as defined for compounds of formula (I);

本發明亦關於具有對映異構體過量式(I-R)之式(I)化合物,其中變數Het、R1 及R2 如式(I)化合物中所定義;

Figure 02_image009
The present invention also relates to compounds of formula (I) having enantiomeric excess formula (IR), wherein the variables Het, R and R are as defined for compounds of formula (I);
Figure 02_image009

式(I)之嘧啶鎓化合物、式(I)之非外消旋化合物或具有對映異構體過量式I-R化合物之式(I)化合物及其農業上可接受之鹽對動物有害生物,亦即有害節肢動物及線蟲,尤其對藉由其他方式難以控制的昆蟲及蟎科具有高度活性。Pyrimidinium compounds of formula (I), non-racemic compounds of formula (I) or compounds of formula (I) having an enantiomeric excess of compounds of formula I-R and agriculturally acceptable salts thereof are harmful to animal organisms, and also That is, harmful arthropods and nematodes, especially insects and acaridae that are difficult to control by other means are highly active.

此外,本發明係關於且包括以下實施例: - 組合物,其包含至少一種如上文及下文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物; - 農業及獸醫學組合物,其包含一定量的至少一種如上文及下文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物,或其對映異構體、非對映異構體或鹽; - 一種用於對抗無脊椎有害生物、無脊椎有害生物侵染或感染之方法,該方法包含使該有害生物或其食物供應地、棲息地或繁殖地與殺有害生物有效量之至少一種如上文及下文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物或其組合物接觸; - 一種用於控制無脊椎有害生物、無脊椎有害生物侵染或感染之方法,該方法包含使該有害生物或其食物供應地、棲息地或繁殖地與殺有害生物有效量之至少一種如上文及下文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物,或包含至少一種式(I)化合物或式(I)之非外消旋化合物或具有對映異構體過量式I-R化合物之式(I)化合物的組合物接觸; - 一種用於預防或防止無脊椎有害生物之方法,其包含使無脊椎有害生物或其食物供應地、棲息地或繁殖地與如上文及下文所定義之通式(I)之經取代之嘧啶鎓化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物,或包含至少一種如上文及下文所定義之式(I)化合物或式(I)之非外消旋化合物或具有對映異構體過量式I-R化合物之式(I)化合物的組合物,或包含至少一種式(I)化合物或式(I)之非外消旋化合物或具有對映異構體過量式I-R化合物之式(I)化合物的組合物接觸; - 一種用於保護作物、植物、植物繁殖材料及/或生長植物免受無脊椎有害生物侵襲或侵染之方法,其包含用殺有害生物有效量之至少一種如上文及下文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物,或包含至少一種式(I)化合物或式(I)之非外消旋化合物或具有對映異構體過量式I-R化合物之式(I)化合物的組合物接觸或處理作物、植物、植物繁殖材料及生長植物,或儲存作物、植物、植物繁殖材料或植物生長的土壤、材料、表面、空間、區域或水; - 一種用於處理受寄生蟲浸染或感染之動物或預防動物受寄生蟲浸染或感染或保護動物免受寄生蟲侵染或感染的非治療方法,其包含向該等動物經口、局部或非經腸投與或施用殺寄生蟲有效量之如上文及下文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物,或包含至少一種式(I)化合物或式(I)之非外消旋化合物或具有對映異構體過量式I-R化合物之式(I)化合物的組合物; - 一種用於處理、控制、預防或保護動物免受寄生蟲侵染或感染之方法,其係藉由向該等動物經口、局部或非經腸投與或施用如上文及下文所定義之通式(I)之經取代之嘧啶鎓化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物,或包含至少一種式(I)化合物或式(I)之非外消旋化合物或具有對映異構體過量式I-R化合物之式(I)化合物的組合物; - 種子,其包含每100 kg種子0.1 g至10 kg之量的如上文及下文所定義之式(I)化合物、或式(I)之非外消旋化合物或具有對映異構體過量式I-R化合物之式(I)化合物; - 如上文及下文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物用於保護生長植物或植物繁殖材料免受無脊椎有害生物侵襲或侵染的用途; - 式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物,或其對映異構體、非對映異構體或獸醫學上可接受之鹽用於對抗動物體內及體表寄生蟲的用途; - 一種製備用於處理、控制、預防或保護動物免受寄生蟲侵染或感染之獸醫用組合物的方法,其包含將殺寄生蟲有效量之如本文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物,或其對映異構體、非對映異構體及/或獸醫學上可接受之鹽添加至適用於獸醫用途的載體組合物; - 如本文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物,或其對映異構體、非對映異構體及/或獸醫學上可接受之鹽用於製備供處理、控制、預防或保護動物免受寄生蟲侵染或感染用之藥物的用途。Furthermore, the present invention relates to and includes the following embodiments: - a composition comprising at least one compound of formula (I) as defined above and below, or a non-racemic compound of formula (I), or a compound of formula (I) with an enantiomeric excess of a compound of formula I-R ; - agricultural and veterinary compositions comprising an amount of at least one compound of formula (I) as defined above and below, or a non-racemic compound of formula (I), or having an enantiomeric excess of formula I-R A compound of formula (I), or an enantiomer, diastereomer or salt thereof; - A method for combating invertebrate pests, infestation or infection by invertebrate pests, the method comprising exposing the pest or its food supply, habitat or breeding grounds to at least one of the above pesticidally effective amounts and a compound of formula (I) as defined below, or a non-racemic compound of formula (I), or a compound of formula (I) having an enantiomeric excess of a compound of formula I-R, or a composition thereof; - a method for controlling invertebrate pests, infestation or infection by invertebrate pests, the method comprising exposing the pest or its food supply, habitat or breeding grounds to at least one of the above pesticidally effective amounts and a compound of formula (I) as defined below, or a non-racemic compound of formula (I), or a compound of formula (I) having an enantiomeric excess of a compound of formula I-R, or comprising at least one compound of formula (I) or a non-racemic compound of formula (I) or a composition of a compound of formula (I) having an enantiomeric excess of a compound of formula I-R; - A method for preventing or preventing invertebrate pests, which comprises combining an invertebrate pest or its food supply, habitat or breeding ground with a substituted pyrimidine of general formula (I) as defined above and below Onium compounds, or non-racemic compounds of formula (I), or compounds of formula (I) having an enantiomeric excess of compounds of formula I-R, or comprising at least one compound of formula (I) as defined above and below, or Compositions of non-racemic compounds of formula (I) or compounds of formula (I) having an enantiomeric excess of compounds of formula I-R, or comprising at least one compound of formula (I) or non-racemic compounds of formula (I) contacting a compound or a composition of a compound of formula (I) having an enantiomeric excess of a compound of formula I-R; - a method for protecting crops, plants, plant propagation material and/or growing plants from attack or infestation by invertebrate pests, comprising administering a pesticidally effective amount of at least one of the formulas as defined above and below ( I) compound, or a non-racemic compound of formula (I), or a compound of formula (I) having an enantiomeric excess of a compound of formula I-R, or comprising at least one compound of formula (I) or a non-racemic compound of formula (I) Racemic compounds or compositions of compounds of formula (I) having an enantiomeric excess of compounds of formula I-R Contact or treatment of crops, plants, plant propagation material and growing plants, or storage of crops, plants, plant propagation material or plant growth soil, material, surface, space, area or water; - a non-therapeutic method for treating or preventing an animal infested or infected with a parasite or protecting an animal from an infestation or infection by a parasite comprising oral, topical or non-therapeutic administration of Enteral administration or administration of a parasiticidally effective amount of a compound of formula (I) as defined above and below, or a non-racemic compound of formula (I), or a compound of formula I-R with an enantiomeric excess (I) compounds, or compositions comprising at least one compound of formula (I) or a non-racemic compound of formula (I) or a compound of formula (I) having an enantiomeric excess of a compound of formula I-R; - a method for the treatment, control, prevention or protection of animals against parasitic infestation or infection by administering or administering to such animals orally, topically or parenterally a A substituted pyrimidinium compound of general formula (I), or a non-racemic compound of formula (I), or a compound of formula (I) having an enantiomeric excess of a compound of formula I-R, or comprising at least one compound of formula (I ) compound or a non-racemic compound of formula (I) or a composition of a compound of formula (I) having an enantiomeric excess of a compound of formula I-R; - Seeds comprising a compound of formula (I) as defined above and below, or a non-racemic compound of formula (I) or having an enantiomeric excess of the formula (I) in an amount of from 0.1 g to 10 kg per 100 kg of seed Compounds of formula (I) of I-R compounds; - a compound of formula (I) as defined above and below, or a non-racemic compound of formula (I), or a compound of formula (I) having an enantiomeric excess of a compound of formula I-R for the protection of growing plants or plants Use of propagating material to protect against infestation or infestation by invertebrate pests; - a compound of formula (I), or a non-racemic compound of formula (I), or a compound of formula (I) having an enantiomeric excess of a compound of formula I-R, or its enantiomers, diastereoisomers Use of salts acceptable in human or veterinary medicine for combating endo- and ectoparasites in animals; - a method for the preparation of a veterinary composition for the treatment, control, prevention or protection of animals from parasitic infestation or infection comprising a parasiticidally effective amount of a compound of formula (I) as defined herein, or A non-racemic compound of formula (I), or a compound of formula (I) having an enantiomeric excess of a compound of formula I-R, or its enantiomers, diastereoisomers and/or veterinarily acceptable Accepted salts are added to carrier compositions suitable for veterinary use; - a compound of formula (I) as defined herein, or a non-racemic compound of formula (I), or a compound of formula (I) having an enantiomeric excess of a compound of formula I-R, or an enantiomer thereof, Use of diastereoisomers and/or veterinarily acceptable salts for the manufacture of a medicament for the treatment, control, prevention or protection of animals from parasitic infestation or infection.

此外,本發明亦關於且包括以下實施例: - 如本文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物,其用於控制水稻中之水稻有害生物,尤其水稻有害無脊椎動物; - 包含至少一種如本文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物的組合物,其用於控制水稻中之水稻有害生物,尤其水稻有害無脊椎動物; - 農業組合物,其包含一定量的至少一種如本文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物,或如上文所定義之其對映異構體、非對映異構體或鹽,用於控制水稻中之水稻有害生物,尤其水稻有害無脊椎動物; - 一種用於對抗水稻有害無脊椎動物、水稻有害無脊椎動物侵染或感染之方法,該方法包含使該有害生物或其食物供應地、棲息地或繁殖地與殺有害生物有效量之至少一種如上文及下文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物或其組合物接觸; - 一種用於控制水稻有害無脊椎動物、無脊椎有害生物侵染或感染之方法,該方法包含使該有害生物或其食物供應地、棲息地或繁殖地與殺有害生物有效量之至少一種如上文及下文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物,或包含至少一種式(I)化合物或式(I)之非外消旋化合物或具有對映異構體過量式I-R化合物之式(I)化合物的組合物接觸; - 一種用於預防或防止水稻有害無脊椎動物之方法,其包含使水稻有害無脊椎動物或其食物供應地、棲息地或繁殖地與如上文所定義之通式(I)之經取代之嘧啶鎓化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物,或包含至少一種如上文及下文所定義之式(I)化合物或式(I)之非外消旋化合物或具有對映異構體過量式I-R化合物之式(I)化合物的組合物接觸; - 一種用於保護水稻、水稻植物、水稻植物繁殖材料及/或生長的水稻植物免受水稻有害無脊椎動物侵襲或侵染之方法,其包含用殺有害生物有效量之至少一種如上文及下文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物,或包含至少一種式(I)化合物或式(I)之非外消旋化合物或具有對映異構體過量式I-R化合物之式(I)化合物的組合物接觸或處理水稻、水稻植物、水稻植物繁殖材料及生長的水稻植物,或儲存水稻、水稻植物、水稻植物繁殖材料或水稻植物生長的土壤、材料、表面、空間、區域或水; - 一種用於增加水稻植物健康(尤其在稻田中)之方法,其包含用至少一種如本文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物處理; - 一種用於增加水稻植物產量之方法,其包含用至少一種如本文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物處理; - 水稻種子,其包含每100 kg種子0.1 g至10 kg之量的如上文及下文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物; - 如上文及下文所定義之式(I)化合物、或式(I)之非外消旋化合物、或具有對映異構體過量式I-R化合物之式(I)化合物用於保護生長的水稻植物或水稻植物繁殖材料免受水稻有害無脊椎動物侵襲或侵染的用途。In addition, the present invention also relates to and includes the following embodiments: - a compound of formula (I) as defined herein, or a non-racemic compound of formula (I), or a compound of formula (I) having an enantiomeric excess of a compound of formula I-R, for the control of Oryza sativa in rice Pests, especially invertebrates that are harmful to rice; - a composition comprising at least one compound of formula (I) as defined herein, or a non-racemic compound of formula (I), or a compound of formula (I) having an enantiomeric excess of a compound of formula I-R, for use in In the control of rice pests, especially rice harmful invertebrates; - an agricultural composition comprising an amount of at least one compound of formula (I) as defined herein, or a non-racemic compound of formula (I), or a compound of formula (I) having an enantiomeric excess of formula I-R ) compounds, or their enantiomers, diastereomers or salts as defined above, for the control of rice pests, especially rice harmful invertebrates, in rice; - A method for combating harmful invertebrates of rice, infestation or infection of harmful invertebrates of rice, the method comprising exposing the harmful organism or its food supply, habitat or breeding ground to at least one of a pesticidally effective amount contacting a compound of formula (I) as defined above and below, or a non-racemic compound of formula (I), or a compound of formula (I) having an enantiomeric excess of a compound of formula I-R, or a composition thereof; - a method for controlling harmful invertebrates of rice, invertebrate pest infestation or infection, the method comprising making the pest or its food supply, habitat or breeding ground and at least one of the above pesticidally effective amount A compound of formula (I) as defined hereinbelow, or a non-racemic compound of formula (I), or a compound of formula (I) having an enantiomeric excess of a compound of formula I-R, or comprising at least one compound of formula (I) contacting a compound or a non-racemic compound of formula (I) or a composition of a compound of formula (I) having an enantiomeric excess of a compound of formula I-R; - A method for preventing or preventing harmful invertebrates of rice, which comprises combining harmful invertebrates of rice or their food supply, habitat or breeding ground with a substituted pyrimidine of the general formula (I) as defined above Onium compounds, or non-racemic compounds of formula (I), or compounds of formula (I) having an enantiomeric excess of compounds of formula I-R, or comprising at least one compound of formula (I) as defined above and below, or Contacting a non-racemic compound of formula (I) or a composition of a compound of formula (I) having an enantiomeric excess of a compound of formula I-R; - A method for protecting rice, rice plants, rice plant propagation material and/or growing rice plants from attack or infestation by rice harmful invertebrates, comprising using a pesticidally effective amount of at least one of the above and below A compound of formula (I) as defined, or a non-racemic compound of formula (I), or a compound of formula (I) having an enantiomeric excess of a compound of formula I-R, or comprising at least one compound of formula (I) or Non-racemic compounds of (I) or compositions of compounds of formula (I) having enantiomeric excess of compounds of formula I-R contact or treat rice, rice plants, rice plant propagation material and growing rice plants, or store rice , rice plants, rice plant propagation material or the soil, material, surface, space, area or water on which rice plants grow; - a method for increasing the health of rice plants, especially in paddy fields, comprising using at least one compound of formula (I) as defined herein, or a non-racemic compound of formula (I), or having an enantiomerically Treatment of the compound of formula (I) with excess of the compound of formula I-R; - a method for increasing the yield of rice plants comprising using at least one compound of formula (I) as defined herein, or a non-racemic compound of formula (I), or a compound of formula I-R with enantiomeric excess Formula (I) compound treatment; - Rice seeds comprising a compound of formula (I) as defined above and below, or a non-racemic compound of formula (I), or having an enantiomer in an amount of 0.1 g to 10 kg per 100 kg of seed a compound of formula (I) in excess of a compound of formula I-R; - a compound of formula (I) as defined above and below, or a non-racemic compound of formula (I), or a compound of formula (I) having an enantiomeric excess of a compound of formula I-R for the protection of growing rice plants Or use of rice plant propagation material to protect against attack or infestation by rice harmful invertebrates.

本發明之所有化合物,包括(若適用)其立體異構體、其互變異構體、其鹽或其N-氧化物以及其組合物,特別適用於控制無脊椎有害生物,特別是用於控制節肢動物及線蟲以及尤其昆蟲。因此,本發明係關於如本發明所揭示之化合物用於對抗或控制無脊椎有害生物,特別是昆蟲、蛛形綱動物或線蟲之群之無脊椎有害生物的用途。All compounds of the present invention, including (where applicable) their stereoisomers, their tautomers, their salts or their N-oxides and combinations thereof, are particularly suitable for controlling invertebrate pests, especially for controlling Arthropods and nematodes and especially insects. Accordingly, the present invention relates to the use of compounds as disclosed in the present invention for combating or controlling invertebrate pests, especially invertebrate pests of groups of insects, arachnids or nematodes.

如本發明中所用之術語「根據本發明之化合物」或「式(I)化合物」係指且包含如本文所定義之化合物及/或其立體異構體、鹽、互變異構體或N-氧化物。術語「本發明之化合物」應理解為等同於術語「根據本發明之化合物」,因此亦包含式(I)化合物之立體異構體、鹽、互變異構體或N-氧化物。The term "compound according to the present invention" or "compound of formula (I)" as used in the present invention refers to and includes a compound as defined herein and/or its stereoisomer, salt, tautomer or N- oxide. The term "compounds of the invention" is understood to be equivalent to the term "compounds according to the invention", thus also encompassing stereoisomers, salts, tautomers or N-oxides of the compounds of formula (I).

如本文中所用之術語「化合物I-R」或「式(I-R)化合物」為同義詞。As used herein, the terms "compound I-R" or "compound of formula (I-R)" are synonymous.

術語「根據本發明之組合物」或「本發明之組合物」涵蓋包含至少一種如上文所定義之根據本發明之式(I)化合物或具有對映異構體過量式I-R化合物之式(I)化合物的組合物,因此亦包括式(I)化合物之立體異構體、農業上或獸醫學上可接受之鹽、互變異構體或N-氧化物。The term "composition according to the invention" or "composition of the invention" encompasses a compound of formula (I) comprising at least one compound of formula (I) according to the invention as defined above or a compound of formula I-R having an enantiomeric excess ) compounds, thus also including stereoisomers, agriculturally or veterinarily acceptable salts, tautomers or N-oxides of compounds of formula (I).

式(I)化合物以內消旋形式存在。此等形式可以不同的等電子式表示,其各自在不同的原子上具有形式正電荷及負電荷(如下所示)。本發明擴展至式I化合物之所有代表性等電子結構。

Figure 02_image011
Compounds of formula (I) exist in meso form. These forms can be represented by different isoelectronic formulas, each with formal positive and negative charges on different atoms (as shown below). The invention extends to all representative isoelectronic structures of the compounds of formula I.
Figure 02_image011

視取代型而定,式(I)化合物具有一或多個對掌性中心,在此情況下該等化合物以對映異構體或非對映異構體之混合物形式存在。本發明提供式(I)化合物之單一純對映異構體或純非對映異構體及其混合物,以及式(I)化合物之純對映異構體或純非對映異構體或其混合物之根據本發明的用途。適合之式(I)化合物亦包括所有可能的幾何立體異構體(順/反異構體)及其混合物。順/反異構體可相對於烯烴、碳-氮雙鍵或醯胺基存在。術語「立體異構體」涵蓋光學異構體,諸如對映異構體或非對映異構體,後者由於分子中多於一個對掌性中心而存在,以及幾何異構體(順/反異構體)。本發明係關於式(I)化合物之每一可能的立體異構體,亦即單一對映異構體或非對映異構體以及其混合物。下文更詳細地描述特定對映異構體的較佳實施例,如式(I-R)及(I-S)之化合物。Depending on the substitution pattern, the compounds of the formula (I) possess one or more chiral centers, in which case the compounds exist as mixtures of enantiomers or diastereomers. The present invention provides a single pure enantiomer or pure diastereoisomer of a compound of formula (I) and a mixture thereof, and a pure enantiomer or pure diastereoisomer of a compound of formula (I) or Use according to the invention of mixtures thereof. Suitable compounds of formula (I) also include all possible geometric stereoisomers (cis/trans isomers) and mixtures thereof. Cis/trans isomers may exist relative to olefins, carbon-nitrogen double bonds, or amido groups. The term "stereoisomer" encompasses optical isomers, such as enantiomers or diastereomers, which exist as a result of more than one chiral center in the molecule, as well as geometric isomers (cis/trans isomer). The present invention relates to each possible stereoisomer, ie individual enantiomers or diastereomers, of the compounds of formula (I) and mixtures thereof. Preferred embodiments of specific enantiomers, such as compounds of formula (I-R) and (I-S), are described in more detail below.

視取代型而定,式(I)化合物可以其互變異構體之形式存在。因此,本發明亦關於式(I)之互變異構體及該等互變異構體之立體異構體、鹽、互變異構體及N-氧化物。Depending on the substitution pattern, the compounds of formula (I) may exist in the form of their tautomers. Accordingly, the present invention also relates to the tautomers of formula (I) and the stereoisomers, salts, tautomers and N-oxides of these tautomers.

式(I)化合物之鹽較佳為農業上及/或獸醫學上可接受之鹽。其可以習用方法形式,例如若式(I)化合物具有鹼性官能基,則藉由使化合物與所討論之陰離子的酸反應,或藉由使式(I)之酸性化合物與適合之鹼反應。The salt of the compound of formula (I) is preferably an agriculturally and/or veterinarily acceptable salt. This can be done by customary methods, eg by reacting the compound with the acid of the anion in question if the compound of formula (I) has a basic function, or by reacting an acidic compound of formula (I) with a suitable base.

適合之農業上或獸醫學上有用之鹽尤其為彼等陽離子之鹽或彼等酸之酸加成鹽,其陽離子及陰離子分別對根據本發明之化合物的作用沒有任何不利影響。適合之陽離子具體為鹼金屬,較佳鋰、鈉及鉀;鹼土金屬,較佳鈣、鎂及鋇;及過渡金屬,較佳錳、銅、鋅及鐵之離子,以及銨(NH4 + )及經取代之銨,其中一至四個氫原子經C1 -C4 烷基、C1 -C4 羥基烷基、C1 -C4 烷氧基、C1 -C4 烷氧基-C1 -C4 烷基、羥基-C1 -C4 烷氧基-C1 -C4 烷基、苯基或苯甲基置換。經取代之銨離子的實例包含甲基銨、異丙基銨、二甲基銨、二異丙基銨、三甲基銨、四甲基銨、四乙基銨、四丁基銨、2-羥基乙基銨、2-(2-羥基乙氧基)乙基銨、雙(2-羥乙基)銨、苯甲基三甲基銨及苯甲基三乙基銨,此外,鏻離子、鋶離子,較佳三(C1 -C4 烷基)鋶,及氧化鋶離子,較佳三(C1 -C4 烷基)氧化鋶。Suitable agriculturally or veterinarily useful salts are especially the salts of their cations or the acid addition salts of their acids, the cations and anions of which, respectively, do not have any adverse effect on the action of the compounds according to the invention. Suitable cations are in particular alkali metals, preferably lithium, sodium and potassium; alkaline earth metals, preferably calcium, magnesium and barium; and transition metals, preferably manganese, copper, zinc and iron ions, and ammonium (NH 4 + ) And substituted ammonium, wherein one to four hydrogen atoms are replaced by C 1 -C 4 alkyl, C 1 -C 4 hydroxyalkyl, C 1 -C 4 alkoxy, C 1 -C 4 alkoxy-C 1 -C 4 alkyl, hydroxy-C 1 -C 4 alkoxy-C 1 -C 4 alkyl, phenyl or benzyl substitution. Examples of substituted ammonium ions include methylammonium, isopropylammonium, dimethylammonium, diisopropylammonium, trimethylammonium, tetramethylammonium, tetraethylammonium, tetrabutylammonium, 2- Hydroxyethylammonium, 2-(2-hydroxyethoxy)ethylammonium, bis(2-hydroxyethyl)ammonium, benzyltrimethylammonium and benzyltriethylammonium, in addition, phosphonium ion, Calcite ion, preferably tri(C 1 -C 4 alkyl) calcite, and calcite oxide ion, preferably tri(C 1 -C 4 alkyl) calcite oxide.

有用的酸加成鹽的陰離子主要為氯離子、溴離子、氟離子、硫酸氫根、硫酸根、磷酸二氫根、磷酸氫根、磷酸根、硝酸根、碳酸氫根、碳酸根、六氟矽酸根、六氟磷酸根、苯甲酸根及C1 -C4 烷酸之陰離子,較佳甲酸根、乙酸根、丙酸根及丁酸根。其可藉由使式I化合物與相應陰離子之酸,較佳鹽酸、氫溴酸、硫酸、磷酸或硝酸反應來形成。The anions of useful acid addition salts are mainly chloride, bromide, fluoride, hydrogen sulfate, sulfate, dihydrogen phosphate, hydrogen phosphate, phosphate, nitrate, bicarbonate, carbonate, hexafluoro Anions of silicate, hexafluorophosphate, benzoate and C 1 -C 4 alkanoic acid, preferably formate, acetate, propionate and butyrate. It can be formed by reacting a compound of formula I with an acid of the corresponding anion, preferably hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid.

術語「N-氧化物」包括具有至少一個氧化成N-氧化物部分之三級氮原子的任何本發明化合物。The term "N-oxide" includes any compound of the invention having at least one tertiary nitrogen atom oxidized to an N-oxide moiety.

上文變數定義中提及之有機部分基團(如術語鹵素)為個別基團成員之個別清單的集合術語。在各情況下,字首Cn -Cm 指示基團中之可能碳原子數。The organic moiety groups mentioned above in the variable definitions (eg the term halogen) are collective terms for individual listings of individual group members. In each case, the prefix Cn - Cm indicates the possible number of carbon atoms in the group.

有機部分可具有與其連接之其他取代基,亦即有機部分可「經」其他部分(例如鹵素、氟、烷基)「取代」,其有時亦表示為「由……取代」,但在此上下文中具有相同的含義。An organic moiety may have other substituents attached to it, i.e. an organic moiety may be "substituted by" other moieties (e.g. halogen, fluorine, alkyl), which is also sometimes expressed as "substituted by", but here have the same meaning in context.

在各情況下,「鹵素」表示氟、溴、氯或碘,尤其氟、氯或溴。"Halogen" denotes in each case fluorine, bromine, chlorine or iodine, especially fluorine, chlorine or bromine.

術語「部分或完全鹵化」意謂給定基團之1或多個,例如1、2、3、4或5個或所有氫原子已經鹵素原子置換,尤其經氟或氯置換。The term "partially or fully halogenated" means that 1 or more, eg 1, 2, 3, 4 or 5 or all of the hydrogen atoms of a given group have been replaced by halogen atoms, especially by fluorine or chlorine.

如本文所用之術語「Cn -Cm 烷基」係指具有n至m個,例如1至10個碳原子,較佳1至6個碳原子的分支鏈或未分支鏈飽和烴基,例如甲基、乙基、丙基、1-甲基乙基、丁基、1-甲基丙基、2-甲基丙基、1,1-二甲基乙基、戊基、1-甲基丁基、2-甲基丁基、3-甲基丁基、2,2-二甲基丙基、1-乙基丙基、己基、1,1-二甲基丙基、1,2-二甲基丙基、1-甲基戊基、2-甲基戊基、3-甲基戊基、4-甲基戊基、1,1-二甲基丁基、1,2-二甲基丁基、1,3-二甲基丁基、2,2-二甲基丁基、2,3-二甲基丁基、3,3-二甲基丁基、1-乙基丁基、2-乙基丁基、1,1,2-三甲基丙基、1,2,2-三甲基丙基、1-乙基-1-甲基丙基、1-乙基-2-甲基丙基、庚基、辛基、2-乙基己基、壬基及癸基及其異構體。C1 -C4 烷基意謂例如甲基、乙基、丙基、1-甲基乙基、丁基、1-甲基丙基、2-甲基丙基或1,1-二甲基乙基。As used herein, the term "C n -C m alkyl" refers to a branched or unbranched saturated hydrocarbon group having n to m, such as 1 to 10 carbon atoms, preferably 1 to 6 carbon atoms, such as methyl Base, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, pentyl, 1-methylbutyl base, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1,1-dimethylpropyl, 1,2-di Methylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethyl Butyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, 1-ethyl-2- Methylpropyl, heptyl, octyl, 2-ethylhexyl, nonyl and decyl and their isomers. C 1 -C 4 Alkyl means for example methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethyl ethyl.

如本文所用之術語「Cn -Cm 鹵烷基」係指具有n至m個碳原子,例如1至10個,尤其1至6個碳原子之直鏈或分支鏈烷基(如上文所提及),其中此等基團中之一些或全部氫原子可經如上文所提及之鹵素原子置換,例如C1 -C4 鹵烷基,諸如氯甲基、溴甲基、二氯甲基、三氯甲基、氟甲基、二氟甲基、三氟甲基、氯氟甲基、二氯氟甲基、氯二氟甲基、1-氯乙基、1-溴乙基、1-氟乙基、2-氟乙基、2,2-二氟乙基、2,2,2-三氟乙基、2-氯-2-氟乙基、2-氯-2,2-二氟乙基、2,2-二氯-2-氟乙基、2,2,2-三氯乙基、五氟乙基及其類似基團。術語C1 -C10 鹵烷基特別包含C1 -C2 氟烷基,其與1、2、3、4或5個氫原子經氟原子取代之甲基或乙基同義,諸如氟甲基、二氟甲基、三氟甲基、1-氟乙基、2-氟乙基、2,2-二氟乙基、2,2,2-三氟乙基及五氟甲基。在此情形下,烷基部分稱為經鹵素或氟取代,有時亦表示為「由」鹵素或氟「取代」。The term " Cn - Cm haloalkyl" as used herein refers to a straight or branched chain alkyl group (as mentioned above) having n to m carbon atoms, such as 1 to 10, especially 1 to 6 carbon atoms mentioned), wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as mentioned above, for example C 1 -C 4 haloalkyl, such as chloromethyl, bromomethyl, dichloromethane group, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2- Difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl and the like. The term C 1 -C 10 haloalkyl especially includes C 1 -C 2 fluoroalkyl, which is synonymous with methyl or ethyl in which 1, 2, 3, 4 or 5 hydrogen atoms are replaced by fluorine atoms, such as fluoromethyl , difluoromethyl, trifluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl and pentafluoromethyl. In this case, the alkyl moiety is said to be substituted with halogen or fluorine, and is sometimes also expressed as "substituted by" halogen or fluorine.

類似地,「Cn -Cm 烷氧基」及「Cn -Cm 烷硫基」(或Cn -Cm 烷基次磺醯基,分別)係指在烷基中之任何鍵處經由氧(或硫鍵聯,分別)鍵結的具有n至m個碳原子,例如1至10個,尤其1至6個或1至4個碳原子的直鏈或分支鏈烷基(如上文所提及)。實例包括C1 -C4 烷氧基,諸如甲氧基、乙氧基、丙氧基、異丙氧基、丁氧基、第二丁氧基、異丁氧基及第三丁氧基,另外C1 -C4 烷硫基,諸如甲硫基、乙硫基、丙硫基、異丙硫基及正丁硫基。Similarly, "C n -C m alkoxy" and "C n -C m alkylthio" (or C n -C m alkylsulfenyl, respectively) refer to any bond in the alkyl group Straight-chain or branched-chain alkyl groups (as above) having n to m carbon atoms, for example 1 to 10, especially 1 to 6 or 1 to 4 carbon atoms, bonded via oxygen (or sulfur linkage, respectively) mentioned). Examples include C 1 -C 4 alkoxy, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butoxy, isobutoxy and tert-butoxy, Also C 1 -C 4 alkylthio, such as methylthio, ethylthio, propylthio, isopropylthio and n-butylthio.

因此,術語「Cn -Cm 鹵烷氧基」係指在烷基中之任何鍵處分別經由氧鍵聯鍵結的具有n至m個碳原子,例如1至10個,尤其1至6個或1至4個碳原子的直鏈或分支鏈烷基(如上文所提及),其中此等基團中之一些或全部氫原子可經如上文所提及之鹵素原子置換,例如C1 -C2 鹵烷氧基,諸如氯甲氧基、溴甲氧基、二氯甲氧基、三氯甲氧基、氟甲氧基、二氟甲氧基、三氟甲氧基、氯氟甲氧基、二氯氟甲氧基、氯二氟甲氧基、1-氯乙氧基、1-溴乙氧基、1-氟乙氧基、2-氟乙氧基、2,2-二氟乙氧基、2,2,2-三氟乙氧基、2-氯-2-氟乙氧基、2-氯-2,2-二氟乙氧基、2,2-二氯-2-氟乙氧基、2,2,2-三氯乙氧基及五氟乙氧基。類似地,術語C1 -C2 氟烷氧基係指經由氧原子與分子之其餘部分鍵結的C1 -C2 氟烷基。Thus, the term " Cn - Cm haloalkoxy" refers to a group having n to m carbon atoms, such as 1 to 10, especially 1 to 6, bonded via an oxygen linkage at any bond in the alkyl group, respectively. straight or branched chain alkyl groups (as mentioned above) of 1 or 1 to 4 carbon atoms, wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as mentioned above, for example C 1 - C2 haloalkoxy, such as chloromethoxy, bromomethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorine Fluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 1-chloroethoxy, 1-bromoethoxy, 1-fluoroethoxy, 2-fluoroethoxy, 2,2 -Difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro -2-fluoroethoxy, 2,2,2-trichloroethoxy and pentafluoroethoxy. Similarly, the term C 1 -C 2 fluoroalkoxy refers to a C 1 -C 2 fluoroalkyl group bonded to the rest of the molecule via an oxygen atom.

如本文所用之術語「C2 -Cm 烯基」意指具有2至m個,例如2至10個或2至6個碳原子及任何位置之雙鍵的分支鏈或未分支鏈不飽和烴基,諸如乙烯基、1-丙烯基、2-丙烯基、1-甲基-乙烯基、1-丁烯基、2-丁烯基、3-丁烯基、1-甲基-1-丙烯基、2-甲基-1-丙烯基、1-甲基-2-丙烯基、2-甲基-2-丙烯基、1-戊烯基、2-戊烯基、3-戊烯基、4-戊烯基、1-甲基-1-丁烯基、2-甲基-1-丁烯基、3-甲基-1-丁烯基、1-甲基-2-丁烯基、2-甲基-2-丁烯基、3-甲基-2-丁烯基、1-甲基-3-丁烯基、2-甲基-3-丁烯基、3-甲基-3-丁烯基、1,1-二甲基-2-丙烯基、1,2-二甲基-1-丙烯基、1,2-二甲基-2-丙烯基、1-乙基-1-丙烯基、1-乙基-2-丙烯基、1-己烯基、2-己烯基、3-己烯基、4-己烯基、5-己烯基、1-甲基-1-戊烯基、2-甲基-1-戊烯基、3-甲基-1-戊烯基、4-甲基-1-戊烯基、1-甲基-2-戊烯基、2-甲基-2-戊烯基、3-甲基-2-戊烯基、4-甲基-2-戊烯基、1-甲基-3-戊烯基、2-甲基-3-戊烯基、3-甲基-3-戊烯基、4-甲基-3-戊烯基、1-甲基-4-戊烯基、2-甲基-4-戊烯基、3-甲基-4-戊烯基、4-甲基-4-戊烯基、1,1-二甲基-2-丁烯基、1,1-二甲基-3-丁烯基、1,2-二甲基-1-丁烯基、1,2-二甲基-2-丁烯基、1,2-二甲基-3-丁烯基、1,3-二甲基-1-丁烯基、1,3-二甲基-2-丁烯基、1,3-二甲基-3-丁烯基、2,2-二甲基-3-丁烯基、2,3-二甲基-1-丁烯基、2,3-二甲基-2-丁烯基、2,3-二甲基-3-丁烯基、3,3-二甲基-1-丁烯基、3,3-二甲基-2-丁烯基、1-乙基-1-丁烯基、1-乙基-2-丁烯基、1-乙基-3-丁烯基、2-乙基-1-丁烯基、2-乙基-2-丁烯基、2-乙基-3-丁烯基、1,1,2-三甲基-2-丙烯基、1-乙基-1-甲基-2-丙烯基、1-乙基-2-甲基-1-丙烯基及1-乙基-2-甲基-2-丙烯基。The term "C 2 -C m alkenyl" as used herein means a branched or unbranched unsaturated hydrocarbon group having 2 to m, for example, 2 to 10 or 2 to 6 carbon atoms and double bonds in any position , such as vinyl, 1-propenyl, 2-propenyl, 1-methyl-vinyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl , 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4 -pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2 -Methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3- Butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2-propenyl, 1-ethyl-1- propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1- Pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl, 2- Methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3-pentenyl Alkenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 3-methyl Base-4-pentenyl, 4-methyl-4-pentenyl, 1,1-dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl, 1,2 -Dimethyl-1-butenyl, 1,2-dimethyl-2-butenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-1-butenyl Alkenyl, 1,3-dimethyl-2-butenyl, 1,3-dimethyl-3-butenyl, 2,2-dimethyl-3-butenyl, 2,3-di Methyl-1-butenyl, 2,3-dimethyl-2-butenyl, 2,3-dimethyl-3-butenyl, 3,3-dimethyl-1-butenyl , 3,3-Dimethyl-2-butenyl, 1-ethyl-1-butenyl, 1-ethyl-2-butenyl, 1-ethyl-3-butenyl, 2- Ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl -1-methyl-2-propenyl, 1-ethyl-2-methyl-1-propenyl and 1-ethyl-2-methyl-2-propenyl.

如本文所用之術語「芳基」係指單環、雙環或三環芳族烴基,諸如苯基或萘基,尤其苯基(作為取代基亦稱為C6 H5 )。The term "aryl" as used herein refers to a monocyclic, bicyclic or tricyclic aromatic hydrocarbon group, such as phenyl or naphthyl, especially phenyl (also known as C 6 H 5 as a substituent).

術語「環系統」表示兩個或更多個直接連接的環。The term "ring system" means two or more directly connected rings.

如本文所用之術語「C3 -Cm 環烷基」係指3員至m員單環飽和環脂族基團,例如環丙基、環丁基、環戊基、環己基、環庚基、環辛基及環癸基。As used herein, the term "C 3 -C m cycloalkyl" refers to a 3-membered to m-membered monocyclic saturated cycloaliphatic group, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl , cyclooctyl and cyclodecyl.

如本文所用之術語「五員或六員碳環或雜環」係指飽和環、部分不飽和環或芳環,其可含有1、2、3或4個雜原子或雜原子基團,其中彼等雜原子(基團)係選自N (N取代之基團)、O及S (S取代之基團),如本文所用之雜環基團係指單環基團,該等單環基團為飽和的、部分不飽和的或芳族的(完全不飽和的)。雜環基團可經由碳環成員或經由氮環成員與分子之其餘部分連接。As used herein, the term "five-membered or six-membered carbocyclic or heterocyclic ring" refers to a saturated ring, partially unsaturated ring or aromatic ring, which may contain 1, 2, 3 or 4 heteroatoms or heteroatom groups, wherein These heteroatoms (groups) are selected from N (groups substituted by N), O and S (groups substituted by S), and heterocyclic groups as used herein refer to monocyclic groups, and these monocyclic The groups are saturated, partially unsaturated or aromatic (fully unsaturated). A heterocyclic group can be attached to the rest of the molecule via a carbocyclic member or via a nitrogen ring member.

五員或六員碳環或雜環之實例包括環戊烷及環己烷、環己烯、苯基、吡啶基、2-四氫呋喃基、3-四氫呋喃基、2-四氫噻吩基、3-四氫噻吩基、2-吡咯啶基、3-吡咯啶基、3-吡唑啶基、4-吡唑啶基、5-吡唑啶基、2-咪唑啶基、4-咪唑啶基、2-噁唑啶基、4-噁唑啶基、5-噁唑啶基、3-異噁唑啶基、4-異噁唑啶基、5-異噁唑啶基、2-噻唑啶基、4-噻唑啶基、5-噻唑啶基、3-異噻唑啶基、4-異噻唑啶基、5-異噻唑啶基、1,2,4-噁二唑啶-3-基、1,2,4-噁二唑啶-5-基、1,2,4-噻二唑啶-3-基、1,2,4-噻二唑啶-5-基、1,2,4-三唑啶-3-基、1,3,4-噁二唑啶-2-基、1,3,4-噻二唑啶-2-基、1,3,4-三唑啶-2-基、2-四氫哌喃基、4-四氫哌喃基、1,3-二噁烷-5-基、1,4-二噁烷-2-基、2-哌啶基、3-哌啶基、4-哌啶基、3-六氫嗒嗪基、4-六氫嗒嗪基、2-六氫嘧啶基、4-六氫嘧啶基、5-六氫嘧啶基、2-哌嗪基、1,3,5-六氫三嗪-2-基及1,2,4-六氫三嗪-3-基、2-嗎啉基、3-嗎啉基、2-硫代嗎啉基、3-硫代嗎啉基、1-側氧基硫代嗎啉-2-基、1-側氧基硫代嗎啉-3-基、1,1-二側氧基硫代嗎啉-2-基、1,1-二側氧基硫代嗎啉-3-基及其類似基團。Examples of five- or six-membered carbocyclic or heterocyclic rings include cyclopentane and cyclohexane, cyclohexene, phenyl, pyridyl, 2-tetrahydrofuryl, 3-tetrahydrofuryl, 2-tetrahydrothiophenyl, 3- Tetrahydrothienyl, 2-pyrrolidinyl, 3-pyrrolidinyl, 3-pyrazolidinyl, 4-pyrazolidinyl, 5-pyrazolidinyl, 2-imidazolidinyl, 4-imidazolidinyl, 2-oxazolidine, 4-oxazolidine, 5-oxazolidine, 3-isoxazolidine, 4-isoxazolidine, 5-isoxazolidine, 2-thiazolidinyl , 4-thiazolidinyl, 5-thiazolidinyl, 3-isothiazolidinyl, 4-isothiazolidinyl, 5-isothiazolidinyl, 1,2,4-oxadiazolidin-3-yl, 1 ,2,4-oxadiazolidin-5-yl, 1,2,4-thiadiazolidin-3-yl, 1,2,4-thiadiazolidin-5-yl, 1,2,4- Triazolidine-3-yl, 1,3,4-oxadiazolidin-2-yl, 1,3,4-thiadiazolidin-2-yl, 1,3,4-triazolidine-2- Base, 2-tetrahydropyranyl, 4-tetrahydropyranyl, 1,3-dioxan-5-yl, 1,4-dioxan-2-yl, 2-piperidinyl, 3- Piperidinyl, 4-piperidinyl, 3-hexahydropyridazinyl, 4-hexahydropyridazinyl, 2-hexahydropyrimidinyl, 4-hexahydropyrimidinyl, 5-hexahydropyrimidinyl, 2-piperidinyl Azinyl, 1,3,5-hexahydrotriazin-2-yl and 1,2,4-hexahydrotriazin-3-yl, 2-morpholinyl, 3-morpholinyl, 2-thiomorpholinyl Linyl, 3-thiomorpholinyl, 1-oxothiomorpholin-2-yl, 1-oxothiomorpholin-3-yl, 1,1-dioxothiomorpholin-2-yl Lin-2-yl, 1,1-dioxothiomorpholin-3-yl and the like.

5員或6員部分不飽和雜環基或雜環之實例包括:2,3-二氫呋喃-2-基、2,3-二氫呋喃-3-基、2,4-二氫呋喃-2-基、2,4-二氫呋喃-3-基、2,3-二氫噻吩-2-基、2,3-二氫噻吩-3-基、2,4-二氫噻吩-2-基、2,4-二氫噻吩-3-基、2-吡咯啉-2-基、2-吡咯啉-3-基、3-吡咯啉-2-基、3-吡咯啉-3-基、2-異噁唑啉-3-基、3-異噁唑啉-3-基、4-異噁唑啉-3-基、2-異噁唑啉-4-基、3-異噁唑啉-4-基、4-異噁唑啉-4-基、2-異噁唑啉-5-基、3-異噁唑啉-5-基、4-異噁唑啉-5-基、2-異噻唑啉-3-基、3-異噻唑啉-3-基、4-異噻唑啉-3-基、2-異噻唑啉-4-基、3-異噻唑啉-4-基、4-異噻唑啉-4-基、2-異噻唑啉-5-基、3-異噻唑啉-5-基、4-異噻唑啉-5-基、2,3-二氫吡唑-1-基、2,3-二氫吡唑-2-基、2,3-二氫吡唑-3-基、2,3-二氫吡唑-4-基、2,3-二氫吡唑-5-基、3,4-二氫吡唑-1-基、3,4-二氫吡唑-3-基、3,4-二氫吡唑-4-基、3,4-二氫吡唑-5-基、4,5-二氫吡唑-1-基、4,5-二氫吡唑-3-基、4,5-二氫吡唑-4-基、4,5-二氫吡唑-5-基、2,3-二氫噁唑-2-基、2,3-二氫噁唑-3-基、2,3-二氫噁唑-4-基、2,3-二氫噁唑-5-基、3,4-二氫噁唑-2-基、3,4-二氫噁唑-3-基、3,4-二氫噁唑-4-基、3,4-二氫噁唑-5-基、3,4-二氫噁唑-2-基、3,4-二氫噁唑-3-基、3,4-二氫噁唑-4-基、2-、3-、4-、5-或6-二氫吡啶基或四氫吡啶基、3-二氫嗒嗪基或四氫嗒嗪基、4-二氫嗒嗪基或四氫嗒嗪基、2-二氫嘧啶基或四氫嘧啶基、4-二氫嘧啶基或四氫嘧啶基、5-二氫嘧啶基或四氫嘧啶基、二氫吡嗪基或四氫吡嗪基、1,3,5-二氫三嗪或四氫三嗪-2-基、1,2,4-二氫三嗪或四氫三嗪-3-基。Examples of 5-membered or 6-membered partially unsaturated heterocyclic groups or heterocycles include: 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,4-dihydrofuran- 2-yl, 2,4-dihydrofuran-3-yl, 2,3-dihydrothiophen-2-yl, 2,3-dihydrothiophen-3-yl, 2,4-dihydrothiophen-2- Base, 2,4-dihydrothiophen-3-yl, 2-pyrroline-2-yl, 2-pyrroline-3-yl, 3-pyrroline-2-yl, 3-pyrroline-3-yl, 2-isoxazolin-3-yl, 3-isoxazolin-3-yl, 4-isoxazolin-3-yl, 2-isoxazolin-4-yl, 3-isoxazolin -4-yl, 4-isoxazolin-4-yl, 2-isoxazolin-5-yl, 3-isoxazolin-5-yl, 4-isoxazolin-5-yl, 2 -isothiazolin-3-yl, 3-isothiazolin-3-yl, 4-isothiazolin-3-yl, 2-isothiazolin-4-yl, 3-isothiazolin-4-yl, 4 -isothiazolin-4-yl, 2-isothiazolin-5-yl, 3-isothiazolin-5-yl, 4-isothiazolin-5-yl, 2,3-dihydropyrazole-1- Base, 2,3-dihydropyrazol-2-yl, 2,3-dihydropyrazol-3-yl, 2,3-dihydropyrazol-4-yl, 2,3-dihydropyrazol- 5-yl, 3,4-dihydropyrazol-1-yl, 3,4-dihydropyrazol-3-yl, 3,4-dihydropyrazol-4-yl, 3,4-dihydropyrazole Azol-5-yl, 4,5-dihydropyrazol-1-yl, 4,5-dihydropyrazol-3-yl, 4,5-dihydropyrazol-4-yl, 4,5-di Hydrogen pyrazol-5-yl, 2,3-dihydrooxazol-2-yl, 2,3-dihydrooxazol-3-yl, 2,3-dihydrooxazol-4-yl, 2,3 -Dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 3 ,4-Dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl , 2-, 3-, 4-, 5- or 6-dihydropyridyl or tetrahydropyridyl, 3-dihydropyridazinyl or tetrahydropyridazinyl, 4-dihydropyridazinyl or tetrahydropyridyl Azinyl, 2-dihydropyrimidinyl or tetrahydropyrimidinyl, 4-dihydropyrimidinyl or tetrahydropyrimidinyl, 5-dihydropyrimidinyl or tetrahydropyrimidinyl, dihydropyrazinyl or tetrahydropyrazinyl , 1,3,5-dihydrotriazine or tetrahydrotriazin-2-yl, 1,2,4-dihydrotriazine or tetrahydrotriazin-3-yl.

5員或6員芳族雜環基(雜芳基)或雜芳環之實例為:2-呋喃基、3-呋喃基、2-噻吩基、3-噻吩基、2-吡咯基、3-吡咯基、3-吡唑基、4-吡唑基、5-吡唑基、2-噁唑基、4-噁唑基、5-噁唑基、2-噻唑基、4-噻唑基、5-噻唑基、2-咪唑基、4-咪唑基、1,3,4-三唑-2-基、2-吡啶基、3-吡啶基、4-吡啶基、3-嗒嗪基、4-嗒嗪基、2-嘧啶基、4-嘧啶基、5-嘧啶基及2-吡嗪基。Examples of 5-membered or 6-membered aromatic heterocyclic groups (heteroaryl) or heteroaryl rings are: 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyrrolyl, 3- Pyrrolyl, 3-pyrazolyl, 4-pyrazolyl, 5-pyrazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, 2-thiazolyl, 4-thiazolyl, 5 -thiazolyl, 2-imidazolyl, 4-imidazolyl, 1,3,4-triazol-2-yl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 3-pyridazinyl, 4- pyrazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl and 2-pyrazinyl.

除非另外規定,否則術語「至少XX%」係指≥XX%至≤100%,例如至少55%係指≥55%至≤100%。Unless otherwise specified, the term "at least XX%" means > XX% to < 100%, eg at least 55% means > 55% to < 100%.

術語「式(I)之非外消旋化合物」係指式(I)之化合物,其中其R-及S-對映異構體不以相等的量存在。The term "non-racemic compound of formula (I)" refers to a compound of formula (I) wherein its R- and S-enantiomers are not present in equal amounts.

術語「對映異構體過量」表明對映異構體在對映異構體混合物中過量,且根據下式計算:ee = [│m1 ─ m2 │/ (m1 + m2 )] × 100%ee :對映異構體過量 m1 :對映異構體1之分數 m2 :對映異構體2之分數The term "enantiomeric excess" indicates the excess of an enantiomer in a mixture of enantiomers and is calculated according to the following formula: ee = [│m 1 ─ m 2 │/ (m 1 + m 2 )] × 100% ee : enantiomeric excess m 1 : fraction of enantiomer 1 m 2 : fraction of enantiomer 2

如本文所用且除非另有說明,否則術語「對映異構體」意謂本發明化合物之各單獨的光學活性形式。As used herein and unless otherwise indicated, the term "enantiomer" means each individual optically active form of a compound of the invention.

如本文所用之術語「具有對映異構體過量」係指其中關於所用術語具有「對映異構體過量」之對映異構體與其他對映異構體相比以對映異構體過量存在,較佳以對映異構體混合物之至少60%、較佳至少80%、更佳至少95%、最佳至少98%之量存在的對映異構體混合物。例如,術語「具有對映異構體過量化合物I-R-1之式I-1化合物」係指其中化合物I-R-1與化合物I-S-1相比以對映異構體過量,較佳以至少60%、較佳至少80%、更佳至少95%、最佳至少98%之量存在的式I-1化合物。As used herein, the term "having enantiomeric excess" means that the enantiomer having "enantiomeric excess" with respect to the term used has an enantiomeric excess compared to the other enantiomer The mixture of enantiomers is present in excess, preferably in an amount of at least 60%, preferably at least 80%, more preferably at least 95%, most preferably at least 98% of the mixture of enantiomers. For example, the term "compound of formula I-1 having an enantiomeric excess of compound I-R-1" means that compound I-R-1 is in enantiomeric excess compared to compound I-S-1, preferably at least 60%. , preferably at least 80%, more preferably at least 95%, most preferably at least 98% of the compound of formula I-1 present.

根據本發明之化合物可如WO2014/167084中所述或如下所述製備。上述式(I)化合物之製備可使其以異構體混合物形式獲得。若需要,其可藉由習用於此目的之方法解析,諸如結晶或層析,亦可對光學活性吸附物解析,得到純的異構體。Compounds according to the invention can be prepared as described in WO2014/167084 or as follows. The preparation of the above compound of formula (I) allows it to be obtained as a mixture of isomers. If desired, they can be resolved by methods customary for the purpose, such as crystallization or chromatography, also for optically active adsorbates, to give the pure isomers.

化合物I之農藝學上可接受之鹽可以習用方式形成,例如藉由與所討論之陰離子的酸反應。Agronomically acceptable salts of compounds I can be formed in customary manner, for example by reaction with an acid of the anion in question.

式(I)化合物可以類似於Holyoke等人在WO 2009/099929中描述之方法(方案1),由經適當取代之化合物(III)製備。Compounds of formula (I) can be prepared from appropriately substituted compounds (III) analogously to the method described by Holyoke et al. in WO 2009/099929 (Scheme 1).

方案1

Figure 02_image013
化合物(III)可藉由例如Brian R. Dixon等人在US 6, 353, 006中所述之方法由例如2-氯乙胺類化合物(V)製備,及藉由與其類似之方法,用經適當取代之反應物製備。plan 1
Figure 02_image013
Compound (III) can be prepared from, for example, 2-chloroethylamine compound (V) by the method described in US 6,353,006 by, for example, Brian R. Dixon et al., and by a method similar thereto, using Preparation of appropriately substituted reactants.

方案2

Figure 02_image015
2-氯乙胺化合物(V)又可例如藉由還原亞磺醯亞胺來獲得,如Denolf, Bram等人, Journal of Organic Chemistry, 72(9), 3211-3217; 2007中所例示。Scenario 2
Figure 02_image015
2-Chloroethylamine compound (V) can be obtained, for example, by reducing sulfenimine, as exemplified in Denolf, Bram et al., Journal of Organic Chemistry, 72(9), 3211-3217; 2007.

方案3

Figure 02_image017
化合物(VII)係由α-鹵基-酮獲得,其為熟習此項技術者所熟知。Option 3
Figure 02_image017
Compound (VII) is obtained from α-halo-ketones, which are well known to those skilled in the art.

具有對映異構體過量之式I化合物可藉由下文所述之方法或與實例部分中所述之方法類似的方法製備: 具有對映異構體過量之式I化合物可藉由包含至少以下步驟之方法製備: (A) 使式III化合物

Figure 02_image019
其中 W為鹵素、O-對甲苯磺醯基、O-甲磺醯基或O-三氟甲磺醯基; Het如式I化合物中所定義; 與M2 ORAC 反應,其中M2 係選自鋰、鈉、鉀、鋁、鋇、銫、鈣及鎂;RAC 為C(=O)C1 -C4 烷基; 以獲得式IV化合物,
Figure 02_image021
其中Het及RAC 如本文所定義; (B) 在酸或鹼存在下水解如本文所定義之式IV化合物,以獲得式V化合物,
Figure 02_image023
其中Het如式IV化合物中所定義; (C) 使式V化合物與X2 SO2 NH2 反應,其中X2 為鹵素, 以獲得式VI化合物
Figure 02_image025
其中Het如式V化合物中所定義, (D) 式VI化合物在氫化催化劑MXLn, 其中 M為來自元素週期表第VIII族至第XII族之過渡金屬; X為陰離子; Ln為Ln1或Ln2, 其中 Ln1為式Ln1之對掌性配體
Figure 02_image027
其中 C*為S或R-組態之不對稱碳原子; R10 為OH或NH-SO2 -R11 ;其中 R11 為未經取代或經鹵素、C1 -C10 烷基、C1 -C4 烷氧基、C3 -C6 環烷基、SO3 H或SO3 Na取代之芳基, 或 C1 -C10 全氟烷基或R13 R14 N,其中R13 及R14 獨立地表示未經取代或經C6 -C10 芳基取代之C1 -C10 烷基,或R13 及R14 表示C6 -C10 環烷基; R12 獨立地表示芳基或C6 -C10 環烷基環,其中該環未經取代或彼此獨立地經鹵素、C1 -C10 烷基、C1 -C4 烷氧基、C3 -C6 環烷基、SO3 H或SO3 Na取代,或兩個R12 連接在一起以形成3員至6員碳環或5員至10員部分不飽和碳環; Ln2為對掌性磷配體; 及選自a) N(R)3 ,其中R為H或C1 -C6 烷基,及HCOOH之混合物,b) HCOONa,及c)異丙醇及t -BuOK或t -BuONa或t -BuOLi之混合物的氫源存在下氫化; 以獲得式VII化合物
Figure 02_image029
其中 C*為S或R-組態之不對稱碳原子; Het如式VI化合物中所定義, (E) 使式VII化合物,
Figure 02_image031
其中 C*為S或R-組態之不對稱碳原子; Het如本文所定義; 與R1 NCS在鹼存在下反應,其中R1 為C1 -C4 烷基、C3 -C6 環烷基、C2 -C4 烯基或-CH2 -苯基,該等基團未經取代或經鹵素或C1 -C4 烷基取代; 以獲得式VIII化合物,
Figure 02_image033
其中 C*及Het如式VII化合物中所定義; R1 如本文所定義, (F) 使如本文所定義之式VIII化合物與式IX化合物反應
Figure 02_image035
其中, LG為選自鹵素、ORu 或SRu 之離去基;其中 Ru 為鹵素、C1 -C6 烷基或芳基,其未經取代或經鹵素取代; R2 如式I化合物中所定義; 以獲得如本文所定義之具有對映異構體過量之式I化合物。Compounds of formula I with enantiomeric excess can be prepared by the methods described below or in analogy to the methods described in the Examples section: Compounds of formula I with enantiomeric excess can be prepared by comprising at least The method preparation of step: (A) make formula III compound
Figure 02_image019
Wherein W is halogen, O-p-toluenesulfonyl, O-methylsulfonyl or O-trifluoromethanesulfonyl; Het is as defined in the compound of formula I; reacts with M 2 OR AC , wherein M 2 is selected from From lithium, sodium, potassium, aluminum, barium, cesium, calcium and magnesium; R AC is C (=O) C 1 -C 4 alkyl; To obtain the compound of formula IV,
Figure 02_image021
wherein Het and R AC are as defined herein; (B) hydrolyzing a compound of formula IV as defined herein in the presence of an acid or base to obtain a compound of formula V,
Figure 02_image023
wherein Het is as defined in the compound of formula IV; (C) reacting the compound of formula V with X 2 SO 2 NH 2 , wherein X 2 is halogen, to obtain the compound of formula VI
Figure 02_image025
Wherein Het is as defined in the compound of formula V, (D) the compound of formula VI is in the hydrogenation catalyst MXLn, wherein M is a transition metal from Group VIII to Group XII of the Periodic Table of Elements; X is an anion; Ln is Ln1 or Ln2, wherein Ln1 is the chiral ligand of formula Ln1
Figure 02_image027
Where C* is an asymmetric carbon atom in S or R-configuration; R 10 is OH or NH-SO 2 -R 11 ; where R 11 is unsubstituted or halogenated, C 1 -C 10 alkyl, C 1 -C 4 alkoxy, C 3 -C 6 cycloalkyl, SO 3 H or SO 3 Na substituted aryl, or C 1 -C 10 perfluoroalkyl or R 13 R 14 N, wherein R 13 and R 14 independently represents C 1 -C 10 alkyl unsubstituted or substituted by C 6 -C 10 aryl, or R 13 and R 14 represent C 6 -C 10 cycloalkyl; R 12 independently represents aryl or C 6 -C 10 cycloalkyl ring, wherein the ring is unsubstituted or independently of each other by halogen, C 1 -C 10 alkyl, C 1 -C 4 alkoxy, C 3 -C 6 cycloalkyl, SO 3 H or SO 3 Na is substituted, or two R 12 are connected together to form a 3-6-membered carbocycle or a 5-10-membered partially unsaturated carbocycle; Ln2 is a pair of chiral phosphorus ligands; and is selected from a ) N(R) 3 , wherein R is H or C 1 -C 6 alkyl, and a mixture of HCOOH, b) HCOONa, and c) a mixture of isopropanol and t -BuOK or t -BuONa or t -BuOLi Hydrogenation in the presence of a hydrogen source; to obtain a compound of formula VII
Figure 02_image029
Wherein C* is an asymmetric carbon atom of S or R-configuration; Het is as defined in the compound of formula VI, (E) makes the compound of formula VII,
Figure 02_image031
wherein C* is an asymmetric carbon atom of S or R-configuration; Het is as defined herein; reacts with R 1 NCS in the presence of a base, wherein R 1 is C 1 -C 4 alkyl, C 3 -C 6 ring Alkyl, C 2 -C 4 alkenyl or -CH 2 -phenyl, these groups are unsubstituted or substituted by halogen or C 1 -C 4 alkyl; to obtain the compound of formula VIII,
Figure 02_image033
wherein C* and Het are as defined in the compound of formula VII; R 1 is as defined herein, (F) reacting a compound of formula VIII as defined herein with a compound of formula IX
Figure 02_image035
Among them, LG is a leaving group selected from halogen, OR u or SR u ; wherein R u is halogen, C 1 -C 6 alkyl or aryl, which is unsubstituted or substituted by halogen; R 2 is as a compound of formula I as defined in; to obtain a compound of formula I having an enantiomeric excess as defined herein.

優先選擇 在本發明之一個實施例中,R1 為C1 -C4 烷基、C3 -C6 環烷基、C2 -C4 烯基。Preferably in one embodiment of the present invention, R 1 is C 1 -C 4 alkyl, C 3 -C 6 cycloalkyl, C 2 -C 4 alkenyl.

在另一個實施例中,R1 為C1 -C4 烷基。在另一個實施例中,R1 為甲基或乙基。In another embodiment, R 1 is C 1 -C 4 alkyl. In another embodiment, R 1 is methyl or ethyl.

在本發明之一個實施例中,R2 為苯基、吡啶基或噻吩,其可未經取代、經R2a 部分或完全取代。In one embodiment of the present invention, R 2 is phenyl, pyridyl or thiophene, which may be unsubstituted, partially or fully substituted by R 2a .

在另一個實施例中,R2 為苯基,其可未經取代、經R2a 部分或完全取代,其中R2a 為鹵素、C1 -C6 鹵烷基、C1 -C6 鹵烷氧基、ORc 、C(=O)ORc 、C(=O)NRb Rc 、苯基或吡啶基,其可經鹵素、C1 -C6 鹵烷基或C1 -C6 鹵烷氧基取代。In another embodiment, R 2 is phenyl, which may be unsubstituted, partially or fully substituted by R 2a , wherein R 2a is halogen, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy group, OR c , C(=O)OR c , C(=O)NR b R c , phenyl or pyridyl, which can be modified by halogen, C 1 -C 6 haloalkyl or C 1 -C 6 haloalkane Oxygen substitution.

在另一個實施例中,R2 為苯基,其可未經取代、經鹵素、C1 -C4 烷基或C1 -C3 鹵烷基部分或完全取代。In another embodiment, R 2 is phenyl, which may be unsubstituted, partially or fully substituted with halogen, C 1 -C 4 alkyl, or C 1 -C 3 haloalkyl.

在另一個實施例中,R2 為苯基,其可未經取代、經三氟甲基或鹵素(較佳氯)部分或完全取代;In another embodiment, R is phenyl, which may be unsubstituted, partially or fully substituted with trifluoromethyl or halogen (preferably chlorine);

在另一個實施例中,R2 為苯基、3,5-二氯苯基、3-三氟甲基苯基。In another embodiment, R 2 is phenyl, 3,5-dichlorophenyl, 3-trifluoromethylphenyl.

在另一個實施例中,R2 為苯基。In another embodiment, R2 is phenyl.

在另一個實施例中,R2 為3,5-二氯苯基。In another embodiment, R 2 is 3,5-dichlorophenyl.

在另一個實施例中,R2 為3-三氟甲基苯基。In another embodiment, R 2 is 3-trifluoromethylphenyl.

在本發明之一個實施例中,Het為五員或六員碳環或雜環芳環。In one embodiment of the present invention, Het is a five- or six-membered carbocyclic or heterocyclic aromatic ring.

在本發明之一個實施例中,Het為D-2。In one embodiment of the invention, Het is D-2.

在本發明之一個實施例中,Het為D-2,其中 Ra 為鹵素、C1 -C4 鹵烷基、C1 -C4 烷氧基或C1 -C4 烷硫基; n為1或2。In one embodiment of the present invention, Het is D-2, wherein R a is halogen, C 1 -C 4 haloalkyl, C 1 -C 4 alkoxy or C 1 -C 4 alkylthio; n is 1 or 2.

在本發明之一個實施例中,Het係選自D-1、D-2及D-3,其中 Ra 為氯, n為1。In one embodiment of the present invention, Het is selected from D-1, D-2 and D-3, wherein R a is chlorine, and n is 1.

在另一個實施例中,Het為D-1a、D-2a及D-3a:

Figure 02_image037
In another embodiment, Het is D-1a, D-2a and D-3a:
Figure 02_image037

在另一個實施例中,Het為D-1a。In another embodiment, Het is D-1a.

在另一個實施例中,Het為D-2a。In another embodiment, Het is D-2a.

在另一個實施例中,Het為D-3a。In another embodiment, Het is D-3a.

在本發明之一個實施例中,式(I)化合物為以下化合物I-1至I-6中之一者:

Figure 107134558-A0304-0001
In one embodiment of the present invention, the compound of formula (I) is one of the following compounds I-1 to I-6:
Figure 107134558-A0304-0001

在本發明之一個實施例中,式(I)化合物為化合物I-1。In one embodiment of the present invention, the compound of formula (I) is compound I-1.

在本發明之一個實施例中,式(I)化合物為化合物I-2。In one embodiment of the present invention, the compound of formula (I) is compound I-2.

在本發明之一個實施例中,式(I)化合物為化合物I-3。In one embodiment of the present invention, the compound of formula (I) is compound I-3.

在本發明之一個實施例中,式(I)化合物為化合物I-4。In one embodiment of the present invention, the compound of formula (I) is compound I-4.

在本發明之一個實施例中,式(I)化合物為化合物I-5。In one embodiment of the present invention, the compound of formula (I) is compound I-5.

在本發明之一個實施例中,式(I)化合物為化合物I-6。In one embodiment of the present invention, the compound of formula (I) is compound I-6.

在本發明之一個實施例中,式(I)化合物具有以下如式(I-R)中之立體化學:

Figure 02_image043
In one embodiment of the present invention, the compound of formula (I) has the following stereochemistry as in formula (IR):
Figure 02_image043

式(I-R)化合物顯示與其式(I-S)之立體異構體相比更高的殺有害生物功效,如生物學實例所證實。化合物(I-R)對如酶或受體之生物靶標的選擇性不同於化合物(I-S)的選擇性。Compounds of formula (I-R) show higher pesticidal efficacy compared to their stereoisomers of formula (I-S), as demonstrated by biological examples. The selectivity of compound (I-R) for biological targets such as enzymes or receptors differs from the selectivity of compound (I-S).

在另一個實施例中,根據本發明之化合物具有如式(I-R)中之立體化學,且R1 為C1 -C4 烷基、C3 -C6 環烷基、C2 -C4 烯基,R1 較佳為C1 -C4 烷基,R1 較佳為甲基或乙基。In another embodiment, compounds according to the present invention have stereochemistry as in formula (IR), and R 1 is C 1 -C 4 alkyl, C 3 -C 6 cycloalkyl, C 2 -C 4 alkenyl Group, R 1 is preferably C 1 -C 4 alkyl, R 1 is preferably methyl or ethyl.

在另一個實施例中,根據本發明之化合物具有如式(I-R)中之立體化學,且R2 為苯基、吡啶基或噻吩,其可未經取代、經R2a 部分或完全取代,其中R2a 為鹵素、C1 -C6 鹵烷基、C1 -C6 鹵烷氧基、ORc 、C(=O)ORc 、C(=O)NRb Rc 、苯基或吡啶基,其可經鹵素、C1 -C6 鹵烷基或C1 -C6 鹵烷氧基取代。In another embodiment, the compound according to the present invention has the stereochemistry as in formula (IR), and R 2 is phenyl, pyridyl or thiophene, which may be unsubstituted, partially or fully substituted by R 2a , wherein R 2a is halogen, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, OR c , C(=O)OR c , C(=O)NR b R c , phenyl or pyridyl , which may be substituted by halogen, C 1 -C 6 haloalkyl or C 1 -C 6 haloalkoxy.

在另一個實施例中,根據本發明之化合物具有如式(I-R)中之立體化學,且R2 為苯基,其可未經取代、經如上文所定義之R2a 部分或完全取代。In another embodiment, compounds according to the present invention have stereochemistry as in formula (IR), and R 2 is phenyl, which may be unsubstituted, partially or fully substituted with R 2a as defined above.

在另一個實施例中,根據本發明之化合物具有如式(I-R)中之立體化學,且R2 為苯基,其可未經取代、經鹵素、C1 -C4 烷基或C1 -C3 鹵烷基部分或完全取代;較佳地,R2 為苯基,其可未經取代、經三氟甲基或鹵素(較佳氯)部分或完全取代。In another embodiment, the compound according to the present invention has the stereochemistry as in formula (IR), and R 2 is phenyl, which can be unsubstituted, halogen, C 1 -C 4 alkyl or C 1 - C 3 haloalkyl is partially or fully substituted; preferably, R 2 is phenyl, which may be unsubstituted, partially or fully substituted with trifluoromethyl or halogen (preferably chlorine).

在另一個實施例中,根據本發明之化合物具有如式(I-R)中之立體化學,且R2 為苯基、3,5-二氯苯基、3-三氟甲基苯基。In another embodiment, compounds according to the present invention have stereochemistry as in formula (IR), and R 2 is phenyl, 3,5-dichlorophenyl, 3-trifluoromethylphenyl.

在另一個實施例中,根據本發明之化合物具有如式(I-R)中之立體化學,且R2 為苯基。In another embodiment, compounds according to the invention have the stereochemistry as in formula (IR), and R2 is phenyl.

在另一個實施例中,根據本發明之化合物具有如式(I-R)中之立體化學,且R2 為3,5-二氯苯基。In another embodiment, compounds according to the present invention have the stereochemistry as in formula (IR), and R 2 is 3,5-dichlorophenyl.

在另一個實施例中,根據本發明之化合物具有如式(I-R)中之立體化學,且R2 為3-三氟甲基苯基。In another embodiment, compounds according to the present invention have the stereochemistry as in formula (IR), and R 2 is 3-trifluoromethylphenyl.

在本發明之另一個實施例中,Het為D-2。In another embodiment of the present invention, Het is D-2.

在本發明之另一個實施例中,Het為D-2,其中 Ra 為鹵素、C1 -C4 鹵烷基、C1 -C4 烷氧基或C1 -C4 烷硫基; n為1或2。In another embodiment of the present invention, Het is D-2, wherein R a is halogen, C 1 -C 4 haloalkyl, C 1 -C 4 alkoxy or C 1 -C 4 alkylthio; n is 1 or 2.

在另一個實施例中,根據本發明之化合物具有如式(I-R)中之立體化學,且Het係選自D-1、D-2及D-3,其中Ra 為氯,n為1。In another embodiment, the compound according to the present invention has the stereochemistry as in formula (IR), and Het is selected from D-1, D-2 and D-3, wherein Ra is chlorine and n is 1.

在另一個實施例中,根據本發明之化合物具有如式(I-R)中之立體化學,且Het為D-1a、D-2a或D-3a。In another embodiment, the compound according to the present invention has the stereochemistry as in formula (I-R), and Het is D-1a, D-2a or D-3a.

在另一個實施例中,根據本發明之化合物具有如式(I-R)中之立體化學,且Het為D-1a。In another embodiment, the compound according to the present invention has the stereochemistry as in formula (I-R), and Het is D-1a.

在另一個實施例中,根據本發明之化合物具有如式(I-R)中之立體化學,且Het為D-2a。In another embodiment, the compound according to the present invention has the stereochemistry as in formula (I-R), and Het is D-2a.

在另一個實施例中,根據本發明之化合物具有如式(I-R)中之立體化學,且Het為D-3a。In another embodiment, the compound according to the present invention has the stereochemistry as in formula (I-R), and Het is D-3a.

在本發明之一個實施例中,式(I)化合物為以下化合物I-R-1至I-R-6中之一者:

Figure 02_image045
In one embodiment of the present invention, the compound of formula (I) is one of the following compounds IR-1 to IR-6:
Figure 02_image045

在本發明之一個實施例中,式(I)化合物為化合物I-R-1。In one embodiment of the present invention, the compound of formula (I) is compound I-R-1.

在本發明之一個實施例中,式(I)化合物為化合物I-R-2。In one embodiment of the present invention, the compound of formula (I) is compound I-R-2.

在本發明之一個實施例中,式(I)化合物為化合物I-R-3。In one embodiment of the present invention, the compound of formula (I) is compound I-R-3.

在本發明之一個實施例中,式(I)化合物為化合物I-R-4。In one embodiment of the present invention, the compound of formula (I) is compound I-R-4.

在本發明之一個實施例中,式(I)化合物為化合物I-R-5。In one embodiment of the present invention, the compound of formula (I) is compound I-R-5.

在本發明之一個實施例中,式(I)化合物為化合物I-R-6。In one embodiment of the present invention, the compound of formula (I) is compound I-R-6.

在本發明之一個實施例中,式(I)化合物係指具有對映異構體過量式(I-R)之式(I)化合物,其中變數Het、R1 及R2 如式(I)化合物中所定義。In one embodiment of the present invention, the compound of formula (I) refers to the compound of formula (I) having enantiomeric excess formula (IR), wherein the variables Het, R 1 and R 2 are as in the compound of formula (I) defined.

在本發明之一個實施例中,式(I)化合物係指具有至少55%對映異構體過量式(I-R)之式(I)化合物。In one embodiment of the invention, the compound of formula (I) refers to the compound of formula (I) having at least 55% enantiomeric excess of formula (I-R).

在本發明之一個實施例中,式(I)化合物係指具有至少60%對映異構體過量式(I-R)之式(I)化合物。In one embodiment of the invention, the compound of formula (I) refers to the compound of formula (I) having at least 60% enantiomeric excess of formula (I-R).

在本發明之一個實施例中,式(I)化合物係指具有至少65%對映異構體過量式(I-R)之式(I)化合物。In one embodiment of the invention, the compound of formula (I) refers to the compound of formula (I) having at least 65% enantiomeric excess of formula (I-R).

在本發明之一個實施例中,式(I)化合物係指具有至少70%對映異構體過量式(I-R)之式(I)化合物。In one embodiment of the invention, the compound of formula (I) refers to the compound of formula (I) having at least 70% enantiomeric excess of formula (I-R).

在本發明之一個實施例中,式(I)化合物係指具有至少75%對映異構體過量式(I-R)之式(I)化合物。In one embodiment of the invention, the compound of formula (I) refers to the compound of formula (I) having at least 75% enantiomeric excess of formula (I-R).

在本發明之一個實施例中,式(I)化合物係指具有至少80%對映異構體過量式(I-R)之式(I)化合物。In one embodiment of the invention, the compound of formula (I) refers to the compound of formula (I) having at least 80% enantiomeric excess of formula (I-R).

在本發明之一個實施例中,式(I)化合物係指具有至少85%對映異構體過量式(I-R)之式(I)化合物。In one embodiment of the invention, the compound of formula (I) refers to the compound of formula (I) having at least 85% enantiomeric excess of formula (I-R).

在本發明之一個較佳實施例中,式(I)化合物係指具有至少90%對映異構體過量式(I-R)之式(I)化合物。In a preferred embodiment of the present invention, the compound of formula (I) refers to the compound of formula (I) having at least 90% enantiomeric excess of formula (I-R).

在本發明之另一個較佳實施例中,式(I)化合物係指具有至少95%對映異構體過量式(I-R)之式(I)化合物。In another preferred embodiment of the present invention, the compound of formula (I) refers to the compound of formula (I) having at least 95% enantiomeric excess of formula (I-R).

在本發明之另一個較佳實施例中,式(I)化合物係指具有至少98%對映異構體過量式(I-R)之式(I)化合物。In another preferred embodiment of the present invention, the compound of formula (I) refers to the compound of formula (I) having at least 98% enantiomeric excess of formula (I-R).

在本發明之另一個較佳實施例中,式(I)化合物係指具有至少99%對映異構體過量式(I-R)之式(I)化合物。In another preferred embodiment of the present invention, the compound of formula (I) refers to the compound of formula (I) having at least 99% enantiomeric excess of formula (I-R).

在本發明之另一個實施例中,式(I)化合物具有以下如式(I-S)中之立體化學:

Figure 02_image047
In another embodiment of the present invention, the compound of formula (I) has the following stereochemistry as in formula (IS):
Figure 02_image047

在另一個實施例中,根據本發明之化合物具有如式(I-S)中之立體化學,且R1 為C1 -C4 烷基、C3 -C6 環烷基、C2 -C4 烯基,R1 較佳為C1 -C4 烷基,R1 較佳為甲基或乙基。In another embodiment, the compound according to the present invention has the stereochemistry as in formula (IS), and R 1 is C 1 -C 4 alkyl, C 3 -C 6 cycloalkyl, C 2 -C 4 alkenyl Group, R 1 is preferably C 1 -C 4 alkyl, R 1 is preferably methyl or ethyl.

在另一個實施例中,根據本發明之化合物具有如式(I-S)中之立體化學,且R2 為苯基、吡啶基或噻吩,其可未經取代、經R2a 部分或完全取代,其中R2a 為鹵素、C1 -C6 鹵烷基、C1 -C6 鹵烷氧基、ORc 、C(=O)ORc 、C(=O)NRb Rc 、苯基或吡啶基,其可經鹵素、C1 -C6 鹵烷基或C1 -C6 鹵烷氧基取代。In another embodiment, the compound according to the present invention has the stereochemistry as in formula (IS), and R 2 is phenyl, pyridyl or thiophene, which may be unsubstituted, partially or fully substituted by R 2a , wherein R 2a is halogen, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, OR c , C(=O)OR c , C(=O)NR b R c , phenyl or pyridyl , which may be substituted by halogen, C 1 -C 6 haloalkyl or C 1 -C 6 haloalkoxy.

在另一個實施例中,根據本發明之化合物具有如式(I-S)中之立體化學,且R2 為苯基,其可未經取代、經如上文所定義之R2a 部分或完全取代。In another embodiment, the compound according to the present invention has the stereochemistry as in formula (IS), and R 2 is phenyl, which may be unsubstituted, partially or fully substituted with R 2a as defined above.

在另一個實施例中,根據本發明之化合物具有如式(I-S)中之立體化學,且R2 為苯基,其可未經取代、經鹵素、C1 -C4 烷基或C1 -C3 鹵烷基部分或完全取代;較佳地,R2 為苯基,其可未經取代、經三氟甲基或鹵素(較佳氯)部分或完全取代。In another embodiment, the compound according to the present invention has the stereochemistry as in formula (IS), and R 2 is phenyl, which can be unsubstituted, halogen, C 1 -C 4 alkyl or C 1 - C 3 haloalkyl is partially or fully substituted; preferably, R 2 is phenyl, which may be unsubstituted, partially or fully substituted with trifluoromethyl or halogen (preferably chlorine).

在另一個實施例中,根據本發明之化合物具有如式(I-S)中之立體化學,且R2 為苯基、3,5-二氯苯基、3-三氟甲基苯基。In another embodiment, compounds according to the present invention have stereochemistry as in formula (IS), and R 2 is phenyl, 3,5-dichlorophenyl, 3-trifluoromethylphenyl.

在另一個實施例中,根據本發明之化合物具有如式(I-S)中之立體化學,且R2 為苯基。In another embodiment, compounds according to the invention have the stereochemistry as in formula (IS), and R 2 is phenyl.

在另一個實施例中,根據本發明之化合物具有如式(I-S)中之立體化學,且R2 為3,5-二氯苯基。In another embodiment, compounds according to the invention have the stereochemistry as in formula (IS), and R 2 is 3,5-dichlorophenyl.

在另一個實施例中,根據本發明之化合物具有如式(I-S)中之立體化學,且R2 為3-三氟甲基苯基。In another embodiment, compounds according to the invention have the stereochemistry as in formula (IS), and R 2 is 3-trifluoromethylphenyl.

在另一個實施例中,根據本發明之化合物具有如式(I-S)中之立體化學,且Het係選自D-1、D-2及D-3,其中Ra 為氯,n為1。In another embodiment, the compound according to the present invention has the stereochemistry as in formula (IS), and Het is selected from D-1, D-2 and D-3, wherein Ra is chlorine and n is 1.

在另一個實施例中,根據本發明之化合物具有如式(I-S)中之立體化學,且Het為D-1a、D-2a或D-3a;In another embodiment, the compound according to the present invention has the stereochemistry as in formula (I-S), and Het is D-1a, D-2a or D-3a;

在另一個實施例中,根據本發明之化合物具有如式(I-S)中之立體化學,且Het為D-1a。In another embodiment, the compound according to the present invention has the stereochemistry as in formula (I-S), and Het is D-1a.

在另一個實施例中,根據本發明之化合物具有如式(I-S)中之立體化學,且Het為D-2a。In another embodiment, the compound according to the present invention has the stereochemistry as in formula (I-S), and Het is D-2a.

在另一個實施例中,根據本發明之化合物具有如式(I-S)中之立體化學,且Het為D-3a。In another embodiment, the compound according to the present invention has the stereochemistry as in formula (I-S), and Het is D-3a.

具有對映異構體過量式(I-R)之式(I)化合物顯示與外消旋混合物或具有對映異構體過量式(I-S)之式(I)化合物相比更高的殺有害生物功效,如生物學實例所證實。Compounds of formula (I) with enantiomeric excess formula (I-R) show higher pesticidal efficacy compared to racemic mixtures or compounds of formula (I) with enantiomeric excess formula (I-S) , as demonstrated by biological examples.

在另一個實施例中,根據本發明之化合物為具有對映異構體過量式(I-R)之式(I)化合物,其中R1 為C1 -C4 烷基、C3 -C6 環烷基、C2 -C4 烯基,R1 較佳為C1 -C4 烷基,R1 較佳為甲基或乙基。In another embodiment, the compound according to the invention is a compound of formula (I) having enantiomeric excess formula (IR), wherein R 1 is C 1 -C 4 alkyl, C 3 -C 6 cycloalkane Group, C 2 -C 4 alkenyl, R 1 is preferably C 1 -C 4 alkyl, R 1 is preferably methyl or ethyl.

在另一個實施例中,根據本發明之化合物為具有對映異構體過量式(I-R)之式(I)化合物,其中R2 為苯基、吡啶基或噻吩,其可未經取代、經R2a 部分或完全取代,其中R2a 為鹵素、C1 -C6 鹵烷基、C1 -C6 鹵烷氧基、ORc 、C(=O)ORc 、C(=O)NRb Rc 、苯基或吡啶基,其可經鹵素、C1 -C6 鹵烷基或C1 -C6 鹵烷氧基取代。In another embodiment, the compound according to the present invention is a compound of formula (I) having enantiomeric excess formula (IR), wherein R 2 is phenyl, pyridyl or thiophene, which may be unsubstituted, modified R 2a is partially or fully substituted, wherein R 2a is halogen, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, OR c , C(=O)OR c , C(=O)NR b R c , phenyl or pyridyl, which may be substituted by halogen, C 1 -C 6 haloalkyl or C 1 -C 6 haloalkoxy.

在另一個實施例中,根據本發明之化合物為具有對映異構體過量式(I-R)之式(I)化合物,其中R2 為苯基,其可未經取代、經如上文所定義之R2a 部分或完全取代。In another embodiment, the compound according to the present invention is a compound of formula (I) having enantiomeric excess formula (IR), wherein R is phenyl, which may be unsubstituted, as defined above R 2a is partially or fully substituted.

在另一個實施例中,根據本發明之化合物為具有對映異構體過量式(I-R)之式(I)化合物,其中R2 為苯基,其可未經取代、經鹵素、C1 -C4 烷基或C1 -C3 鹵烷基部分或完全取代;較佳地,R2 為苯基,其可未經取代、經三氟甲基或鹵素(較佳氯)部分或完全取代。In another embodiment, the compound according to the present invention is a compound of formula (I) having enantiomeric excess formula (IR), wherein R 2 is phenyl, which may be unsubstituted, halogenated, C 1 - C 4 alkyl or C 1 -C 3 haloalkyl is partially or fully substituted; preferably, R is phenyl, which may be unsubstituted, partially or fully substituted with trifluoromethyl or halogen (preferably chlorine) .

在另一個實施例中,根據本發明之化合物為具有對映異構體過量式(I-R)之式(I)化合物,其中R2 為苯基、3,5-二氯苯基、3-三氟甲基苯基。In another embodiment, the compound according to the invention is a compound of formula (I) having enantiomeric excess formula (IR), wherein R is phenyl, 3,5-dichlorophenyl, 3-tri Fluoromethylphenyl.

在另一個實施例中,根據本發明之化合物為具有對映異構體過量式(I-R)之式(I)化合物,其中R2 為苯基。In another embodiment, the compound according to the invention is a compound of formula (I) having enantiomeric excess formula (IR), wherein R 2 is phenyl.

在另一個實施例中,根據本發明之化合物為具有對映異構體過量式(I-R)之式(I)化合物,其中R2 為3,5-二氯苯基。In another embodiment, the compound according to the invention is a compound of formula (I) having enantiomeric excess formula (IR), wherein R 2 is 3,5-dichlorophenyl.

在另一個實施例中,根據本發明之化合物為具有對映異構體過量式(I-R)之式(I)化合物,其中R2 為3-三氟甲基苯基。In another embodiment, the compound according to the invention is a compound of formula (I) having enantiomeric excess formula (IR), wherein R 2 is 3-trifluoromethylphenyl.

在另一個實施例中,根據本發明之化合物為具有對映異構體過量式(I-R)之式(I)化合物,其中Het係選自D-1、D-2及D-3,其中Ra 為氯,n為0或1。In another embodiment, the compound according to the present invention is a compound of formula (I) having enantiomeric excess formula (IR), wherein Het is selected from D-1, D-2 and D-3, wherein R a is chlorine, and n is 0 or 1.

在另一個實施例中,根據本發明之化合物為具有對映異構體過量式(I-R)之式(I)化合物,其中Het為D-2;In another embodiment, the compound according to the invention is a compound of formula (I) having enantiomeric excess formula (I-R), wherein Het is D-2;

在另一個實施例中,根據本發明之化合物為具有對映異構體過量式(I-R)之式(I)化合物,其中Het為D-2,其中 Ra 為鹵素、C1 -C4 鹵烷基、C1 -C4 烷氧基或C1 -C4 烷硫基; n為1或2。In another embodiment, the compound according to the invention is a compound of formula (I) having enantiomeric excess formula (IR), wherein Het is D-2, wherein R a is halogen, C 1 -C 4 halogen Alkyl, C 1 -C 4 alkoxy or C 1 -C 4 alkylthio; n is 1 or 2.

在另一個實施例中,根據本發明之化合物為具有對映異構體過量式(I-R)之式(I)化合物,其中Het為D-1a、D-2a或D-3a。In another embodiment, the compound according to the invention is a compound of formula (I) having enantiomeric excess formula (I-R), wherein Het is D-1a, D-2a or D-3a.

在另一個實施例中,根據本發明之化合物為具有對映異構體過量式(I-R)之式(I)化合物,其中Het為D-1a。In another embodiment, the compound according to the invention is a compound of formula (I) having enantiomeric excess formula (I-R), wherein Het is D-1a.

在另一個實施例中,根據本發明之化合物為具有對映異構體過量式(I-R)之式(I)化合物,其中Het為D-2a。In another embodiment, the compound according to the invention is a compound of formula (I) having enantiomeric excess formula (I-R), wherein Het is D-2a.

在另一個實施例中,根據本發明之化合物為具有對映異構體過量式(I-R)之式(I)化合物,其中Het為D-3a。In another embodiment, the compound according to the invention is a compound of formula (I) having enantiomeric excess formula (I-R), wherein Het is D-3a.

在本發明之一個實施例中,式(I)化合物係選自分別具有對映異構體過量R-對映異構體化合物I-R-1至I-R-6之化合物I-1至I-6。In one embodiment of the invention, the compound of formula (I) is selected from compounds I-1 to I-6 having enantiomeric excess of R-enantiomer compounds I-R-1 to I-R-6, respectively.

在本發明之一個實施例中,式(I)化合物為具有對映異構體過量化合物I-R-1之化合物I-1。In one embodiment of the present invention, the compound of formula (I) is compound I-1 having an enantiomeric excess of compound I-R-1.

在本發明之一個實施例中,式(I)化合物為具有對映異構體過量化合物I-R-2之化合物I-2。In one embodiment of the invention, the compound of formula (I) is compound 1-2 having an enantiomeric excess of compound I-R-2.

在本發明之一個實施例中,式(I)化合物為具有對映異構體過量化合物I-R-3之化合物I-3。In one embodiment of the invention, the compound of formula (I) is compound 1-3 having an enantiomeric excess of compound I-R-3.

在本發明之一個實施例中,式(I)化合物為具有對映異構體過量化合物I-R-4之化合物I-4。In one embodiment of the invention, the compound of formula (I) is compound 1-4 having an enantiomeric excess of compound I-R-4.

在本發明之一個實施例中,式(I)化合物為具有對映異構體過量化合物I-R-5之化合物I-5。In one embodiment of the invention, the compound of formula (I) is compound 1-5 having an enantiomeric excess of compound I-R-5.

在本發明之一個實施例中,式(I)化合物為具有對映異構體過量化合物I-R-6之化合物I-6。In one embodiment of the invention, the compound of formula (I) is compound 1-6 having an enantiomeric excess of compound I-R-6.

在本發明之一個實施例中,式(I)化合物為以下化合物I-S-1至I-S-6中之一者:

Figure 02_image049
In one embodiment of the present invention, the compound of formula (I) is one of the following compounds IS-1 to IS-6:
Figure 02_image049

在本發明之一個實施例中,式(I)化合物為化合物I-S-1。In one embodiment of the present invention, the compound of formula (I) is compound I-S-1.

在本發明之一個實施例中,式(I)化合物為化合物I-S-2。In one embodiment of the present invention, the compound of formula (I) is compound I-S-2.

在本發明之一個實施例中,式(I)化合物為化合物I-S-3。In one embodiment of the present invention, the compound of formula (I) is compound I-S-3.

在本發明之一個實施例中,式(I)化合物為化合物I-S-4。In one embodiment of the present invention, the compound of formula (I) is compound I-S-4.

在本發明之一個實施例中,式(I)化合物為化合物I-S-5。In one embodiment of the present invention, the compound of formula (I) is compound I-S-5.

在本發明之一個實施例中,式(I)化合物為化合物I-S-6。In one embodiment of the present invention, the compound of formula (I) is compound I-S-6.

在本發明之一個實施例中,式(I)化合物係指具有對映異構體過量式(I-R)之式(I)化合物,其中式(I-R)以≥55%至≤100%之量存在且式(I-S)以≤45%至≥0%之量存在。In one embodiment of the present invention, the compound of formula (I) refers to the compound of formula (I) having enantiomeric excess formula (I-R), wherein formula (I-R) is present in an amount of ≥ 55% to ≤ 100% And formula (I-S) is present in an amount of ≤45% to ≥0%.

在本發明之一個實施例中,式(I)化合物係指具有對映異構體過量式(I-R)之式(I)化合物,其中式(I-R)以≥60%至≤100%之量存在且式(I-S)以≤40%至≥0%之量存在。In one embodiment of the present invention, the compound of formula (I) refers to the compound of formula (I) having enantiomeric excess formula (I-R), wherein formula (I-R) is present in an amount of ≥ 60% to ≤ 100% And the formula (I-S) is present in an amount of ≤40% to ≥0%.

在本發明之一個實施例中,式(I)化合物係指具有對映異構體過量式(I-R)之式(I)化合物,其中式(I-R)以≥65%至≤100%之量存在且式(I-S)以≤35%至≥0%之量存在。In one embodiment of the present invention, the compound of formula (I) refers to the compound of formula (I) having enantiomeric excess formula (I-R), wherein formula (I-R) is present in an amount of ≥ 65% to ≤ 100% And the formula (I-S) is present in an amount of ≤35% to ≥0%.

在本發明之一個實施例中,式(I)化合物係指具有對映異構體過量式(I-R)之式(I)化合物,其中式(I-R)以≥70%至≤100%之量存在且式(I-S)以≤30%至≥0%之量存在。In one embodiment of the present invention, the compound of formula (I) refers to the compound of formula (I) having enantiomeric excess formula (I-R), wherein formula (I-R) is present in an amount of ≥ 70% to ≤ 100% And the formula (I-S) is present in an amount of ≤30% to ≥0%.

在本發明之一個實施例中,式(I)化合物係指具有對映異構體過量式(I-R)之式(I)化合物,其中式(I-R)以≥75%至≤100%之量存在且式(I-S)以≤25%至≥0%之量存在。In one embodiment of the present invention, the compound of formula (I) refers to the compound of formula (I) having enantiomeric excess formula (I-R), wherein formula (I-R) is present in an amount of ≥ 75% to ≤ 100% And formula (I-S) is present in an amount of ≤25% to ≥0%.

在本發明之一個實施例中,式(I)化合物係指具有對映異構體過量式(I-R)之式(I)化合物,其中式(I-R)以≥80%至≤100%之量存在且式(I-S)以≤20%至≥0%之量存在。In one embodiment of the present invention, the compound of formula (I) refers to the compound of formula (I) having enantiomeric excess formula (I-R), wherein formula (I-R) is present in an amount of ≥ 80% to ≤ 100% And the formula (I-S) is present in an amount of ≤20% to ≥0%.

在本發明之一個實施例中,式(I)化合物係指具有對映異構體過量式(I-R)之式(I)化合物,其中式(I-R)以≥85%至≤100%之量存在且式(I-S)以≤15%至≥0%之量存在。In one embodiment of the present invention, the compound of formula (I) refers to the compound of formula (I) having enantiomeric excess formula (I-R), wherein formula (I-R) is present in an amount of ≥ 85% to ≤ 100% And formula (I-S) is present in an amount of ≤ 15% to ≥ 0%.

在本發明之另一個實施例中,式(I)化合物係指具有對映異構體過量式(I-R)之式(I)化合物,其中式(I-R)以≥90%至≤100%之量存在且式(I-S)以≤10%至≥0%之量存在。In another embodiment of the present invention, the compound of formula (I) refers to the compound of formula (I) having enantiomeric excess formula (I-R), wherein the amount of formula (I-R) is ≥ 90% to ≤ 100% exists and the formula (I-S) is present in an amount of ≤10% to ≥0%.

在本發明之另一個實施例中,式(I)化合物係指具有對映異構體過量式(I-R)之式(I)化合物,其中式(I-R)以≥95%至≤100%之量存在且式(I-S)以≤5%至≥0%之量存在。In another embodiment of the present invention, the compound of formula (I) refers to the compound of formula (I) having enantiomeric excess formula (I-R), wherein the amount of formula (I-R) is ≥ 95% to ≤ 100% exists and the formula (I-S) is present in an amount of ≤5% to ≥0%.

在本發明之另一個實施例中,式(I)化合物係指具有對映異構體過量式(I-R)之式(I)化合物,其中式(I-R)以≥98%至≤100%、較佳≥99%至≤100%之量存在,且式(I-S)以≤2%至≥0%、較佳≤1%至≥0%之量存在。In another embodiment of the present invention, the compound of formula (I) refers to the compound of formula (I) having enantiomeric excess formula (I-R), wherein formula (I-R) is ≥ 98% to ≤ 100%, more Preferably present in an amount of ≥99% to ≤100%, and formula (I-S) is present in an amount of ≤2% to ≥0%, preferably ≤1% to ≥0%.

混合物 在有害生物控制領域中出現的一個典型問題在於需要降低活性成分之劑量率以減少或避免不利的環境或毒理學效應,同時仍允許有效的有害生物控制。mixture A typical problem that arises in the field of pest control is the need to reduce the dosage rate of an active ingredient in order to reduce or avoid adverse environmental or toxicological effects, while still allowing effective pest control.

遇到的另一個問題涉及需要具有有效對抗廣譜有害生物之可用有害生物控制劑。Another problem encountered relates to the need to have available pest control agents effective against a broad spectrum of pests.

亦存在對組合擊倒活性與長期控制,即快速作用與持久作用之有害生物控制劑的需求。There is also a need for pest control agents that combine knockdown activity and long-term control, ie both fast acting and long lasting.

與殺有害生物劑之使用相關的另一個困難在於,重複及專門施用單獨的殺有害生物化合物在許多情況下導致快速選擇對所討論之活性化合物已產生天然或適應性抗性之有害生物。因此,需要有助於防止或克服殺有害生物劑誘發之耐受性的有害生物控制劑。A further difficulty associated with the use of pesticides is that the repeated and exclusive application of individual pesticidal compounds leads in many cases to rapid selection of pests which have developed natural or adaptive resistance to the active compound in question. Accordingly, there is a need for pest control agents that help prevent or overcome pesticide-induced tolerance.

此外,需要在施用時改良植物之殺有害生物劑化合物或化合物組合,其可導致「植物健康」、「植物繁殖材料之活力」或「增加植物產率」。Furthermore, there is a need for pesticide compounds or combinations of compounds which improve plants when applied, which result in "plant health", "vigor of plant propagation material" or "increased plant yield".

因此,本發明之一個目的為提供農業組合,其解決所論述之一或多個問題,如 - 降低劑量率, - 增強活性譜, - 組合擊倒活性與長期控制, - 改良抗性管理, - 改良植物健康; - 提高植物繁殖材料之活力,亦稱為種子活力; - 增加植物產量It is therefore an object of the present invention to provide an agricultural combination which solves one or more of the problems discussed, such as - reduced dose rate, - enhanced activity spectrum, - combined knockdown activity with long-term control, - improved resistance management, - Improved plant health; - Improve the vigor of plant propagation material, also known as seed vigor; - Increase plant production

因此,本發明之一個目的為提供殺有害生物混合物,其解決至少一個所論述之問題,如降低劑量率、增強活性譜或組合擊倒活性與長期控制,或關於抗性管理。It was therefore an object of the present invention to provide pesticidal mixtures which solve at least one of the problems discussed, such as reduced dose rates, enhanced activity spectrum or combined knockdown activity with long-term control, or with regard to resistance management.

已發現,此目的部分或全部藉由如本文所定義之活性化合物的組合實現。It has been found that this object is partly or fully achieved by combinations of active compounds as defined herein.

因此,在本發明之一個特定實施例中,根據本發明之化合物與至少一種其他活性成分混合。Thus, in a particular embodiment of the invention, the compound according to the invention is admixed with at least one other active ingredient.

如本文所用,術語「本發明之混合物」或「根據本發明之混合物」係指包含如上文所定義之式(I)化合物或具有對映異構體過量式(I-R)化合物之式(I)化合物,其亦稱為「式(I)之化合物」或「化合物I」或「式(I)化合物」,及如下文所定義之化合物(II),其亦稱為「式II化合物」或「化合物II」之混合物。As used herein, the term "mixture of the invention" or "mixture according to the invention" refers to a compound of formula (I) comprising a compound of formula (I) as defined above or having an enantiomeric excess of formula (I-R) Compound, which is also referred to as "compound of formula (I)" or "compound I" or "compound of formula (I)", and compound (II) as defined below, which is also referred to as "compound of formula II" or "compound of formula (I)" Compound II" mixture.

式I化合物或式(I)之非外消旋化合物或對映異構體過量之式(I)化合物,及化合物II應理解為包括其鹽、互變異構體、立體異構體及N-氧化物。Compounds of formula I or non-racemic compounds of formula (I) or compounds of formula (I) in excess of enantiomers, and compound II are understood to include salts, tautomers, stereoisomers and N- oxide.

在本發明之一個實施例中,本發明係關於包含以下之混合物: (1) 至少一種如本文所定義之式(I)化合物或式(I)之非外消旋化合物或具有對映異構體過量式(I-R)或(I-S)化合物之式(I)化合物、其對映異構體、鹽、互變異構體、立體異構體及N-氧化物, 及 (2) 至少一種化合物II,其選自以下之群: M.1 乙醯膽鹼酯酶(AChE)抑制劑:M.1A胺基甲酸酯類,例如得滅克(aldicarb)、棉靈威(alanycarb)、惡蟲威(bendiocarb)、免扶克(benfuracarb)、丁酮威(butocarboxim)、丁酮碸威(butoxycarboxim)、加保利(carbaryl)、加保扶(carbofuran)、丁基加保扶(carbosulfan)、殺蟲丹(ethiofencarb)、仲丁威(fenobucarb)、複滅蟎(formetanate)、呋線威(furathiocarb)、葉蟬散(isoprocarb)、滅賜克(methiocarb)、納乃得(methomyl)、速滅威(metolcarb)、歐殺滅(oxamyl)、比加普(pirimicarb)、安丹(propoxur)、硫敵克(thiodicarb)、久效威(thiofanox)、混滅威(trimethacarb)、XMC、滅殺威(xylylcarb)及唑蚜威(triazamate);或M.1B有機磷酸酯類,例如歐殺松(acephate)、亞滅松(azamethiphos)、乙基穀速松(azinphos-ethyl)、甲基穀速松(azinphosmethyl)、硫線磷(cadusafos)、氯氧磷(chlorethoxyfos)、克芬松(chlorfenvinphos)、氯甲磷(chlormephos)、陶斯松(chlorpyrifos)、甲基陶斯松(chlorpyrifos-methyl)、蠅毒磷(coumaphos)、殺螟腈(cyanophos)、甲基硫代內吸磷(demeton-S-methyl)、大利松(diazinon)、二氯松(dichlorvos)/DDVP、雙特松(dicrotophos)、大滅松(dimethoate)、甲基毒蟲畏(dimethylvinphos)、二硫松(disulfoton)、EPN、愛殺松(ethion)、普伏松(ethoprophos)、氨磺磷(famphur)、芬滅松(fenamiphos)、撲滅松(fenitrothion)、芬殺松(fenthion)、噻唑磷(fosthiazate)、庚烯磷(heptenophos)、新菸磷(imicyafos)、異柳磷(isofenphos)、O-(甲氧基-胺基硫基-磷醯基)水楊酸異丙酯、加福松(isoxathion)、馬拉硫磷(malathion)、滅蚜磷(mecarbam)、達馬松(methamidophos)、滅大松(methidathion)、美文松(mevinphos)、亞素靈(monocrotophos)、二溴磷(naled)、氧樂果(omethoate)、甲基滅多松(oxydemeton-methyl)、巴拉松(parathion)、甲基巴拉松(parathion-methyl)、賽達松(phenthoate)、福瑞松(phorate)、裕必松(phosalone)、益滅松(phosmet)、福賜米松(phosphamidon)、巴賽松(phoxim)、甲基亞特松(pirimiphos-methyl)、布飛松(profenofos)、巴胺磷(propetamphos)、普硫松(prothiofos)、吡唑硫磷(pyraclofos)、嗒嗪硫磷(pyridaphenthion)、喹惡磷(quinalphos)、治螟磷(sulfotep)、丁基嘧啶磷(tebupirimfos)、雙硫磷(temephos)、託福松(terbufos)、樂本松(tetrachlorvinphos)、甲基乙拌磷(thiometon)、三落松(triazophos)、三氯松(trichlorfon)及蚜滅多(vamidothion); M.2. GABA閘控氯離子通道拮抗劑:M.2A環二烯有機氯化合物,例如安殺番(endosulfan)或氯丹(chlordane);或M.2B苯基吡唑類(fiproles) (苯基吡唑),例如乙蟲清(ethiprole)、氟蟲腈(fipronil)、丁蟲腈(flufiprole)、吡嗪氟蟲腈(pyrafluprole)及派瑞樂(pyriprole); M.3 M.3A擬除蟲菊酯類鈉通道調節劑,例如阿納寧(acrinathrin)、丙烯除蟲菊酯(allethrin)、d-順-反丙烯除蟲菊酯、d-反丙烯除蟲菊酯、畢芬寧(bifenthrin) (尤其κ-畢芬寧)、百亞列寧(bioallethrin)、百亞列寧S-環戊烯基、苄呋菊酯(bioresmethrin)、乙氰菊酯(cycloprothrin)、賽扶寧(cyfluthrin)、β-賽扶寧、賽洛寧(cyhalothrin)、λ-賽洛寧、γ-賽洛寧、賽滅寧(cypermethrin)、α-賽滅寧、β-賽滅寧、θ-賽滅寧、ζ-賽滅寧、賽酚寧(cyphenothrin)、第滅寧(deltamethrin)、烯炔菊酯(empenthrin)、益化利(esfenvalerate)、依芬寧(etofenprox)、芬普寧(fenpropathrin)、芬化利(fenvalerate)、護賽寧(flucythrinate)、氟氯苯菊酯(flumethrin)、τ-福化利(tau-fluvalinate)、苄蟎醚(halfenprox)、七氟甲醚菊酯(heptafluthrin)、依普寧(imiprothrin)、氯氟醚菊酯(meperfluthrin)、甲氧苄氟菊酯(metofluthrin)、沫氟寧(momfluorothrin) (尤其ε-沫氟寧)、百滅寧(permethrin)、苯醚菊酯(phenothrin)、普亞列寧(prallethrin)、丙氟菊酯(profluthrin)、必列寧(pyrethrin)(除蟲菊(pyrethrum))、列滅寧(resmethrin)、矽護芬(silafluofen)、七氟菊酯(tefluthrin) (尤其κ-七氟菊酯)、四氟醚菊酯(tetramethylfluthrin)、治滅寧(tetramethrin)、泰滅寧(tralomethrin)及拜富寧(transfluthrin);或M.3B鈉通道調節劑,諸如DDT或甲氧滴滴涕(methoxychlor); M.4 菸鹼乙醯膽鹼受體促效劑(nAChR):M.4A新菸鹼類似物(neonicotinoids),例如啶蟲脒(acetamiprid)、噻蟲胺(clothianidin)、環氧蟲啶(cycloxaprid)、呋蟲胺(dinotefuran)、吡蟲啉(imidacloprid)、烯啶蟲胺(nitenpyram)、噻蟲啉(thiacloprid)及噻蟲嗪(thiamethoxam);或化合物M.4A.1 4,5-二氫-N-硝基-1-(2-環氧乙烷基甲基)-1H-咪唑-2-胺,M.4A.2:(2E-)-1-[(6-氯吡啶-3-基)甲基]-N'-硝基-2-亞戊肼甲脒;或M4.A.3:1-[(6-氯吡啶-3-基)甲基]-7-甲基-8-硝基-5-丙氧基-1,2,3,5,6,7-六氫咪唑并[1,2-a]吡啶;或M.4B菸鹼;M.4C氟啶蟲胺腈(sulfoxaflor);M.4D氟吡呋喃酮(flupyradifurone);M.4E三氟苯嘧啶(triflumezopyrim); M.5 菸鹼乙醯膽鹼受體異位活化劑:多殺黴素類(spinosyns),例如賜諾殺(spinosad)或賜諾特(spinetoram); M.6 阿維菌素類(avermectins)及米爾倍黴素類(milbemycins)之氯離子通道活化劑,例如阿巴汀(abamectin)、因滅汀(emamectin benzoate)、伊維菌素(ivermectin)、雷皮菌素(lepimectin)或密滅汀(milbemectin); M.7 保幼激素模擬物,諸如M.7A保幼激素類似物烯蟲乙酯(hydroprene)、烯蟲炔酯(kinoprene)及美賜平(methoprene);或M.7B芬諾克(fenoxycarb),或M.7C百利普芬(pyriproxyfen); M.8 各種非特異性(多位點)抑制劑,例如M.8A烷基鹵化物,如溴化甲烷及其他烷基鹵化物,M.8B氯化苦(chloropicrin),M.8C硫醯氟,M.8D硼砂或M.8E吐酒石(tartar emetic); M.9 弦音器TRPV通道調節劑,例如M.9B派滅淨(pymetrozine);哌氟喹腙(pyrifluquinazon); M.10 蟎生長抑制劑,例如M.10A克芬蟎(clofentezine)、合賽多(hexythiazox)及氟蟎嗪(diflovidazin),或M.10B依殺蟎(etoxazole); M.12 粒線體ATP合成酶抑制劑,例如M.12A汰芬諾克(diafenthiuron)或M.12B有機錫殺壁蟲劑,諸如三唑錫(azocyclotin)、錫蟎丹(cyhexatin)或芬布錫(fenbutatin oxide),M.12C毆蟎多(propargite)或M.12D四氯殺蟎碸(tetradifon); M.13 經由破壞質子梯度之氧化磷酸化去偶合劑,例如克凡派(chlorfenapyr)、DNOC或氟蟲胺(sulfluramid); M.14 菸鹼乙醯膽鹼受體(nAChR)通道阻斷劑,例如沙蠶毒素(nereistoxin)類似物殺蟲磺(bensultap)、培丹鹽酸鹽(cartap hydrochloride)、硫賜安(thiocyclam)或殺蟲雙(thiosultap sodium); M.15 甲殼素生物合成類型0之抑制劑,諸如苯甲醯基脲類,例如雙三氟蟲脲(bistrifluron)、克福隆(chlorfluazuron)、二福隆(diflubenzuron)、氟環脲(flucycloxuron)、氟芬隆(flufenoxuron)、六伏隆(hexaflumuron)、祿芬隆(lufenuron)、諾伐隆(novaluron)、多氟脲(noviflumuron)、得福隆(teflubenzuron)或三福隆(triflumuron); M.16 甲殼素生物合成類型1之抑制劑,例如布芬淨(buprofezin); M.17 雙翅目昆蟲蛻皮干擾劑,例如賽滅淨(cyromazine); M.18 蛻皮素受體促效劑,諸如雙醯肼,例如滅芬諾(methoxyfenozide)、得芬諾(tebufenozide)、合芬隆(halofenozide)、呋喃蟲醯肼(fufenozide)或環蟲醯肼(chromafenozide); M.19 章魚胺受體促效劑,例如三亞蟎(amitraz); M.20 粒線體複合物III電子傳遞抑制劑,例如M.20A愛美松(hydramethylnon),M.20B亞醌蟎(acequinocyl),M.20C嘧蟎酯(fluacrypyrim);或M.20D畢芬載(bifenazate); M.21 粒線體複合物I電子傳遞抑制劑,例如M.21A METI殺蟎劑及殺昆蟲劑,諸如芬殺蟎(fenazaquin)、芬普蟎(fenpyroximate)、嘧蟎醚(pyrimidifen)、比達本(pyridaben)、得芬瑞(tebufenpyrad)或脫芬瑞(tolfenpyrad),或M.21B魚藤酮(rotenone); M.22 電壓依賴性鈉通道阻斷劑,例如M.22A因得克(indoxacarb),M.22B氰氟蟲胺(metaflumizone),或M.22B.1:2-[2-(4-氰基苯基)-1-[3-(三氟甲基)苯基]亞乙基]-N-[4-(二氟甲氧基)苯基]-肼甲醯胺或M.22B.2:N-(3-氯-2-甲基苯基)-2-[(4-氯苯基)[4-[甲基(甲基磺醯基)胺基]苯基]亞甲基]-肼甲醯胺; M.23 乙醯CoA羧化酶之抑制劑,諸如特窗酸(Tetronic acid)及特特拉姆酸(Tetramic acid)衍生物,例如賜派芬(spirodiclofen)、螺甲蟎酯(spiromesifen)或螺蟲乙酯(spirotetramat);M.23.1螺派酮(spiropidion); M.24 粒線體複合物IV電子傳遞抑制劑,例如M.24A膦,諸如磷化鋁、磷化鈣、磷化氫或磷化鋅,或M.24B氰化物; M.25 粒線體複合物II電子傳遞抑制劑,諸如β-酮基腈衍生物,例如腈吡蟎酯(cyenopyrafen)或丁氟蟎酯(cyflumetofen); M.28 二醯胺類之利阿諾定(Ryanodine)受體調節劑,例如氟蟲雙醯胺(flubendiamide)、氯蟲苯甲醯胺(chlorantraniliprole)、氰蟲醯胺(cyantraniliprole)、氟氰蟲醯胺(tetraniliprole),M.28.1:(R)-3-氯-N1-{2-甲基-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基}-N2-(1-甲基-2-甲基磺醯基乙基)鄰苯二甲醯胺,M.28.2:(S)-3-氯-N1-{2-甲基-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基}-N2-(1-甲基-2-甲基磺醯基乙基)鄰苯二甲醯胺,M.28.3:環溴蟲醯胺(cyclaniliprole)或M.28.4:甲基-2-[3,5-二溴-2-({[3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基]羰基}胺基)苯甲醯基]-1,2-二甲肼甲酸酯;或M.28.5a) N-[4,6-二氯-2-[(二乙基-λ-4-亞硫基)胺甲醯基]-苯基]-2-(3-氯-2-吡啶基)-5-(三氟甲基)吡唑-3-甲醯胺;M.28.5b) N-[4-氯-2-[(二乙基-λ-4-亞硫基)胺甲醯基]-6-甲基-苯基]-2-(3-氯-2-吡啶基)-5-(三氟甲基)吡唑-3-甲醯胺;M.28.5c) N-[4-氯-2-[(二-2-丙基-λ-4-亞硫基)胺甲醯基]-6-甲基-苯基]-2-(3-氯-2-吡啶基)-5-(三氟甲基)吡唑-3-甲醯胺;M.28.5d) N-[4,6-二氯-2-[(二-2-丙基-λ-4-亞硫基)胺甲醯基]-苯基]-2-(3-氯-2-吡啶基)-5-(三氟甲基)吡唑-3-甲醯胺;M.28.5h) N-[4,6-二溴-2-[(二乙基-λ-4-亞硫基)胺甲醯基]-苯基]-2-(3-氯-2-吡啶基)-5-(三氟甲基)吡唑-3-甲醯胺;M.28.5i) N-[2-(5-胺基-1,3,4-噻二唑-2-基)-4-氯-6-甲基苯基]-3-溴-1-(3-氯-2-吡啶基)-1H-吡唑-5-甲醯胺;M.28.5j) 3-氯-1-(3-氯-2-吡啶基)-N-[2,4-二氯-6-[[(1-氰基-1-甲基乙基)胺基]羰基]苯基]-1H-吡唑-5-甲醯胺;M.28.5k) 3-溴-N-[2,4-二氯-6-(甲基胺甲醯基)苯基]-1-(3,5-二氯-2-吡啶基)-1H-吡唑-5-甲醯胺;M.28.5l) N-[4-氯-2-[[(1,1-二甲基乙基)胺基]羰基]-6-甲基苯基]-1-(3-氯-2-吡啶基)-3-(氟甲氧基)-1H-吡唑-5-甲醯胺;或 M.28.6:氯氟氰蟲醯胺(cyhalodiamide);或 M.29:弦音器調節劑-不確定的靶位點,例如氟啶蟲醯胺(flonicamid); M.UN. 作用模式未知或不明確之殺昆蟲活性化合物,例如雙丙環蟲酯(afidopyropen)、阿福拉納(afoxolaner)、印楝素(azadirachtin)、安米氟美(amidoflumet)、苯蟎特(benzoximate)、溴蟲氟苯雙醯胺(broflanilide)、溴蟎酯(bromopropylate)、蟎離丹(chinomethionat)、冰晶石(cryolite)、敵克美施(dicloromezotiaz)、開樂散(dicofol)、氟芬內林(flufenerim)、氟美特喹(flometoquin)、氟噻蟲碸(fluensulfone)、福薩豐(fluhexafon)、氟吡菌醯胺(fluopyram)、弗拉拉納(fluralaner)、噁蟲酮(metoxadiazone)、增效醚(piperonyl butoxide)、吡氟丁醯胺(pyflubumide)、啶蟲丙醚(pyridalyl)、泰噁殺芬(tioxazafen),M.UN.3:11-(4-氯-2,6-二甲基苯基)-12-羥基-1,4-二氧雜-9-氮雜二螺[4.2.4.2]-十四-11-烯-10-酮, M.UN.4:3-(4'-氟-2,4-二甲基聯苯-3-基)-4-羥基-8-氧雜-1-氮雜螺[4.5]癸-3-烯-2-酮, M.UN.5:1-[2-氟-4-甲基-5-[(2,2,2-三氟乙基)亞磺醯基]苯基]-3-(三氟甲基)-1H-1,2,4-三唑-5-胺,或基於強固芽胞桿菌(bacillus firmus ) (Votivo, I-1582)之活性劑; M.UN.6:氟吡嘧(flupyrimin); M.UN.8:三氟咪啶醯胺(fluazaindolizine);M.UN.9.a):4-[5-(3,5-二氯苯基)-5-(三氟甲基)-4H-異噁唑-3-基]-2-甲基-N-(1-側氧基硫雜環丁烷-3-基)苯甲醯胺;M.UN.9.b):氟唑醯胺(fluxametamide);M.UN.10:5-[3-[2,6-二氯-4-(3,3-二氯烯丙氧基)苯氧基]丙氧基]-1H-吡唑; M.UN.11.b) 3-(苯甲醯基甲胺基)-N-[2-溴-4-[1,2,2,3,3,3-六氟-1-(三氟甲基)丙基]-6-(三氟甲基)苯基]-2-氟-苯甲醯胺;M.UN.11.c) 3-(苯甲醯基甲胺基)-2-氟-N-[2-碘-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]-苯甲醯胺;M.UN.11.d) N-[3-[[[2-碘-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]胺基]羰基]苯基]-N-甲基-苯甲醯胺;M.UN.11.e) N-[3-[[[2-溴-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]胺基]羰基]-2-氟-苯基]-4-氟-N-甲基-苯甲醯胺;M.UN.11.f) 4-氟-N-[2-氟-3-[[[2-碘-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]胺基]羰基]苯基]-N-甲基-苯甲醯胺;M.UN.11.g) 3-氟-N-[2-氟-3-[[[2-碘-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]胺基]羰基]苯基]-N-甲基-苯甲醯胺;M.UN.11.h) 2-氯-N-[3-[[[2-碘-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]胺基]羰基]苯基]-3-吡啶甲醯胺;M.UN.11.i) 4-氰基-N-[2-氰基-5-[[2,6-二溴-4-[1,2,2,3,3,3-六氟-1-(三氟甲基)丙基]苯基]胺甲醯基]苯基]-2-甲基-苯甲醯胺;M.UN.11.j) 4-氰基-3-[(4-氰基-2-甲基-苯甲醯基)胺基]-N-[2,6-二氯-4-[1,2,2,3,3,3-六氟-1-(三氟甲基)丙基]苯基]-2-氟-苯甲醯胺;M.UN.11.k) N-[5-[[2-氯-6-氰基-4-[1,2,2,3,3,3-六氟-1-(三氟甲基)丙基]苯基]胺甲醯基]-2-氰基-苯基]-4-氰基-2-甲基-苯甲醯胺;M.UN.11.l) N-[5-[[2-溴-6-氯-4-[2,2,2-三氟-1-羥基-1-(三氟甲基)乙基]苯基]胺甲醯基]-2-氰基-苯基]-4-氰基-2-甲基-苯甲醯胺;M.UN.11.m) N-[5-[[2-溴-6-氯-4-[1,2,2,3,3,3-六氟-1-(三氟甲基)丙基]苯基]胺甲醯基]-2-氰基-苯基]-4-氰基-2-甲基-苯甲醯胺;M.UN.11.n) 4-氰基-N-[2-氰基-5-[[2,6-二氯-4-[1,2,2,3,3,3-六氟-1-(三氟甲基)丙基]苯基]胺甲醯基]苯基]-2-甲基-苯甲醯胺;M.UN.11.o) 4-氰基-N-[2-氰基-5-[[2,6-二氯-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基]胺甲醯基]苯基]-2-甲基-苯甲醯胺;M.UN.11.p) N-[5-[[2-溴-6-氯-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基]胺甲醯基]-2-氰基-苯基]-4-氰基-2-甲基-苯甲醯胺;或 M.UN.12.a) 2-(1,3-二氧雜環己烷-2-基)-6-[2-(3-吡啶基)-5-噻唑基]-吡啶;M.UN.12.b) 2-[6-[2-(5-氟-3-吡啶基)-5-噻唑基]-2-吡啶基]-嘧啶;M.UN.12.c) 2-[6-[2-(3-吡啶基)-5-噻唑基]-2-吡啶基]-嘧啶;M.UN.12.d) N-甲基磺醯基-6-[2-(3-吡啶基)噻唑-5-基]吡啶-2-甲醯胺;M.UN.12.e) N-甲基磺醯基-6-[2-(3-吡啶基)噻唑-5-基]吡啶-2-甲醯胺;M.UN.12.f) N-乙基-N-[4-甲基-2-(3-吡啶基)噻唑-5-基]-3-甲硫基-丙醯胺;M.UN.12.g) N-甲基-N-[4-甲基-2-(3-吡啶基)噻唑-5-基]-3-甲硫基-丙醯胺;M.UN.12.h) N,2-二甲基-N-[4-甲基-2-(3-吡啶基)噻唑-5-基]-3-甲硫基-丙醯胺;M.UN.12.i) N-乙基-2-甲基-N-[4-甲基-2-(3-吡啶基)噻唑-5-基]-3-甲硫基-丙醯胺;M.UN.12.j) N-[4-氯-2-(3-吡啶基)噻唑-5-基]-N-乙基-2-甲基-3-甲硫基-丙醯胺;M.UN.12.k) N-[4-氯-2-(3-吡啶基)噻唑-5-基]-N,2-二甲基-3-甲硫基-丙醯胺;M.UN.12.l) N-[4-氯-2-(3-吡啶基)噻唑-5-基]-N-甲基-3-甲硫基-丙醯胺;M.UN.12.m) N-[4-氯-2-(3-吡啶基)噻唑-5-基]-N-乙基-3-甲硫基-丙醯胺; M.UN.14a) 1-[(6-氯-3-吡啶基)甲基]-1,2,3,5,6,7-六氫-5-甲氧基-7-甲基-8-硝基-咪唑并[1,2-a]吡啶;或M.UN.14b) 1-[(6-氯吡啶-3-基)甲基]-7-甲基-8-硝基-1,2,3,5,6,7-六氫咪唑并[1,2-a]吡啶-5-醇; M.UN.16a) 1-異丙基-N,5-二甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;或M.UN.16b) 1-(1,2-二甲基丙基)-N-乙基-5-甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;M.UN.16c) N,5-二甲基-N-嗒嗪-4-基-1-(2,2,2-三氟-1-甲基-乙基)吡唑-4-甲醯胺;M.UN.16d) 1-[1-(1-氰基環丙基)乙基]-N-乙基-5-甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;M.UN.16e) N-乙基-1-(2-氟-1-甲基-丙基)-5-甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;M.UN.16f) 1-(1,2-二甲基丙基)-N,5-二甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;M.UN.16g) 1-[1-(1-氰基環丙基)乙基]-N,5-二甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;M.UN.16h) N-甲基-1-(2-氟-1-甲基-丙基]-5-甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;M.UN.16i) 1-(4,4-二氟環己基)-N-乙基-5-甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;或M.UN.16j) 1-(4,4-二氟環己基)-N,5-二甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺, M.UN.17a) N-(1-甲基乙基)-2-(3-吡啶基)-2H-吲唑-4-甲醯胺;M.UN.17b) N-環丙基-2-(3-吡啶基)-2H-吲唑-4-甲醯胺;M.UN.17c) N-環己基-2-(3-吡啶基)-2H-吲唑-4-甲醯胺;M.UN.17d) 2-(3-吡啶基)-N-(2,2,2-三氟乙基)-2H-吲唑-4-甲醯胺;M.UN.17e) 2-(3-吡啶基)-N-[(四氫-2-呋喃基)甲基]-2H-吲唑-5-甲醯胺;M.UN.17f) 2-[[2-(3-吡啶基)-2H-吲唑-5-基]羰基]肼甲酸甲酯;M.UN.17g) N-[(2,2-二氟環丙基)甲基]-2-(3-吡啶基)-2H-吲唑-5-甲醯胺;M.UN.17h) N-(2,2-二氟丙基)-2-(3-吡啶基)-2H-吲唑-5-甲醯胺;M.UN.17i) 2-(3-吡啶基)-N-(2-嘧啶基甲基)-2H-吲唑-5-甲醯胺;M.UN.17j) N-[(5-甲基-2-吡嗪基)甲基]-2-(3-吡啶基)-2H-吲唑-5-甲醯胺, M.UN.18a) N-[3-氯-1-(3-吡啶基)吡唑-4-基]-N-乙基-3-(3,3,3-三氟丙基硫基)丙醯胺;M.UN.18b) N-[3-氯-1-(3-吡啶基)吡唑-4-基]-N-乙基-3-(3,3,3-三氟丙基亞磺醯基)丙醯胺;M.UN.18c) N-[3-氯-1-(3-吡啶基)吡唑-4-基]-3-[(2,2-二氟環丙基)甲基硫基]-N-乙基-丙醯胺;M.UN.18d) N-[3-氯-1-(3-吡啶基)吡唑-4-基]-3-[(2,2-二氟環丙基)甲基亞磺醯基]-N-乙基-丙醯胺; M.UN.19薩洛拉納(sarolaner),M.UN.20洛替拉納(lotilaner); M.UN.21 N-[4-氯-3-[[(苯基甲基)胺基]羰基]苯基]-1-甲基-3-(1,1,2,2,2-五氟乙基)-4-(三氟甲基)-1H-吡唑-5-甲醯胺;M.UN.22a 2-(3-乙基磺醯基-2-吡啶基)-3-甲基-6-(三氟甲基)咪唑并[4,5-b]吡啶,或M.UN.22b 2-[3-乙基磺醯基-5-(三氟甲基)-2-吡啶基]-3-甲基-6-(三氟甲基)咪唑并[4,5-b]吡啶; M.UN.23a 4-[5-(3,5-二氯苯基)-5-(三氟甲基)-4H-異噁唑-3-基]-N-[(4R)-2-乙基-3-側氧基異噁唑啶-4-基]-2-甲基-苯甲醯胺,或M.UN.23b 4-[5-(3,5-二氯-4-氟-苯基)-5-(三氟甲基)-4H-異噁唑-3-基]-N-[(4R)-2-乙基-3-側氧基-異噁唑啶-4-基]-2-甲基-苯甲醯胺; M.UN.24a) N-[4-氯-3-(環丙基胺甲醯基)苯基]-2-甲基-5-(1,1,2,2,2-五氟乙基)-4-(三氟甲基)吡唑-3-甲醯胺或M.UN.24b) N-[4-氯-3-[(1-氰基環丙基)胺甲醯基]苯基]-2-甲基-5-(1,1,2,2,2-五氟乙基)-4-(三氟甲基)吡唑-3-甲醯胺;M.UN.25艾諾派瑞(acynonapyr);M.UN.26苯吡莫安(benzpyrimoxan);M.UN.27 2-氯-N-(1-氰基環丙基)-5-[1-[2-甲基-5-(1,1,2,2,2-五氟乙基)-4-(三氟甲基)吡唑-3-基]吡唑-4-基]苯甲醯胺;M.29.28噁唑沙非(oxazosulfyl) (2-(3-乙基磺醯基-2-吡啶基)-5-(三氟甲基磺醯基)-1,3-苯并噁唑); A) 呼吸抑制劑 - Qo位點之複合物III的抑制劑:亞托敏(azoxystrobin) (A.1.1),甲香菌酯(coumethoxystrobin) (A.1.2),丁香菌酯(coumoxystrobin) (A.1.3),地莫菌胺(dimoxystrobin) (A.1.4),烯肟菌酯(enestroburin) (A.1.5),烯肟菌胺(fenaminstrobin) (A.1.6),菌蟎酯(fenoxystrobin)/氟菌蟎酯(flufenoxystrobin) (A.1.7),氟嘧菌酯(fluoxastrobin) (A.1.8),克收欣(kresoxim-methyl) (A.1.9),曼德托冰(mandestrobin) (A.1.10),苯氧菌胺(metominostrobin) (A.1.11),肟醚菌胺(orysastrobin) (A.1.12),啶氧菌酯(picoxystrobin) (A.1.13),百克敏(pyraclostrobin) (A.1.14),唑胺菌酯(pyrametostrobin) (A.1.15),唑菌酯(pyraoxystrobin) (A.1.16),三氟敏(trifloxystrobin) (A.1.17),2 (2-(3-(2,6-二氯苯基)-1-甲基-亞烯丙基胺氧基甲基)-苯基)-2 甲氧亞胺基-N 甲基-乙醯胺(A.1.18),吡菌苯威(pyribencarb) (A.1.19),三環吡菌威(triclopyricarb)/氯啶菌酯(chlorodincarb) (A.1.20),凡殺同(famoxadone) (A.1.21),咪唑菌酮(fenamidone) (A.1.21),甲基-N-[2-[(1,4-二甲基-5 苯基-吡唑-3-基)氧基甲基]苯基]-N-甲氧基-胺基甲酸酯(A.1.22),1-[3-氯-2 [[1 (4-氯苯基)-1H-吡唑-3-基]氧基甲基]苯基]-4-甲基-四唑-5-酮(A.1.23),1-[3-溴-2-[[1-(4-氯苯基)吡唑-3-基]氧基甲基]苯基]-4-甲基-四唑-5-酮(A.1.24),1-[2-[[1-(4-氯苯基)吡唑-3-基]氧基甲基]-3-甲基-苯基]-4-甲基-四唑-5-酮(A.1.25),1-[2-[[1-(4-氯苯基)吡唑-3-基]氧基甲基]-3-氟-苯基]-4-甲基-四唑-5-酮(A.1.26),1-[2-[[1-(2,4-二氯苯基)吡唑-3-基]氧基甲基]-3-氟-苯基]-4-甲基-四唑-5-酮(A.1.27),1-[3-環丙基-2-[[2-甲基-4 (1 甲基吡唑-3-基)苯氧基]甲基]苯基]-4 甲基-四唑-5-酮(A.1.30),1 [3 (二氟甲氧基)-2-[[2-甲基-4-(1 甲基吡唑-3 基)苯氧基]甲基]苯基]-4 甲基-四唑-5-酮(A.1.31),1-甲基-4-[3-甲基-2 [[2 甲基-4-(1-甲基吡唑-3 基)苯氧基]甲基]苯基]四唑-5-酮(A.1.32),(Z,2E)-5-[1-(2,4-二氯苯基)吡唑-3-基]­氧基-2-甲氧亞胺基-N,3-二甲基-戊-3-烯醯胺(A.1.34),(Z,2E) 5 [1 (4-氯苯基)吡唑-3-基]氧基-2-甲氧亞胺基-N,3-二甲基-戊-3-烯醯胺(A.1.35),嘧蟎胺(pyriminostrobin) (A.1.36),吡氟菌酯(bifujunzhi) (A.1.37),2-(鄰-((2,5-二甲基苯基-氧基-亞甲基)苯基)-3-甲氧基-丙烯酸甲酯(A.1.38); - Qi位點之複合物III的抑制劑:賽座滅(cyazofamid) (A.2.1),吲唑磺菌胺(amisulbrom) (A.2.2),[(6S,7R,8R) 2-甲基丙酸8 苯甲基-3-[(3-羥基-4-甲氧基-吡啶-2-羰基)胺基]-6-甲基-4,9-二側氧基-1,5-二側氧基壬-7-基]酯(A.2.3),芬吡醯胺(fenpicoxamid) (A.2.4); - 複合物II之抑制劑:麥鏽靈(benodanil) (A.3.1),苯丙烯氟菌唑(benzovindiflupyr) (A.3.2),必殺吩(bixafen) (A.3.3),白可列(boscalid) (A.3.4),萎鏽靈(carboxin) (A.3.5),甲呋醯胺(fenfuram) (A.3.6),氟吡菌醯胺(fluopyram) (A.3.7),福多寧(flutolanil) (A.3.8),氟唑菌醯胺(fluxapyroxad) (A.3.9),福拉比(furametpyr) (A.3.10),艾索非他米(isofetamid) (A.3.11),吡唑萘菌胺(isopyrazam) (A.3.12),滅普寧(mepronil) (A.3.13),嘉保信(oxycarboxin) (A.3.14),噴福芬(penflufen) (A.3.15),吡噻菌胺(penthiopyrad) (A.3.16),吡二氟甲多芬(pydiflumetofen) (A.3.17),吡瑞氟密得(pyraziflumid) (A.3.18),氟唑環菌胺(sedaxane) (A.3.19),克枯爛(tecloftalam) (A.3.20),賽氟滅(thifluzamide) (A.3.21),3 (二氟甲基)-1-甲基-N-(1,1,3-三甲基茚滿-4-基)吡唑-4 甲醯胺(A.3.22),3 (三氟甲基)-1-甲基-N-(1,1,3-三甲基茚滿-4-基)吡唑-4 甲醯胺(A.3.23),1,3-二甲基-N-(1,1,3-三甲基茚滿-4-基)吡唑-4-甲醯胺(A.3.24),3-(三氟甲基)-1,5 二甲基-N-(1,1,3-三甲基茚滿-4-基)吡唑-4-甲醯胺(A.3.25),1,3,5-三甲基-N-(1,1,3-三甲基茚滿-4-基)吡唑-4-甲醯胺(A.3.26),3-(二氟甲基)-1,5 二甲基-N-(1,1,3-三甲基茚滿-4-基)吡唑-4-甲醯胺(A.3.27),3-(二氟甲基)-N (7 氟-1,1,3-三甲基-茚滿-4-基)-1-甲基-吡唑-4-甲醯胺(A.3.28),N-[(5-氯-2-異丙基-苯基)甲基]-N-環丙基-5-氟-1,3-二甲基-吡唑-4-甲醯胺(A.3.29),(E)-2-[2-[(5-氰基-2-甲基-苯氧基)甲基]苯基]-3-甲氧基-丙-2 烯酸甲酯(A.3.30),N-[(5-氯-2-異丙基-苯基)甲基]-N-環丙基-3-(二氟甲基)-5 氟-1-甲基-吡唑-4-甲醯胺(A.3.31),2-(二氟甲基)-N-(1,1,3-三甲基-茚滿-4-基)吡啶-3-甲醯胺(A.3.32),2-(二氟甲基)-N-[(3R)-1,1,3-三甲基茚滿-4-基]吡啶-3-甲醯胺(A.3.33),2-(二氟甲基)-N-(3-乙基-1,1-二甲基-茚滿-4-基)吡啶-3-甲醯胺(A.3.34),2-(二氟甲基)-N-[(3R)-3-乙基-1,1-二甲基-茚滿-4-基]吡啶-3-甲醯胺(A.3.35),2-(二氟甲基)-N-(1,1-二甲基-3-丙基-茚滿-4-基)吡啶-3-甲醯胺(A.3.36),2-(二氟甲基)-N-[(3R)-1,1-二甲基-3-丙基-茚滿-4-基]吡啶-3-甲醯胺(A.3.37),2-(二氟甲基)-N-(3-異丁基-1,1-二甲基-茚滿-4-基)吡啶-3-甲醯胺(A.3.38),2-(二氟甲基)-N-[(3R)-3-異丁基-1,1-二甲基-茚滿-4 基]吡啶-3-甲醯胺(A.3.39); - 其他呼吸抑制劑:二氟林(diflumetorim) (A.4.1);硝苯基衍生物:百蟎克(binapacryl) (A.4.2),大脫蟎(dinobuton) (A.4.3),白粉克(dinocap) (A.4.4),扶吉胺(fluazinam) (A.4.5),敵蟎普(meptyldinocap) (A.4.6),富米綜(ferimzone) (A.4.7);有機金屬化合物:薯瘟錫鹽(fentin salts),例如三苯醋錫(fentin-acetate) (A.4.8)、三苯氯錫(fentin chloride) (A.4.9)或三苯羥錫(fentin hydroxide) (A.4.10);辛唑嘧菌胺(ametoctradin) (A.4.11);矽硫芬(silthiofam) (A.4.12); B) 固醇生物合成抑制劑(SBI殺真菌劑) - C14去甲基酶抑制劑:三唑類:氧環唑(azaconazole) (B.1.1)、比多農(bitertanol) (B.1.2)、糠菌唑(bromuconazole) (B.1.3)、環克座(cyproconazole) (B.1.4)、待克利(difenoconazole) (B.1.5)、達克利(diniconazole) (B.1.6)、高效達克利(diniconazole-M) (B.1.7)、依普座(epoxiconazole) (B.1.8)、芬克座(fenbuconazole) (B.1.9)、氟喹唑(fluquinconazole) (B.1.10)、護矽得(flusilazole) (B.1.11)、護汰芬(flutriafol) (B.1.12)、菲克利(hexaconazole) (B.1.13)、亞胺唑(imibenconazole) (B.1.14)、種菌唑(ipconazole) (B.1.15)、滅特座(metconazole) (B.1.17)、邁克尼(myclobutanil) (B.1.18)、噁咪唑(oxpoconazole) (B.1.19)、多效唑(paclobutrazole) (B.1.20)、平克座(penconazole) (B.1.21)、普克利(propiconazole) (B.1.22)、丙硫菌唑(prothioconazole) (B.1.23)、矽氟唑(simeconazole) (B.1.24)、得克利(tebuconazole) (B.1.25)、四克利(tetraconazole) (B.1.26)、三泰芬(triadimefon) (B.1.27)、三泰隆(triadimenol) (B.1.28)、滅菌唑(triticonazole) (B.1.29)、烯效唑(uniconazole) (B.1.30)、伊分三康唑(ipfentrifluconazole) (B.1.37)、甲分三康唑(mefentrifluconazole) (B.1.38)、2-(氯甲基)-2-甲基-5-(對甲苯基甲基)-1 (1,2,4-三唑-1-基甲基)環戊醇(B.1.43);咪唑類:依滅列(imazalil) (B.1.44)、披扶座(pefurazoate) (B.1.45)、咪醯胺(prochloraz) (B.1.46)、賽福座(triflumizol) (B.1.47);嘧啶類、吡啶類及哌嗪類:芬瑞莫(fenarimol) (B.1.49)、比芬諾(pyrifenox) (B.1.50)、賽福寧(triforine) (B.1.51)、[3-(4-氯-2-氟-苯基)-5-(2,4-二氟苯基)異噁唑-4-基]-(3-吡啶基)甲醇(B.1.52); - δ14-還原酶抑制劑:阿迪嗎啉(aldimorph) (B.2.1)、嗎菌靈(dodemorph) (B.2.2)、嗎菌靈乙酸鹽(dodemorph-acetate) (B.2.3)、芬普福(fenpropimorph) (B.2.4)、三得芬(tridemorph) (B.2.5)、苯鏽啶(fenpropidin) (B.2.6)、粉病靈(piperalin) (B.2.7)、螺環菌胺(spiroxamine) (B.2.8); - 3-酮基還原酶之抑制劑:環醯菌胺(fenhexamid) (B.3.1); - 其他固醇生物合成抑制劑:氯苯肟唑(chlorphenomizole) (B.4.1); C) 核酸合成抑制劑 - 苯基醯胺或醯基胺基酸殺真菌劑:苯霜靈(benalaxyl) (C.1.1)、甲霜靈苯霜靈(benalaxyl-M) (C.1.2)、精苯霜靈(kiralaxyl) (C.1.3)、甲霜靈(metalaxyl) (C.1.4)、高效甲霜靈(metalaxyl-M) (C.1.5)、呋醯胺(ofurace) (C.1.6)、歐殺斯(oxadixyl) (C.1.7); - 其他核酸合成抑制劑:殺紋寧(hymexazole) (C.2.1)、辛噻酮(octhilinone) (C.2.2)、歐索林酸(oxolinic acid) (C.2.3)、布瑞莫(bupirimate) (C.2.4)、5-氟胞嘧啶(C.2.5)、5-氟-2-(對甲苯基甲氧基)嘧啶-4 胺(C.2.6)、5-氟-2-(4-氟苯基甲氧基)嘧啶-4 胺(C.2.7)、5-氟-2 (4 氯苯基甲氧基)嘧啶-4 胺(C.2.8); D) 細胞分裂及細胞骨架抑制劑 - 微管蛋白抑制劑:免賴得(benomyl) (D.1.1),貝芬替(carbendazim) (D.1.2),麥穗靈(fuberidazole) (D1.3),腐絕(thiabendazole) (D.1.4),甲基托布津(thiophanate-methyl) (D.1.5),3-氯-4-(2,6-二氟苯基)-6-甲基-5-苯基-嗒嗪(D.1.6),3-氯-6-甲基-5-苯基-4-(2,4,6-三氟苯基)嗒嗪(D.1.7),N 乙基-2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]丁醯胺(D.1.8),N-乙基-2-[(3-乙炔基-8 甲基-6 喹啉基)氧基]-2-甲基硫基-乙醯胺(D.1.9),2-[(3-乙炔基-8-甲基-6-喹啉-基)氧基]-N (2-氟乙基)丁醯胺(D.1.10),2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]-N-(2-氟乙基)-2-甲氧基-乙醯胺(D.1.11),2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]-N-丙基-丁醯胺(D.1.12),2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]-2-甲氧基-N-丙基-乙醯胺(D.1.13),2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]-2-甲基硫基-N-丙基-乙醯胺(D.1.14),2 [(3 乙炔基-8-甲基-6-喹啉基)氧基]-N-(2-氟乙基)-2-甲基硫基-乙醯胺(D.1.15),4-(2-溴-4-氟-苯基)-N-(2-氯-6-氟-苯基)-2,5-二甲基-吡唑-3 胺(D.1.16); - 其他細胞分裂抑制劑:乙黴威(diethofencarb) (D.2.1)、噻唑菌胺(ethaboxam) (D.2.2)、賓克隆(pencycuron) (D.2.3)、氟吡菌胺(fluopicolide) (D.2.4)、座賽胺(zoxamide) (D.2.5)、滅芬農(metrafenone) (D.2.6)、吡芬酮(pyriofenone) (D.2.7); E) 胺基酸及蛋白質合成抑制劑 - 甲硫胺酸合成抑制劑:嘧菌環胺(cyprodinil) (E.1.1)、嘧菌胺(mepanipyrim) (E.1.2)、嘧黴胺(pyrimethanil) (E.1.3); - 蛋白質合成抑制劑:殺稻瘟菌素-S (blasticidin-S) (E.2.1)、春日黴素(kasugamycin) (E.2.2)、春日黴素鹽酸鹽水合物(E.2.3)、米多黴素(mildiomycin) (E.2.4)、鏈黴素(streptomycin) (E.2.5)、土黴素(oxytetracyclin) (E.2.6); F) 信號轉導抑制劑 - MAP/組胺酸激酶抑制劑:氟菌安(fluoroimid) (F.1.1)、依普同(iprodione) (F.1.2)、撲滅寧(procymidone) (F.1.3)、免克寧(vinclozolin) (F.1.4)、護汰寧(fludioxonil) (F.1.5); - G蛋白抑制劑:快諾芬(quinoxyfen) (F.2.1); G) 脂質及膜合成抑制劑 - 磷脂生物合成抑制劑:護粒松(edifenphos) (G.1.1)、丙基喜樂松(iprobenfos) (G.1.2)、白粉松(pyrazophos) (G.1.3)、稻瘟靈(isoprothiolane) (G.1.4); - 脂質過氧化:氯硝胺(dicloran) (G.2.1)、五氯硝基苯(quintozene) (G.2.2)、四氯硝基苯(tecnazene) (G.2.3)、脫克松(tolclofos-methyl) (G.2.4)、聯苯(G.2.5)、地茂散(chloroneb) (G.2.6)、依得利(etridiazole) (G.2.7); - 磷脂生物合成及細胞壁沈積:達滅芬(dimethomorph) (G.3.1)、氟嗎啉(flumorph) (G.3.2)、雙炔醯菌胺(mandipropamid) (G.3.3)、丁吡嗎啉(pyrimorph) (G.3.4)、苯噻菌胺(benthiavalicarb) (G.3.5)、纈黴威(iprovalicarb) (G.3.6)、威利芬那雷特(valifenalate) (G.3.7); - 影響細胞膜滲透性及脂肪酸之化合物:霜黴威(propamocarb) (G.4.1); - 氧化固醇結合蛋白之抑制劑:奧賽普林(oxathiapiprolin) (G.5.1),甲磺酸2-{3-[2-(1-{[3,5-雙(二氟甲基-1H-吡唑-1-基]乙醯基}哌啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2 噁唑-5-基}苯酯(G.5.2),甲磺酸2-{3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}哌啶-4-基) 1,3-噻唑-4-基]-4,5-二氫-1,2-噁唑-5 基}-3-氯苯酯(G.5.3),4-[1-[2-[3-(二氟甲基)-5-甲基-吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.4),4-[1-[2-[3,5-雙(二氟甲基)吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.5),4-[1-[2-[3-(二氟甲基)-5-(三氟甲基)吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.6),4-[1-[2-[5-環丙基-3-(二氟甲基)吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.7),4-[1-[2-[5-甲基-3-(三氟甲基)吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.8),4-[1-[2-[5-(二氟甲基)-3-(三氟甲基)吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.9),4 [1 [2-[3,5-雙(三氟甲基)吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.10),(4-[1-[2-[5-環丙基-3-(三氟甲基)吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.11); H) 具有多位點作用之抑制劑 - 無機活性物質:波爾多液(H.1.1)、銅(H.1.2)、乙酸銅(H.1.3)、氫氧化銅(H.1.4)、鹼性氯氧化銅(H.1.5)、鹼式硫酸銅(H.1.6)、硫(H.1.7); - 硫代及二硫代胺基甲酸鹽:福美鐵(ferbam) (H.2.1)、鋅錳乃浦(mancozeb) (H.2.2)、錳乃浦(maneb) (H.2.3)、威百畝(metam) (H.2.4)、免得爛(metiram) (H.2.5)、甲基鋅乃浦(propineb) (H.2.6)、得恩地(thiram) (H.2.7)、鋅乃浦(zineb) (H.2.8)、益穗(ziram) (H.2.9); - 有機氯化合物:敵菌靈(anilazine) (H.3.1)、四氯異苯腈(chlorothalonil) (H.3.2)、四氯丹(captafol) (H.3.3)、蓋普丹(captan) (H.3.4)、福爾培(folpet) (H.3.5)、益發靈(dichlofluanid) (H.3.6)、二氯酚(dichlorophen) (H.3.7)、六氯苯(H.3.8)、五氯酚(H.3.9)及其鹽、苯酞(phthalide) (H.3.10)、甲基益發靈(tolylfluanid) (H.3.11); - 胍類及其他:胍(H.4.1)、多寧(dodine) (H.4.2)、多寧游離鹼(H.4.3)、雙胍鹽(guazatine) (H.4.4)、雙胍鹽乙酸鹽(H.4.5)、克熱淨(iminoctadine) (H.4.6)、克熱淨三乙酸鹽(H.4.7)、克熱淨參(烷苯磺酸鹽) (H.4.8)、腈硫醌(dithianon) (H.4.9)、2,6-二甲基-1H,5H-[1,4]二噻𠯤并[2,3-c:5,6-c']二吡咯-1,3,5,7(2H,6H)-四酮(H.4.10); I) 細胞壁合成抑制劑 - 葡聚糖合成抑制劑:維利微素(validamycin) (I.1.1)、保粒黴素B (polyoxin B) (I.1.2); - 黑色素合成抑制劑:百快隆(pyroquilon) (I.2.1)、三賽唑(tricyclazole) (I.2.2)、加普胺(carpropamid) (I.2.3)、雙氯氰菌胺(dicyclomet) (I.2.4)、氰菌胺(fenoxanil) (I.2.5); J) 植物防護誘導劑 - 酸化苯并噻二唑-S-甲酯(acibenzolar-S-methyl) (J.1.1)、撲殺熱(probenazole) (J.1.2)、異噻菌胺(isotianil) (J.1.3)、汰敵寧(tiadinil) (J.1.4)、調環酸鈣(prohexadione-calcium) (J.1.5);膦酸鹽:福賽得(fosetyl) (J.1.6)、乙磷鋁(fosetyl-aluminum) (J.1.7)、亞磷酸及其鹽(J.1.8)、膦酸鈣(J.1.11)、膦酸鉀(J.1.12)、碳酸氫鉀或碳酸氫鈉(J.1.9)、4 環丙基-N-(2,4-二甲氧基苯基)噻二唑-5-甲醯胺(J.1.10); K) 作用模式未知 - 溴硝醇(bronopol) (K.1.1),蟎離丹(chinomethionat) (K.1.2),環氟菌胺(cyflufenamid) (K.1.3),克絕(cymoxanil) (K.1.4),邁隆(dazomet) (K.1.5),咪菌威(debacarb) (K.1.6),二氯西莫(diclocymet) (K.1.7),達滅淨(diclomezine) (K.1.8),野燕枯(difenzoquat) (K.1.9),野燕枯甲基硫酸鹽(K.1.10),二苯胺(diphenylamin) (K.1.11),種衣酯(fenitropan) (K.1.12),胺苯吡菌酮(fenpyrazamine) (K.1.13),氟醯菌胺(flumetover) (K.1.14),氟硫滅(flusulfamide) (K.1.15),氟替尼(flutianil) (K.1.16),超敏蛋白(harpin) (K.1.17),磺菌威(metha-sulfocarb) (K.1.18),氯啶(nitrapyrin) (K.1.19),異丙消(nitrothal-isopropyl) (K.1.20),托普洛卡(tolprocarb) (K.1.21),快得寧(oxin-copper) (K.1.22),丙氧喹啉(proquinazid) (K.1.23),特普弗洛奎(tebufloquin) (K.1.24),克枯爛(tecloftalam) (K.1.25),咪唑嗪(triazoxide) (K.1.26),N'-(4-(4-氯-3-三氟甲基-苯氧基)-2,5-二甲基-苯基)-N-乙基-N 甲基 甲脒(K.1.27),N' (4-(4-氟-3-三氟甲基-苯氧基)-2,5-二甲基-苯基)-N-乙基-N-甲基 甲脒(K.1.28),N'-[4-[[3-[(4-氯苯基)甲基]-1,2,4-噻二唑-5-基]氧基]-2,5-二甲基-苯基]-N-乙基-N-甲基-甲脒(K.1.29),N'-(5-溴-6-茚滿-2-基氧基-2-甲基-3-吡啶基)-N-乙基-N-甲基-甲脒(K.1.30),N'-[5-溴-6-[1-(3,5-二氟苯基)乙氧基]-2-甲基-3-吡啶基]-N-乙基-N-甲基-甲脒(K.1.31),N'-[5-溴-6-(4-異丙基環己氧基)-2-甲基-3-吡啶基]-N-乙基-N-甲基-甲脒(K.1.32),N' [5 溴-2-甲基-6-(1-苯基乙氧基)-3-吡啶基]-N-乙基-N-甲基-甲脒(K.1.33),N'-(2-甲基-5-三氟甲基-4-(3-三甲基矽烷基-丙氧基)-苯基)-N-乙基-N-甲基 甲脒(K.1.34),N'-(5-二氟甲基-2 甲基-4-(3-三甲基矽烷基-丙氧基)-苯基)-N-乙基-N-甲基 甲脒(K.1.35),2-(4-氯-苯基)-N-[4-(3,4-二甲氧基-苯基)-異噁唑-5 基]-2-丙-2-炔氧基-乙醯胺(K.1.36),3 [5-(4-氯-苯基)-2,3-二甲基-異噁唑啶-3-基]-吡啶 (啶菌噁唑(pyrisoxazole)) (K.1.37),3-[5-(4-甲基苯基)-2,3-二甲基-異噁唑啶-3 基]-吡啶(K.1.38),5-氯-1 (4,6-二甲氧基-嘧啶-2-基)-2-甲基-1H-苯并咪唑(K.1.39),(Z) 3 胺基-2-氰基-3-苯基-丙-2-烯酸乙酯(K.1.40),皮卡布西(picarbutrazox) (K.1.41),N-[6-[[(Z)-[(1-甲基四唑-5-基)-苯基-亞甲基]胺基]氧基甲基]-2-吡啶基]胺基甲酸戊酯(K.1.42),N-[6-[[(Z)-[(1-甲基四唑-5-基)-苯基-亞甲基]胺基]氧基甲基]-2-吡啶基]胺基甲酸丁-3-炔基酯(K.1.43),2-[2-[(7,8-二氟-2-甲基-3-喹啉基)氧基]-6-氟-苯基]丙-2-醇(K.1.44),2-[2-氟-6-[(8-氟-2-甲基-3-喹啉基)氧基]苯基]丙-2-醇(K.1.45),喹氟美林(quinofumelin) (K.1.47),9-氟-2,2-二甲基-5-(3-喹啉基)-3H 1,4 苯并噁氮呯(K.1.49),2-(6-苯甲基-2-吡啶基)喹唑啉(K.1.50),2-[6-(3-氟-4 甲氧基-苯基)-5-甲基-2-吡啶基]喹唑啉(K.1.51),二氯苯噻(dichlobentiazox) (K.1.52),N'-(2,5-二甲基-4-苯氧基-苯基)-N-乙基-N-甲基-甲脒(K.1.53); 二哌美酮(dipymetitrone)、異氟塞蘭(isoflucypram);氟英達派(fluindapyr)、英派氟先(inpyrfluxam)、派里芬胺(pyrifenamine)。In one embodiment of the invention, the invention relates to a mixture comprising: (1) at least one compound of formula (I) or a non-racemic compound of formula (I) as defined herein or having an enantiomer Compounds of formula (I), enantiomers, salts, tautomers, stereoisomers and N-oxides of compounds of formula (IR) or (IS) in excess, and (2) at least one compound II , which is selected from the following group: M.1 Acetylcholinesterase (AChE) inhibitors: M.1A carbamates, such as aldicarb, alanycarb, dimecarb (bendiocarb), benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, butyl carbosulfan, insecticide Ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, methiocarb (metolcarb), oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, trimethacarb, XMC, methacarb (xylylcarb) and triazamate; or M.1B organophosphates, such as acephate, azamethiphos, azinphos-ethyl, methyl triazine Azinphosmethyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, chlorpyrifos-methyl (coumaphos), cyanophos, demeton-S-methyl, diazinon, dichlorvos/DDVP, dicrotophos, dameton Dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos , fenitrothion, fenthion, fosthiazate, heptenophos, imicyafos, isofenphos, O-(methoxy-amino Thio-phosphoryl) isopropyl salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, methidathion (mevinphos), monocrotophos, naled, omethoate, oxydemeton-methyl, parathion, parathion- methyl), phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, methyl yatson ( pirimiphos-methyl), profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, moth control Sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, three Trichlorfon and vamidothion; M.2. GABA-gated chloride channel antagonists: M.2A cyclodiene organochlorine compounds, such as endosulfan or chlordane; or M.2B Phenylpyrazoles (fiproles) (phenylpyrazoles), such as ethiprole, fipronil, flufiprole, pyrazine and pyrafluprole Pyriprole; M.3 M.3A Pyrethroid sodium channel modulators such as acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, Bifenning (bifenthrin) (especially κ-bifenning), Baiyalenin (bioallethrin), Baiyalenin S-cyclopentenyl, resmethrin (bioresmethrin), promethrin ( cycloprothrin), cyfluthrin, β-saifuning, cyhalothrin, λ-sailuoning, γ-sailuoning, cypermethrin, α-saiminging, β- Cyphenin, θ-cyphenin, ζ-cyphenothrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, etofenprox ), fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvalinate, halfenprox, seven Heptafluthrin, imiprothrin, meperfluthrin, metofluthrin, momfluothrin (especially ε-mofluthrin), perfluthrin Permethrin, phenothrin, prallethrin, profluthrin, pyrethrin (pyrethrum), resmethrin, Silafluofen, tefluthrin (especially kappa-tefluthrin), tetramethylfluthrin, tetramethrin, tralomethrin, and bifluthrin (transfluthrin); or M.3B sodium channel modulators such as DDT or methoxychlor; M.4 Nicotinic acetylcholine receptor agonists (nAChR): M.4A neonicotinoid analogs ( neonicotinoids), such as acetamiprid, clothianidin, cycloxaprid, dinotefuran, imidacloprid, nitenpyram, thiacloprid ( thiacloprid) and thiamethoxam; or compound M.4A.1 4,5-dihydro-N-nitro-1-(2-oxiranylmethyl)-1H-imidazol-2-amine , M.4A.2: (2E-)-1-[(6-chloropyridin-3-yl)methyl]-N'-nitro-2-pentylidene carboxamidine; or M4.A.3: 1-[(6-chloropyridin-3-yl)methyl]-7-methyl-8-nitro-5-propoxy-1,2,3,5,6,7-hexahydroimidazo[ 1,2-a]pyridine; or M.4B Nicotine; M.4C Sulfoxaflor; M.4D Flupyradifurone; M.4E Triflumezopyrim; M .5 Nicotinic acetylcholine receptor ectopic activators: spinosyns, such as spinosad or spinetoram; M.6 avermectins and chloride channel activators of milbemycins, such as abamectin, emamectin benzoate, ivermectin, lepimectin, or M.7 Juvenile hormone mimetics, such as M.7A Juvenile hormone analogs hydroprene, kinoprene and methoprene; or M.7B Fenoxycarb, or M.7C pyriproxyfen; M.8 various non-specific (multi-site) inhibitors, such as M.8A alkyl halides, such as methyl bromide and other alkanes Base halide, M.8B chloropicrin (chloropicrin), M.8C sulfuryl fluoride, M.8D borax or M.8E tartar emetic; M.9 stringer TRPV channel modulator, such as M. 9B pymetrozine; pyrifluquinazon; M.10 Mite growth inhibitors such as M.10A clofentezine, hexythiazox and diflovidazin, or M.10B etoxazole; M.12 mitochondrial ATP synthase inhibitors, such as M.12A diafenthiuron or M.12B organotin insecticides, such as azocyclotin ), cyhexatin or fenbutatin oxide, M.12C propargite or M.12D tetradifon; M.13 Oxidative phosphorylation by disrupting the proton gradient Decouplers such as chlorfenapyr, DNOC or sulfluramid; M.14 Nicotinic acetylcholine receptor (nAChR) channel blockers such as nereistoxin analogues bensultap, cartap hydrochloride, thiocyclam or thiosultap sodium; M.15 Chitin biosynthesis type 0 inhibitors, such as benzoyl urea Classes such as bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron (lufenuron), novaluron, noviflumuron, teflubenzuron or triflumuron; M.16 Inhibitors of chitin biosynthesis type 1, such as ibufenuron ( buprofezin); M.17 Diptera insect molting disruptors, such as cyromazine; M.18 Ecdysone receptor agonists, such as dihydrazine, such as methoxyfenozide, defenox ( tebufenozide), halofenozide, fufenozide or chromafenozide; M.19 Octopamine receptor agonists such as amitraz; M.20 Mitochondria Complex III electron transport inhibitors, such as M.20A hydramethylnon, M.20B acequinocyl, M.20C fluacrypyrim; or M.20D bifenazate; M .21 Mitochondrial complex I electron transport inhibitors such as M.21A METI acaricides and insecticides such as fenazaquin, fenpyroximate, pyrimidifen, bidar Ben (pyridaben), tebufenpyrad or tolfenpyrad, or M.21B rotenone; M.22 voltage-dependent sodium channel blocker, such as M.22A indoxacarb , M.22B metaflumizone, or M.22B.1: 2-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylene ]-N-[4-(difluoromethoxy)phenyl]-hydrazine amide or M.22B.2: N-(3-chloro-2-methylphenyl)-2-[(4- Chlorophenyl)[4-[methyl(methylsulfonyl)amino]phenyl]methylene]-hydrazinamide; M.23 Inhibitors of acetyl CoA carboxylase, such as tetronic acid (Tetronic acid) and Tetramic acid derivatives, such as spirodiclofen, spiromesifen or spirotetramat; M.23.1 Spiropidion ; M.24 Mitochondrial complex IV electron transport inhibitors, for example M.24A Phosphines such as aluminum phosphide, calcium phosphide, phosphine or zinc phosphide, or M.24B Cyanides; M.25 Mitochondrial Electron transport inhibitors of complex II, such as β-ketonitrile derivatives, for example cyenopyrafen or cyflumetofen; M.28 Diamides of ryanodine Receptor modulators such as flubendiamide, chlorantraniliprole, cyantraniliprole, tetraniliprole, M.28.1: (R)- 3-chloro-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-N2-(1-methyl-2 -Methylsulfonylethyl)phthalamide, M.28.2: (S)-3-chloro-N1-{2-methyl-4-[1,2,2,2-tetrafluoro- 1-(trifluoromethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamide, M.28.3: cyclobromide ( cyclaniliprole) or M.28.4: Methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl ]carbonyl}amino)benzoyl]-1,2-dimethylcarbazate; or M.28.5a) N-[4,6-dichloro-2-[(diethyl-λ-4 -thio)aminoformyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; M.28.5b) N-[4-Chloro-2-[(diethyl-λ-4-sulfide)aminoformyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl) -5-(trifluoromethyl)pyrazole-3-carboxamide; M.28.5c) N-[4-chloro-2-[(di-2-propyl-λ-4-sulfide)amine Formyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; M.28.5d) N -[4,6-Dichloro-2-[(di-2-propyl-λ-4-sulfide)aminoformyl]-phenyl]-2-(3-chloro-2-pyridyl) -5-(trifluoromethyl)pyrazole-3-carboxamide; M.28.5h) N-[4,6-dibromo-2-[(diethyl-λ-4-sulfide)amine Formyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; M.28.5i) N-[2-( 5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridyl)-1H -pyrazole-5-carboxamide; M.28.5j) 3-chloro-1-(3-chloro-2-pyridyl)-N-[2,4-dichloro-6-[[(1-cyano Base-1-methylethyl)amino]carbonyl]phenyl]-1H-pyrazole-5-carboxamide; M.28.5k) 3-bromo-N-[2,4-dichloro-6- (Methylcarbamoyl)phenyl]-1-(3,5-dichloro-2-pyridyl)-1H-pyrazole-5-carboxamide; M.28.5l) N-[4-chloro -2-[[(1,1-Dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridyl)-3-(fluoromethoxy )-1H-pyrazole-5-carboxamide; or M.28.6: cyhalodiamide; or M.29: cyhalodiamide - undetermined target site, e.g. Amines (flonicamid); M.UN. Insecticidal active compounds with unknown or unclear modes of action, such as afidopyropen, afoxolaner, azadirachtin, and amflumet (amidoflumet), benzoximate, broflanilide, bromopropylate, chinomethionat, cryolite, dicloromezotiaz, Dicofol, flufenerim, flometoquin, fluensulfone, fluhexafon, fluopyram, peralana (fluralaner), metoxadiazone, piperonyl butoxide, pyflubumide, pyridalyl, tioxazafen, M.UN.3: 11-(4-Chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-ene-10 - Keto, M.UN.4: 3-(4'-Fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]decane -3-en-2-one, M.UN.5: 1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl] -3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine, or an active agent based on bacillus firmus (Votivo, I-1582); M.UN.6 : Flupyrimin (flupyrimin); M.UN.8: Trifluzaindolizine; M.UN.9.a): 4-[5-(3,5-dichlorophenyl)-5 -(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide; M.UN .9.b): Fluxametamide; M.UN.10: 5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy ]propoxy]-1H-pyrazole; M.UN.11.b) 3-(benzoylmethylamino)-N-[2-bromo-4-[1,2,2,3,3 ,3-Hexafluoro-1-(trifluoromethyl)propyl]-6-(trifluoromethyl)phenyl]-2-fluoro-benzamide; M.UN.11.c) 3-( Benzoylmethylamino)-2-fluoro-N-[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(tri fluoromethyl)phenyl]-benzamide; M.UN.11.d) N-[3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-( Trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; M.UN.11.e) N-[ 3-[[[2-bromo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl ]-2-fluoro-phenyl]-4-fluoro-N-methyl-benzamide; M.UN.11.f) 4-fluoro-N-[2-fluoro-3-[[[2- Iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N- Methyl-benzamide; M.UN.11.g) 3-fluoro-N-[2-fluoro-3-[[[2-iodo-4-[1,2,2,2-tetrafluoro- 1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; M.UN.11.h) 2-Chloro-N-[3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl) phenyl]amino]carbonyl]phenyl]-3-pyridinecarboxamide; M.UN.11.i) 4-cyano-N-[2-cyano-5-[[2,6-dibromo -4-[1,2,2,3,3,3-Hexafluoro-1-(trifluoromethyl)propyl]phenyl]aminoformyl]phenyl]-2-methyl-benzoyl Amine; M.UN.11.j) 4-cyano-3-[(4-cyano-2-methyl-benzoyl)amino]-N-[2,6-dichloro-4- [1,2,2,3,3,3-Hexafluoro-1-(trifluoromethyl)propyl]phenyl]-2-fluoro-benzamide; M.UN.11.k) N- [5-[[2-Chloro-6-cyano-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl ]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; M.UN.11.l) N-[5-[[2-bromo-6-chloro-4 -[2,2,2-Trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2 -Methyl-benzamide; M.UN.11.m) N-[5-[[2-bromo-6-chloro-4-[1,2,2,3,3,3-hexafluoro- 1-(Trifluoromethyl)propyl]phenyl]aminoformyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; M.UN.11. n) 4-cyano-N-[2-cyano-5-[[2,6-dichloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethane yl)propyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide; M.UN.11.o) 4-cyano-N-[2-cyano-5- [[2,6-Dichloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]aminoformyl]phenyl]-2-methyl -Benzamide; M.UN.11.p) N-[5-[[2-bromo-6-chloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl ) ethyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; or M.UN.12.a) 2-(1 ,3-dioxan-2-yl)-6-[2-(3-pyridyl)-5-thiazolyl]-pyridine; M.UN.12.b) 2-[6-[2 -(5-fluoro-3-pyridyl)-5-thiazolyl]-2-pyridyl]-pyrimidine; M.UN.12.c) 2-[6-[2-(3-pyridyl)-5 -thiazolyl]-2-pyridyl]-pyrimidine; M.UN.12.d) N-methylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridin-2- Formamide; M.UN.12.e) N-Methylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide; M.UN.12 .f) N-ethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propionamide; M.UN.12.g) N -Methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propionamide; M.UN.12.h) N,2-di Methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propionamide; M.UN.12.i) N-ethyl-2 -Methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propionamide; M.UN.12.j) N-[4- Chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-2-methyl-3-methylthio-propionamide; M.UN.12.k) N-[4- Chloro-2-(3-pyridyl)thiazol-5-yl]-N,2-dimethyl-3-methylthio-propionamide; M.UN.12.l) N-[4-chloro- 2-(3-pyridyl)thiazol-5-yl]-N-methyl-3-methylthio-propionamide; M.UN.12.m) N-[4-chloro-2-(3- Pyridyl)thiazol-5-yl]-N-ethyl-3-methylthio-propionamide; M.UN.14a) 1-[(6-chloro-3-pyridyl)methyl]-1, 2,3,5,6,7-Hexahydro-5-methoxy-7-methyl-8-nitro-imidazo[1,2-a]pyridine; or M.UN.14b) 1-[ (6-chloropyridin-3-yl)methyl]-7-methyl-8-nitro-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridine-5 -alcohol; M.UN.16a) 1-isopropyl-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; or M.UN.16b) 1- (1,2-Dimethylpropyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; M.UN.16c) N,5- Dimethyl-N-pyridazin-4-yl-1-(2,2,2-trifluoro-1-methyl-ethyl)pyrazole-4-carboxamide; M.UN.16d) 1- [1-(1-cyanocyclopropyl)ethyl]-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; M.UN.16e) N-ethyl-1-(2-fluoro-1-methyl-propyl)-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; M.UN.16f) 1-(1,2-Dimethylpropyl)-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; M.UN.16g) 1-[1 -(1-cyanocyclopropyl)ethyl]-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; M.UN.16h) N-methyl -1-(2-fluoro-1-methyl-propyl]-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; M.UN.16i) 1-(4 ,4-difluorocyclohexyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; or M.UN.16j) 1-(4,4 -Difluorocyclohexyl)-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide, M.UN.17a) N-(1-methylethyl)- 2-(3-pyridyl)-2H-indazole-4-carboxamide; M.UN.17b) N-cyclopropyl-2-(3-pyridyl)-2H-indazole-4-carboxamide Amine; M.UN.17c) N-cyclohexyl-2-(3-pyridyl)-2H-indazole-4-carboxamide; M.UN.17d) 2-(3-pyridyl)-N- (2,2,2-Trifluoroethyl)-2H-indazole-4-carboxamide; M.UN.17e) 2-(3-pyridyl)-N-[(tetrahydro-2-furyl )Methyl]-2H-indazol-5-carboxamide; M.UN.17f) Methyl 2-[[2-(3-pyridyl)-2H-indazol-5-yl]carbonyl]hydrazinecarboxylate ; M.UN.17g) N-[(2,2-difluorocyclopropyl)methyl]-2-(3-pyridyl)-2H-indazole-5-carboxamide; M.UN.17h ) N-(2,2-difluoropropyl)-2-(3-pyridyl)-2H-indazole-5-carboxamide; M.UN.17i) 2-(3-pyridyl)-N -(2-pyrimidinylmethyl)-2H-indazole-5-carboxamide; M.UN.17j) N-[(5-methyl-2-pyrazinyl)methyl]-2-(3 -pyridyl)-2H-indazole-5-carboxamide, M.UN.18a) N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl- 3-(3,3,3-Trifluoropropylthio)propionamide; M.UN.18b) N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N -Ethyl-3-(3,3,3-trifluoropropylsulfinyl)propionamide; M.UN.18c) N-[3-chloro-1-(3-pyridyl)pyrazole- 4-yl]-3-[(2,2-difluorocyclopropyl)methylthio]-N-ethyl-acrylamide; M.UN.18d) N-[3-chloro-1-( 3-pyridyl)pyrazol-4-yl]-3-[(2,2-difluorocyclopropyl)methylsulfinyl]-N-ethyl-acrylamide; M.UN.19Sa Lolaner (sarolaner), M.UN.20 Lotilaner (lotilaner); M.UN.21 N-[4-chloro-3-[[(phenylmethyl)amino]carbonyl]phenyl] -1-Methyl-3-(1,1,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)-1H-pyrazole-5-carboxamide; M.UN.22a 2-(3-Ethylsulfonyl-2-pyridyl)-3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridine, or M.UN.22b 2-[ 3-Ethylsulfonyl-5-(trifluoromethyl)-2-pyridyl]-3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridine; M.UN .23a 4-[5-(3,5-Dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-N-[(4R)-2-ethyl- 3-oxoisoxazolidine-4-yl]-2-methyl-benzamide, or M.UN.23b 4-[5-(3,5-dichloro-4-fluoro-phenyl )-5-(trifluoromethyl)-4H-isoxazol-3-yl]-N-[(4R)-2-ethyl-3-oxo-isoxazolidine-4-yl]- 2-Methyl-benzamide; M.UN.24a) N-[4-chloro-3-(cyclopropylaminoformyl)phenyl]-2-methyl-5-(1,1, 2,2,2-Pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3-carboxamide or M.UN.24b) N-[4-chloro-3-[(1-cyano Cyclopropyl)aminoformyl]phenyl]-2-methyl-5-(1,1,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3- Formamide; M.UN.25 Ainuo Pai Rui (acynonapyr); M.UN.26 Benzpyrimoxan (benzpyrimoxan); M.UN.27 2-Chloro-N-(1-cyanocyclopropyl)- 5-[1-[2-Methyl-5-(1,1,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yl]pyrazole-4- base] benzamide; M.29.28 oxazosulfyl (oxazosulfyl) (2-(3-ethylsulfonyl-2-pyridyl)-5-(trifluoromethylsulfonyl)-1,3 - benzoxazole); A) respiratory inhibitors - inhibitors of complex III of the Qo site: azoxystrobin (A.1.1), coumethoxystrobin (A.1.2), clove coumoxystrobin (A.1.3), dimoxystrobin (A.1.4), enestroburin (A.1.5), fenaminstrobin (A.1.6), Fenoxystrobin/flufenoxystrobin (A.1.7), fluoxastrobin (A.1.8), kresoxim-methyl (A.1.9), Mandalore Ice (mandestrobin) (A.1.10), fenoxystrobin (metominostrobin) (A.1.11), orysastrobin (orysastrobin) (A.1.12), picoxystrobin (picoxystrobin) (A.1.13), hundred Kemin (pyraclostrobin) (A.1.14), pyraclostrobin (pyrametostrobin) (A.1.15), pyraoxystrobin (pyraoxystrobin) (A.1.16), trifluorosensitive (trifloxystrobin) (A.1.17), 2 (2 -(3-(2,6-dichlorophenyl)-1-methyl-allylaminooxymethyl)-phenyl)-2 methoxyimino-N methyl-acetamide ( A.1.18), pyribencarb (A.1.19), triclopyricarb/chlorodincarb (A.1.20), famoxadone (A.1.21 ), Fenamidone (A.1.21), methyl-N-[2-[(1,4-dimethyl-5-phenyl-pyrazol-3-yl)oxymethyl]phenyl ]-N-methoxy-carbamate (A.1.22), 1-[3-chloro-2[[1(4-chlorophenyl)-1H-pyrazol-3-yl]oxymethyl Base] phenyl] -4-methyl-tetrazol-5-one (A.1.23), 1-[3-bromo-2-[[1-(4-chlorophenyl) pyrazole-3-yl] Oxymethyl]phenyl]-4-methyl-tetrazol-5-one (A.1.24), 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxy Methyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one (A.1.25), 1-[2-[[1-(4-chlorophenyl)pyrazole- 3-yl]oxymethyl]-3-fluoro-phenyl]-4-methyl-tetrazol-5-one (A.1.26), 1-[2-[[1-(2,4-two Chlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl]-4-methyl-tetrazol-5-one (A.1.27), 1-[3-cyclopropyl -2-[[2-Methyl-4 (1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl-tetrazol-5-one (A.1.30), 1 [3 (difluoromethoxy)-2-[[2-methyl-4-(1 methylpyrazol-3 base)phenoxy]methyl]phenyl]-4 methyl-tetrazole-5 - Ketone (A.1.31), 1-methyl-4-[3-methyl-2 [[2 methyl-4-(1-methylpyrazol-3 base) phenoxy] methyl] phenyl ]tetrazol-5-one (A.1.32), (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxyl-2-methoxyimine Base-N,3-dimethyl-pent-3-enamide (A.1.34), (Z,2E) 5 [1 (4-chlorophenyl) pyrazol-3-yl] oxy-2- Methoxyimino-N,3-dimethyl-pent-3-enamide (A.1.35), pyriminostrobin (A.1.36), pyrflustrobin (bifujunzhi) (A.1.37 ), 2-(o-((2,5-dimethylphenyl-oxy-methylene)phenyl)-3-methoxy-methyl acrylate (A.1.38); Inhibitors of complex III: cyazofamid (A.2.1), amisulbrom (A.2.2), [(6S,7R,8R) 2-methylpropionic acid 8 benzyl Base-3-[(3-hydroxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-two-side oxy-1,5-two-side oxynonyl- 7-yl] esters (A.2.3), fenpicoxamid (A.2.4); - complex II inhibitors: benodanil (A.3.1), benzacrylfluconazole ( benzovindiflupyr) (A.3.2), bixafen (A.3.3), boscalid (A.3.4), carboxin (A.3.5), fenfuram (A.3.6), fluopyram (fluopyram) (A.3.7), fudolanil (flutolanil) (A.3.8), fluoxapyroxad (fluxapyroxad) (A.3.9), Fulabi ( furametpyr (A.3.10), isofetamid (A.3.11), isopyrazam (A.3.12), mepronil (A.3.13), Carborough ( oxycarboxin) (A.3.14), penflufen (A.3.15), penthiopyrad (A.3.16), pydiflumetofen (A.3.17), pyridoxine Pyraziflumid (A.3.18), sedaxane (A.3.19), tecloftalam (A.3.20), thifluzamide (A.3.21), 3 (difluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4 carboxamide (A.3.22), 3 (trifluoromethyl Base)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4 carboxamide (A.3.23), 1,3-dimethyl-N- (1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.24), 3-(trifluoromethyl)-1,5 dimethyl-N-( 1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.25), 1,3,5-trimethyl-N-(1,1,3-tri Methylindan-4-yl)pyrazole-4-carboxamide (A.3.26), 3-(difluoromethyl)-1,5 dimethyl-N-(1,1,3-trimethyl Indan-4-yl)pyrazole-4-carboxamide (A.3.27), 3-(difluoromethyl)-N(7-fluoro-1,1,3-trimethyl-indan-4 -yl)-1-methyl-pyrazole-4-carboxamide (A.3.28), N-[(5-chloro-2-isopropyl-phenyl)methyl]-N-cyclopropyl- 5-fluoro-1,3-dimethyl-pyrazole-4-carboxamide (A.3.29), (E)-2-[2-[(5-cyano-2-methyl-phenoxy ) methyl] phenyl] -3-methoxy-prop-2-enoic acid methyl ester (A.3.30), N-[(5-chloro-2-isopropyl-phenyl) methyl]-N- Cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-pyrazole-4-carboxamide (A.3.31), 2-(difluoromethyl)-N-(1,1 , 3-trimethyl-indan-4-yl)pyridine-3-carboxamide (A.3.32), 2-(difluoromethyl)-N-[(3R)-1,1,3-tri Methylindan-4-yl]pyridine-3-carboxamide (A.3.33), 2-(difluoromethyl)-N-(3-ethyl-1,1-dimethyl-indan- 4-yl)pyridine-3-carboxamide (A.3.34), 2-(difluoromethyl)-N-[(3R)-3-ethyl-1,1-dimethyl-indan-4 - Base] pyridine-3-carboxamide (A.3.35), 2-(difluoromethyl)-N-(1,1-dimethyl-3-propyl-indan-4-yl)pyridine- 3-formamide (A.3.36), 2-(difluoromethyl)-N-[(3R)-1,1-dimethyl-3-propyl-indan-4-yl]pyridine-3 -Formamide (A.3.37), 2-(difluoromethyl)-N-(3-isobutyl-1,1-dimethyl-indan-4-yl)pyridine-3-formamide (A.3.38), 2-(difluoromethyl)-N-[(3R)-3-isobutyl-1,1-dimethyl-indan-4 base]pyridine-3-formamide ( A.3.39); - other respiratory inhibitors: diflumetorim (A.4.1); nitrophenyl derivatives: binapacryl (A.4.2), dinobuton (A. 4.3), dinocap (A.4.4), fluazinam (A.4.5), meptyldinocap (A.4.6), ferimzone (A.4.7); Organometallic compounds: fentin salts, such as fentin-acetate (A.4.8), fentin chloride (A.4.9) or fentin hydroxide ) (A.4.10); ametoctradin (A.4.11); silthiofam (A.4.12); B) Sterol biosynthesis inhibitors (SBI fungicides) - C14 to Methylase inhibitors: triazoles: azaconazole (B.1.1), bitertanol (B.1.2), bromuconazole (B.1.3), cyclogram ( cyproconazole) (B.1.4), difenoconazole (B.1.5), diniconazole (B.1.6), diniconazole-M (B.1.7), epoxiconazole (B.1.8), fenbuconazole (B.1.9), fluquinazole (fluquinconazole) (B.1.10), flusilazole (B.1.11), flutriafol (B.1.11) .1.12), hexaconazole (B.1.13), imibenconazole (B.1.14), ipconazole (B.1.15), metconazole (B.1.17), Myclobutanil (B.1.18), oxpoconazole (B.1.19), paclobutrazole (B.1.20), penconazole (B.1.21), propiconazole ( B.1.22), prothioconazole (B.1.23), simeconazole (B.1.24), tebuconazole (B.1.25), tetraconazole (B.1.26 ), triadimefon (B.1.27), triadimenol (B.1.28), triticonazole (B.1.29), uniconazole (B.1.30), Yifen Triconazole (ipfentrifluconazole) (B.1.37), mefentrifluconazole (B.1.38), 2-(chloromethyl)-2-methyl-5-(p-tolylmethyl)-1 (1,2,4-triazol-1-ylmethyl)cyclopentanol (B.1.43); imidazoles: imazalil (B.1.44), pefurazoate (B.1.45 ), prochloraz (B.1.46), triflumizol (B.1.47); pyrimidines, pyridines and piperazines: fenarimol (B.1.49), bifen Pyrifenox (B.1.50), triforine (B.1.51), [3-(4-chloro-2-fluoro-phenyl)-5-(2,4-difluorophenyl) Isoxazol-4-yl]-(3-pyridyl)methanol (B.1.52); - δ14-reductase inhibitors: adimorph (aldimorph) (B.2.1), mobendazim (dodemorph) (B .2.2), dodemorph-acetate (B.2.3), fenpropimorph (B.2.4), tridemorph (B.2.5), fenpropidin (B.2.6), piperalin (B.2.7), spiroxamine (B.2.8); - 3-keto reductase inhibitors: fenhexamid ( B.3.1); - Other sterol biosynthesis inhibitors: chlorphenomizole (B.4.1); C) Nucleic acid synthesis inhibitors - phenylamide or amido-amino acid fungicides: Benzolid benalaxyl (C.1.1), metalaxyl benalaxyl (benalaxyl-M) (C.1.2), fine benalaxyl (kiralaxyl) (C.1.3), metalaxyl (metalaxyl) (C.1.4 ), metalaxyl-M (C.1.5), ofurace (C.1.6), oxadixyl (C.1.7); Hymexazole (C.2.1), octhilinone (C.2.2), oxolinic acid (C.2.3), bupirimate (C.2.4), 5- Flucytosine (C.2.5), 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4amine (C.2.6), 5-fluoro-2-(4-fluorophenylmethoxy)pyrimidine -4-amine (C.2.7), 5-fluoro-2(4-chlorophenylmethoxy)pyrimidin-4-amine (C.2.8); D) Inhibitors of cell division and cytoskeleton - tubulin inhibitors: immunity Benomyl (D.1.1), carbendazim (D.1.2), fuberidazole (D1.3), thiabendazole (D.1.4), thiophanate-methyl (thiophanate-methyl) (D.1.5), 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyridazine (D.1.6), 3-chloro- 6-methyl-5-phenyl-4-(2,4,6-trifluorophenyl)pyridazine (D.1.7), N ethyl-2-[(3-ethynyl-8-methyl- 6-quinolyl)oxy]butyramide (D.1.8), N-ethyl-2-[(3-ethynyl-8 methyl-6 quinolinyl)oxy]-2-methylthio Base-acetamide (D.1.9), 2-[(3-ethynyl-8-methyl-6-quinolin-yl)oxy]-N (2-fluoroethyl)butyramide (D. 1.10), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-N-(2-fluoroethyl)-2-methoxy-acetamide (D.1.11 ), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-N-propyl-butyramide (D.1.12), 2-[(3-ethynyl-8 -Methyl-6-quinolyl)oxy]-2-methoxy-N-propyl-acetamide (D.1.13), 2-[(3-ethynyl-8-methyl-6- Quinolinyl)oxy]-2-methylthio-N-propyl-acetamide (D.1.14), 2 [(3 ethynyl-8-methyl-6-quinolyl)oxy] -N-(2-fluoroethyl)-2-methylsulfanyl-acetamide (D.1.15), 4-(2-bromo-4-fluoro-phenyl)-N-(2-chloro-6 - fluoro-phenyl)-2,5-dimethyl-pyrazol-3-amine (D.1.16); - other cell division inhibitors: diethofencarb (D.2.1), ethaboxam ) (D.2.2), pencycuron (D.2.3), fluopicolide (D.2.4), zoxamide (D.2.5), metrafenone ( D.2.6), pyriofenone (D.2.7); E) amino acid and protein synthesis inhibitors - methionine synthesis inhibitors: cyprodinil (E.1.1), pyrimidine mepanipyrim (E.1.2), pyrimethanil (E.1.3); - protein synthesis inhibitors: blasticidin-S (blasticidin-S) (E.2.1), kasugamycin (kasugamycin) (E.2.2), kasugamycin hydrochloride hydrate (E.2.3), midiomycin (mildiomycin) (E.2.4), streptomycin (E.2.5), oxytetracycline (oxytetracyclin) (E.2.6); F) Signal transduction inhibitors - MAP/histidine kinase inhibitors: fluoroimid (F.1.1), iprodione (F.1.2), procymidone (F.1.3), vinclozolin (F.1.4), fludioxonil (F.1.5); - G protein inhibitors: quinoxyfen (F.2.1 ); G) Inhibitors of lipid and membrane synthesis - phospholipid biosynthesis inhibitors: edifenphos (G.1.1), propyl pine (iprobenfos) (G.1.2), pyrazophos (G. 1.3), isoprothiolane (G.1.4); - lipid peroxidation: dicloran (G.2.1), quintozene (G.2.2), tetrachloronitro Benzene (tecnazene) (G.2.3), tolclofos-methyl (G.2.4), biphenyl (G.2.5), chloroneb (G.2.6), etridiazole (G.2.7); - Phospholipid biosynthesis and cell wall deposition: dimethomorph (G.3.1), flumorph (G.3.2), mandipropamid (G.3.3 ), pyrimorph (G.3.4), benthiavalicarb (G.3.5), iprovalicarb (G.3.6), valifenalate ( G.3.7); - Compounds affecting cell membrane permeability and fatty acids: propamocarb (G.4.1); - Inhibitors of oxidosterol-binding proteins: oxathiapiprolin (G.5.1), A Sulfonic acid 2-{3-[2-(1-{[3,5-bis(difluoromethyl-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3 -Thiazol-4-yl]-4,5-dihydro-1,2 oxazol-5-yl}phenyl ester (G.5.2), methanesulfonic acid 2-{3-[2-(1-{[3 ,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)1,3-thiazol-4-yl]-4,5-dihydro-1 ,2-oxazol-5 base}-3-chlorophenyl ester (G.5.3), 4-[1-[2-[3-(difluoromethyl)-5-methyl-pyrazol-1-yl ]acetyl]-4-piperidinyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.4), 4-[1-[2-[3,5-bis( Difluoromethyl)pyrazol-1-yl]acetyl]-4-piperidinyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.5), 4-[1 -[2-[3-(Difluoromethyl)-5-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-piperidinyl]-N-tetralin-1-yl- Pyridine-2-carboxamide (G.5.6), 4-[1-[2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetyl]-4- Piperidinyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.7), 4-[1-[2-[5-methyl-3-(trifluoromethyl)pyridine Azol-1-yl]acetyl]-4-piperidinyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.8), 4-[1-[2-[5 -(Difluoromethyl)-3-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-piperidinyl]-N-tetralin-1-yl-pyridine-2-formyl Amine (G.5.9), 4[1[2-[3,5-bis(trifluoromethyl)pyrazol-1-yl]acetyl]-4-piperidinyl]-N-tetralin-1 -yl-pyridine-2-carboxamide (G.5.10), (4-[1-[2-[5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]acetyl ]-4-piperidinyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.11); H) Inhibitor with multi-site action - Inorganic active substance: Bordeaux mixture (H .1.1), copper (H.1.2), copper acetate (H.1.3), copper hydroxide (H.1.4), basic copper oxychloride (H.1.5), basic copper sulfate (H.1.6), sulfur (H.1.7); - Thio- and dithiocarbamates: ferbam (H.2.1), zinc manganese (mancozeb) (H.2.2), manganese (maneb) ( H.2.3), metam (H.2.4), metiram (H.2.5), propineb (H.2.6), thiram (H. 2.7), zineb (H.2.8), ziram (H.2.9); - organochlorine compounds: anilazine (H.3.1), chlorothalonil ) (H.3.2), captafol (H.3.3), captan (captan) (H.3.4), folpet (H.3.5), dichlofluanid (H. .3.6), dichlorophen (dichlorophen) (H.3.7), hexachlorobenzene (H.3.8), pentachlorophenol (H.3.9) and its salts, phthalide (phthalide) (H.3.10), methyl Yifaling (tolylfluanid) (H.3.11); - Guanidines and others: guanidine (H.4.1), dodine (H.4.2), donin free base (H.4.3), biguanide salt (guazatine) (H.4.4), biguanide salt acetate (H.4.5), kerejing (iminoctadine) (H.4.6), kerejing triacetate (H.4.7), gramrejing ginseng (alkane benzene sulfonate ) (H.4.8), dithianon (dithianon) (H.4.9), 2,6-dimethyl-1H,5H-[1,4]dithiano[2,3-c:5,6 -c'] dipyrrole-1,3,5,7(2H,6H)-tetraketone (H.4.10); I) cell wall synthesis inhibitor-dextran synthesis inhibitor: validamycin (validamycin) ( I.1.1), polyoxin B (I.1.2); - melanin synthesis inhibitors: pyroquilon (I.2.1), tricyclazole (I.2.2), Carpropamid (I.2.3), dicyclomet (I.2.4), fenoxanil (I.2.5); J) Plant protection inducers - acidified benzothiadiene Acibenzolar-S-methyl (acibenzolar-S-methyl) (J.1.1), probenazole (J.1.2), isotianil (J.1.3), tiadinil ( J.1.4), prohexadione-calcium (J.1.5); phosphonates: fosetyl (J.1.6), fosetyl-aluminum (J.1.7), Phosphorous acid and its salts (J.1.8), calcium phosphonate (J.1.11), potassium phosphonate (J.1.12), potassium or sodium bicarbonate (J.1.9), 4 cyclopropyl-N-( 2,4-Dimethoxyphenyl)thiadiazole-5-carboxamide (J.1.10); K) Mode of action unknown - bronopol (K.1.1), chinomethionat (K.1.2), cyflufenamid (K.1.3), cymoxanil (K.1.4), dazomet (K.1.5), debacarb (K. 1.6), Diclocymet (K.1.7), Diclomezine (K.1.8), Difenzoquat (K.1.9), Difenzoquat methyl sulfate (K. 1.10), diphenylamine (K.1.11), fenitropan (K.1.12), fenpyrazamine (K.1.13), flumetover (K. 1.14), Flusulfamide (K.1.15), Flutianil (K.1.16), Harpin (K.1.17), Metha-sulfocarb (K. 1.18), nitrapyrin (K.1.19), nitrothal-isopropyl (K.1.20), tolprocarb (K.1.21), oxin-copper ( K.1.22), Proquinazid (K.1.23), Tebufloquin (K.1.24), Tecloftalam (K.1.25), Triazoxide ( K.1.26), N'-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methylformamidine (K.1.27), N'(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methylmethanol Amidine (K.1.28), N'-[4-[[3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl]oxy]-2,5 -Dimethyl-phenyl]-N-ethyl-N-methyl-formamidine (K.1.29), N'-(5-bromo-6-indan-2-yloxy-2-methyl -3-pyridyl)-N-ethyl-N-methyl-formamidine (K.1.30), N'-[5-bromo-6-[1-(3,5-difluorophenyl)ethoxy Base]-2-methyl-3-pyridyl]-N-ethyl-N-methyl-formamidine (K.1.31), N'-[5-bromo-6-(4-isopropylcyclohexane Oxygen)-2-methyl-3-pyridyl]-N-ethyl-N-methyl-formamidine (K.1.32), N'[5 bromo-2-methyl-6-(1-benzene Ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine (K.1.33), N'-(2-methyl-5-trifluoromethyl-4-(3 -Trimethylsilyl-propoxy)-phenyl)-N-ethyl-N-methylformamidine (K.1.34), N'-(5-difluoromethyl-2 methyl-4- (3-trimethylsilyl-propoxy)-phenyl)-N-ethyl-N-methylformamidine (K.1.35), 2-(4-chloro-phenyl)-N-[4 -(3,4-dimethoxy-phenyl)-isoxazol-5 base]-2-prop-2-ynyloxy-acetamide (K.1.36), 3 [5-(4-chloro -phenyl)-2,3-dimethyl-isoxazolidine-3-yl]-pyridine (pyrisoxazole (pyrisoxazole)) (K.1.37), 3-[5-(4-methylbenzene Base)-2,3-dimethyl-isoxazolidine-3 base]-pyridine (K.1.38), 5-chloro-1 (4,6-dimethoxy-pyrimidin-2-yl)-2 -Methyl-1H-benzimidazole (K.1.39), (Z) 3 amino-2-cyano-3-phenyl-prop-2-enoic acid ethyl ester (K.1.40), picabucil ( picarbutrazox) (K.1.41), N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2 -pyridyl]amyl carbamate (K.1.42), N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino] Oxymethyl]-2-pyridyl]but-3-ynyl carbamate (K.1.43), 2-[2-[(7,8-difluoro-2-methyl-3-quinoline Base) oxy]-6-fluoro-phenyl]propan-2-ol (K.1.44), 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl) Oxy]phenyl]propan-2-ol (K.1.45), quinofumelin (K.1.47), 9-fluoro-2,2-dimethyl-5-(3-quinolinyl )-3H 1,4 benzoxazepine (K.1.49), 2-(6-benzyl-2-pyridyl)quinazoline (K.1.50), 2-[6-(3-fluoro- 4 methoxy-phenyl)-5-methyl-2-pyridyl]quinazoline (K.1.51), dichlorobenzenethia (dichlobentiazox) (K.1.52), N'-(2,5-di Methyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine (K.1.53); dipymetitrone (dipymetitrone), isoflurane (isoflucypram); Fluinda Fluindapyr, inpyrfluxam, pyrifenamine.

以上列出之M組的市售化合物可見於The Pesticide Manual, 第17版, C. MacBean, British Crop Protection Council (2015)以及其他出版物。在線殺有害生物劑手冊定期更新,可經由http://bcpcdata.com/pesticide-manual.html訪問。Commercially available compounds of Group M listed above can be found in The Pesticide Manual, 17th Edition, C. MacBean, British Crop Protection Council (2015) and other publications. The online Pesticide Manual is regularly updated and can be accessed at http://bcpcdata.com/pesticide-manual.html.

另一個提供ISO通用名稱之殺有害生物劑在線資料庫為http://www.alanwood.net/pesticides。Another online database of pesticides that provides ISO common names is http://www.alanwood.net/pesticides.

M.4環氧蟲啶由WO2010/069266及WO2011/069456已知。M.4A.1由CN 103814937;CN105367557、CN 105481839已知。M.4A.2戊吡蟲胍(guadipyr)由WO 2013/003977已知,且M.4A.3 (在中國核准為哌蟲啶(paichongding))由WO 2007/101369已知。M.22B.1描述於CN10171577中且M.22B.2描述於CN102126994中。螺派酮M.23.1由WO 2014/191271已知。M.28.1及M.28.2由WO2007/101540已知。M.28.3描述於WO2005/077934中。M.28.4描述於WO2007/043677中。M.28.5a)至M.28.5d)及M.28.5h)描述於WO 2007/006670、WO2013/024009及WO 2013/024010中,M.28.5i)描述於WO2011/085575中,M.28.5j)描述於WO2008/134969中,M.28.5k)描述於US2011/046186中且M.28.5l)描述於WO2012/034403中。M.28.6可見於WO2012/034472中。M.UN.3由WO2006/089633已知且M.UN.4由WO2008/067911已知。M.UN.5描述於WO2006/043635中,且基於強固芽胞桿菌之生物控制劑描述於WO2009/124707中。氟吡嘧描述於WO2012/029672中。M.UN.8由WO2013/055584已知。M.UN.9.a)描述於WO2013/050317中。M.UN.9.b)描述於WO2014/126208中。M.UN.10由WO2010/060379已知。溴蟲氟苯雙醯胺及M.UN.11.b)至M.UN.11.h)描述於WO2010/018714中,且M.UN.11i)至M.UN.11.p)描述於WO 2010/127926中。M.UN.12.a)至M.UN.12.c)由WO2010/006713已知,M.UN.12.d)及M.UN.12.e)由WO2012/000896已知,且M.UN.12.f)至M.UN.12.m)由WO 2010/129497已知。M.UN.14a)及M.UN.14b)由WO2007/101369已知。M.UN.16.a)至M.UN.16h)分別描述於WO2010/034737、WO2012/084670及WO2012/143317中,且M.UN.16i)及M.UN.16j)描述於WO2015/055497中。M.UN.17a)至M.UN.17.j)描述於WO2015/038503中。M.UN.18a)至M.UN.18d)描述於US2014/0213448中。M.UN.19描述於WO2014/036056中。M.UN.20由WO2014/090918已知。M.UN.21由EP2910126已知。M.UN.22a及M.UN.22b由WO2015/059039及WO2015/190316已知。M.UN.23a及M.UN.23b由WO2013/050302已知。M.UN.24a及M.UN.24b由WO2012/126766已知。艾諾派瑞M.UN.25由WO 2011/105506已知。苯吡莫安M.UN.26由WO2016/104516已知。M.UN.27由WO2016174049已知。化合物M.29.28由WO2017104592已知。M.4 Cyclopyrid is known from WO2010/069266 and WO2011/069456. M.4A.1 is known from CN 103814937; CN105367557, CN 105481839. M.4A.2 guadipyr is known from WO 2013/003977 and M.4A.3 (approved in China as paichongding) is known from WO 2007/101369. M.22B.1 is described in CN10171577 and M.22B.2 is described in CN102126994. Spiperone M.23.1 is known from WO 2014/191271. M.28.1 and M.28.2 are known from WO2007/101540. M.28.3 is described in WO2005/077934. M.28.4 is described in WO2007/043677. M.28.5a) to M.28.5d) and M.28.5h) are described in WO 2007/006670, WO 2013/024009 and WO 2013/024010, M.28.5i) in WO 2011/085575, M.28.5j ) is described in WO2008/134969, M.28.5k) in US2011/046186 and M.28.5l) in WO2012/034403. M.28.6 can be found in WO2012/034472. M.UN.3 is known from WO2006/089633 and M.UN.4 is known from WO2008/067911. M.UN.5 is described in WO2006/043635 and Bacillus firmus based biocontrol agents are described in WO2009/124707. Fluoropyrazines are described in WO2012/029672. M.UN.8 is known from WO2013/055584. M.UN.9.a) is described in WO2013/050317. M.UN.9.b) is described in WO2014/126208. M.UN.10 is known from WO2010/060379. Bromfluflubenil and M.UN.11.b) to M.UN.11.h) are described in WO2010/018714, and M.UN.11i) to M.UN.11.p) are described in in WO 2010/127926. M.UN.12.a) to M.UN.12.c) are known from WO2010/006713, M.UN.12.d) and M.UN.12.e) are known from WO2012/000896, and M .UN.12.f) to M.UN.12.m) are known from WO 2010/129497. M.UN.14a) and M.UN.14b) are known from WO 2007/101369. M.UN.16.a) to M.UN.16h) are described in WO2010/034737, WO2012/084670 and WO2012/143317 respectively, and M.UN.16i) and M.UN.16j) are described in WO2015/055497 middle. M.UN.17a) to M.UN.17.j) are described in WO2015/038503. M.UN.18a) to M.UN.18d) are described in US2014/0213448. M.UN.19 is described in WO2014/036056. M.UN.20 is known from WO2014/090918. M.UN.21 is known from EP2910126. M.UN.22a and M.UN.22b are known from WO2015/059039 and WO2015/190316. M.UN.23a and M.UN.23b are known from WO2013/050302. M.UN.24a and M.UN.24b are known from WO2012/126766. Enopariet M.UN.25 is known from WO 2011/105506. Benzpimoram M.UN.26 is known from WO2016/104516. M.UN.27 is known from WO2016174049. Compound M.29.28 is known from WO2017104592.

由IUPAC命名法描述之殺真菌劑、其製備及其殺有害生物活性亦為已知的(參見Can. J. Plant Sci. 48(6), 587-94, 1968;EP-A 141 317;EP-A 152 031;EP-A 226 917;EP-A 243 970;EP-A 256 503;EP-A 428 941;EP-A 532 022;EP-A 1 028 125;EP-A 1 035 122;EP-A 1 201 648;EP-A 1 122 244,JP 2002316902;DE 19650197;DE 10021412;DE 102005009458;US 3,296,272;US 3,325,503;WO 98/46608;WO 99/14187;WO 99/24413;WO 99/27783;WO 00/29404;WO 00/46148;WO 00/65913;WO 01/54501;WO 01/56358;WO 02/22583;WO 02/40431;WO 03/10149;WO 03/11853;WO 03/14103;WO 03/16286;WO 03/53145;WO 03/61388;WO 03/66609;WO 03/74491;WO 04/49804;WO 04/83193;WO 05/120234;WO 05/123689;WO 05/123690;WO 05/63721;WO 05/87772;WO 05/87773;WO 06/15866;WO 06/87325;WO 06/87343;WO 07/82098;WO 07/90624,WO 10/139271,WO 11/028657,WO2012/168188,WO 2007/006670,WO 2011/77514;WO13/047749,WO 10/069882,WO 13/047441,WO 03/16303,WO 09/90181,WO 13/007767,WO 13/010862,WO 13/127704,WO 13/024009,WO 13/024010及WO 13/047441,WO 13/162072,WO 13/092224,WO 11/135833),CN 1907024,CN 1456054,CN 103387541,CN 1309897,WO 12/84812,CN 1907024,WO 09094442,WO 14/60177,WO 13/116251,WO 08/013622,WO 15/65922,WO 94/01546,EP 2865265,WO 07/129454,WO 12/165511,WO 11/081174,WO 13/47441)。Fungicides described by IUPAC nomenclature, their preparation and their pesticidal activity are also known (see Can. J. Plant Sci. 48(6), 587-94, 1968; EP-A 141 317; EP-A 141 317; -A 152 031; EP-A 226 917; EP-A 243 970; EP-A 256 503; EP-A 428 941; -A 1 201 648; EP-A 1 122 244, JP 2002316902; DE 19650197; DE 10021412; DE 102005009458; US 3,296,272; US 3,325,503; WO 98/46608; 7; WO 99/24413; WO 99/27783 WO 00/29404; WO 00/46148; WO 00/65913; WO 01/54501; WO 01/56358; WO 02/22583; WO 03/16286; WO 03/53145; WO 03/61388; WO 03/66609; WO 03/74491; WO 04/49804; WO 05/63721; WO 05/87772; WO 05/87773; WO 06/15866; WO 06/87325; WO 06/87343; , WO2012/168188, WO 2007/006670, WO 2011/77514; WO13/047749, WO 10/069882, WO 13/047441, WO 03/16303, WO 09/90181, WO 13/007767, WO 13/010862 , WO 13/127704, WO 13/024009, WO 13/024010 and WO 13/047441, WO 13/162072, WO 13/092224, WO 11/135833), CN 1907024, CN 1456054, CN 103387541, CN 1309 897, WO 12/ 84812, CN 1907024, WO 09094442, WO 14/60177, WO 13/116251, WO 08/013622, WO 15/65922, WO 94/01546, EP 2865265, WO 07/129454, WO 12/165511, WO 1 1/081174 , WO 13/47441).

在另一個實施例中,本發明係關於包含如上所述之式(I)化合物,尤其化合物I-1或I-R-1及至少一種化合物II之混合物,該化合物II為聚乙醛,尤其粒狀聚乙醛。In another embodiment, the invention relates to a mixture comprising a compound of formula (I) as described above, especially compound I-1 or I-R-1, and at least one compound II, which compound II is metaldehyde, especially in granular form metaldehyde.

在另一個實施例中,本發明係關於包含如上所述之式(I)化合物,尤其化合物I-1或I-R-1及至少一種選自甲噻誘胺(methiadinil)、蒽醌、β-胺基丁酸、昆布糖、聚葡萄胺糖、硫胺素及核黃素之群之化合物II的混合物。In another embodiment, the present invention relates to a compound comprising formula (I) as described above, especially compound I-1 or I-R-1 and at least one compound selected from the group consisting of methiadinil, anthraquinone, β-amine A mixture of compound II of the group of butyric acid, laminarin, polyglucosamine, thiamine and riboflavin.

在另一個實施例中,本發明係關於根據本發明之方法,其施用包含如上所述之式(I)化合物,尤其化合物I-1或I-R-1及至少一種選自羥烯腺嘌呤(亦稱為玉米素)、活動素(羥烯)腺嘌呤、芸苔素內酯、苦皮藤(Celastrus angulatus)之殺昆蟲提取物、苦參鹼、蛇床子素、四環素之群之化合物II的混合物。In another embodiment, the invention relates to a method according to the invention, the administration of which comprises a compound of formula (I) as described above, especially compound I-1 or I-R-1 and at least one selected from the group consisting of hydroxyadenine (also Compound II of the group known as zeatin), actin (hydroxylene) adenine, brassinolide, insecticidal extract of Celastrus angulatus, matrine, osthole, tetracycline .

在另一個實施例中,本發明係關於包含如上所述之式(I)之非外消旋化合物,尤其具有對映異構體過量化合物I-R-1之化合物I-1及至少一種化合物II的混合物,該化合物II為聚乙醛,尤其粒狀聚乙醛。In another embodiment, the invention relates to compounds comprising a non-racemic compound of formula (I) as described above, especially compound I-1 with an enantiomeric excess of compound I-R-1 and at least one compound II Mixture, the compound II is metaldehyde, especially granular metaldehyde.

在另一個實施例中,本發明係關於包含如上所述之式(I)之非外消旋化合物,尤其具有對映異構體過量化合物I-R-1之化合物I-1,及至少一種選自甲噻誘胺、蒽醌、β-胺基丁酸、昆布糖、聚葡萄胺糖、硫胺素及核黃素之群之化合物II的混合物。In another embodiment, the invention relates to a compound I-1 comprising a non-racemic compound of formula (I) as described above, especially compound I-1 having an enantiomeric excess of compound I-R-1, and at least one selected from A mixture of compound II from the group of thiamin, anthraquinone, β-aminobutyric acid, laminarose, polyglucosamine, thiamine and riboflavin.

在另一個實施例中,本發明係關於根據本發明之方法,其施用包含如上所述之式(I)之非外消旋化合物,尤其具有對映異構體過量化合物I-R-1之化合物I-1及至少一種選自羥烯腺嘌呤(亦稱為玉米素)、活動素(羥烯)腺嘌呤、芸苔素內酯、苦皮藤之殺昆蟲提取物、苦參鹼、蛇床子素、四環素之群之化合物II的混合物。In another embodiment, the invention relates to a method according to the invention for administering a non-racemic compound comprising formula (I) as described above, especially compound I with enantiomeric excess of compound I-R-1 - 1 and at least one selected from the group consisting of hydroxyalkene adenine (also known as zeatin), actin (hydroxyalkene) adenine, brassinolide, insecticidal extract of Phyllostachys chinensis, matrine, osthole . A mixture of compounds II of the group of tetracyclines.

本發明係關於至少一種本發明之化合物I或式(I)之非外消旋化合物或具有對映異構體過量式(I-R)或(I-S)化合物之式(I)化合物作為組分I與至少一種如上文所定義之混合搭配物II的混合物。在一個實施例中,本發明係關於一種組分I與如上文所定義之一種混合搭配物II作為組分II的二元混合物。The invention relates to at least one compound I according to the invention or a non-racemic compound of formula (I) or a compound of formula (I) having an enantiomeric excess of a compound of formula (I-R) or (I-S) as component I and A mixture of at least one mixing partner II as defined above. In one embodiment, the invention relates to a binary mixture of a component I and a mixing partner II as defined above as component II.

此類二元混合物之較佳重量比為10000:1至1:10000、較佳7000:1至1:7000、亦較佳5000:1至1:5000、亦較佳1000:1至1:1000、更佳100:1至1:100、亦更佳70:1至1:70、尤其較佳25:1至1:25、亦尤其較佳10:1至1:10。在此類二元混合物中,組分I及II可以等量使用,或可使用過量組分I或過量組分II。The preferred weight ratio of such binary mixtures is from 10000:1 to 1:10000, preferably from 7000:1 to 1:7000, also preferably from 5000:1 to 1:5000, also preferably from 1000:1 to 1:1000 , more preferably 100:1 to 1:100, more preferably 70:1 to 1:70, especially preferably 25:1 to 1:25, and especially preferably 10:1 to 1:10. In such binary mixtures, components I and II may be used in equal amounts, or an excess of either component I or component II may be used.

在本發明之混合物中,成分可依序使用或彼此組合使用,若適宜,亦僅在使用之前立即添加(槽式混合)。舉例而言,在用組分I處理之前或之後,可用化合物II噴灑植物。In the mixtures according to the invention, the ingredients can be used sequentially or in combination with one another and, if appropriate, only added immediately before use (tank mixing). By way of example, plants can be sprayed with compound II before or after treatment with component I.

在本發明之一個實施例中,本發明之混合物為式(I)化合物,較佳(I-R),較佳化合物I-1、I-R-1、I-2或I-R-2與選自以下之群之化合物的混合物:免賴得、貝芬替、依普座、氟喹唑、護汰芬、護矽得、滅特座、咪醯胺、丙硫菌唑、得克利、滅菌唑、百克敏、三氟敏、白可列、達滅芬、吡噻菌胺、嗎菌靈、凡殺同、芬普福、丙氧喹啉、嘧黴胺、三得芬、錳乃浦、鋅錳乃浦、免得爛、得恩地、四氯異苯腈、腈硫醌、氟硫滅、滅芬農、氟唑菌醯胺、必殺吩、噴福芬、氟唑環菌胺、吡唑萘菌胺、噁唑沙非。尤其較佳為百克敏、噁唑沙非及氟唑菌醯胺。In one embodiment of the present invention, the mixture of the present invention is a compound of formula (I), preferably (I-R), preferably compound I-1, I-R-1, I-2 or I-R-2 and a group selected from the following Mixtures of compounds: Mianlaide, Befenti, Epreza, Fluquinazole, Hutifene, Husilide, Meteza, Amidamide, Prothioconazole, Decrell, Fenconazole, Becamine , Trifluramine, Bai Kelie, Damifen, Penthiopyrad, Mobendazim, Fembuton, Fenpro, Propoxyquinoline, Pyrimethanil, Sandofen, Manganap, Zincmanganate Pu, avoid rotten, deendi, tetrachloroisobenzonitrile, cyanothioquinone, fluthiazide, mefenon, flucloxacin, mustzaphen, penfufen, fluxachlor, pyraclostrobin , Oxazoxafil. Especially preferred are becamine, oxazoxafil, and flufenadim.

在本發明之一個實施例中,本發明之混合物為式(I)化合物,較佳(I-R),較佳化合物I-1、I-R-1、I-2或I-R-2與選自以下之群之化合物的混合物:吡蟲啉、噻蟲胺、呋蟲胺、氯蟲苯甲醯胺、氰蟲醯胺、賜諾特、賜諾殺、乙蟲清、氟蟲腈、三氟苯嘧啶、氟啶蟲醯胺、噁唑沙非及氟氰蟲醯胺。In one embodiment of the present invention, the mixture of the present invention is a compound of formula (I), preferably (I-R), preferably compound I-1, I-R-1, I-2 or I-R-2 and a group selected from the following Mixture of compounds: imidacloprid, clothianidin, dinotefuran, chlorantraniliprole, cyantraniliprole, spinosad, spinosad, ethiprole, fipronil, trifluridine, fluridine Pyridamide, oxazoxafil, and cyantraniliprole.

在本發明之一個實施例中,本發明之混合物為式(I)化合物,較佳(I-R),較佳化合物I-1、I-R-1、I-2或I-R-2與選自以下之群之化合物的混合物:撲殺熱、異噻菌胺、三賽唑、百快隆、稻瘟靈、托普洛卡、加普胺、二氯西莫、亞托敏、噁唑沙非及肟醚菌胺。In one embodiment of the present invention, the mixture of the present invention is a compound of formula (I), preferably (I-R), preferably compound I-1, I-R-1, I-2 or I-R-2 and a group selected from the following Mixtures of compounds: phytopyrene, isotianil, tricypyrazole, bacquilone, rice blastin, toproca, gapamide, dicloximol, yatormin, oxazoxafil, and oxime ether Bacteramine.

在本發明之一個實施例中,本發明之混合物為式(I)化合物,較佳(I-R),較佳化合物I-1、I-R-1、I-2或I-R-2與選自以下之群之化合物的混合物:福拉比、賽氟滅、矽氟唑、噴福芬、亞托敏、肟醚菌胺。In one embodiment of the present invention, the mixture of the present invention is a compound of formula (I), preferably (I-R), preferably compound I-1, I-R-1, I-2 or I-R-2 and a group selected from the following Mixture of compounds: Forabi, cyflufen, silfluazole, penfofen, ytropamine, orysastrobin.

在本發明之一個實施例中,本發明之混合物為式(I)化合物,較佳(I-R),較佳化合物I-1、I-R-1、I-2或I-R-2與噁唑沙非之混合物。In one embodiment of the present invention, the mixture of the present invention is a compound of formula (I), preferably (I-R), preferably compound I-1, I-R-1, I-2 or I-R-2 and oxazoxafil mixture.

在本發明之一個實施例中,本發明之混合物為式(I)之非外消旋化合物,較佳具有對映異構體過量化合物(I-R)之式(I)化合物,較佳具有對映異構體過量化合物I-R-1之化合物I-1,或式(I-R)化合物,較佳化合物I-R-1與選自以下之群之化合物的混合物:M.2:GABA閘控氯離子通道拮抗劑;M.3:鈉通道調節劑;M.4:菸鹼乙醯膽鹼受體促效劑;M.5:菸鹼乙醯膽鹼受體異位活化劑;M.6:阿維菌素類及米爾倍黴素類之氯離子通道活化劑;M.9:弦音器TRPV通道調節劑;M.13:經由破壞質子梯度之氧化磷酸化去偶合劑;M.15:甲殼素生物合成類型0之抑制劑;M.16:甲殼素生物合成類型之抑制劑;M.22:電壓依賴性鈉通道阻斷劑;M.23:乙醯CoA羧化酶之抑制劑;M.28:二醯胺類之利阿諾定受體調節劑;M.29:弦音器調節劑;M.UN.9.b;M.29.28;呼吸抑制劑:Qo位點之複合物III的抑制劑、Qi位點之複合物III的抑制劑、複合物II之抑制劑;固醇生物合成抑制劑;脂質及膜合成抑制劑;細胞壁合成抑制劑,較佳黑色素合成抑制劑;植物防護誘導劑;二氯西莫(K.1.7);托普洛卡(K.1.21)及皮卡布西(K.1.41)。In one embodiment of the invention, the mixture of the invention is a non-racemic compound of formula (I), preferably a compound of formula (I) with enantiomeric excess compound (I-R), preferably with enantiomeric Compound I-1 of isomer excess compound I-R-1, or a compound of formula (I-R), preferably a mixture of compound I-R-1 and a compound selected from the following group: M.2: GABA-gated chloride channel antagonist ; M.3: Sodium channel modulator; M.4: Nicotinic acetylcholine receptor agonist; M.5: Nicotinic acetylcholine receptor ectopic activator; M.6: Avermella M.9: TRPV channel modulator of chitins and milbemycins; M.13: Decoupler of oxidative phosphorylation via disruption of proton gradient; M.15: Chitin biosynthesis Type 0 inhibitors; M.16: Chitin biosynthesis type inhibitors; M.22: Voltage-dependent sodium channel blockers; M.23: Acetyl CoA carboxylase inhibitors; M.28: Rianodine receptor modulators of diamides; M.29: Chord modulators; M.UN.9.b; M.29.28; Respiratory inhibitors: inhibitors of complex III of the Qo site, Inhibitors of complex III at the Qi site, inhibitors of complex II; sterol biosynthesis inhibitors; lipid and membrane synthesis inhibitors; cell wall synthesis inhibitors, preferably melanin synthesis inhibitors; plant protection inducers; II Closimo (K.1.7); Topoloca (K.1.21) and Picabusi (K.1.41).

在本發明之一個實施例中,本發明之混合物為式(I)之非外消旋化合物,較佳具有對映異構體過量化合物(I-R)之式(I)化合物,較佳具有對映異構體過量化合物I-R-1之化合物I-1,或式(I-R)化合物,較佳化合物I-R-1與選自以下之群之化合物的混合物:氟蟲腈、α-賽滅寧、克凡派、氰氟蟲胺、阿巴汀、派滅淨、噻蟲嗪、吡蟲啉、呋蟲胺、呋蟲胺、噻蟲胺、氟啶蟲醯胺、螺蟲乙酯、布芬淨、氯蟲苯甲醯胺、氰蟲醯胺、氟氰蟲醯胺、氟啶蟲胺腈、因得克、三氟苯嘧啶、乙蟲清、賜諾特、賜諾殺、螺派酮、氟唑醯胺、噴福芬、三賽唑、亞托敏、稻瘟靈、托普洛卡、加普胺、二氯西莫、福拉比、矽氟唑、撲殺熱、肟醚菌胺、百快隆、賽氟滅、皮卡布西、噁唑沙非、滅芬諾、氟蟲雙醯胺、氟芬隆、賽座滅、甲霜靈、吲唑磺菌胺、環溴蟲醯胺、雙氯氰菌胺及異噻菌胺。尤其較佳為α-賽滅寧、氟啶蟲醯胺、氟唑醯胺、賜諾特、因得克、噁唑沙非、派滅淨、三氟苯嘧啶、氟芬隆、福拉比、甲霜靈、撲殺熱、雙氯氰菌胺、噴福芬、百快隆、矽氟唑、布芬淨、三賽唑或賜諾殺。In one embodiment of the invention, the mixture of the invention is a non-racemic compound of formula (I), preferably a compound of formula (I) with enantiomeric excess compound (I-R), preferably with enantiomeric Compound I-1 of isomer excess compound I-R-1, or a compound of formula (I-R), preferably a mixture of compound I-R-1 and a compound selected from the following group: fipronil, α-samethonine, Kefan Pie, metaflumizone, abatine, permetrazine, thiamethoxam, imidacloprid, dinotefuran, dinotefuran, clothianidin, sulfonicamid, spirotetramat, bufenjing, chlorantraniliprole Benzamide, cyantraniliprole, flucytraniliprole, sulfoxaflor, Indec, triflumezil, ethiproleil, cinot, ciproxil, spiropedone, fluzolid Ammonium, Penfufen, Trisacetazole, Yatropin, Daobenling, Toproca, Gapramine, Dicloximo, Forabi, Silfluazole, Phthalox, Oryzastrobin, Perquick Long, Seflumet, Pikabuxi, Oxazoxafil, Mefenox, Flubendiamide, Flufenuron, Sazamet, Metalaxyl, Indazole Sulfamide, Cyclotranil, Diphenhydramine Chloramethanil and Isotianil. Especially preferred are α-sermetazim, flunicamid, fluazolamide, cinot, Indec, oxazoxafil, permetazine, triflumezine, flufenon, and frabic , metalaxyl, culmex, diclofenac, penfofen, baclavon, silfluzole, ibufengin, trixazole, or spinosad.

在本發明之一個實施例中,本發明之混合物為式(I)之非外消旋化合物,較佳具有對映異構體過量化合物(I-R)之式(I)化合物,較佳具有對映異構體過量化合物I-R-1之化合物I-1,或式(I-R)化合物,較佳化合物I-R-1與選自以下之群之化合物的混合物:氟蟲腈、α-賽滅寧、克凡派、氰氟蟲胺、阿巴汀、派滅淨、噻蟲嗪、吡蟲啉、呋蟲胺、呋蟲胺、噻蟲胺、氟啶蟲醯胺、螺蟲乙酯、布芬淨、氯蟲苯甲醯胺、氰蟲醯胺、氟氰蟲醯胺、氟啶蟲胺腈、因得克、三氟苯嘧啶、乙蟲清、賜諾特、賜諾殺、螺派酮、氟唑醯胺、噁唑沙非、滅芬諾、氟蟲雙醯胺、氟芬隆及環溴蟲醯胺。In one embodiment of the invention, the mixture of the invention is a non-racemic compound of formula (I), preferably a compound of formula (I) with enantiomeric excess compound (I-R), preferably with enantiomeric Compound I-1 of isomer excess compound I-R-1, or a compound of formula (I-R), preferably a mixture of compound I-R-1 and a compound selected from the following group: fipronil, α-samethonine, Kefan Pie, metaflumizone, abatine, permetrazine, thiamethoxam, imidacloprid, dinotefuran, dinotefuran, clothianidin, sulfonicamid, spirotetramat, bufenjing, chlorantraniliprole Benzamide, cyantraniliprole, flucytraniliprole, sulfoxaflor, Indec, triflumezil, ethiproleil, cinot, ciproxil, spiropedone, fluzolid amines, oxazoxafil, mefenol, flubendiamide, flufenoron, and cyclobromide.

在本發明之一個實施例中,本發明之混合物為式(I)之非外消旋化合物,較佳具有對映異構體過量化合物(I-R)之式(I)化合物,較佳具有對映異構體過量化合物I-R-1之化合物I-1,或式(I-R)化合物,較佳化合物I-R-1與選自以下之群之化合物的混合物:撲殺熱、三賽唑、百快隆、稻瘟靈、托普洛卡、加普胺、二氯西莫、亞托敏、肟醚菌胺、福拉比、賽氟滅、矽氟唑、噴福芬、皮卡布西、賽座滅、甲霜靈、吲唑磺菌胺及異噻菌胺。In one embodiment of the invention, the mixture of the invention is a non-racemic compound of formula (I), preferably a compound of formula (I) with enantiomeric excess compound (I-R), preferably with enantiomeric Compound I-1 of compound I-R-1 with excess isomers, or compound of formula (I-R), preferably compound I-R-1 and a mixture of compounds selected from the following group: phalloxer, trixazole, bactimer, rice Plague, Toproca, Gapromide, Diclosimo, Yatropamine, Oryzastrobin, Forabi, Seflumet, Silfluzole, Penfufen, Picabuxi, Cyzamil, Metalaxyl, Indazolesulfin, and Isotianil.

在本發明之一個實施例中,本發明之混合物為式(I)之非外消旋化合物,較佳具有對映異構體過量化合物(I-R)之式(I)化合物,較佳具有對映異構體過量化合物I-R-1之化合物I-1與選自以下之群之化合物的混合物:氟蟲腈、α-賽滅寧、克凡派、氰氟蟲胺、阿巴汀、派滅淨、噻蟲嗪、吡蟲啉、呋蟲胺、呋蟲胺、噻蟲胺、氟啶蟲醯胺、螺蟲乙酯、布芬淨、氯蟲苯甲醯胺、氰蟲醯胺、氟氰蟲醯胺、氟啶蟲胺腈、因得克、三氟苯嘧啶、乙蟲清、賜諾特、賜諾殺、螺派酮、氟唑醯胺、噴福芬、三賽唑、亞托敏、稻瘟靈、托普洛卡、加普胺、二氯西莫、福拉比、矽氟唑、撲殺熱、肟醚菌胺、百快隆、賽氟滅、皮卡布西、噁唑沙非、滅芬諾、氟蟲雙醯胺、氟芬隆、賽座滅、甲霜靈、吲唑磺菌胺、環溴蟲醯胺、雙氯氰菌胺及異噻菌胺。尤其較佳為α-賽滅寧、氟啶蟲醯胺、氟唑醯胺、賜諾特、因得克、噁唑沙非、派滅淨、三氟苯嘧啶、氟芬隆、福拉比、甲霜靈、撲殺熱、雙氯氰菌胺、噴福芬、百快隆、矽氟唑、布芬淨、三賽唑或賜諾殺。In one embodiment of the invention, the mixture of the invention is a non-racemic compound of formula (I), preferably a compound of formula (I) with enantiomeric excess compound (I-R), preferably with enantiomeric A mixture of compound I-1 of compound I-R-1 with isomer excess and a compound selected from the group consisting of: fipronil, α-samethenin, kefanpai, metaflumizone, abatine, permetazine , thiamethoxam, imidacloprid, dinotefuran, dinotefuran, clothianidin, chlorantraniliprole, spirotetramat, buffungin, chlorantraniliprole, cyantraniliprole, flucytraniliprole Amine, sulfoxaflor, Indec, trifluoropyrimidine, ethipromin, spinoxal, spinosad, spiropedone, flufenamide, penfufen, trisethazole, yatormin, Dablasin, Toproca, Gapromide, Diclosimo, Forabi, Sifluzole, Phthalox, Oryzastrobin, Bacquilone, Seflumet, Picabuxi, Oxazoxafil , Mefenox, Flubendiamide, Flufenuron, Cyclomethan, Metalaxyl, Indazolesulphamide, Cyclotranil, Diclofenamide and Isotianil. Especially preferred are α-sermetazim, flunicamid, fluazolamide, cinot, Indec, oxazoxafil, permetazine, triflumezine, flufenon, and frabic , metalaxyl, culmex, diclofenac, penfofen, baclavon, silfluzole, ibufengin, trixazole, or spinosad.

在本發明之一個實施例中,本發明之混合物為式(I)之非外消旋化合物,較佳具有對映異構體過量化合物(I-R)之式(I)化合物,較佳具有對映異構體過量化合物I-R-1之化合物I-1與選自以下之群之化合物的混合物:氟蟲腈、α-賽滅寧、克凡派、氰氟蟲胺、阿巴汀、派滅淨、噻蟲嗪、吡蟲啉、呋蟲胺、呋蟲胺、噻蟲胺、氟啶蟲醯胺、螺蟲乙酯、布芬淨、氯蟲苯甲醯胺、氰蟲醯胺、氟氰蟲醯胺、氟啶蟲胺腈、因得克、三氟苯嘧啶、乙蟲清、賜諾特、賜諾殺、螺派酮、氟唑醯胺、噁唑沙非、滅芬諾、氟蟲雙醯胺、氟芬隆及環溴蟲醯胺。In one embodiment of the invention, the mixture of the invention is a non-racemic compound of formula (I), preferably a compound of formula (I) with enantiomeric excess compound (I-R), preferably with enantiomeric A mixture of compound I-1 of compound I-R-1 with isomer excess and a compound selected from the group consisting of: fipronil, α-samethenin, kefanpai, metaflumizone, abatine, permetazine , thiamethoxam, imidacloprid, dinotefuran, dinotefuran, clothianidin, chlorantraniliprole, spirotetramat, buffungin, chlorantraniliprole, cyantraniliprole, flucytraniliprole Amine, sulfoxaflor, Indec, triflumepyrim, ethiprole, spinoxate, spinoxal, spiropedone, fluazolamide, oxazoxafil, mefenox, sulfluramid Fenamide, Flufenuron, and Cyclotranil.

在本發明之一個實施例中,本發明之混合物為式(I)之非外消旋化合物,較佳具有對映異構體過量化合物(I-R)之式(I)化合物,較佳具有對映異構體過量化合物I-R-1之化合物I-1與選自以下之群之化合物的混合物:撲殺熱、三賽唑、百快隆、稻瘟靈、托普洛卡、加普胺、二氯西莫、亞托敏、肟醚菌胺、福拉比、賽氟滅、矽氟唑、噴福芬、皮卡布西、賽座滅、甲霜靈、吲唑磺菌胺及異噻菌胺。In one embodiment of the invention, the mixture of the invention is a non-racemic compound of formula (I), preferably a compound of formula (I) with enantiomeric excess compound (I-R), preferably with enantiomeric The mixture of the compound I-1 of the isomer excess compound I-R-1 and the compound selected from the following group: phylloxal, trixazole, bacquiron, rice blastin, toproca, gapamide, dichloro Simox, Yatropin, Oryzastrobin, Forabi, Sefluprom, Silfluzol, Penfofen, Pikabuxi, Cyzam, Metalaxyl, Indazolesulfazan, and Isotianil .

在本發明之一個實施例中,本發明之混合物為式(I)之非外消旋化合物,較佳式(I-R)化合物,較佳化合物I-R-1與選自以下之群之化合物的混合物:氟蟲腈、α-賽滅寧、克凡派、氰氟蟲胺、阿巴汀、派滅淨、噻蟲嗪、吡蟲啉、呋蟲胺、呋蟲胺、噻蟲胺、氟啶蟲醯胺、螺蟲乙酯、布芬淨、氯蟲苯甲醯胺、氰蟲醯胺、氟氰蟲醯胺、氟啶蟲胺腈、因得克、三氟苯嘧啶、乙蟲清、賜諾特、賜諾殺、螺派酮、氟唑醯胺、噴福芬、三賽唑、亞托敏、稻瘟靈、托普洛卡、加普胺、二氯西莫、福拉比、矽氟唑、撲殺熱、肟醚菌胺、百快隆、賽氟滅、皮卡布西、噁唑沙非、滅芬諾、氟蟲雙醯胺、氟芬隆、賽座滅、甲霜靈、吲唑磺菌胺、環溴蟲醯胺、雙氯氰菌胺及異噻菌胺。尤其較佳為α-賽滅寧、氟啶蟲醯胺、氟唑醯胺、賜諾特、因得克、噁唑沙非、派滅淨、三氟苯嘧啶、氟芬隆、福拉比、甲霜靈、撲殺熱、雙氯氰菌胺、噴福芬、百快隆、矽氟唑、布芬淨、三賽唑或賜諾殺。In one embodiment of the present invention, the mixture of the present invention is a mixture of a non-racemic compound of formula (I), preferably a compound of formula (I-R), preferably compound I-R-1 and a compound selected from the following group: Fipronil, α-Semetenin, Kefanpai, Metaflumizone, Abatine, Permetazine, Thiamethoxam, Imidacloprid, Dinotefuran, Dinotefuran, Clothianidin, Sulfacamid , spirotetramat, ibufenjing, chlorantraniliprole, cyantraniliprole, flucytraniliprole, sulfoxaflor, Indec, trifluoropyrim, ethifen, cinot , Spinosad, Spirophenone, Fluazolamide, Penfufen, Trisazole, Yatropin, Daofengling, Toproca, Gapromide, Diclosimo, Forabi, Silicon Fluoride azoles, culpy fever, oryzastrobin, bacquilone, seflumet, picabusil, oxazoxafil, mefenol, flubendiamide, flufenon, cyzamet, metalaxyl, indole Fensulfam, Cyclotranil, Diclofen, and Isotianil. Especially preferred are α-sermetazim, flunicamid, fluazolamide, cinot, Indec, oxazoxafil, permetazine, triflumezine, flufenon, and frabic , metalaxyl, culmex, diclofenac, penfofen, baclavon, silfluzole, ibufengin, trixazole, or spinosad.

在本發明之一個實施例中,本發明之混合物為式(I)之非外消旋化合物,較佳式(I-R)化合物,較佳化合物I-R-1與選自以下之群之化合物的混合物:氟蟲腈、α-賽滅寧、克凡派、氰氟蟲胺、阿巴汀、派滅淨、噻蟲嗪、吡蟲啉、呋蟲胺、呋蟲胺、噻蟲胺、氟啶蟲醯胺、螺蟲乙酯、布芬淨、氯蟲苯甲醯胺、氰蟲醯胺、氟氰蟲醯胺、氟啶蟲胺腈、因得克、三氟苯嘧啶、乙蟲清、賜諾特、賜諾殺、螺派酮、氟唑醯胺、噁唑沙非、滅芬諾、氟蟲雙醯胺、氟芬隆及環溴蟲醯胺。In one embodiment of the present invention, the mixture of the present invention is a mixture of a non-racemic compound of formula (I), preferably a compound of formula (I-R), preferably compound I-R-1 and a compound selected from the following group: Fipronil, α-Semetenin, Kefanpai, Metaflumizone, Abatine, Permetazine, Thiamethoxam, Imidacloprid, Dinotefuran, Dinotefuran, Clothianidin, Sulfacamid , spirotetramat, ibufenjing, chlorantraniliprole, cyantraniliprole, flucytraniliprole, sulfoxaflor, Indec, trifluoropyrim, ethifen, cinot .

在本發明之一個實施例中,本發明之混合物為式(I)之非外消旋化合物,較佳式(I-R)化合物,較佳化合物I-R-1與選自以下之群之化合物的混合物:撲殺熱、三賽唑、百快隆、稻瘟靈、托普洛卡、加普胺、二氯西莫、亞托敏、肟醚菌胺、福拉比、賽氟滅、矽氟唑、噴福芬、皮卡布西、賽座滅、甲霜靈、吲唑磺菌胺及異噻菌胺。In one embodiment of the present invention, the mixture of the present invention is a mixture of a non-racemic compound of formula (I), preferably a compound of formula (I-R), preferably compound I-R-1 and a compound selected from the following group: Culling fever, Trisacetazole, Bacquilon, Daobenling, Topuroca, Gaprimide, Diclosimo, Yatropin, Oryzastrobin, Forabi, Seflumet, Silfluazole, Penfufen, Pikabuxi, Cyzamil, Metalaxyl, Indazolesulfin and Isotianil.

在本發明之一個實施例中,本發明之混合物為式(I)之非外消旋化合物,較佳式(I)化合物,較佳具有對映異構體過量化合物I-R-1之化合物I-1與選自以下之群之化合物的混合物:α-賽滅寧、氟啶蟲醯胺、氟唑醯胺、賜諾特、因得克、噁唑沙非、派滅淨、三氟苯嘧啶、氟芬隆、福拉比、甲霜靈、撲殺熱、雙氯氰菌胺、噴福芬、百快隆、矽氟唑、布芬淨、三賽唑或賜諾殺。In one embodiment of the present invention, the mixture of the present invention is a non-racemic compound of formula (I), preferably a compound of formula (I), preferably compound I- with enantiomeric excess compound I-R-1 1 Mixture with a compound selected from the following group: α-Sermetazine, Fluoxetamid, Fluoxenamide, Sinoxate, Indec, Oxazoxafil, Permethazine, Trifluridine , fenflurone, fulabic, metalaxyl, thuloxal, diclofenac, penfofen, baccaron, silfluzole, ibufengin, trixazole, or spinosad.

在本發明之一個實施例中,本發明之混合物為式(I)之非外消旋化合物,較佳式(I-R)化合物,較佳化合物I-R-1與選自以下之群之化合物的混合物:α-賽滅寧、氟啶蟲醯胺、氟唑醯胺、賜諾特、因得克、噁唑沙非、派滅淨、三氟苯嘧啶、氟芬隆、福拉比、甲霜靈、撲殺熱、雙氯氰菌胺、噴福芬、百快隆、矽氟唑、布芬淨、三賽唑或賜諾殺。In one embodiment of the present invention, the mixture of the present invention is a mixture of a non-racemic compound of formula (I), preferably a compound of formula (I-R), preferably compound I-R-1 and a compound selected from the following group: α-Samilin, Fluoxetamid, Fluazolamide, Cinot, Indec, Oxazoxafil, Permetazine, Trifluridine, Flufenuron, Forabi, Metalaxyl , culling fever, diclofenac, penfufen, baclavon, silfluzole, ibufengin, trixazole, or spinosad.

在本發明之一個實施例中,本發明之混合物為式(I)之非外消旋化合物,較佳式(I)化合物,較佳具有對映異構體過量化合物I-R-1之化合物I-1或具有對映異構體過量化合物I-R-2之I-2與噁唑沙非之混合物。In one embodiment of the present invention, the mixture of the present invention is a non-racemic compound of formula (I), preferably a compound of formula (I), preferably compound I- with enantiomeric excess compound I-R-1 1 or a mixture of 1-2 and oxazoxafil having an enantiomeric excess of compound I-R-2.

根據本發明之尤其較佳的混合物列於下表M中,其中化合物I如本說明書中所定義: 表M

Figure 107134558-A0304-0002
Particularly preferred mixtures according to the invention are listed in Table M below, wherein compound I is as defined in the specification: Table M
Figure 107134558-A0304-0002

類似於混合物M-1至M-138,非外消旋化合物I-1代替化合物I-1之混合物為本發明之一部分。Analogously to mixtures M-1 to M-138, mixtures of non-racemic compound 1-1 instead of compound 1-1 are part of the present invention.

類似於混合物M-1至M-138,I-2代替I-1之混合物為本發明之一部分。Similar to mixtures M-1 to M-138, mixtures in which I-2 replaces I-1 are part of the invention.

類似於混合物M-139至M-276,I-R-2代替I-R-1之混合物為本發明之一部分。Similar to mixtures M-139 to M-276, mixtures in which I-R-2 replaces I-R-1 are part of this invention.

類似於混合物M-1至M-138,I-3代替I-1之混合物為本發明之一部分。Similar to mixtures M-1 to M-138, mixtures in which I-3 replaces I-1 are part of the invention.

類似於混合物M-139至M-276,I-R-3代替I-R-1之混合物為本發明之一部分。Similar to mixtures M-139 to M-276, mixtures in which I-R-3 replaces I-R-1 are part of this invention.

類似於混合物M-1至M-138,I-4代替I-1之混合物為本發明之一部分。Similar to mixtures M-1 to M-138, mixtures in which I-4 replaces I-1 are part of the invention.

類似於混合物M-139至M-276,I-R-4代替I-R-1之混合物為本發明之一部分。Similar to mixtures M-139 to M-276, mixtures in which I-R-4 replaces I-R-1 are part of this invention.

類似於混合物M-1至M-138,I-5代替I-1之混合物為本發明之一部分。Similar to mixtures M-1 to M-138, mixtures in which I-5 replaces I-1 are part of the invention.

類似於混合物M-139至M-276,I-R-5代替I-R-1之混合物為本發明之一部分。Similar to mixtures M-139 to M-276, mixtures in which I-R-5 replaces I-R-1 are part of this invention.

類似於混合物M-1至M-138,I-6代替I-1之混合物為本發明之一部分。Similar to mixtures M-1 to M-138, mixtures in which I-6 replaces I-1 are part of the invention.

類似於混合物M-139至M-276,I-R-6代替I-R-1之混合物為本發明之一部分。Similar to mixtures M-139 to M-276, mixtures in which I-R-6 replaces I-R-1 are part of this invention.

類似於混合物M-1至M-138,具有對映異構體過量化合物I-R-1之I-1代替I-1的混合物為本發明之一部分。Similar to mixtures M-1 to M-138, mixtures having I-1 of compound I-R-1 in enantiomeric excess instead of I-1 are part of the present invention.

額外混合搭配物 本發明之混合物可與其他活性成分組合且混合以在農業中施用,例如與其他殺有害生物劑、殺昆蟲劑、殺線蟲劑、殺真菌劑、除草劑、安全劑、肥料(諸如硝酸銨、尿素、鉀肥及過磷酸鈣)、植物毒劑及植物生長調節因子。extra mix The mixtures according to the invention may be combined and mixed with other active ingredients for application in agriculture, for example with other pesticides, insecticides, nematicides, fungicides, herbicides, safeners, fertilizers such as ammonium nitrate, urea, potash and superphosphate), phytotoxicants and plant growth regulators.

此等混合物亦由術語「本發明之混合物」或「根據本發明之混合物」所涵蓋。Such mixtures are also covered by the term "mixtures according to the invention" or "mixtures according to the invention".

此等額外成分可依序使用或與本發明之混合物組合使用,若適宜,亦僅在使用之前立即添加(槽式混合)。舉例而言,在用其他活性成分處理之前或之後,可用本發明之混合物噴灑植物。These additional ingredients can be used sequentially or in combination with the mixtures according to the invention and, if appropriate, only added immediately before use (tank mixing). By way of example, plants can be sprayed with the mixtures according to the invention either before or after treatment with the other active ingredients.

混合搭配物可選自殺有害生物劑,尤其殺昆蟲劑、殺線蟲劑及殺蟎劑、殺真菌劑、除草劑、植物生長調節因子、肥料及其類似物。較佳混合搭配物為殺昆蟲劑、殺線蟲劑及殺真菌劑。Mixing partners are optionally suicide pests, especially insecticides, nematicides and acaricides, fungicides, herbicides, plant growth regulators, fertilizers and the like. Preferred mixing partners are insecticides, nematicides and fungicides.

在一個實施例中,本發明係關於三元混合物,其包含化合物I、化合物II及另一種化合物III,其與已存在於混合物中之化合物I或II不同。In one embodiment, the invention relates to a ternary mixture comprising compound I, compound II and another compound III which is different from compound I or II already present in the mixture.

在一個子實施例中,本發明係關於一種以下混合物: (1) 式(I)化合物,或式(I)之非外消旋化合物或具有對映異構體過量(I-R)之式(I)化合物或化合物(I-R),較佳非外消旋化合物I-1或具有對映異構體過量I-R-1之化合物I-1或化合物I-R-1或I-2或I-R-2,及 (2) 選自以下之群之化合物:吡蟲啉、噻蟲胺、呋蟲胺、氯蟲苯甲醯胺、氰蟲醯胺、賜諾特、賜諾殺、乙蟲清、氟蟲腈、三氟苯嘧啶、氟啶蟲醯胺、噁唑沙非及氟氰蟲醯胺,及 (3) 選自以下之群之化合物:撲殺熱、異噻菌胺、三賽唑、百快隆、稻瘟靈、托普洛卡、加普胺、二氯西莫、亞托敏、肟醚菌胺。In a sub-embodiment, the invention relates to a mixture of: (1) Compound of formula (I), or non-racemic compound of formula (I) or compound of formula (I) or compound (I-R) with enantiomeric excess (I-R), preferably non-racemic compound I-1 or compound I-1 or compound I-R-1 or I-2 or I-R-2 with enantiomeric excess I-R-1, and (2) Compounds selected from the following group: imidacloprid, clothianidin, dinotefuran, chlorantraniliprole, cyantraniliprole, spinosad, spinosad, ethiprole, fipronil, fluoropyrim, flunicamid, oxazoxafil, and flucynamid, and (3) Compounds selected from the following group: phytopyrene, isotianil, trisacilazole, bacquilon, rice blastin, toproca, gapromide, dicloximol, yatormine, oxime Kyssastrobin.

在一個實施例中,本發明係關於4路混合物,其包含化合物I、化合物II及另外兩種化合物III,其與已存在於混合物中之化合物I或II不同。In one embodiment, the invention relates to a 4-way mixture comprising compound I, compound II and two additional compounds III, different from compound I or II already present in the mixture.

在一個子實施例中,本發明係關於一種以下混合物: (1) 式(I)化合物,或式(I)之非外消旋化合物或具有對映異構體過量(I-R)之式(I)化合物或化合物(I-R),較佳非外消旋化合物I-1或具有對映異構體過量I-R-1之化合物I-1或化合物I-R-1或I-2或I-R-2,及 (2) 選自以下之群之化合物:吡蟲啉、噻蟲胺、呋蟲胺、氯蟲苯甲醯胺、氰蟲醯胺、賜諾特、賜諾殺、乙蟲清、氟蟲腈、三氟苯嘧啶、氟啶蟲醯胺、噁唑沙非及氟氰蟲醯胺,及 (3) 選自以下之群之化合物:撲殺熱、異噻菌胺、三賽唑、百快隆、稻瘟靈、托普洛卡、加普胺、二氯西莫、亞托敏、肟醚菌胺,及 (4) 選自以下之群之化合物:福拉比、賽氟滅、矽氟唑、噴福芬、亞托敏、肟醚菌胺,限制條件為其與(3)中之化合物不同。In a sub-embodiment, the invention relates to a mixture of: (1) Compound of formula (I), or non-racemic compound of formula (I) or compound of formula (I) or compound (I-R) with enantiomeric excess (I-R), preferably non-racemic compound I-1 or compound I-1 or compound I-R-1 or I-2 or I-R-2 with enantiomeric excess I-R-1, and (2) Compounds selected from the following group: imidacloprid, clothianidin, dinotefuran, chlorantraniliprole, cyantraniliprole, spinosad, spinosad, ethiprole, fipronil, fluoropyrim, flunicamid, oxazoxafil, and flucynamid, and (3) Compounds selected from the following group: phytopyrene, isotianil, trisacilazole, bacquilon, rice blastin, toproca, gapromide, dicloximol, yatormine, oxime kysastrobin, and (4) A compound selected from the following group: Forabi, Salfluramine, Silfluzole, Penfofen, Yatropamine, oryzastrobin, provided that it is different from the compound in (3).

在一個實施例中,本發明係關於5路混合物,其包含化合物I、化合物II及另外三種化合物III,其與已存在於混合物中之化合物I或II不同。In one embodiment, the invention relates to a 5-way mixture comprising Compound I, Compound II and three additional Compounds III which are different from Compound I or II already present in the mixture.

調配物 本發明亦關於農用化學組合物,其包含助劑及至少一種本發明化合物或其混合物。formulation The invention also relates to agrochemical compositions comprising an adjuvant and at least one compound according to the invention or a mixture thereof.

農用化學組合物包含殺有害生物有效量之本發明化合物或其混合物。術語「殺有害生物有效量」定義如下。Agrochemical compositions comprise a pesticidally effective amount of a compound of the invention or a mixture thereof. The term "pesticidally effective amount" is defined below.

本發明化合物或其混合物可轉化成習用類型之農用化學組合物,例如溶液、乳液、懸浮液、粉劑(dusts)、粉劑(powders)、糊劑、顆粒劑、壓製劑、膠囊及其混合物。組合物類型之實例為懸浮液(例如SC、OD、FS)、可乳化濃縮物(例如EC)、乳液(例如EW、EO、ES、ME)、膠囊(例如CS、ZC)、糊劑、片劑、可濕潤粉劑(例如WP、SP、WS、DP、DS)、壓製劑(例如BR、TB、DT)、顆粒劑(例如WG、SG、GR、FG、GG、MG)、殺昆蟲製品(例如LN)以及用於處理植物繁殖材料諸如種子之凝膠調配物(例如GF)。此等及其他組合物類型定義於「Catalogue of pesticide formulation types and international coding system」, Technical Monograph第2期, 第6版. 2008年5月, CropLife International中。The compounds of the invention or mixtures thereof can be converted into agrochemical compositions of the customary type, such as solutions, emulsions, suspensions, dusts, powders, pastes, granules, compressed formulations, capsules and mixtures thereof. Examples of composition types are suspensions (e.g. SC, OD, FS), emulsifiable concentrates (e.g. EC), emulsions (e.g. EW, EO, ES, ME), capsules (e.g. CS, ZC), pastes, tablets formulations, wettable powders (eg WP, SP, WS, DP, DS), compressed formulations (eg BR, TB, DT), granules (eg WG, SG, GR, FG, GG, MG), insecticidal preparations ( eg LN) and gel formulations for the treatment of plant propagation material such as seeds (eg GF). These and other composition types are defined in "Catalogue of pesticide formulation types and international coding system", Technical Monograph No. 2, 6th Edition. May 2008, CropLife International.

組合物以已知方式製備,諸如由Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001;或Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005所述。Compositions are prepared in a known manner, such as described by Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.

適合助劑之實例為溶劑、液體載劑、固體載劑或填料、界面活性劑、分散劑、乳化劑、濕潤劑、佐劑、增溶劑、滲透增強劑、保護性膠體、黏著劑、增稠劑、保濕劑、防護劑、引誘劑、餵食刺激劑、增容劑、殺細菌劑、防凍劑、消泡劑、著色劑、增黏劑及黏合劑。Examples of suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetting agents, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesives, thickeners Agents, moisturizers, protective agents, attractants, feeding stimulants, extenders, bactericides, antifreeze agents, defoamers, colorants, thickeners and adhesives.

適合之溶劑及液體載劑為水及有機溶劑,諸如中沸點至高沸點之礦物油餾分,例如煤油、柴油;植物或動物來源之油;脂族、環狀及芳族烴,例如甲苯、石蠟、四氫萘、烷基化萘;醇,例如乙醇、丙醇、丁醇、苯甲醇、環己醇;二醇;DMSO;酮,例如環己酮;酯,例如乳酸酯、碳酸酯、脂肪酸酯、γ-丁內酯;脂肪酸;膦酸酯;胺;醯胺,例如N-甲基吡咯啶酮、脂肪酸二甲基醯胺;及其混合物。Suitable solvents and liquid carriers are water and organic solvents, such as medium to high boiling mineral oil fractions, for example kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, for example toluene, paraffin, Tetrahydronaphthalene, alkylated naphthalene; alcohols such as ethanol, propanol, butanol, benzyl alcohol, cyclohexanol; diols; DMSO; ketones such as cyclohexanone; esters such as lactate, carbonate, fatty acids esters, gamma-butyrolactone; fatty acids; phosphonates; amines; amides such as N-methylpyrrolidone, fatty acid dimethylamide; and mixtures thereof.

適合之固體載劑或填料為礦物土,例如矽酸鹽、矽膠、滑石、高嶺土、石灰石、石灰、白堊、黏土、白雲石、矽藻土、膨潤土、硫酸鈣、硫酸鎂、氧化鎂;多醣粉末,例如纖維素、澱粉;肥料,例如硫酸銨、磷酸銨、硝酸銨、尿素;植物來源之產品,例如穀物粉、樹皮粉、木粉、堅果殼粉及其混合物。Suitable solid carriers or fillers are mineral earths, such as silicate, silica gel, talc, kaolin, limestone, lime, chalk, clay, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharide powder , such as cellulose, starch; fertilizers, such as ammonium sulfate, ammonium phosphate, ammonium nitrate, urea; products of plant origin, such as cereal flour, bark flour, wood flour, nut shell flour and mixtures thereof.

適合之界面活性劑為表面活性化合物,諸如陰離子型、陽離子型、非離子型及兩性界面活性劑;嵌段聚合物、聚電解質及其混合物。此類界面活性劑可用作乳化劑、分散劑、增溶劑、濕潤劑、滲透增強劑、保護性膠體或佐劑。界面活性劑之實例列於McCutcheon之第1卷: Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (國際版或北美版)中。Suitable surfactants are surface-active compounds such as anionic, cationic, nonionic and amphoteric surfactants; block polymers, polyelectrolytes and mixtures thereof. Such surfactants can be used as emulsifiers, dispersants, solubilizers, wetting agents, penetration enhancers, protective colloids or adjuvants. Examples of surfactants are listed in McCutcheon's Volume 1: Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International or North American version).

適合之陰離子型界面活性劑為磺酸鹽、硫酸鹽、磷酸鹽、羧酸鹽之鹼金屬、鹼土金屬或銨鹽及其混合物。磺酸鹽之實例為烷芳基磺酸鹽、二苯基磺酸鹽、α-烯烴磺酸鹽、木質素磺酸鹽、脂肪酸及油之磺酸鹽、乙氧基化烷基酚之磺酸鹽、烷氧基化芳基酚之磺酸鹽、縮合萘之磺酸鹽、十二烷基及十三烷基苯之磺酸鹽、萘及烷基萘之磺酸鹽、磺基琥珀酸鹽或磺基琥珀醯胺酸鹽。硫酸鹽之實例為脂肪酸及油、乙氧基化烷基酚、醇、乙氧基化醇或脂肪酸酯之硫酸鹽。磷酸酯之實例為磷酸酯。羧酸鹽之實例為烷基羧酸鹽及羧化醇或烷基苯酚乙氧基化物。Suitable anionic surfactants are alkali metal, alkaline earth metal or ammonium salts of sulfonates, sulfates, phosphates, carboxylates and mixtures thereof. Examples of sulfonates are alkylarylsulfonates, diphenylsulfonates, alpha-olefinsulfonates, lignosulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols Acid salts, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalene, sulfonates of dodecyl and tridecylbenzene, sulfonates of naphthalene and alkylnaphthalene, sulfosuccinate salt or sulfosuccinamate. Examples of sulfates are the sulfates of fatty acids and oils, ethoxylated alkylphenols, alcohols, ethoxylated alcohols or fatty acid esters. Examples of phosphoric acid esters are phosphoric acid esters. Examples of carboxylates are alkyl carboxylates and carboxylated alcohol or alkylphenol ethoxylates.

適合之非離子型界面活性劑為烷氧基化物、N-取代之脂肪酸醯胺、胺氧化物、酯、糖基界面活性劑、聚合物界面活性劑及其混合物。烷氧基化物之實例為已用1至50當量烷氧基化之化合物,諸如醇、烷基酚、胺、醯胺、芳基酚、脂肪酸或脂肪酸酯。可採用環氧乙烷及/或環氧丙烷,較佳環氧乙烷進行烷氧基化。N-取代之脂肪酸醯胺的實例為脂肪酸葡糖醯胺或脂肪酸烷醇醯胺。酯之實例為脂肪酸酯、甘油酯或單酸甘油酯。糖基界面活性劑之實例為脫水山梨糖醇、乙氧基化脫水山梨糖醇、蔗糖及葡萄糖酯或烷基聚葡糖苷。聚合物界面活性劑之實例為乙烯基吡咯啶酮、乙烯醇或乙酸乙烯酯之均聚物或共聚物。Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are compounds which have been alkoxylated with 1 to 50 equivalents, such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters. The alkoxylation can be carried out with ethylene oxide and/or propylene oxide, preferably ethylene oxide. Examples of N-substituted fatty acid amides are fatty acid glucosamides or fatty acid alkanolamides. Examples of esters are fatty acid esters, glycerides or monoglycerides. Examples of sugar-based surfactants are sorbitan, ethoxylated sorbitan, sucrose and glucose esters or alkyl polyglucosides. Examples of polymeric surfactants are homopolymers or copolymers of vinylpyrrolidone, vinyl alcohol or vinyl acetate.

適合之陽離子型界面活性劑為四級界面活性劑,例如具有一或兩個疏水性基團之四級銨化合物,或長鏈一級胺之鹽。適合之兩性界面活性劑為烷基甜菜鹼及咪唑啉。適合之嵌段聚合物為包含聚環氧乙烷及聚環氧丙烷嵌段之A-B或A-B-A型嵌段聚合物,或包含烷醇、聚環氧乙烷及聚環氧丙烷之A-B-C型嵌段聚合物。適合之聚電解質為多元酸或多元鹼。多元酸之實例為聚丙烯酸之鹼金屬鹽或多元酸梳狀聚合物。多元鹼之實例為聚乙烯胺或聚伸乙胺。Suitable cationic surfactants are quaternary surfactants, such as quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants are alkyl betaines and imidazolines. Suitable block polymers are A-B or A-B-A type block polymers comprising polyethylene oxide and polypropylene oxide blocks, or A-B-C type block comprising alkanol, polyethylene oxide and polypropylene oxide blocks polymer. Suitable polyelectrolytes are polyacids or bases. Examples of polyacids are alkali metal salts of polyacrylic acid or polyacid comb polymers. Examples of polybasic bases are polyvinylamine or polyethyleneamine.

適合之佐劑為本身具有可忽略的殺有害生物活性或甚至無殺有害生物活性,且改良本發明化合物對目標之生物效能的化合物。實例為界面活性劑、礦物油或植物油及其他助劑。其他實例由Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, 第5章列舉。Suitable adjuvants are compounds which themselves have negligible or even no pesticidal activity and which improve the biological efficacy of the compounds according to the invention on the target. Examples are surfactants, mineral or vegetable oils and other auxiliaries. Other examples are given by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, Chapter 5.

適合之增稠劑為多糖(例如三仙膠、羧甲基纖維素)、非有機黏土(經有機改質或未經改質)、聚羧酸鹽及矽酸鹽。Suitable thickeners are polysaccharides (eg Sanxian gum, carboxymethylcellulose), non-organic clays (organically modified or not), polycarboxylates and silicates.

適合之殺細菌劑為溴硝醇及異噻唑啉酮衍生物,諸如烷基異噻唑啉酮及苯并異噻唑啉酮。Suitable bactericides are bronopol and isothiazolinone derivatives, such as alkylisothiazolinones and benzisothiazolinones.

適合之防凍劑為乙二醇、丙二醇、尿素及甘油。Suitable antifreezes are ethylene glycol, propylene glycol, urea and glycerin.

適合之消泡劑為聚矽氧、長鏈醇及脂肪酸鹽。Suitable defoamers are silicones, long-chain alcohols and fatty acid salts.

適合之著色劑(例如呈紅色、藍色或綠色)為低水溶性顏料及水溶性染料。實例為無機著色劑(例如氧化鐵、氧化鈦、六氰亞鐵酸鐵)及有機著色劑(例如茜素菁、偶氮菁及酞菁著色劑)。Suitable colorants, eg red, blue or green, are low water soluble pigments and water soluble dyes. Examples are inorganic colorants such as iron oxide, titanium oxide, ferric hexacyanoferrate and organic colorants such as alizarin, azocyanine and phthalocyanine colorants.

適合之增黏劑或黏合劑為聚乙烯吡咯啶酮、聚乙酸乙烯酯、聚乙烯醇、聚丙烯酸酯、生物或合成蠟及纖維素醚。Suitable tackifiers or binders are polyvinylpyrrolidone, polyvinyl acetate, polyvinyl alcohol, polyacrylates, biological or synthetic waxes and cellulose ethers.

組合物類型及其製備之實例為: i) 水溶性濃縮物(SL、LS) 將10-60重量%根據本發明之化合物I或II或混合物及5-15重量%濕潤劑(例如醇烷氧基化物)溶解於水及/或水溶性溶劑(例如醇)中直至100重量%。活性物質在用水稀釋時溶解。 ii) 可分散濃縮物(DC) 將5-25重量%根據本發明之化合物I或II或混合物及1-10重量%分散劑(例如聚乙烯吡咯啶酮)溶解於至多100重量%有機溶劑(例如環己酮)中。用水稀釋得到分散液。 iii) 可乳化濃縮物(EC) 將15-70重量%根據本發明之化合物I或II或混合物及5-10重量%乳化劑(例如十二烷基苯磺酸鈣及蓖麻油乙氧基化物)溶解於至多100重量%水不溶性有機溶劑(例如芳族烴)中。用水稀釋得到乳液。 iv) 乳液(EW、EO、ES) 將5-40重量%根據本發明之化合物I或II或混合物及1-10重量%乳化劑(例如十二烷基苯磺酸鈣及蓖麻油乙氧基化物)溶解於20-40重量%水不溶性有機溶劑(例如芳族烴)中。藉助於乳化機將此混合物引入至多100重量%水中且製成均質乳液。用水稀釋得到乳液。 v) 懸浮液(SC、OD、FS) 在攪動式球磨機中,將20-60重量%根據本發明之化合物I或II或混合物粉碎,添加2-10重量%分散劑及濕潤劑(例如木質素磺酸鈉及醇乙氧基化物)、0,1-2重量%增稠劑(例如三仙膠)及至多100重量%水,得到細活性物質懸浮液。用水稀釋得到活性物質之穩定懸浮液。對於FS型組合物,添加高達40重量%黏合劑(例如聚乙烯醇)。 vi) 水分散性顆粒劑及水溶性顆粒劑(WG、SG) 將50-80重量%根據本發明之化合物I或II或混合物細磨,添加至多100重量%分散劑及濕潤劑(例如木質素磺酸鈉及醇乙氧基化物)且藉助於工業級設備(例如擠出、噴霧塔、流化床)製備為水分散性或水溶性顆粒劑。用水稀釋得到活性物質之穩定分散液或溶液。 vii) 水分散性粉劑及水溶性粉劑(WP、SP、WS) 將50-80重量%根據本發明之化合物I或II或混合物在轉子-定子磨機中研磨,添加1-5重量%分散劑(例如木質素磺酸鈉)、1-3重量%濕潤劑(例如醇乙氧基化物)及至多100重量%固體載劑,例如矽膠。用水稀釋得到活性物質之穩定分散液或溶液。 viii) 凝膠(GW、GF) 在攪動式球磨機中,將5-25重量%根據本發明之化合物I或II或混合物粉碎,添加3-10重量%分散劑(例如木質素磺酸鈉)、1-5重量%增稠劑(例如羧甲基纖維素)及至多100重量%水,得到活性物質之細懸浮液。用水稀釋得到活性物質之穩定懸浮液。 ix) 微乳液(ME) 將5-20重量%根據本發明之化合物I或II或混合物添加至5-30重量%有機溶劑摻合物(例如脂肪酸二甲醯胺及環己酮)、10-25重量%界面活性劑摻合物(例如醇乙氧基化物及芳基酚乙氧基化物)及補足至100%之水中。攪拌此混合物1小時以自發地產生熱力學上穩定之微乳液。 x) 微膠囊(CS) 將包含5-50重量%根據本發明之化合物I或II或混合物的油相、0-40重量%水不溶性有機溶劑(例如芳族烴)、2-15重量%丙烯酸單體(例如甲基丙烯酸甲酯、甲基丙烯酸及二丙烯酸酯或三丙烯酸酯)分散於保護性膠體(例如聚乙烯醇)之水溶液中。由自由基引發劑引發之自由基聚合使得聚(甲基)丙烯酸酯微膠囊形成。或者,將包含5-50重量%根據本發明之化合物I或II或混合物的油相、0-40重量%水不溶性有機溶劑(例如芳族烴)及異氰酸酯單體(例如二苯基亞甲基-4,4'-二異氰酸酯)分散於保護性膠體(例如聚乙烯醇)之水溶液。添加多元胺(例如己二胺)使得形成聚脲微膠囊。單體共計1-10重量%。wt%係關於整個CS組合物。 xi) 可撒佈粉劑(DP、DS) 將1-10重量%根據本發明之化合物I或II或混合物細磨且與至多100重量%固體載劑(例如細粉狀高嶺土)緊密混合。 xii) 顆粒劑(GR、FG) 將0.5-30重量%根據本發明之化合物I或II或混合物細磨且與至多100重量%固體載劑(例如矽酸鹽)相關聯。藉由擠出、噴霧乾燥或流化床實現造粒。 xiii) 超低容量液體(UL) 將1-50重量%根據本發明之化合物I或II或混合物溶解於至多100重量%有機溶劑(例如芳族烴)中。Examples of composition types and their preparation are: i) Water-soluble concentrates (SL, LS) 10-60% by weight of compounds I or II or mixtures according to the invention and 5-15% by weight of wetting agents (e.g. alcohol alkoxylates) are dissolved in water and/or water-soluble solvents (e.g. alcohols) up to 100% by weight . The active substance dissolves on dilution with water. ii) Dispersible Concentrate (DC) 5-25% by weight of compounds I or II or mixtures according to the invention and 1-10% by weight of dispersants (eg polyvinylpyrrolidone) are dissolved in up to 100% by weight of organic solvents (eg cyclohexanone). Dilute with water to obtain a dispersion. iii) Emulsifiable Concentrate (EC) 15-70% by weight of compounds I or II or mixtures according to the invention and 5-10% by weight of emulsifiers (such as calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in up to 100% by weight of water-insoluble in organic solvents such as aromatic hydrocarbons. Dilute with water to give an emulsion. iv) Emulsions (EW, EO, ES) Dissolve 5-40% by weight of compound I or II or mixtures according to the invention and 1-10% by weight of emulsifiers (such as calcium dodecylbenzenesulfonate and castor oil ethoxylate) in 20-40% by weight of water in insoluble organic solvents such as aromatic hydrocarbons. This mixture is introduced into up to 100% by weight of water by means of an emulsifier and a homogeneous emulsion is produced. Dilute with water to give an emulsion. v) Suspensions (SC, OD, FS) In an agitating ball mill, 20-60% by weight of compounds I or II or mixtures according to the invention are pulverized, 2-10% by weight of dispersants and wetting agents (such as sodium lignosulfonate and alcohol ethoxylates) are added, 0,1-2% by weight thickener (such as Sanxian gum) and up to 100% by weight water, resulting in a fine active substance suspension. Dilution with water gives a stable suspension of the active substance. For FS-type compositions, up to 40% by weight of binder (eg polyvinyl alcohol) is added. vi) Water-dispersible granules and water-soluble granules (WG, SG) 50-80% by weight of compounds I or II or mixtures according to the invention are finely ground, up to 100% by weight of dispersants and wetting agents (such as sodium lignosulfonate and alcohol ethoxylates) are added and with the aid of technical equipment ( eg extrusion, spray tower, fluidized bed) are prepared as water-dispersible or water-soluble granules. Dilution with water gives a stable dispersion or solution of the active substance. vii) Water-dispersible powder and water-soluble powder (WP, SP, WS) 50-80% by weight of compounds I or II or mixtures according to the invention are ground in a rotor-stator mill with the addition of 1-5% by weight of a dispersant (for example sodium lignosulfonate), 1-3% by weight of a wetting agent ( such as alcohol ethoxylates) and up to 100% by weight solid carrier such as silica gel. Dilution with water gives a stable dispersion or solution of the active substance. viii) Gels (GW, GF) In an agitating ball mill, 5-25% by weight of compound I or II or mixtures according to the present invention are pulverized, 3-10% by weight of dispersants (such as sodium lignosulfonate), 1-5% by weight of thickeners ( For example carboxymethylcellulose) and up to 100% by weight of water give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance. ix) Microemulsion (ME) Add 5-20% by weight of compound I or II or mixture according to the invention to 5-30% by weight of organic solvent blend (such as fatty acid dimethylamide and cyclohexanone), 10-25% by weight of surfactant blend Compounds (such as alcohol ethoxylates and arylphenol ethoxylates) and water made up to 100%. This mixture was stirred for 1 hour to spontaneously generate a thermodynamically stable microemulsion. x) Microcapsules (CS) An oil phase comprising 5-50% by weight of compound I or II or a mixture according to the invention, 0-40% by weight of a water-insoluble organic solvent (such as an aromatic hydrocarbon), 2-15% by weight of an acrylic acid monomer (such as methacrylic acid Methyl esters, methacrylic acid and diacrylates or triacrylates) are dispersed in aqueous solutions of protective colloids such as polyvinyl alcohol. Free radical polymerization initiated by a free radical initiator leads to the formation of poly(meth)acrylate microcapsules. Alternatively, an oil phase comprising 5-50% by weight of compound I or II or a mixture according to the invention, 0-40% by weight of a water-insoluble organic solvent (such as an aromatic hydrocarbon) and an isocyanate monomer (such as diphenylmethylene -4,4'-diisocyanate) dispersed in an aqueous solution of a protective colloid (such as polyvinyl alcohol). Addition of polyamines such as hexamethylenediamine results in the formation of polyurea microcapsules. The monomers amount to 1-10% by weight. The wt% relates to the total CS composition. xi) Spreadable powders (DP, DS) 1-10% by weight of compounds I or II or mixtures according to the invention are finely ground and intimately mixed with up to 100% by weight of a solid carrier (eg finely divided kaolin). xii) Granules (GR, FG) 0.5-30% by weight of compounds I or II or mixtures according to the invention are finely ground and associated with up to 100% by weight of solid carriers (eg silicates). Granulation is achieved by extrusion, spray drying or fluidized bed. xiii) Ultra Low Volume Liquid (UL) 1-50% by weight of compounds I or II or mixtures according to the invention are dissolved in up to 100% by weight of organic solvents (eg aromatic hydrocarbons).

組合物類型i)至xi)可視情況包含其他助劑,諸如0.1-1重量%殺細菌劑、5-15重量%防凍劑、0.1-1重量%消泡劑及0.1-1重量%著色劑。Composition types i) to xi) optionally contain further auxiliaries, such as 0.1-1% by weight of bactericides, 5-15% by weight of antifreeze agents, 0.1-1% by weight of defoamers and 0.1-1% by weight of colorants.

農用化學組合物一般包含0.01至95重量%、較佳0.1至90重量%且最佳0.5至75重量%之活性物質。所用活性物質之純度為90%至100%、較佳95%至100% (根據NMR譜)。The agrochemical compositions generally comprise 0.01 to 95% by weight, preferably 0.1 to 90% by weight and optimally 0.5 to 75% by weight of active substance. The purity of the active substances used is from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).

可將各種類型之油、濕潤劑、佐劑、肥料或微量營養素及其他殺有害生物劑(例如除草劑、殺昆蟲劑、殺真菌劑、生長調節因子、安全劑)添加至活性物質或包含活性物質之組合物中作為預混物,或若適宜直至使用之前立即添加(槽式混合)。此等試劑可以1:100至100:1、較佳1:10至10:1之重量比與根據本發明之組合物混合。Various types of oils, wetting agents, adjuvants, fertilizers or micronutrients and other pesticidal agents (e.g. herbicides, insecticides, fungicides, growth regulators, safeners) can be added to the active substance or contained in the active Compositions of substances are used as premixes or, if appropriate, added immediately prior to use (tank mix). These agents can be mixed with the composition according to the invention in a weight ratio of 1:100 to 100:1, preferably 1:10 to 10:1.

使用者通常自前給藥式裝置、背負式噴霧器、噴霧槽、噴霧飛機或灌溉系統施用根據本發明之組合物。通常,農用化學組合物用水、緩衝劑及/或其他助劑配製成所需施用濃度,且由此獲得即用型噴霧液或根據本發明之農用化學組合物。通常,每公頃農業有用區域施用20至2000公升、較佳50至400公升即用型噴霧液。The user usually applies the composition according to the invention from a pre-dose device, a knapsack sprayer, a spray tank, a spray plane or an irrigation system. As a rule, the agrochemical compositions are formulated with water, buffers and/or other auxiliaries to the desired application concentration, and thus a ready-to-use spray liquid or an agrochemical composition according to the invention is obtained. In general, 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agriculturally useful area.

根據一個實施例,根據本發明之組合物的個別組分,諸如套組之部分或二元或三元混合物之部分,可由使用者自己在噴霧槽中混合,且若適宜可添加其他助劑。According to one embodiment, the individual components of the compositions according to the invention, such as parts of kits or parts of binary or ternary mixtures, can be mixed by the user himself in a spray tank and, if appropriate, further auxiliaries can be added.

在另一個實施例中,根據本發明之組合物的個別組分或部分預混合的組分,例如包含本發明化合物及/或如上文所定義之混合搭配物的組分,可由使用者在噴霧槽中混合,且若適宜可添加其他助劑及添加劑。In another embodiment, the individual components or partially premixed components of the composition according to the invention, for example comprising the compounds of the invention and/or the mixing partners as defined above, can be sprayed by the user Mix in the tank, and add other auxiliaries and additives if appropriate.

在另一個實施例中,根據本發明之組合物的個別組分或部分預混合的組分,例如包含本發明化合物及/或如上文所定義之混合搭配物的組分,可共同(例如在槽式混合之後)或連續施用。In another embodiment, the individual components or partially premixed components of the composition according to the invention, for example comprising the compounds of the invention and/or the mixing partners as defined above, may be used together (for example in after tank mixing) or continuous application.

施用方法 本發明之化合物及混合物適用於保護作物、植物、植物繁殖材料(諸如種子)或植物生長之土壤或水免受動物有害生物侵襲或侵染。因此,本發明亦關於植物保護方法,其包含使作物、植物、植物繁殖材料(諸如種子)或植物生長之土壤或水與殺有害生物有效量之本發明化合物接觸以免受動物有害生物侵襲或侵染。Application method The compounds and mixtures according to the invention are suitable for protecting crops, plants, plant propagation material (such as seeds) or the soil or water in which plants are grown against attack or infestation by animal pests. Accordingly, the present invention also relates to a method for the protection of plants, which comprises contacting a crop, a plant, plant propagation material (such as seeds) or the soil or water in which a plant is growing, with a pesticidally effective amount of a compound according to the invention against attack or infestation by animal pests. dye.

本發明之化合物及混合物亦適用於對抗或控制動物有害生物。因此,本發明亦關於一種對抗或控制動物有害生物之方法,其包含使動物有害生物、其棲息地、繁殖地或食物供應地,或作物、植物、植物繁殖材料(諸如種子),或土壤,或動物有害生物正生長或可生長之區域、材料或環境與殺有害生物有效量之本發明化合物接觸。The compounds and mixtures according to the invention are also suitable for combating or controlling animal pests. Accordingly, the present invention also relates to a method of combating or controlling animal pests, which comprises causing the animal pest, its habitat, breeding ground or food supply, or crops, plants, plant propagation material (such as seeds), or soil, Or an area, material or environment where an animal pest is growing or could grow is contacted with a pesticidally effective amount of a compound of the invention.

本發明之化合物及混合物經由接觸及攝入均為有效的。此外,本發明之化合物及混合物可施用於任何及所有發育階段,諸如卵、幼蟲、蛹及成蟲。The compounds and mixtures of the invention are effective upon contact and ingestion. Furthermore, the compounds and mixtures of the invention may be administered to any and all developmental stages, such as eggs, larvae, pupae and adults.

本發明之化合物及混合物可原樣施用或以如上文所定義之包含其之組合物形式施用。此外,本發明之化合物及混合物可與如上文所定義之混合搭配物一起施用或以如上文所定義之包含該等混合物之組合物形式施用。該混合物之組分可同時、共同或分開、或依次(亦即一個緊接著另一個)施用,從而在所需位置(例如植物)「原位」產生混合物,在分開施用之情況下,順序一般對控制措施之結果無任何影響。The compounds and mixtures of the invention may be applied as such or in the form of compositions comprising them as defined above. Furthermore, the compounds and mixtures according to the invention can be applied together with mixture partners as defined above or in the form of compositions comprising such mixtures as defined above. The components of the mixture may be applied simultaneously, together or separately, or sequentially (i.e. one immediately after the other) to produce the mixture "in situ" at the desired location (e.g. the plant), in the case of separate applications the sequence is generally Has no effect on the outcome of the control measures.

施用可在有害生物侵染作物、植物、植物繁殖材料(諸如種子)、土壤、或區域、材料或環境之前及之後進行。Application can be performed before and after infestation of the crop, plant, plant propagation material (such as seeds), soil, or area, material or environment by the pest.

適合之施用方法尤其包括土壤處理、種子處理、犁溝施用、進水口施用(例如在灌溉期間的稻田中)及葉面施用。土壤處理方法包括浸透土壤、滴灌(滴注施用於土壤)、浸根、塊莖或鱗莖、或土壤注入。種子處理技術包括拌種、種子包衣、種子撒粉、種子浸泡及種子丸化。犁溝施用通常包括在耕地上形成犁溝,用種子播種犁溝,將殺有害生物活性組分I或II或混合物施用於犁溝及封閉犁溝的步驟。葉面施用係指將殺有害生物活性組分I或II或混合物施用於植物葉子,例如經由噴霧設備。對於葉面施用,藉由使用信息素與本發明之化合物及混合物的組合來改變有害生物的行為可為有利的。用於特定作物及有害生物之適合的信息素為技術人員已知的,且可自信息素及化學信息素之資料庫公開獲得,諸如http://www.pherobase.com。Suitable methods of application include, inter alia, soil treatment, seed treatment, in-furrow application, water-inlet application (for example in paddy fields during irrigation) and foliar application. Soil treatment methods include saturating the soil, drip irrigation (drip application to the soil), soaking the roots, tubers or bulbs, or soil injection. Seed treatment techniques include seed dressing, seed coating, seed dusting, seed soaking and seed pelleting. In-furrow application generally includes the steps of forming a furrow on arable land, sowing the furrow with seeds, applying the pesticidally active component I or II or the mixture to the furrow and sealing the furrow. Foliar application means the application of pesticidally active ingredients I or II or mixtures to the foliage of plants, for example via spray equipment. For foliar application, it may be advantageous to modify the behavior of pests by using pheromones in combination with the compounds and mixtures of the invention. Suitable pheromones for specific crops and pests are known to the skilled person and are publicly available from databases of pheromones and semiochemicals, such as http://www.pherobase.com.

如本文所用,術語「接觸」包括直接接觸(將化合物/組合物直接施用於動物有害生物或植物 - 通常施用於植物的葉、莖或根)及間接接觸(將化合物/組合物施用於動物有害生物或植物的所在地,亦即棲息地、繁殖地、植物、種子、土壤、有害生物正生長或可生長的區域、材料或環境)。As used herein, the term "contact" includes direct contact (applying the compound/composition directly to the animal pest or the plant - usually to the leaves, stems or roots of the plant) and indirect contact (applying the compound/composition to the animal pest The locus of an organism or plant, i.e. habitat, breeding ground, plant, seed, soil, area, material or environment in which a pest is growing or may grow).

術語「動物有害生物」包括節肢動物、腹足動物及線蟲。根據本發明之較佳動物有害生物為節肢動物,較佳昆蟲及蛛形綱動物,尤其昆蟲。與作物特別相關之昆蟲通常稱為作物害蟲。The term "animal pest" includes arthropods, gastropods and nematodes. Preferred animal pests according to the invention are arthropods, preferably insects and arachnids, especially insects. Insects that are particularly associated with crops are often referred to as crop pests.

術語「作物」係指生長及收穫的作物。The term "crop" refers to grown and harvested crops.

術語「植物」包括穀類,例如硬粒小麥及其他小麥、黑麥、大麥、黑小麥、燕麥、水稻或玉米(飼料玉米及糖玉米/甜玉米及普通玉米);甜菜,例如糖用甜菜或飼料甜菜;水果,諸如梨果、核果或軟果,例如蘋果、梨、李子、桃、油桃、杏仁、櫻桃、木瓜、草莓、覆盆子、黑莓或醋栗;豆科植物,諸如菜豆、扁豆、豌豆、苜蓿或大豆;油料植物,諸如菜籽(油菜)、蕪菁油菜、芥末、橄欖、向日葵、椰子、可可豆、蓖麻油植物、油棕櫚、花生或大豆;瓜類,諸如南瓜、番瓜、黃瓜或甜瓜;纖維植物,諸如棉花、亞麻、大麻或黃麻;柑橘類水果,諸如橙、檸檬、葡萄柚或蜜橘;蔬菜,諸如茄子、菠菜、萵苣(例如卷心萵苣)、菊苣、甘藍、蘆筍、甘藍、胡蘿蔔、洋蔥、大蒜、韭菜、蕃茄、馬鈴薯、葫蘆或甜椒;月桂科屬植物,諸如鱷梨、肉桂或樟腦;能源及原料植物,諸如玉米、大豆、菜籽、甘蔗或油棕;菸草;堅果,例如胡桃;開心果;咖啡;茶;香蕉;藤本植物(鮮食葡萄及葡萄汁葡萄藤);蛇麻子;甜葉(亦稱為甜菊);天然橡膠植物或觀賞植物及林業植物,諸如花(例如康乃馨、矮牽牛、老鸛草/天竺葵、三色紫羅蘭及鳳仙花)、灌木、闊葉樹(例如白楊)或常青樹,例如針葉樹;桉樹;草皮;草坪;草,諸如用於動物飼料或觀賞用途之草。較佳植物包括馬鈴薯、糖用甜菜、菸草、小麥、黑麥、大麥、燕麥、水稻、玉米、棉花、大豆、菜籽、豆類、向日葵、咖啡或甘蔗;水果;藤本植物;觀賞植物;或蔬菜,諸如黃瓜、蕃茄、菜豆或南瓜。The term "plant" includes cereals such as durum wheat and other wheats, rye, barley, triticale, oats, rice or corn (fodder corn and sugar corn/sweet corn and common corn); sugar beets such as sugar beets or fodder Beets; fruits such as pome, stone or soft fruit, such as apples, pears, plums, peaches, nectarines, almonds, cherries, papayas, strawberries, raspberries, blackberries or gooseberries; legumes such as beans, lentils, Peas, alfalfa or soybeans; oil plants such as rapeseed (rape), turnip rape, mustard, olives, sunflowers, coconuts, cocoa beans, castor oil plants, oil palms, peanuts or soybeans; melons such as pumpkins, pumpkins, Cucumbers or melons; fibrous plants such as cotton, flax, hemp or jute; citrus fruits such as oranges, lemons, grapefruits or tangerines; vegetables such as eggplants, spinach, lettuces (e.g. Asparagus, kale, carrots, onions, garlic, leeks, tomatoes, potatoes, gourds, or bell peppers; laurel plants, such as avocado, cinnamon, or camphor; energy and raw material plants, such as corn, soybeans, rapeseed, sugar cane, or oil Brown; tobacco; nuts, such as walnuts; pistachios; coffee; tea; bananas; vines (table grapes and grape must vines); hops; sweet leaves (also known as stevia); natural rubber plants or ornamental and forestry plants , such as flowers (e.g. carnations, petunias, geraniums/geraniums, pansies and impatiens), shrubs, broad-leaved trees (e.g. poplars) or evergreens such as conifers; eucalyptus; turf; lawns; grasses, such as for animals Forage or ornamental grass. Preferred plants include potatoes, sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rapeseed, beans, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables , such as cucumbers, tomatoes, beans or squash.

術語「植物」應理解為包括野生型植物及已藉由習知育種、或突變誘發或基因工程改造、或藉由其組合修飾以便為植物提供新的性狀或修改已存在的性狀的植物。The term "plant" is understood to include wild-type plants as well as plants which have been modified by conventional breeding, or mutagenesis or genetic engineering, or by a combination thereof, in order to provide the plant with new traits or to modify existing traits.

突變誘發包括使用X射線或突變誘發化學試劑進行隨機突變誘發之技術,以及靶向突變誘發技術,以便在植物基因組之特定基因座產生突變。靶向突變誘發技術常常使用寡核苷酸或蛋白質如CRISPR/Cas、鋅指核酸酶、TALEN或大範圍核酸酶來達成靶向作用。Mutagenesis includes random mutagenesis techniques using X-rays or mutagenic chemical reagents, and targeted mutagenesis techniques to generate mutations at specific loci in the plant genome. Targeted mutagenesis techniques often use oligonucleotides or proteins such as CRISPR/Cas, zinc finger nucleases, TALENs, or meganucleases to achieve targeting.

基因工程改造通常使用重組DNA技術在植物基因組中產生在天然情況下不能容易地藉由雜交育種、突變誘發或天然重組獲得的修飾。通常,將一或多個基因整合於植物基因組中以便增加性狀或改善性狀。此等整合之基因在此項技術中亦稱為轉殖基因,而包含此類轉殖基因之植物稱為轉殖基因植物。植物轉型過程通常產生若干轉型事件,該等轉型事件之不同之處在於已整合轉殖基因之基因組基因座。在特定基因組基因座上包含特定轉殖基因之植物通常描述為包含特定「事件」,其係藉由特定事件名稱指代。已引入植物中或已經改變之性狀特別包括除草劑耐受性、昆蟲抗性、增加之產量及對非生物條件如乾旱之耐受性。Genetic engineering typically uses recombinant DNA techniques to produce modifications in plant genomes that cannot naturally be readily obtained by cross-breeding, mutagenesis, or natural recombination. Typically, one or more genes are integrated into the plant genome in order to increase or improve a trait. Such integrated genes are also referred to as transgenes in the art, and plants containing such transgenes are referred to as transgenic plants. The plant transformation process typically results in several transformation events that differ by the genomic locus into which the transgene has been integrated. A plant containing a particular transgene at a particular genomic locus is often described as containing a particular "event," which is referred to by a particular event name. Traits that have been introduced into plants or have been altered include, inter alia, herbicide tolerance, insect resistance, increased yield and tolerance to abiotic conditions such as drought.

除草劑耐受性係藉由使用突變誘發以及使用基因工程改造產生。已利用習知突變誘發及育種方法而對乙醯乳酸合成酶(ALS)抑制劑除草劑呈現耐受性的植物包含以名稱Clearfield® 市售的植物品種。然而,大部分除草劑耐受性性狀已經由使用轉殖基因產生。Herbicide tolerance is produced by using mutagenesis and by using genetic engineering. Plants that have been rendered tolerant to acetyl lactate synthase (ALS) inhibitor herbicides using conventional mutagenesis and breeding methods include the plant variety marketed under the name Clearfield® . However, most herbicide tolerance traits have been generated using transgenes.

已產生針對草甘膦(glyphosate)、固殺草(glufosinate)、2,4-D、麥草畏(dicamba)、苯腈(oxynil)除草劑(如溴苯腈(bromoxynil)及碘苯腈(ioxynil))、磺醯脲除草劑、ALS抑制劑除草劑及4-羥基苯基丙酮酸雙加氧酶(HPPD)抑制劑(如異噁唑草酮(isoxaflutole)及甲基磺草酮(mesotrione))之除草劑耐受性。Herbicides against glyphosate, glufosinate, 2,4-D, dicamba, oxynil (such as bromoxynil and ioxynil) have been produced )), sulfonylurea herbicides, ALS inhibitor herbicides and 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors (such as isoxaflutole and mesotrione ) herbicide tolerance.

已用於提供除草劑耐受性性狀之轉殖基因包含:對於針對草甘膦之耐受性:cp4 epsps、epsps grg23ace5、mepsps、2mepsps、gat4601、gat4621及goxv247;對於針對固殺草之耐受性:pat及bar;對於針對2,4-D之耐受性:aad-1及aad-12;對於針對麥草畏之耐受性:dmo;對於針對苯腈除草劑之耐受性:bxn;對於針對磺醯脲除草劑之耐受性:zm-hra、csr1-2、gm-hra、S4-HrA;對於針對ALS抑制劑除草劑之耐受性:csr1-2;對於針對HPPD抑制劑除草劑之耐受性:hppdPF、W336及avhppd-03。Transgenes that have been used to provide herbicide tolerance traits include: for tolerance to glyphosate: cp4 epsps, epsps grg23ace5, mepsps, 2mepsps, gat4601, gat4621 and goxv247; Resistance: pat and bar; for tolerance to 2,4-D: aad-1 and aad-12; for tolerance to dicamba: dmo; for tolerance to benzonitrile herbicide: bxn; For tolerance to sulfonylurea herbicides: zm-hra, csr1-2, gm-hra, S4-HrA; for tolerance to ALS inhibitor herbicides: csr1-2; for HPPD inhibitor herbicide Drug tolerance: hppdPF, W336 and avhppd-03.

包含除草劑耐受性基因之轉殖基因玉米事件為如下但不排除其他:DAS40278、MON801、MON802、MON809、MON810、MON832、MON87411、MON87419、MON87427、MON88017、MON89034、NK603、GA21、MZHG0JG、HCEM485、VCO-Ø1981-5、676、678、680、33121、4114、59122、98140、Bt10、Bt176、CBH-351、DBT418、DLL25、MS3、MS6、MZIR098、T25、TC1507及TC6275。Transgenic maize events containing herbicide tolerance genes are as follows but not excluded: DAS40278, MON801, MON802, MON809, MON810, MON832, MON87411, MON87419, MON87427, MON88017, MON89034, NK603, GA21, MZHG0JG, HCEM48 5. VCO-Ø1981-5, 676, 678, 680, 33121, 4114, 59122, 98140, Bt10, Bt176, CBH-351, DBT418, DLL25, MS3, MS6, MZIR098, T25, TC1507 and TC6275.

包含除草劑耐受性基因之轉殖基因大豆事件為如下但不排除其他:GTS 40-3-2、MON87705、MON87708、MON87712、MON87769、MON89788、A2704-12、A2704-21、A5547-127、A5547-35、DP356043、DAS44406-6、DAS68416-4、DAS-81419-2、GU262、SYHTØH2、W62、W98、FG72及CV127。Transgenic soybean events containing herbicide tolerance genes are as follows but not excluded: GTS 40-3-2, MON87705, MON87708, MON87712, MON87769, MON89788, A2704-12, A2704-21, A5547-127, A5547 -35, DP356043, DAS44406-6, DAS68416-4, DAS-81419-2, GU262, SYHTØH2, W62, W98, FG72, and CV127.

包含除草劑耐受性基因之轉殖基因棉花事件為如下但不排除其他:19-51a、31707、42317、81910、281-24-236、3006-210-23、BXN10211、BXN10215、BXN10222、BXN10224、MON1445、MON1698、MON88701、MON88913、GHB119、GHB614、LLCotton25、T303-3及T304-40。Transgenic cotton events containing herbicide tolerance genes are as follows but not excluded: 19-51a, 31707, 42317, 81910, 281-24-236, 3006-210-23, BXN10211, BXN10215, BXN10222, BXN10224, MON1445, MON1698, MON88701, MON88913, GHB119, GHB614, LLCotton25, T303-3 and T304-40.

包含除草劑耐受性基因之轉殖基因芥花事件為如下但不排除其他:MON88302、HCR-1、HCN10、HCN28、HCN92、MS1、MS8、PHY14、PHY23、PHY35、PHY36、RF1、RF2及RF3。Transgenic canola events including herbicide tolerance genes are as follows but not excluded: MON88302, HCR-1, HCN10, HCN28, HCN92, MS1, MS8, PHY14, PHY23, PHY35, PHY36, RF1, RF2 and RF3 .

昆蟲抗性主要藉由將殺昆蟲蛋白質之細菌基因轉移至植物中而產生。最頻繁使用之轉殖基因為芽孢桿菌屬(Bacillus spec.)之毒素基因及其合成變體,如cry1A、cry1Ab、cry1Ab-Ac、cry1Ac、cry1A.105、cry1F、cry1Fa2、cry2Ab2、cry2Ae、mcry3A、ecry3.1Ab、cry3Bb1、cry34Ab1、cry35Ab1、cry9C、vip3A(a)、vip3Aa20。然而,亦已將植物來源之基因轉移至其他植物中。特別是編碼蛋白酶抑制劑的基因,如CpTI及pinII。另一方法使用轉殖基因在植物中產生雙股RNA以靶向及下調昆蟲基因。此類轉殖基因之實例為dvsnf7。Insect resistance arises primarily by transferring bacterial genes for insecticidal proteins into plants. The most frequently used transgenes are toxin genes of Bacillus spec. and their synthetic variants, such as cry1A, cry1Ab, cry1Ab-Ac, cry1Ac, cry1A.105, cry1F, cry1Fa2, cry2Ab2, cry2Ae, mcry3A, ecry3.1Ab, cry3Bbl, cry34Abl, cry35Abl, cry9C, vip3A(a), vip3Aa20. However, genes of plant origin have also been transferred into other plants. In particular, genes encoding protease inhibitors, such as CpTI and pinII. Another approach uses transgenes to produce double-stranded RNA in plants to target and down-regulate insect genes. An example of such a transgene is dvsnf7.

包含殺昆蟲蛋白質或雙股RNA基因之轉殖基因玉米事件為如下但不排除其他:Bt10、Bt11、Bt176、MON801、MON802、MON809、MON810、MON863、MON87411、MON88017、MON89034、33121、4114、5307、59122、TC1507、TC6275、CBH-351、MIR162、DBT418及MZIR098。Transgenic maize events containing insecticidal protein or double-stranded RNA genes are as follows, but not excluded: 59122, TC1507, TC6275, CBH-351, MIR162, DBT418 and MZIR098.

包含殺昆蟲蛋白質基因之轉殖基因大豆事件為如下但不排除其他:MON87701、MON87751及DAS-81419。Transgenic soybean events comprising an insecticidal protein gene are the following but not exclusive: MON87701, MON87751 and DAS-81419.

包含殺昆蟲蛋白質基因之轉殖基因棉花事件為如下但不排除其他:SGK321、MON531、MON757、MON1076、MON15985、31707、31803、31807、31808、42317、BNLA-601、Event1、COT67B、COT102、T303-3、T304-40、GFM Cry1A、GK12、MLS 9124、281-24-236、3006-210-23、GHB119及SGK321。Transgenic cotton events containing insecticidal protein genes are as follows, but not excluded: 3. T304-40, GFM Cry1A, GK12, MLS 9124, 281-24-236, 3006-210-23, GHB119 and SGK321.

產量增加係藉由使用玉米事件MON87403中存在之轉殖基因athb17增加穗生物質量,或藉由使用大豆事件MON87712中存在之轉殖基因bbx32促進光合作用來實現。Yield increases were achieved by increasing ear biomass using the transgene athbl7 present in maize event MON87403, or by enhancing photosynthesis using the transgene bbx32 present in soybean event MON87712.

已藉由使用以下轉殖基因產生包含改良油含量之栽培植物:gm-fad2-1、Pj.D6D、Nc.Fad3、fad2-1A及fatb1-A。包含此等基因中之至少一者的大豆事件為:260-05、MON87705及MON87769。Cultivar plants comprising improved oil content have been produced by using the following transgenes: gm-fad2-1, Pj.D6D, Nc.Fad3, fad2-1A and fatb1-A. Soybean events comprising at least one of these genes are: 260-05, MON87705 and MON87769.

對非生物條件之耐受性,特別是對乾旱之耐受性已藉由使用玉米事件MON87460所包含之轉殖基因cspB及藉由使用大豆事件IND-ØØ41Ø-5所包含之轉殖基因Hahb-4產生。Tolerance to abiotic conditions, especially to drought, has been improved by using the transgene cspB contained in maize event MON87460 and by using the transgene Hahb- contained in soybean event IND-ØØ41Ø-5 4 generated.

性狀常常藉由在轉型事件中組合基因或藉由在育種過程期間組合不同事件來組合。較佳之性狀組合為對不同組除草劑之除草劑耐受性;對不同種類昆蟲之昆蟲抗性,特別是對鱗翅目及鞘翅目昆蟲之抗性;除草劑耐受性與一種或若干類型之昆蟲抗性;除草劑耐受性與增加之產量;以及除草劑耐受性與對非生物條件之耐受性的組合。Traits are often combined by combining genes in transformation events or by combining different events during the breeding process. Preferred combinations of traits are herbicide tolerance to different groups of herbicides; insect resistance to different species of insects, especially resistance to Lepidoptera and Coleoptera; herbicide tolerance in combination with one or several types of Insect resistance; herbicide tolerance and increased yield; and herbicide tolerance in combination with tolerance to abiotic conditions.

包含單一或堆疊性狀之植物以及提供此等性狀之基因及事件為此項技術中熟知的。舉例而言,關於經突變誘發或整合之基因以及相應事件的詳細資訊可自組織「國際農業生物技術應用服務組織(International Service for the Acquisition of Agri-biotech Applications,ISAAA)」(http://www.isaaa.org/gmapprovaldatabase)及「環境風險評估中心(Center for Environmental Risk Assessment,CERA)」(http://cera-gmc.org/GMCropDatabase)之網站以及專利申請案,如EP3028573及WO2017/011288獲得。Plants comprising single or stacked traits and the genes and events that confer such traits are well known in the art. For example, detailed information on mutagenic or integrated genes and corresponding events is available from the International Service for the Acquisition of Agri-biotech Applications (ISAAA) (http://www. .isaaa.org/gmapprovaldatabase) and "Center for Environmental Risk Assessment (CERA)" (http://cera-gmc.org/GMCropDatabase) websites and patent applications, such as EP3028573 and WO2017/011288 obtained .

在本發明之一個實施例中,植物較佳為水稻植物(稻屬物種,較佳稻(Oryza sativa))。最常種植兩種水稻,稻及光稃稻(Oryza glaberrima)。稻之許多亞種為商業上重要的,包括秈稻(Oryza sativa subsp. indica)、粳稻(Oryza sativa subsp. japonica)、爪哇稻(Oryza sativa subsp. javanica)、糯稻(Oryza sativa subsp. glutinosa) (glutinous rice)、香稻(Oryza sativa Aromatica group) (例如巴斯馬蒂香米(basmati))及稻(浮稻)。In one embodiment of the present invention, the plant is preferably a rice plant (Oryza spp., preferably Oryza sativa). Two types of rice are most commonly grown, Oryza glabra and Oryza glaberrima. Many subspecies of rice are commercially important, including indica rice (Oryza sativa subsp. indica), japonica rice (Oryza sativa subsp. japonica), Java rice (Oryza sativa subsp. javanica), glutinous rice (Oryza sativa subsp. glutinosa) (glutinous rice), aromatic rice (Oryza sativa Aromatica group) (eg basmati) and rice (floating rice).

已藉由突變誘發或基因工程改造修飾且具有特別商業重要性之植物包括水稻。在已藉由突變誘發或基因工程改造修飾之植物中,一或多個基因已經誘變或整合至植物之遺傳物質中。一或多個經誘變或整合之基因較佳選自pat、epsps、cry1Ab、bar、cry1Fa2、cry1Ac、cry34Ab1、cry35AB1、cry3A、cryF、cry1F、mcry3a、cry2Ab2、cry3Bb1、cry1A.105、dfr、barnase、vip3Aa20、barstar、als、bxn、bp40、asn1及ppo5。進行一或多個基因之突變誘發或整合以改良植物之某些特性。此類特性,亦稱為性狀,包括非生物脅迫耐受性、改變之生長/產量、抗病性、除草劑耐受性、昆蟲抗性、改良之產品品質及授粉控制。在此等特性中,除草劑耐受性,例如咪唑啉酮耐受性、草甘膦耐受性或固殺草耐受性為特別重要的。Plants of particular commercial importance which have been modified by mutagenesis or genetic engineering include rice. In a plant that has been modified by mutagenesis or genetic engineering, one or more genes have been mutagenized or integrated into the genetic material of the plant. The one or more mutagenized or integrated genes are preferably selected from pat, epsps, cry1Ab, bar, cry1Fa2, cry1Ac, cry34Ab1, cry35AB1, cry3A, cryF, cry1F, mcry3a, cry2Ab2, cry3Bb1, cry1A.105, dfr, barnase , vip3Aa20, barstar, als, bxn, bp40, asn1 and ppo5. Mutagenesis or integration of one or more genes is performed to improve certain characteristics of the plant. Such traits, also known as traits, include abiotic stress tolerance, altered growth/yield, disease resistance, herbicide tolerance, insect resistance, improved product quality, and pollination control. Among these traits, herbicide tolerance, for example imidazolinone tolerance, glyphosate tolerance or immobilized herbicide tolerance, is of particular importance.

已出乎意料地發現,本發明化合物之殺有害生物活性可藉由經修飾之植物的殺昆蟲性狀來增強。此外,已發現本發明化合物適用於防止昆蟲對殺昆蟲性狀產生抗性或對抗已對經修飾之植物的殺昆蟲性狀具有抗性的有害生物。此外,本發明化合物適用於對抗殺昆蟲性狀對其無效之有害生物,因此可有利地使用補充的殺昆蟲活性。It has been unexpectedly found that the pesticidal activity of the compounds according to the invention can be enhanced by the insecticidal traits of the modified plants. Furthermore, the compounds according to the invention have been found to be useful for preventing insects from developing resistance to insecticidal traits or against pests which have become resistant to insecticidal traits in modified plants. Furthermore, the compounds according to the invention are useful against pests against which insecticidal traits are ineffective, so that supplementary insecticidal activity can advantageously be used.

對栽培植物使用根據本發明之組合物可產生特異性針對包含某種基因或事件之栽培植物的效應。此等效應可能涉及生長行為之變化或對生物或非生物脅迫因素之抗性的變化。此類效應可尤其包含增加產量,增強對昆蟲、線蟲、真菌、細菌、支原體、病毒或類病毒病原體之抗性或耐受性,以及早期萌發勢、早熟或延遲成熟、耐寒或耐熱,以及改變胺基酸或脂肪酸譜或含量。The use of the compositions according to the invention on cultivated plants produces an effect specific for the cultivated plant comprising a certain gene or event. These effects may involve changes in growth behavior or changes in resistance to biotic or abiotic stress factors. Such effects may include, inter alia, increased yield, increased resistance or tolerance to insects, nematodes, fungi, bacteria, mycoplasma, viruses or viroid pathogens, as well as early vigor, early or delayed maturation, cold or heat tolerance, and altered Amino acid or fatty acid profile or content.

已出乎意料地發現,本發明之化合物及混合物的殺有害生物活性可藉由經修飾之植物的殺昆蟲性狀來增強。此外,已發現本發明之化合物及混合物適用於防止昆蟲對殺昆蟲性狀產生抗性或對抗已對經修飾之植物的殺昆蟲性狀具有抗性的有害生物。此外,本發明之化合物及混合物適用於對抗殺昆蟲性狀對其無效之有害生物,因此可有利地使用補充的殺昆蟲活性。It has surprisingly been found that the pesticidal activity of the compounds and mixtures according to the invention can be enhanced by the insecticidal traits of the modified plants. Furthermore, it has been found that the compounds and mixtures according to the invention are suitable for preventing the development of resistance in insects to insecticidal traits or for combating pests which have become resistant to insecticidal traits in modified plants. Furthermore, the compounds and mixtures according to the invention are suitable for combating pests against which insecticidal traits are ineffective, so that supplementary insecticidal activity can advantageously be used.

術語「植物繁殖材料」係指植物之所有生殖部分,諸如種子及營養植物材料,諸如插條及塊莖(例如馬鈴薯),其可用於植物的繁殖。此包括種子、根、果實、塊莖、鱗莖、根莖、芽、新枝及植物之其他部分。亦可包括在萌發後或自土壤出苗後移植的幼苗及幼小植物。此等植物繁殖材料可在種植或移植時或之前用植物保護化合物預防性處理。The term "plant propagation material" refers to all reproductive parts of plants, such as seeds and vegetative plant material, such as cuttings and tubers (eg potatoes), which can be used for the propagation of plants. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, buds, shoots and other parts of plants. Seedlings and young plants transplanted after germination or after emergence from soil may also be included. Such plant propagation material can be treated prophylactically with plant protective compounds at or before planting or transplanting.

術語「種子」涵蓋所有類別之種子及植物繁殖體,包括但不限於真正的種子、種子塊、吸根、球莖、鱗莖、果實、塊莖、穀粒、插條、切枝及其類似物,且在一個較佳實施例中意謂真正的種子。The term "seed" covers seeds and plant propagules of all kinds, including but not limited to true seeds, seed pieces, suckers, corms, bulbs, fruits, tubers, grains, cuttings, cuttings and the like, and In a preferred embodiment it means real seeds.

一般而言,「殺有害生物有效量」意謂實現對生長可觀察到的效應,包括壞死、死亡、阻滯、預防及移除、破壞或以其他方式減少目標生物體出現及活動的效應所需的活性成分之量。對於本發明中所用之各種化合物/組合物,殺有害生物有效量可變化。殺有害生物有效量之組合物亦將根據主要條件而變化,諸如所需殺有害生物效應及持續時間、天氣、目標物種、所在地、施用模式及其類似物。In general, "pesticidally effective amount" means the amount required to achieve an observable effect on growth, including necrosis, death, retardation, prevention and removal, destruction or otherwise reducing the presence and activity of the target organism. required amount of active ingredient. The pesticidally effective amount will vary for the various compounds/compositions used in the present invention. The pesticidally effective amount of the composition will also vary depending on prevailing conditions, such as the desired pesticidal effect and duration, weather, target species, location, mode of application, and the like.

在土壤處理、犁溝施用或施用於有害生物棲息地或巢穴之情況下,活性成分之量介於0.0001至500 g/100 m2 、較佳0.001至20 g/100 m2 範圍內。In the case of soil treatment, furrow application or application to pest habitats or nests, the amount of active ingredient is in the range of 0.0001 to 500 g/100 m 2 , preferably 0.001 to 20 g/100 m 2 .

對於例如藉由葉面施用來用於處理作物植物,本發明之活性成分的施用率可在每公頃0.0001 g至4000 g、例如每公頃1 g至2 kg或每公頃1 g至750 g、理想地每公頃1 g至100 g、更理想地每公頃10 g至50 g、例如每公頃10至20 g、每公頃20至30 g、每公頃30至40公克或每公頃40至50 g範圍內。For use in the treatment of crop plants, for example by foliar application, the active ingredient according to the invention may be applied at a rate of from 0.0001 g to 4000 g per hectare, for example from 1 g to 2 kg per hectare or from 1 g to 750 g per hectare, ideally 1 g to 100 g per hectare, more desirably 10 to 50 g per hectare, for example 10 to 20 g per hectare, 20 to 30 g per hectare, 30 to 40 g per hectare or 40 to 50 g per hectare .

本發明之化合物及混合物特別適用於種子的處理,以保護種子免遭害蟲,尤其土壤生活的害蟲,且所得幼苗之根及芽抵抗土壤有害生物及葉面昆蟲。因此,本發明亦關於保護種子免遭昆蟲、尤其土壤昆蟲及保護幼苗之根及芽免遭昆蟲、尤其土壤及葉面昆蟲之方法,該方法包含在播種前及/或在催芽後用本發明化合物處理種子。保護幼苗之根及芽為較佳的。更佳為保護幼苗之芽免遭刺吸昆蟲、咀嚼昆蟲及線蟲。The compounds and mixtures according to the invention are particularly suitable for the treatment of seeds in order to protect the seeds from pests, especially soil-dwelling pests, and the roots and shoots of the resulting seedlings against soil pests and foliar insects. Accordingly, the present invention also relates to a method for protecting seeds from insects, especially soil insects, and protecting roots and shoots of seedlings from insects, especially soil and foliar insects, which method comprises the use of the present invention before sowing and/or after priming. Compounds to treat seeds. It is better to protect the roots and shoots of the seedlings. Better to protect seedling shoots from sucking insects, chewing insects and nematodes.

術語「種子處理」包含此項技術中已知的所有適合之種子處理技術,諸如拌種、種子包衣、種子撒粉、種子浸泡、種子丸化及犁溝施用方法。較佳地,活性化合物I或II或混合物之種子處理施用係在植物播種之前及在植物出苗之前藉由噴灑或藉由撒粉來進行。The term "seed treatment" includes all suitable seed treatment techniques known in the art, such as seed dressing, seed coating, seed dusting, seed soaking, seed pelleting and furrow application methods. Preferably, the seed treatment application of the active compounds I or II or of the mixtures is carried out by spraying or by dusting the plants before sowing of the plants and before emergence of the plants.

本發明亦包含包覆有或含有活性組分I或其混合物之種子。術語「包覆有及/或含有」一般表示活性成分在施用時大部分在繁殖產品之表面上,儘管成分之更多或更少部分可滲透至繁殖產品中,視施用方法而定。當(再)種植該繁殖產品時,其可吸收活性成分。The invention also encompasses seeds coated or containing active ingredient I or mixtures thereof. The term "coated with and/or containing" generally means that the active ingredient is mostly on the surface of the propagation product at the time of application, although a greater or lesser portion of the ingredient may penetrate into the propagation product, depending on the method of application. When the propagation product is (re)planted, it can absorb the active ingredient.

本發明亦包含有包含種子及活性組分I或其混合物之組合物。The invention also includes compositions comprising seeds and active ingredient I or mixtures thereof.

本發明亦包含有包含種子及活性非外消旋化合物I或其混合物之組合物。The invention also encompasses compositions comprising seeds and active non-racemic compound I or mixtures thereof.

本發明亦包含有包含種子及具有對映異構體過量化合物I-R之活性化合物I、較佳具有對映異構體過量化合物I-R-1之化合物I-1或其混合物的組合物。The invention also comprises compositions comprising seed and active compound I in enantiomeric excess of compound I-R, preferably compound I-1 in enantiomeric excess of compound I-R-1 or mixtures thereof.

本發明亦包含有包含種子及活性化合物I-R、較佳化合物I-R-1或其混合物之組合物。The invention also includes compositions comprising seeds and active compound I-R, preferred compound I-R-1 or mixtures thereof.

適合之種子為例如穀物、塊根作物、油料作物、蔬菜、香料、觀賞植物之種子,例如硬粒小麥及其他小麥、大麥、燕麥、黑麥、玉米(飼料玉米及糖玉米/甜玉米及普通玉米)、大豆、油料植物、十字花科植物、棉花、向日葵、香蕉、水稻、油菜、蕪菁油菜、甜菜、飼料甜菜、茄子、馬鈴薯、草、草坪、草皮、飼料草、蕃茄、韭菜、番瓜/南瓜、甘藍、卷心萵苣、胡椒、黃瓜、甜瓜、芸苔屬、甜瓜、菜豆、豌豆、大蒜、洋蔥、胡蘿蔔、塊莖植物諸如馬鈴薯、甘蔗、菸草、葡萄、矮牽牛、老鸛草/天竺葵、三色紫羅蘭及鳳仙花之種子。Suitable seeds are, for example, seeds of cereals, root crops, oil crops, vegetables, spices, ornamental plants, such as durum wheat and other wheat, barley, oats, rye, corn (fodder corn and sugar corn/sweet corn and common corn) ), soybeans, oil plants, cruciferous plants, cotton, sunflower, banana, rice, rapeseed, turnip rape, sugar beet, fodder beet, eggplant, potato, grass, lawn, turf, fodder grass, tomato, leek, pumpkin/ Pumpkins, kale, iceberg lettuce, peppers, cucumbers, melons, Brassicas, melons, beans, peas, garlic, onions, carrots, tubers such as potatoes, sugar cane, tobacco, grapes, petunias, geraniums/geraniums, Seeds of pansies and impatiens.

另外,活性化合物亦可用於處理來自植物之種子,該等植物已藉由突變誘發或基因工程改造修飾,且其例如耐受除草劑或殺真菌劑或殺昆蟲劑之作用。此類經修飾之植物已詳細描述於上文。In addition, the active compounds can also be used for the treatment of seed from plants which have been modified by mutagenesis or genetic engineering and which are, for example, resistant to the action of herbicides or fungicides or insecticides. Such modified plants are described in detail above.

習知種子處理調配物包括例如可流動的濃縮物FS、溶液LS、懸乳劑(SE)、用於乾燥處理之粉劑DS、用於漿料處理之水分散性粉劑WS、水溶性粉劑SS及乳液ES及EC以及凝膠調配物GF。此等調配物可經稀釋或未經稀釋即施用於種子。施用於種子係在播種之前直接在種子上或在種子催芽之後進行。較佳地,施用調配物使得不包括萌發。Conventional seed treatment formulations include, for example, flowable concentrates FS, solutions LS, suspoemulsions (SE), powders DS for dry treatment, water-dispersible powders WS for slurry treatment, water-soluble powders SS and emulsions ES and EC and gel formulation GF. These formulations can be applied to the seed diluted or undiluted. Application to the seed lines is carried out directly on the seeds before sowing or after priming the seeds. Preferably, the formulation is applied such that germination is not involved.

可在二至十倍稀釋後獲得之即用調配物中的活性物質濃度較佳為0.01至60重量%、更佳0.1至40重量%。The active substance concentration in the ready-to-use formulations obtainable after two to ten-fold dilution is preferably from 0.01 to 60% by weight, more preferably from 0.1 to 40% by weight.

在一個較佳實施例中,FS調配物用於種子處理。通常,FS調配物可包含1-800 g/l活性成分、1-200 g/l界面活性劑、0至200 g/l防凍劑、0至400 g/l黏合劑、0至200 g/l顏料及至多1公升溶劑,較佳水。In a preferred embodiment, the FS formulation is used for seed treatment. Typically, FS formulations may comprise 1-800 g/l active ingredient, 1-200 g/l surfactant, 0 to 200 g/l antifreeze, 0 to 400 g/l binder, 0 to 200 g/l Pigment and up to 1 liter of solvent, preferably water.

用於種子處理之本發明之化合物及混合物的尤其較佳的FS調配物通常包含0.1至80重量% (1至800 g/l)活性成分,0.1至20重量% (1至200 g/l)至少一種界面活性劑,例如0.05至5重量%濕潤劑及0.5至15重量%分散劑,至多20重量%、例如5至20%防凍劑,0至15重量%、例如1至15重量%顏料及/或染料,0至40重量%、例如1至40重量%黏合劑(黏著劑),視情況至多5重量%、例如0.1至5重量%增稠劑,視情況0.1至2%消泡劑,及例如0.01至1重量%之量的視情況選用之防腐劑,諸如殺生物劑、抗氧化劑或其類似物,以及至多100重量%之填料/媒劑。Particularly preferred FS formulations of the compounds and mixtures according to the invention for seed treatment generally comprise 0.1 to 80% by weight (1 to 800 g/l) active ingredient, 0.1 to 20% by weight (1 to 200 g/l) at least one surfactant, e.g. 0.05 to 5% by weight wetting agent and 0.5 to 15% by weight dispersant, up to 20% by weight, e.g. 5 to 20% antifreeze, 0 to 15% by weight, e.g. 1 to 15% by weight pigment and / or dyes, 0 to 40% by weight, for example 1 to 40% by weight binder (adhesive), optionally up to 5% by weight, for example 0.1 to 5% by weight thickener, optionally 0.1 to 2% defoamer, And optionally preservatives, such as biocides, antioxidants or the like, for example in an amount of 0.01 to 1% by weight, and fillers/vehicles up to 100% by weight.

在種子處理中,本發明化合物之施加率一般為每100 kg種子0.1 g至10 kg,較佳每100 kg種子1 g至5 kg,更佳每100 kg種子1 g至1000 g且尤其每100 kg種子1 g至200 g,例如每100 kg種子1 g至100 g或5 g至100 g。In seed treatment, the application rate of the compound of the present invention is generally 0.1 g to 10 kg per 100 kg of seeds, preferably 1 g to 5 kg per 100 kg of seeds, more preferably 1 g to 1000 g per 100 kg of seeds and especially per 100 kg of seeds 1 g to 200 g per kg seed, eg 1 g to 100 g or 5 g to 100 g per 100 kg seed.

因此,本發明亦關於包含如本文所定義之本發明化合物或鹽農業上有用之鹽的種子。本發明化合物或其農業上有用之鹽的量一般在每100 kg種子0.1 g至10 kg、較佳每100 kg種子1 g至5 kg、尤其每100 kg種子1 g至1000 g之範圍內變化。對於特定作物(諸如萵苣),比率可更高。Accordingly, the present invention also relates to seeds comprising a compound of the invention or an agriculturally useful salt of the salt as defined herein. The amount of the compound of the present invention or its agriculturally useful salt generally varies within the range of 0.1 g to 10 kg per 100 kg of seeds, preferably 1 g to 5 kg per 100 kg of seeds, especially 1 g to 1000 g per 100 kg of seeds . For certain crops (such as lettuce), the ratio may be higher.

本發明之化合物及混合物亦可用於改善植物之健康。因此,本發明亦關於一種用於改善植物健康之方法,其係藉由用有效且無植物毒性量之本發明化合物處理植物、植物繁殖材料及/或植物生長或將要生長之所在地。The compounds and mixtures of the invention can also be used to improve the health of plants. Accordingly, the present invention also relates to a method for improving the health of plants by treating plants, plant propagation material and/or the locus where plants grow or are to grow with an effective and non-phytotoxic amount of the compounds according to the invention.

如本文所用,「有效且無植物毒性量」意指組分I或II或混合物之使用量允許獲得所需效應,但不會在經處理之植物上或在自經處理之繁殖體或經處理之土壤生長的植物上產生任何植物毒性症狀。As used herein, "effective and non-phytotoxic amount" means that component I or II or the mixture is used in an amount which allows the desired effect to be obtained, but which does not appear on the treated plants or from the treated propagules or treated produce any phytotoxic symptoms on plants grown in the same soil.

術語「植物」及「植物繁殖材料」如上文所定義。The terms "plant" and "plant propagation material" are as defined above.

「植物健康」定義為植物及/或其產品之條件,其係藉由單獨的數個態樣或彼此組合來確定,諸如產量(例如增加生物質量及/或增加有價值的成分的含量)、品質(例如改良某些成分之含量或組成或存放期)、植物萌發勢(例如改良植物生長及/或葉子更綠(「綠化效果」)、對非生物(例如乾旱)及/或生物脅迫(例如疾病)之抗性及生產效率(例如收穫效率、可加工性)。"Plant health" is defined as the condition of a plant and/or its products, which is determined by several aspects alone or in combination with each other, such as yield (for example increased biomass and/or increased content of valuable components), quality (e.g. improved content or composition of certain ingredients or shelf life), plant vigor (e.g. improved plant growth and/or greener leaves (“greening effect”), response to abiotic (e.g. drought) and/or biotic stress ( eg disease) resistance and production efficiency (eg harvest efficiency, processability).

上述確定的植物健康狀況指標可相互依賴且可由彼此產生。各指標在此項技術中加以定義且可藉由技術人員已知的方法確定。The above-identified indicators of plant health can be interdependent and can be generated from each other. Each index is defined in the art and can be determined by methods known to the skilled person.

本發明化合物亦適用於針對非作物害蟲。為針對該等非作物有害生物,本發明之化合物及混合物可用作誘鉺組合物、凝膠、一般昆蟲噴霧劑、氣溶膠、作為超低容量施用及蚊帳(浸漬或表面施用)。此外,可使用浸透及通渠方法。The compounds of the invention are also suitable for use against non-crop pests. To target such non-crop pests, the compounds and mixtures of the invention can be used as bait compositions, gels, general insect sprays, aerosols, as ultra-low volume applications and mosquito nets (dipping or surface application). In addition, soak and channel methods can be used.

如本文所用,術語「非作物害蟲」係指特別與非作物目標相關之有害生物,諸如螞蟻、白蟻、黃蜂、蒼蠅、蜱、蚊子、蟋蟀或蟑螂,較佳蚊子,更佳黃熱病蚊子。As used herein, the term "non-crop pest" refers to pests particularly associated with non-crop targets, such as ants, termites, wasps, flies, ticks, mosquitoes, crickets or cockroaches, preferably mosquitoes, more preferably yellow fever mosquitoes.

誘鉺可為液體、固體或半固體製劑(例如凝膠)。組合物中採用之誘鉺為一種足夠有吸引力以誘使諸如螞蟻、白蟻、黃蜂、蒼蠅、蚊子、蟋蟀等或蟑螂之昆蟲食用的產品。可藉由使用取食刺激劑或性信息素操縱吸引力。食物刺激劑選自例如但不限於動物及/或植物蛋白質(肉粉、魚粉或血粉、昆蟲部分、蛋黃),動物及/或植物來源之脂肪及油,或單糖、寡糖或多糖,尤其蔗糖、乳糖、果糖、右旋糖、葡萄糖、澱粉、果膠或甚至糖蜜或蜂蜜。果實、作物、植物、動物、昆蟲或其特定部分之新鮮或腐爛部分亦可充當取食刺激劑。已知性信息素更具昆蟲特異性。特定信息素描述於文獻中(例如http://www.pherobase.com)且為熟習此項技術者已知的。The bait may be a liquid, solid or semi-solid formulation (eg gel). The bait employed in the composition is a product that is attractive enough to induce the consumption of insects such as ants, termites, wasps, flies, mosquitoes, crickets, etc. or cockroaches. Attraction can be manipulated through the use of feeding stimulants or sex pheromones. Food stimulants are selected from, for example but not limited to, animal and/or vegetable proteins (meat meal, fish meal or blood meal, insect parts, egg yolk), fats and oils of animal and/or vegetable origin, or monosaccharides, oligosaccharides or polysaccharides, especially sucrose , lactose, fructose, dextrose, glucose, starch, pectin or even molasses or honey. Fresh or decayed parts of fruits, crops, plants, animals, insects or specific parts thereof may also act as feeding stimulants. Sex pheromones are known to be more insect specific. Specific pheromones are described in the literature (eg http://www.pherobase.com) and are known to those skilled in the art.

為用於誘鉺組合物,活性成分之典型含量為0.001重量%至15重量%,理想地0.001重量%至5%重量%活性組分I或混合物。For use in erbium bait compositions, the typical content of active ingredient is 0.001% to 15% by weight, ideally 0.001% to 5% by weight of active ingredient I or mixtures.

呈氣溶膠(例如噴霧罐)、油噴霧劑或泵噴霧劑形式之本發明之化合物及混合物的調配物非常適合於非專業使用者控制有害生物,諸如蒼蠅、跳蚤、蜱、蚊子或蟑螂。氣溶膠配方較佳由活性化合物I或混合物、溶劑、其他助劑諸如乳化劑、香料油、(若適宜)穩定劑及(必要時)推進劑構成。Formulations of the compounds and mixtures of the invention in the form of aerosols (eg spray cans), oil sprays or pump sprays are well suited for the lay user to control pests such as flies, fleas, ticks, mosquitos or cockroaches. Aerosol formulations preferably consist of the active compounds I or mixtures, solvents, other auxiliaries such as emulsifiers, perfume oils, if appropriate stabilizers and, if necessary, propellants.

噴油調配物與氣溶膠配方之不同之處在於不使用推進劑。Oil spray formulations differ from aerosol formulations in that no propellants are used.

為用於噴霧組合物,活性成分之含量為0.001至80重量%、較佳0.01至50重量%且最佳0.01至15重量%。For spray compositions, the content of active ingredient is 0.001 to 80% by weight, preferably 0.01 to 50% by weight and most preferably 0.01 to 15% by weight.

本發明之化合物及混合物及其相應組合物亦可用於蚊香及薰蒸線圈、菸盒、蒸發器板或長期蒸發器,且亦用於娥紙、娥墊或其他不依賴於加熱的蒸發器系統。The compounds and mixtures of the present invention and their corresponding compositions can also be used in mosquito coils and fumigation coils, cigarette cases, evaporator plates or long-term evaporators, and also in evaporator paper, evaporator pads or other evaporator systems that do not rely on heating .

用本發明之化合物及混合物及其相應組合物控制由昆蟲傳播之感染性疾病(例如瘧疾、登革熱及黃熱病、淋巴絲蟲病及利什曼體病)的方法亦包含處理棚屋及房屋表面、空氣噴灑及浸漬窗簾、帳篷、衣物、蚊帳、采采蠅捕捉器或其類似物。施用於纖維、織物、針織品、非編織品、網狀材料或箔及防水布之殺昆蟲組合物較佳包含包括殺昆蟲劑、視情況存在之驅蟲劑及至少一種黏合劑的混合物。The method of controlling infectious diseases transmitted by insects, such as malaria, dengue and yellow fever, lymphatic filariasis and leishmaniasis, using the compounds and mixtures of the present invention and their corresponding compositions also comprises the treatment of sheds and house surfaces , air sprayed and impregnated curtains, tents, clothing, mosquito nets, tsetse traps or the like. Insecticidal compositions for application to fibres, fabrics, knits, nonwovens, netting materials or foils and tarpaulins preferably comprise a mixture comprising an insecticide, optionally a repellent and at least one binder.

本發明之化合物及混合物及其組合物可用於保護木質材料,諸如樹木、木柵欄、枕木、框架、藝術品等及建築物,且亦用於保護構築材料、傢俱、皮革、纖維、乙烯基製品、電線及電纜等免遭螞蟻及/或白蟻,以及用於控制螞蟻及白蟻對作物或人類造成傷害(例如當有害生物侵入房屋及公共設施時)。The compounds and mixtures of the present invention and compositions thereof can be used for the protection of wooden materials such as trees, wooden fences, sleepers, frames, works of art, etc. and buildings, and also for the protection of construction materials, furniture, leather, fibers, vinyl products , wires and cables, etc. from ants and/or termites, and to control ants and termites that cause damage to crops or humans (such as when pests invade houses and public facilities).

材料保護中之習用施用率為例如每m2 處理材料0.001 g至2000 g或0.01 g至1000 g活性組分I或混合物,理想地0.1 g至50 g/m2Customary application rates in material protection are, for example, 0.001 g to 2000 g or 0.01 g to 1000 g of active ingredient I or the mixture per m 2 of treated material, ideally 0.1 g to 50 g/m 2 .

用於浸漬材料之殺昆蟲組合物通常含有0.001至95重量%、較佳0.1至45重量%且更佳1至25重量%至少一種驅蟲劑及/或殺昆蟲劑。Insecticidal compositions for impregnating materials generally contain 0.001 to 95% by weight, preferably 0.1 to 45% by weight and more preferably 1 to 25% by weight of at least one repellent and/or insecticide.

有害生物 本發明化合物尤其適用於有效對抗動物有害生物,諸如節肢動物、腹足動物及線蟲,包括但不限於: 鱗翅目昆蟲,例如小蠟螟(Achroia grisella );長翅卷葉蛾屬(Acleris spp.),諸如黃斑長翅卷葉蛾(A. fimbriana )、西部黑頭長翅卷葉蛾(A. gloverana )、東部黑頭長翅卷葉蛾(A. variana );蔥鄰菜蛾(Acrolepiopsis assectella );桑劍紋夜蛾(Acronicta major );褐帶巻蛾屬(Adoxophyes spp),諸如擬小黃卷蛾(A. cyrtosema )、棉褐帶卷蛾(A. orana );白斑煩夜蛾(Aedia leucomelas );地老虎屬(Agrotis spp.),諸如警紋地老虎(A. exclamationis )、燕青地老虎(A. fucosa )、小地老虎(A. ipsilon )、西部灰地老虎(A. orthogoma )、黃地老虎(A. segetum )、粒膚地老虎(A. subterranea );棉葉波紋夜蛾(Alabama argillacea );螺旋粉虱(Aleurodicus dispersus );波林尺蛾(Alsophila pometaria );葡萄天蛾(Ampelophaga rubiginosa );臍橙螟(Amyelois transitella );白肩包蛾(Anacampsis sarcitella );地中海粉斑螟(Anagasta kuehniella );桃條麥蛾(Anarsia lineatella );櫟黃條大蠶蛾(Anisota senatoria );柞蠶(Antheraea pernyi );幹煞夜蛾屬(Anticarsia (=Thermesia) spp.),諸如黎豆夜蛾(A. gemmatalis );竹筍夜蛾屬(Apamea spp.);鉤麥蛾(Aproaerema modicella );黃卷蛾屬(Archips spp.),諸如果樹黃卷蛾(A. argyrospila )、杏黃卷蛾(A. fuscocupreanus )、玫瑰黃卷蛾(A. rosana )、梣黃卷蛾(A. xyloseanus );蘋果銀蛾(Argyresthia conjugella );條小卷蛾屬(Argyroploce spp.);帶卷蛾屬(Argyrotaenia spp),諸如短葉松帶卷蛾(A. velutinana );粗皮夜蛾(Athetis mindara );棉小葉蟬(Austroasca viridigrisea );丫紋夜蛾(Autographa gamma );黑點丫紋夜蛾(Autographa nigrisigna );甘藍夜蛾(Barathra brassicae );潛葉蛾屬(Bedellia spp.);巴西蘋果卷葉螟(Bonagota salubricola );秈弄蝶(Borbo cinnara );棉葉穿孔潛蛾(Bucculatrix thurberiella );松尺蠖(Bupalus piniarius );蛀褐夜蛾屬(Busseola spp.);卷葉蛾屬(Cacoecia spp.),諸如樅卷葉蛾(C. murinana )、黃尾卷葉蛾(C. podana );穿孔螟(Cactoblastis cactorum );粉斑螟蛾(Cadra cautella );巴西貓頭鷹環蝶(Calingo braziliensis );茶細蛾(Caloptilis theivora );菸捲蛾(Capua reticulana );蛀果蛾屬(Carposina spp.),諸如桃蛀果蛾(C. niponensis )、桃小食心蟲(C. sasakii );莖蜂屬(Cephus spp.);麥莖大跳甲(Chaetocnema aridula );冬尺蛾(Cheimatobia brumata );禾草螟屬(Chilo spp),諸如印度條螟(C. Indicus )、二化螟(C. suppressalis )、斑禾草螟(C. partellus );蘋果舞蛾(Choreutis pariana );色卷蛾屬(Choristoneura spp.),諸如柳色卷蛾(C. conflictana )、雲杉色卷蛾(C. fumiferana )、蘋果大卷葉蛾(C. longicellana )、歐洲雲杉卷葉蛾(C. murinana )、西部雲杉色卷蛾(C. occidentalis )、玫瑰色卷蛾(C. rosaceana );夜蛾屬(Chrysodeixis (=Pseu-doplusia) spp.),諸如南方錁夜蛾(C. eriosoma )、大豆尺蠖(C. includens );黏蟲(Cirphis unipuncta );葡萄果蠹蛾(Clysia ambiguella );縱卷葉野螟屬(Cnaphalocerus spp.);稻縱卷葉野螟(Cnaphalocrocis medinalis );雲卷蛾屬(Cnephasia spp.);向日葵螟(Cochylis hospes );鞘蛾屬(Coleophora spp.);紋黃豆粉蝶(Colias eurytheme );茶枝尖細蛾屬(Conopomorpha spp.);球頸象屬(Conotrachelus spp.);Copitarsia spp.;米螟(Corcyra cephalonica );玉米根結網毛蟲(Crambus caliginosellus );早熟禾草螟(Crambus teterrellus );豆根蟲(Crocidosema (=Epinotia) aporema );黃楊木蛾(Cydalima (=Diaphania) perspectalis );小卷蛾屬(Cydia (=Carpocapsa) spp.),諸如蘋果小卷蛾(C. pomonella )、堅果卷葉蛾(C. latiferreana );Dalaca noctuides ;核桃配片舟蛾(Datana integerrima );松毒蛾(Dasychira pinicola );松毛蟲屬(Dendrolimus spp.),諸如歐洲松毛蟲(D. pini )、赤松毛蟲(D. spectabilis )、落葉松毛蟲(D. sibiricus );葡萄小卷葉野螟(Desmia funeralis );絹野螟屬(Diaphania spp.),諸如黃瓜絹野螟(D. nitidalis )、甜瓜絹野螟(D. hyalinata );西南玉米桿草螟(Diatraea grandiosella );小蔗螟(Diatraea saccharalis );灰緣黃夜蛾(Diphthera festiva );鑽夜蛾屬 (Earias spp. ),諸如埃及金剛鑽(E. insulana )、翠紋金剛鑽(E. vittella );柑橘果蛀蟲(Ecdytolopha aurantianu );柑橘地香(Egira (=Xylomyges) curialis );南美玉米苗斑螟(Elasmopalpus lignosellus );甘蔗鑽心蟲(Eldana saccharina );葡萄小食心蟲(Endopiza viteana );榆秋黃尺蛾(Ennomos subsignaria );墨西哥水稻螟(Eoreuma loftini );粉斑螟屬(Ephestia spp.),諸如乾果粉斑螟(E. cautella )、菸草粉斑螟(E. elutella )、地中海粉斑螟(E. kuehniella );夜小卷蛾(Epinotia aporema );蘋果褐卷蛾(Epiphyas postvittana );菩提松尺蛾(Erannis tiliaria );蕉弄蝶(Erionota thrax );螟蛾屬(Etiella spp.);棕卷蛾屬(Eulia spp.);女貞細卷蛾(Eupoecilia ambiguella );黃毒蛾(Euproctis chrysorrhoea );切夜蛾屬(Euxoa spp.);歐松梢小卷蛾(Evetria bouliana );Faronta albilinea ,髒切葉蛾屬(Feltia spp.),諸如粒膚地虎(F.Subterranean );蠟螟(Galleria mellonella ),江蘺屬(Gracillaria spp.),食心蟲屬(Grapholita spp.),諸如李小食心蟲(G.funebrana )、梨小食心蟲(G.molesta ),蘋果小食心蟲(G.inopinata );Halysidota spp.,Harrisina americanaHedylepta spp.,鈴夜蛾屬(Helicoverpa spp.),諸如棉鈴蟲(H.armigera( Heliothis armigera) )、穀實夜蛾(H.zea( Heliothis zea) );實夜蛾屬(Heliothis spp.),諸如菸實夜蛾(H.assulta ))、H.subflexa 、美洲菸葉蛾(H.virescens );菜螟屬(Hellula spp.),諸如菜螟(H.undalis )、大菜螟(H.rogatalis );Helocoverpa gelotopoeon ,行列大蠶蛾(Hemileuca oliviae ),水稻切葉野螟(Herpetogramma licarsisalis ),Hibernia defoliaria ,褐織蛾(Hofmannophila pseudospretella ),向日葵同斑螟(Homoeosoma electellum ),茶長卷蛾(Homona magnanima ),苜蓿綠夜蛾(Hypena scabra ),美國白蛾(Hyphantria cunea ),櫻桃巢蛾(Hyponomeuta padella ),蘋果巢蛾(Hyponomeuta malinellus ),柿蒂蟲(Kakivoria flavofasciata ),番茄蟲蛾(Keiferia lycopersicella ),鐵杉尺蠖蛾(Lambdina fiscelaria fiscellaria ),西方鐵杉尺蠖蛾(Lambdina fiscellaria lugubrosa ),豆卷葉螟(Lamprosema indicata ),蠹食心蟲(Laspeyresia molesta ),大豆食心蟲(Leguminivora glycinivorella ),稻縱卷葉螟(Lerodea eufala ),茄黃斑螟(Leucinodes orbonalis ),雪毒蛾(Leucoma salicis ),潛蛾屬(Leucoptera spp.),諸如咖啡點潛蛾(L.coffeella )、旋紋潛蛾(L.scitella );Leuminivora lycinivorella ,蘋果斑幕潛葉蛾(Lithocolletis blancardella ),綠果冬夜蛾(Lithophane antennata ),大豆小夜蛾(Llattia octo( Amyna axis) ),葡萄漿果小卷蛾(Lobesia botrana ),Lophocampa spp.,豆白隆切根蟲(Loxagrotis albicosta ),草地螟屬(Loxostege spp.),諸如草地螟(L. sticticalis )、L. cereralis ;毒蛾屬(Lymantria spp.),諸如舞毒蛾(L.dispar )、模毒蛾(L.monacha );窄翅潛葉蛾(Lyonetia clerkella ),銀紋潛葉蛾(Lyonetia prunifoliella ),天幕毛蟲屬(Malacosoma spp.),諸如蘋天幕毛蟲(M.americanum )、加州天幕毛蟲(M.californicum )、森林天幕毛蟲(M.constrictum )、黃褐天幕毛蟲(M.neustria );夜蛾屬(Mamestra spp.),諸如甘藍夜蛾(M.brassicae )、蓓帶夜蛾(M.configurata );Mamstra brassicaeManduca spp.,諸如番茄天蛾(M.quinquemaculata )、菸草天蛾(M.sexta );刷鬚野螟屬(Marasmia spp),Marmara spp.,豆莢野螟(Maruca testulalis ),Megalopyge lanataMelanchra picta ,暮眼蝶(Melanitis leda ),Mocis spp.,諸如M.lapites ,稻毛脛夜蛾(M.repanda );南美毛脛夜蛾(Mocis latipes ),Monochroa fragariae ,黏蟲(Mythimna separata ),橡長角蛾(Nemapogon cloacella ),Neoleucinodes elegantalis ,偽尺蛾屬(Nepytia spp.),萍螟屬(Nymphula spp.),Oiketicus spp.,豆嚙葉野螟(Omiodes indicata ),甘薯莖螟(Omphisa anastomosalis ),冬尺蠖蛾(Operophtera brumata ),黃杉合毒蛾(Orgyia pseudotsugata ),Oria spp.,粗鬚螟蛾(Orthaga thyrisalis ),稈野螟屬(Ostrinia spp.),諸如歐洲玉米螟(O.nubilalis );稻葉甲(Oulema oryzae ),春尺蠖(Paleacrita vernata ),冬夜蛾(Panolis flammea ),稻弄蝶屬(Parnara spp.),蛀莖夜蛾(Papaipema nebris ),大鳳蝶(Papilio cresphontes ),臍橙螟蛾(Paramyelois transitella ),葡萄透翅蛾(Paranthrene regalis ),無棕櫚蝶蛾(Paysandisia archon ),紅鈴蟲屬(Pectinophora spp.),諸如紅鈴蟲(P.gossypiella );豆雜角夜蛾(Peridroma saucia ),潛葉蛾屬(Perileucoptera spp.),諸如咖啡潛葉蛾(P.coffeella );圓掌舟蛾(Phalera bucephala ),Phryganidia californica ,菸尺蛾屬(Phthorimaea spp.),諸如馬鈴薯塊莖蛾(P.operculella );橘細潛蛾(Phyllocnistis citrella ),小潛細蛾屬(Phyllonorycter spp.),諸如斑幕潛葉蛾(P.blancardella ),山楂潛葉蛾(P.crataegella ),P.issikii ,金紋小潛細蛾(P.ringoniella );粉蝶屬(Pieris spp.),諸如歐洲粉蝶(P.brassicae )、菜粉蝶(P.rapae )、暗脈粉蝶(P.napi );Pilocrocis tripunctata ,苜蓿綠夜蛾(Plathypena scabra ),卷蛾屬(Platynota spp.),諸如雜色卷葉蛾(P.flavedana ),蘋果芽小卷蛾(P.idaeusalis ),雜色卷葉蛾(P.stultana );荷蘭石竹小卷蛾(Platyptilia carduidactyla ),豆灰蝶(Plebejus argus ),印度穀螟(Plodia interpunctella ),銀紋夜蛾屬(Plusia spp),菜蛾(Plutella maculipennis ),小菜蛾(Plutella xylostella ),Pontia protodica ,巢蛾屬(Prays spp.),斜紋夜蛾屬(Prodenia spp.),二點委夜蛾(Proxenus lepigone ),黏蟲屬(Pseudaletia spp.),諸如夜蛾(P.sequax ),一星黏蟲(P.unipuncta );玉米螟(Pyrausta nubilalis ),薄荷灰夜蛾(Rachiplusia nu ),Richia albicosta ,暗色瓢蟲(Rhizobius ventralis ),美松梢小卷蛾(Rhyacionia frustrana ),病狀尺蠖(Sabulodes aegrotata ),紅山背舟蛾(Schizura concinna ),稻褐邊螟屬(Schoenobius spp.),Schreckensteinia festaliella ,白禾螟屬(Scirpophaga spp.),諸如三化螟(S.incertulas)、S.innotata ;黃地老虎(Scotia segetum ),大螟屬(Sesamia spp.),諸如水稻大螟(S.inferens ),葡萄虎蛾(Seudyra subflava ),麥蛾(Sitotroga cerealella ),葡萄長鬚卷葉蛾(Sparganothis pilleriana ),芽白小卷蛾(Spilonota lechriaspis ),蘋白小卷蛾(S.ocellana ),灰翅夜蛾屬(Spodoptera( Lamphygma) spp.),諸如S.cosmoides ,亞熱帶黏蟲(S.eridania ),甜菜夜蛾(S.exigua ),草地黏蟲(S.frugiperda )、S.latisfascia ,海灰翅夜蛾(S.littoralis )、斜紋夜蛾(S.litura )、黃條黏蟲(S.omithogalli );微蛾屬(Stigmella spp.),花生卷葉麥蛾(Stomopteryx subsecivella ),Strymon bazochii ,棉卷葉野螟(Sylepta derogata ),翅蛾屬(Synanthedon spp.),諸如小桃翅蛾(S.exitiosa ),安第斯馬鈴薯塊莖蛾(Tecia solanivora ),Telehin licusThaumatopoea pityocampa ,蘋果異形小卷蛾(Thaumatotibia (=Cryptophlebia) leucotreta ),松異舟蛾(Thaumetopoea pityocampa ),灰蛾屬(Thecla spp.),Theresimima ampelophaga ,尺蛾屬(Thyrinteina spp),Tildenia inconspicuella ,衣蛾屬(Tinea spp.),諸如木塞穀蛾(T. Cloacella ),袋穀蛾(T. Pellionella );衣蛾(Tineola bisselliella ),卷葉蛾屬(Tortrix spp.),諸如櫟綠卷蛾(T. Viridana );毛氈衣蛾(Trichophaga tapetzella ),粉紋夜蛾屬(Trichoplusia spp.),諸如粉紋夜蛾(T. ni );番茄斑潛蠅(Tuta (=Scrobipal-pula) absoluta ),結網野螟屬(Udea spp.),諸如溫室結網野螟(U. rubigalis ),溫室結網野螟(U. rubigalis );灰蝶屬(Virachola spp.),蘋果巢蛾(Yponomeuta padella )以及雲杉線小卷蛾(Zeiraphera canadensis ); 鞘翅目(Coleoptera)昆蟲,例如條紋黃瓜甲蟲(Acalymma vittatum ),菜豆象(Acanthoscehdes obtectus ),喙麗金龜屬(Adoretus spp.),楊樹螢葉甲(Agelastica alni ),窄吉丁屬(Agrilus spp.),諸如樺銅窄吉丁(A.anxius )、白蠟窄吉丁(A.Planipennis )、梨窄吉丁(A.sinuatus );叩頭蟲屬(Agriotes spp.),諸如細胸叩頭蟲(A.fuscicollis )、直條叩頭蟲(A.lineatus )、暗色叩頭蟲(A.obscurus );外米擬步行蟲(Alphitobius diaperinus ),馬鈴薯鰓金龜(Amphimallus solstitialis ),Anisandrus dispar ,奧地利麗金龜(Anisoplia austriaca ),傢俱竊蠹(Anobium punctatum ),銅綠麗金龜(Anomala corpulenta ),紅銅麗金龜(Anomala rufocuprea ),星天牛屬(Anoplophora spp.),諸如光肩星天牛(A.glabripennis );花象屬(Anthonomus spp.),諸如胡椒花象(A.eugenii )、棉鈴象甲(A.grandis )、蘋果花象(A.pomorum );圓皮蠹屬(Anthrenus spp.),Aphthona euphoridae ,長喙小象屬(Apion spp.),甘蔗金龜屬(Apogonia spp.),Athous haemorrhoidalis ,隱翅甲屬(Atomaria spp.),諸如甜菜隱食甲(A.linearis );毛皮蠹屬(Attagenus spp.),黃守瓜(Aulacophora femoralis ),縱坑切梢小蠹(Blastophagus piniperda ),Blitophaga undata ,惡條豆象(Bruchidius obtectus ),豆象屬(Bruchus spp.),諸如歐洲兵豆象(B.lentis )、豌豆象(B.pisorum )、蠶豆象(B.rufimanus );梨卷葉象甲(Byctiscus betulae ),紅翅杉天牛(Callidiellum rufipenne ),Callopistria floridensis ,綠豆象(Callosobruchus chinensis ),歐洲七葉樹潛葉蟲(Cameraria ohridella ),甜菜大龜甲(Cassida nebulosa ),豆葉甲(Cerotoma trifurcata ),金花金龜(Cetonia aurata ),龜象屬(Ceuthorhynchus spp.),諸如白菜籽象甲(C.assimilis )、芫菁龜象(C.napi );甜菜脛跳甲(Chaetocnema tibialis ),Cleonus mendicus ,寬胸叩頭蟲屬(Conoderus spp.),諸如菸草金針蟲(C.vespertinus );李象鼻蟲(Conotrachelus nenuphar ),根頸象屬(Cosmopolites spp.),褐新西蘭肋翅觸角金龜(Costelytra zealandica ),天冬負泥甲(Crioceris asparagi ),鏽赤扁穀盜(Cryptolestes ferrugineus ),楊幹象(Cryptorhynchus lapathi ),叩甲屬(Ctenicera spp.),諸如C.destructor ;象蟲屬(Curculio spp.),細枝象屬(Cylindrocopturus spp.),方頭甲屬(Cyclocephala spp.),玉米鐵甲蟲(Dactylispa balyi ),蛀莖蟲(Dectes texanus ),皮蠹屬(Dermestes spp.),根葉甲屬(Diabrotica spp.),諸如黃瓜十一星葉甲(D.undecimpunctata ),南美葉甲(D.speciosa ),長角葉甲(D.longicornis ),D.semipunctata ,玉米根葉甲(D.virgifera );柑椐象鼻蟲(Diaprepes abbreviates ),姓野螟屬(Dichocrocis spp.),水稻鐵甲蟲(Dicladispa armigera ),阿根廷兜蟲(Diloboderus abderus ),椰花二點象(Diocalandra frumenti(Diocalandra stigmaticollis) ),櫟紅天牛(Enaphalodes rufulus ),食植瓢蟲屬(Epilachna spp.),諸如墨西哥豆瓢蟲(E.varivestis )、馬鈴薯瓢蟲(E.vigintioctomaculata );毛跳甲屬(Epitrix spp.),諸如菸草跳甲(E.hirtipennis )、E.similarisEutheola humilis ,棉灰蒙象變種(Eutinobothrus brasiliensis ),蛀莖象甲(Faustinus cubae ),裸蛛甲(Gibbium psylloides ),闊角穀盜(Gnathocerus cornutus ),菜螟(Hellula undalis ),黑異爪蔗金龜(Heteronychus arator ),Hylamorpha elegans ,松樹皮象(Hylobius abietis ),北美家天牛(Hylotrupes bajulus ),葉象屬(Hypera spp.),諸如埃及苜蓿葉象(H.brunneipennis )、紫苜蓿葉象(H.postica );綠鱗象甲(Hypomeces squamosus ),果小蠹屬(Hypothenemus spp.),雲杉八齒小蠹(Ips typographus ),甘蔗大褐齒爪鰓金龜(Lachnosterna consanguinea ),菸草甲(Lasioderma serricorne ),長首穀甲(Latheticus oryzae ),薪甲屬(Lathridius spp.),負泥蟲屬(Lema spp.),諸如菸草負泥蟲(L.bilineata ),黑角負泥蟲(L.melanopus );瘦蹌葉甲屬(Leptinotarsa spp.),諸如馬鈴薯甲蟲(L.decemlineata );小卷葉甲(Leptispa pygmaea ),甜菜叩甲(Limonius californicus ),稻象甲(Lissorhoptrus oryzophilus ),筒喙象屬(Lixus spp.),Luperodes spp.,粉蠹屬(Lyctus spp.),諸如褐粉蠹(L.bruneus );福克金龜(Liogenys fuscus ),大趾屬(Macrodactylus spp.),諸如薔薇刺金龜(M.subspinosus );瑪絹金龜(Maladera matrida ),Megaplatypus mutatesMegascelis spp.,Melanotus communis ,菜花露尾甲屬(Meligethes spp.),諸如油菜露尾甲(M.aeneus );鰓金龜屬(Melolontha spp.),諸如大栗鰓金龜(M.hippocastani )、西方五月鰓金龜(M.melolontha );西印度蔗螟(Metamasius hemipterus ),Microtheca spp.,Migdolus spp.,諸如M.fryanus ,墨天牛屬(Monochamus spp.),諸如松墨天牛(M.alternatus );南美果樹象甲(Naupactus xanthographus ),黃蛛甲(Niptus hololeucus ),Oberia brevisOemona hirta ,椰子犀角金龜(Oryctes rhinoceros ),鋸胸粉扁蟲(Oryzaephilus surinamensis ),Oryzaphagus oryzae ,黑葡萄耳象(Otiorrhynchus sulcatus ),草莓根象甲(Otiorrhynchus ovatus ),黑葡萄耳象(Otiorrhynchus sulcatus ),黑角負泥蟲(Oulema melanopus ),稻負泥蟲(Oulema oryzae ),小青花金龜(Oxycetonia jucunda ),猿葉甲屬(Phaedon spp.),諸如小猿葉蟲(P.brassicae )、辣根猿葉甲(P.cochleariae );桉黃天牛(Phoracantha recurva ),梨樹葉象(Phyllobius pyri ),庭園發麗金龜(Phyllopertha horticola ),鰓角金龜屬(Phyllophaga spp.),諸如鰓金龜(P.helleri );條跳甲屬(Phyllotreta spp.),諸如P.chrysocephala 、大豆淡足跳甲(P.nemorum )、黃曲條跳甲(P.striolata )、黃狹條跳甲(P.vittula );庭園發麗金龜(Phyllopertha horticola ),日本麗金龜(Popillia japonica ),小象甲屬(Premnotrypes spp.),黃星天牛(Psacothea hilaris ),油菜藍跳甲(Psylliodes chrysocephala ),大穀蠹(Prostephanus truncates ),跳甲屬(Psylliodes spp.),蛛甲屬(Ptinus spp.),Pulga saltona ,穀蠹(Rhizopertha dominica ),隱喙象屬(Rhynchophorus spp.),諸如R.billineatus ,紅棕象甲(R.ferrugineus ),棕櫚象甲(R.palmarum ),紫棕象甲(R.phoenicis ),亞棕象甲(R.vulneratus );蘋楔天牛(Saperda candida ),臍腹小蠹蟲(Scolytus schevyrewi ),劍麻象甲(Scyphophorus acupunctatus ),豌豆根瘤象(Sitona lineatus ),象蟲屬(Sitophilus spp.),諸如穀象(S.granaria ),米象(S.oryzae ),玉米象(S.zeamais );尖隱喙象屬(Sphenophorus spp.),諸如S.levis ;藥材甲(Stegobium paniceum ),莖幹象屬(Sternechus spp.),諸如大豆莖象(S.subsignatus );Strophomorphus ctenotus ,寬幅天牛屬(Symphyletes spp.),Tanymecus spp.,黃粉蟲(Tenebrio molitor ),大穀盜(Tenebrioides mauretanicus );擬穀盜屬(Tribolium spp.),諸如赤擬穀盜(T.castaneum );斑皮蠹屬(Trogoderma spp.)、籽象屬(Tychius spp.)、脊虎天牛屬(Xylotrechus spp.),諸如葡萄虎天牛(X.pyrrhoderus );以及距步甲屬(Zabrus spp.),諸如玉米距步甲(Z.Tenebrioides ); 雙翅目(Diptera)昆蟲,例如伊蚊屬(Aedes spp.),諸如埃及伊蚊(A.aegypti )、白紋伊蚊(A.albopictus )、剌擾伊蚊(A.vexans );墨西哥果蠅(Anastrepha ludens );按蚊屬(Anopheles spp.),諸如白足按蚊(A.albimanus )、災難按蚊(A.crucians )、費氏按蚊(A.freeborni )、岡比亞按蚊(A.gambiae )、白踝按蚊(A.leucosphyrus )、五斑按蚊(A.maculipennis )、微小按蚊(A.minimus )、四斑按蚊(A.quadrimaculatus )、中華按蚊(A.sinensis );入侵實蠅(Bactrocera invadens ),花園毛蚊(Bibio hortulanus ),綠頭蠅(Calliphora erythrocephala ),紅頭麗蠅(Calliphora vicina ),地中海實蠅(Ceratitis capitata ),金蠅屬(Chrysomyia spp.),諸如蛆症金蠅(C.bezziana ),C.hominivorax 、腐敗金蠅(C.macellaria );大西洋虻(Chrysops atlanticus ),鹿蠅(Chrysops discalis ),靜斑虻(Chrysops silacea ),錐蠅屬(Cochliomyia spp.),諸如螺旋蠅(C.hominivorax );癭蚊屬(Contarinia spp.),諸如高粱癭蚊(C.sorghicola );嗜人瘤蠅蛆(Cordylobia anthropophaga ),庫蚊屬(Culex spp.),諸如斑蚊(C.nigripalpus ),尖音庫蚊(C.pipiens ),致倦庫蚊(C.quinquefasciatus ),媒斑蚊(C.tarsalis ),三帶喙庫蚊(C.tritaeniorhynchus );狂怒庫蠓(Culicoides furens ),無飾脈毛蚊(Culiseta inornata ),黑尾脈毛蚊(Culiseta melanura ),黃蠅屬(Cuterebra spp.),瓜蠅(Dacus cucurbitae ),油橄欖實蠅(Dacus oleae ),油菜葉癭蚊(Dasineura brassicae ),Dasineura oxycoccana ,地種蠅屬(Delia spp.),諸如蔥蠅(D.antique ),麥地種蠅(D.coarctata ),灰地種蠅(D.platura ),甘藍地種蠅(D.radicum );人膚皮蠅(Dermatobia hominis ),果蠅屬(Drosophila spp.),諸如斑翅果蠅(D.suzukii ),廁蠅屬(Fannia spp.),諸如小毛廁蠅(F.canicularis );胃蠅屬(Gastraphilus spp.),諸如馬蠅(G.intestinalis );Geomyza tipunctata ,舌蠅屬(Glossina spp.),諸如梭毒舌蠅(G.fuscipes )、刺舌蠅(G.morsitans )、鬚舌蠅(G.palpalis )、膠舌蠅(G.tachinoides ),擾血蠅(Haematobia irritans ),Haplodiplosis equestris ,潛蠅屬(Hippelates spp.),黑蠅屬(Hylemyia spp.),諸如花生田灰地種蠅(H.platura );皮蠅屬(Hypoderma spp.),諸如紋皮蠅(H.lineata );虱蠅屬(Hyppobosca spp.),水稻菲島毛眼水蠅(Hydrellia philippina ),托氏細蠓(Leptoconops torrens ),斑潛蠅屬(Liriomyza spp.),諸如美洲斑潛蠅(L.sativae )、美國潛葉蠅(L.trifolii );綠蠅屬(Lucilia spp.),諸如L.caprina 、銅綠蠅(L.cuprina )、絲光綠蠅(L.sericata );Lycoria pectoralisMansonia titillanus ,麥癭蚊屬(Mayetiola spp.),諸如麥癭蚊(M.destructor );蠅屬(Musca spp.),諸如秋家蠅(M.autumnalis )、家蠅(M.domestica );廄腐蠅(Muscina stabulans );狂蠅屬(Oestrus spp.),諸如羊鼻蠅(O.ovis );Opomyza florum ,稈蠅屬(Oscinella spp.),諸如瑞典麥稈蠅(O.frit );稻癭蚊(Orseolia oryzae ),天仙子泉蠅(Pegomya hysocyami ),銀足白蛉(Phlebotomus argentipes ),草種蠅屬(Phorbia spp.),諸如蔥蠅(P.antiqua )、蘿蔔蠅(P.brassicae )、麥地種蠅(P.coarctata );蔥屬潛葉蟲(Phytomyza gymnostoma ),Prosimulium mixtum ,胡蘿蔔莖蠅(Psila rosae ),哥倫比亞鱗蚊(Psorophora columbiae ),Psorophora discolor ,實蠅屬(Rhagoletis spp.),諸如櫻桃實蠅(R.cerasi )、R.cingulate 、西部櫻桃實蠅(R.indifferens )、藍橘繞實蠅(R.mendax )、蘋果實蠅(R.pomonella );Rivellia quadrifasciata ,麻蠅屬(Sarcophaga spp.),諸如赤尾麻蠅(S.haemorrhoidalis );帶蚋(Simulium vittatum ),麥紅吸漿蟲(Sitodiplosis mosellana ),螫蠅屬(Stomoxys spp.),諸如廄螫蠅(S.calcitrans );虻屬(Tabanus spp.),諸如北美黑虻(T.atratus )、牛虻(T.bovinus )、紅色原虻(T.lineola )、二毛蟲(T.similis );Tannia spp.,松針癭蚊(Thecodiplosis japonensis ),Tipula oleracea ,歐洲大蚊(Tipula paludosa )及污蠅屬(Wohlfahrtia spp.); 纓翅目(Thysanoptera)昆蟲,例如稻薊馬(Baliothrips biformis ),蘭花薊馬(Dichromothrips corbetti ),Dichromothrips ssp.,美棘薊馬(Echinothrips americanus ),Enneothrips flavens ,花薊馬屬(Frankliniella spp.),諸如菸褐薊馬(F. fusca )、苜蓿花薊馬(F. occidentalis )、東方花薊馬(F.tritici );陽薊馬屬(Heliothrips spp.),溫室薊馬(Hercinothrips femoralis ),卡薊馬屬(Kakothrips spp.),腹小頭薊馬(Microcephalothrips abdominalis ),孔雀草板背薊馬(Neohydatothrips samayunkur ),柑橘薊馬(Pezothrips kellyanus ),腹突皺針薊馬(Rhipiphorothrips cruentatus ),硬薊馬屬(Scirtothrips spp.),諸如桔硬薊馬(S.citri ),小黃薊馬(S.dorsalis ),鱷梨薊馬(S.perseae );直鬃薊馬屬(Stenchaetothrips spp),Taeniothrips cardamoni ,梨帶薊馬(Taeniothrips inconsequens );薊馬屬(Thrips spp.),諸如澳洲疫薊馬(T.imagines )、黃胸薊馬(T.hawaiiensis )、稻薊馬(T.oryzae )、棕櫚薊馬(T.palmi )、T.parvispinus 、菸薊馬(T.tabaci ); 半翅目(Hemiptera)昆蟲,例如合歡木虱(Acizzia jamatonica ),綠蝽屬(Acrosternum spp.),諸如擬綠蝽(A. hilare );無網長管蚜屬(Acyrthosipon spp.),諸如A. onobrychis 、豌豆蚜(A. pisum );落葉松球蚜(Adelges laricis ),鐵杉球蚜(Adelges tsugae ),苜蓿盲蝽屬(Adelphocoris spp.),諸如A. rapidusA. superbus ;沫蜂屬(Aeneolamia spp.),隆脈木虱屬(Agonoscena spp.),茄無網蚜(Aulacorthum solani ),桔黑刺粉虱(Aleurocanthus woglumi ),白粉虱屬(Aleurodes spp.),螺旋粉虱(Aleurodicus disperses ),甘蔗穴粉虱(Aleurolobus barodensis ),絲絨粉虱屬(Aleurothrixus spp.),杧果葉蟬屬(Amrasca spp.),南瓜緣蝽(Anasa tristis ),擬麗蝽屬(Antestiopsis spp.),飛廉短尾蚜(Anuraphis cardui ),腎圓盾蚧屬(Aonidiella spp.),梨瘤蚜(Aphanostigma piri ),Aphidula nasturtii ,蚜屬(Aphis spp.),諸如苜蓿蚜(A. craccivora ),甜菜蚜(A. fabae )、草莓根蚜(A. forbesi )、棉蚜(A. gossypii )、北美茶藨子蚜(A. grossulariae )、玉米根蚜(A. maidiradicis ),蘋果蚜(A. pomi )、接骨木蚜(A. sambuci )、希奈德蚜(A. schneideri )、卷葉蚜(A. spiraecola );葡萄阿小葉蟬(Arboridia apicalis ),輪背獵蝽(Arilus critatus ),小圓盾蚧屬(Aspidiella spp.),圓盾蚧屬(Aspidiotus spp.),Atanus spp.,蘇鐵白輪盾蚧(Aulacaspis yasumatsui ),茄無網蚜(Aulacorthum solani ),Bactericera cockerelli (Paratrioza cockerelli) ,粉虱屬(Bemisia spp.),諸如銀葉粉虱(B. argentifolii )、菸粉虱(B. tabaci (Aleurodes tabaci) );土長蝽屬(Blissus spp.),諸如玉米長蝽(B. leucopterus );短尾蚜屬(Brachycaudus spp.),諸如飛廉短尾蚜(B. cardui ),李短尾蚜(B. helichrysi ),桃短尾蚜(B. persicae ),B. prunicola ;微管蚜屬(Brachycolus spp.),Brachycorynella asparagi ,甘藍蚜(Brevicoryne brassicae ),Cacopsylla spp.,諸如C. fulguralis 、梨木虱C. pyricola (Psylla piri) ;小褐稻虱(Calligypona marginata ),俊盲蝽屬(Calocoris spp.),斑腿微刺盲蝽(Campylomma livida ),Capitophorus horniCarneocephala fulgida ,異背長蝽屬(Cavelerius spp.),Ceraplastes spp.,Ceratovacuna lanigeraCeroplastes ceriferusCerosipha gossypiiChaetosiphon fragaefoliiChionaspis tegalensisChlorita onukiiChromaphis juglandicolaChrysomphalus ficusCicadulina mbilaCimex spp.,諸如熱帶臭蟲(C. hemipterus )、溫帶臭蟲(C. lectularius );Coccomytilus halli ,軟蚧屬(Coccus spp.),諸如C. hesperidumC. pseudomagnoliarumCorythucha arcuataCreontiades dilutus ,茶藨子隱瘤蚜(Cryptomyzus ribis ),Chrysomphalus aonidum ,茶藨隱瘤蚜(Cryptomyzus ribis ),Ctenarytaina spatulata ,黑斑菸盲蝽(Cyrtopeltis notatus ),Dalbulus spp.,胡椒緣蝽(Dasynus piperis ),粉虱屬(Dialeurodes spp.),諸如D. citrifoliiDalbulus maidis ,木虱屬(Diaphorina spp.),諸如D. citri ;白背盾蚧屬(Diaspis spp.),諸如D. bromeliaeDichelops furcatus ,厚氏長棒網蝽(Diconocoris hewetti ),Doralis spp.,高加索冷杉椎球蚜(Dreyfusia nordmannianae ),雲杉椎球蚜(Dreyfusia piceae ),履綿蚧屬(Drosicha spp.);西圓尾蚜屬(Dysaphis spp.),諸如車前圓尾蚜(D. plantaginea )、梨西圓尾蚜(D. pyri )、居根西圓尾蚜(D. radicola );Dysaulacorthum pseudosolani ;棉紅蝽屬(Dysdercus spp.),諸如棉紅蝽(D. cingulatus )、D. intermedius ;灰粉蚧屬(Dysmicoccus spp.),Edessa spp.,Geocoris spp.,小綠葉蟬屬(Empoasca spp.),諸如蠶豆微葉蟬(E. fabae )、索拉納小綠葉蝶(E. solana );Epidiaspis leperii ,綿蚜屬(Eriosoma spp.),諸如E. lanigerumE. pyricola ;斑葉蟬屬(Erythroneura spp.);扁盾蝽屬(Eurygaster spp.),諸如麥扁盾蝽(E. integriceps );鈍鼻葉蟬(Euscelis bilobatus ),美洲蝽屬(Euschistus spp.),諸如大豆褐椿(E. heros )、菸草蝽(E. impictiventris )、褐臭蝽(E. servus );Fiorinia theae ,咖啡地粉蚧(Geococcus coffeae ),Glycaspis brimblecombei ;茶翅蝽屬(Halyomorpha spp.),諸如茶翅蝽(H. halys );角盲椿(Heliopeltis spp.),玻璃葉蟬(Homalodisca vitripennis (=H. coagulata) ),Horcias nobilellus ,李大尾蚜(Hyalopterus pruni ),茶藨苦菜超瘤蚜(Hyperomyzus lactucae ),吹綿蚧屬(Icerya spp.),諸如I. purchase ;片角葉蟬屬(Idiocerus spp.),扁喙葉蟬屬(Idioscopus spp.),斑飛虱(Laodelphax striatellus ),蠟蚧屬(Lecanium spp.),Lecanoideus floccissimus ,蠣盾蚧屬(Lepidosaphes spp.),諸如L. ulmi ;稻緣蝽屬(Leptocorisa spp.),棉紅鈴喙緣蝽(Leptoglossus phyllopus ),蘿蔔蚜(Lipaphis erysimi ),草盲蝽屬(Lygus spp.),諸如草盲蝽(L. hesperus )、美洲牧草盲蝽(L. lineolaris )、牧草盲蝽(L. pratensis );Maconellicoccus hirsutusMarchalina hellenica ,蔗黑長蝽(Macropes excavatus ),長管蚜屬(Macrosiphum spp.),諸如薔薇長管蚜(M. rosae )、麥長管蚜(M. avenae )、大戟長管蚜(M. euphorbiae );Macrosteles quadrilineatusMahanarva fimbriolata ,篩豆龜蝽(Megacopta cribraria ),巢萊修尾蚜(Megoura viciae ),Melanaphis pyrarius ,高粱蚜(Melanaphis sacchari );Melanocallis (=Tinocallis) caryaefoliaeMetcafiella spp.,麥無網蚜(Metopolophium dirhodum ),黑緣平翅斑蚜(Monellia costalis ),Monelliopsis pecanisMyzocallis coryliMurgantia spp.,瘤蚜屬(Myzus spp.),諸如冬蔥蚜(M. ascalonicus )、李瘤蚜(M. cerasi )、M. nicotianae 、桃蚜(M. persicae )、黃藥子瘤蚜(M. varians );黑茶藨子衲長管蚜(Nasonovia ribis-nigri ),Neotoxoptera formosanaNeomegalotomus spp ,黑尾葉蟬屬(Nephotettix spp.),諸如馬來亞黑尾葉蟬(N. malayanus )、二條黑尾葉蟬(N. nigropictus )、細小黑尾葉蟬(N. parvus )、二點黑尾葉蟬(N. virescens );綠蝽屬(Nezara spp.),諸如稻綠蝽(N. viridula );褐稻虱(Nilaparvata lugens ),Nysius huttoni ,稻蝽屬(Oebalus spp.),諸如美洲稻蝽(O. pugnax );Oncometopia spp.,Orthezia praelongaOxycaraenus hyalinipennis ,楊梅粉虱(Parabemisia myricae ),片盾蚧屬(Parlatoria spp.),Parthenolecanium spp.,諸如P. corniP. persicae ;癭綿蚜屬(Pemphigus spp.),諸如囊柄癭綿蚜(P. bursarius )、P. populivenae ;玉米蠟蟬(Peregrinus maidis )、蔗飛虱(Perkinsiella saccharicida )、綿粉蚧屬(Phenacoccus spp.),諸如P. acerisP. gossypii ;楊平翅綿蚜(Phloeomyzus passerinii ),忽布疣蚜(Phorodon humuli ),葡萄根瘤蚜屬(Phylloxera spp.),諸如P. devastatrix ;甜菜擬網蝽(Piesma quadrata ),壁蝽屬(Piezodorus spp.),諸如P. guildinii ;蘇鐵褐點並盾蚧(Pinnaspis aspidistrae ),臀紋粉蚧屬(Planococcus spp.),諸如P. citriP. ficusProsapia bicincta ,梨形原綿蚧(Protopulvinaria pyriformis ),棉偽斑腿盲蝽(Psallus seriatus ),Pseudacysta persea ,桑盾蚧(Pseudaulacaspis pentagona ),粉蚧屬(Pseudococcus spp.),諸如康氏粉蚧(P. comstocki );木虱屬(Psylla spp.),諸如蘋木虱(P. mali );金小蜂屬(Pteromalus spp.),Pulvinaria amygdaliPyrilla spp.,笠圓盾蚧屬(Quadraspidiotus spp.),諸如Q. perniciosusQuesada gigas ,平刺粉蚧屬(Rastrococcus spp.),Reduvius senilisRhizoecus americanus ,紅獵蝽屬(Rhodnius spp.),冬蔥瘤蛾蚜(Rhopalomyzus ascalonicus );縊管蚜屬(Rhopalosiphum spp.),諸如蘿蔔蚜(R. pseudobrassicas )、蘋草縊管蚜(R. insertum )、玉米蚜(R. maidis )、禾穀縊管蚜(R. padi );Sagatodes spp.,可可褐盲蝽(Sahlbergella singularis ),黑盔蚧屬(Saissetia spp.),Sappaphis malaSappaphis maliScaptocoris spp. ,葡萄帶葉蟬(Scaphoides titanus ),麥二叉蚜(Schizaphis graminum ),Schizoneura lanuginosa ,稻黑蝽屬(Scotinophora spp.),刺盾蚧(Selenaspidus articulatus ),禾穀網蚜(Sitobion avenae ),長唇基飛虱屬(Sogata spp.),白背飛虱(Sogatella furcifera ),Solubea insularisSpissistilus festinus (=Stictocephala festina) ,梨冠網蝽(Stephanitis nashi ),Stephanitis pyrioidesStephanitis takeyaiTenalaphara malayensisTetraleurodes perseaeTherioaphis maculateThyanta spp.,諸如T. accerraT. perditorTibraca spp.,廣胸沫蟬屬(Tomaspis spp.),聲蚜屬(Toxoptera spp.),諸如桔二叉蚜(T. aurantii );白粉虱屬(Trialeurodes spp.),諸如T. abutiloneaT. ricini 、白粉虱(T. vaporariorum );錐獵蝽屬(Triatoma spp.),個木虱屬(Trioza spp.),小葉蟬屬(Typhlocyba spp.),尖盾蚧屬(Unaspis spp.),諸如U. citri 、矢尖蚧(U. yanonensis );以及葡萄根瘤蚜(Viteus vitifolii ); 膜翅目(Hymenoptera)昆蟲,例如Acanthomyops interjectus ,新疆菜葉蜂(Athalia rosae ),Atta spp.,諸如A. capiguara 、切葉蟻(A. cephalotes )、切葉蟻(A. cephalotes )、A. laevigataA. robustaA. sexdensA. texana ,熊蜂屬(Bombus spp.),Brachymyrmex spp.,弓背蟻屬(Camponotus spp.),諸如佛羅里達弓背蟻(C. floridanus )、黑弓背蟻(C. pennsylvanicus )、C. modocCardiocondyla nudaChalibion sp ,舉腹蟻屬(Crematogaster spp.),天鵝絨螞蟻(Dasymutilla occidentalis ),松葉蜂屬(Diprion spp.),姬胡蜂(Dolichovespula maculata ),Dorymyrmex spp.,Dryocosmus kuriphilusFormica spp.,實蜂屬(Hoplocampa spp.),諸如H. minuta 、蘋葉蜂(H. testudinea );Iridomyrmex humilis ,毛蟻屬(Lasius spp.),諸如黑毛蟻(L. niger ),阿根廷蟻(Linepithema humile ),Liometopum spp.,Leptocybe invasaMonomorium spp.,諸如小黃家蟻(M. pharaonis ),MonomoriumNylandria fulva ,中華厚結猛蟻(Pachycondyla chinensis ),長角立毛蟻(Paratrechina longicornis ),Paravespula spp.,諸如P. germanicaP. pennsylvanicaP. vulgarisPheidole spp.,諸如褐大頭蟻(P. megacephala );Pogonomyrmex spp.,諸如紅螞蟻(P. barbatus )、收割機螞蟻(P. californicus ),胡蜂(Polistes rubiginosa ),Prenolepis impairsPseudomyrmex gracilisSchelipron spp.,Sirex cyaneusSolenopsis spp.,諸如熱帶火蟻(S. geminata )、紅火蟻(S.invicta )、S. molesta 、黑火蟻(S. richteri )、南方火蟻(S. xyloni );Sphecius speciosusSphex spp.,Tapinoma spp.,諸如T. melanocephalumT. sessileTetramorium spp.,諸如T. caespitumT. bicarinatum ,大胡蜂屬(Vespa spp.),諸如黃邊胡蜂(V. crabro );Vespula spp.,諸如大黃蜂(V. squamosal );Wasmannia auropunctataXylocopa sp; 直翅目(Orthoptera)昆蟲,例如居屋艾蟋(Acheta domesticus ),意大利蝗(Calliptamus italicus ),澳洲草棲蝗(Chortoicetes terminifera ),Ceuthophilus spp.,Diastrammena asynamora ,摩洛哥戟紋蝗(Dociostaurus maroccanus ),Gryllotalpa spp.,諸如非洲螻蛄(G. africana )、螻蛄(G. gryllotalpa );Gryllus spp.,非洲蔗蝗(Hieroglyphus daganensis ),印度黃檀蝗(Kraussaria angulifera ),飛蝗屬(Locusta spp.),諸如飛蝗(L. migratoria )、褐色擬飛蝗(L. pardalina );黑蝗屬(Melanoplus spp.),諸如雙紋黑蝗(M. bivittatus )、紅足黑蝗(M. femurrubrum )、墨西哥黑蝗(M. mexicanus )、遷飛黑蝗(M. sanguinipes )、石棲黑蝗(M. spretus );條紋紅蝗(Nomadacris septemfasciata ),塞納加爾小車蝗(Oedaleus senegalensis ),Scapteriscus spp.,沙漠蝗屬(Schistocerca spp.),諸如美洲沙漠蝗(S. americana ),沙漠蝗(S. gregaria ),Stemopelmatus spp.,庭疾灶螽(Tachycines asynamorus )及Zonozerus variegatus ; 蜘蛛綱(Arachnida)有害生物,例如蜱蟎目(Acari),諸如軟蜱科(Argasidae)、硬蜱科(Ixodidae)及疥蟎科(Sarcoptidae),諸如花蜱屬(Amblyomma spp.) (例如長星形蜱(A. americanum )、熱帶花蜱(A. variegatum )、斑點鈍眼蜱(A. maculatum )),銳緣蜱屬(Argas spp.),諸如波斯銳緣蜱(A. persicu ),牛蜱屬(Boophilus spp.),諸如牛壁虱(B. annulatus )、消色牛蜱(B. decoloratus )、微小牛蜱(B. microplus ),Dermacentor spp.,諸如森林革蜱(D.silvarum )、安氏革蜱(D. andersoni )、美洲大革蜱(D. variabilis ),璃眼蜱屬(Hyalomma spp.),諸如長喙璃眼蜱(H. truncatum ),硬蜱屬(Ixodes spp.),諸如蓖子硬蜱(I. ricinus )、淺紅硬蜱(I. rubicundus )、黑腳硬蜱(I. scapularis )、全環硬蜱(I. holocyclus )、太平洋硬蜱(I. pacificus ),Rhipicephalus sanguineus ,鈍緣蜱屬(Ornithodorus spp.),諸如毛白鈍緣蜱(O. moubata )、赫氏鈍緣蜱(O. hermsi )、回歸熱蜱(O. turicata ),柏氏禽刺蟎(Ornithonyssus bacoti ),刺耳扁虱(Otobius megnini ),雞皮刺蟎(Dermanyssus gallinae ),癢蟎屬(Psoroptes spp.),諸如綿羊疥病(P. ovis ),扇頭蜱屬(Rhipicephalus spp.),諸如血紅扇頭蜱(R. sanguineus )、具尾扇頭蜱(R. appendiculatus )、外翻扇頭蜱(Rhipicephalus evertsi ),根蟎屬(Rhizoglyphus spp.),疥蟎屬(Sarcoptes spp.),諸如人疥蟎(S. Scabiei );以及癭蟎科(Eriophyidae),包括Aceria spp.,諸如A. sheldoniA. anthocoptesAcallitus spp.,刺皮節蜱屬(Aculops spp.),諸如A. lycopersici 、桔鏽蟎(A. pelekassi );刺癭蟎屬(Aculus spp.),諸如蘋果刺鏽蟎(A. schlechtendali );Colomerus vitis ,棗葉鏽蟎(Epitrimerus pyri ),桔皺葉刺癭蟎(Phyllocoptruta oleivora );Eriophytes ribis 及癭蟎屬(Eriophyes spp.),諸如柑橘癭蟎(Eriophyes sheldoni );跗絨蟎科(Tarsonemidae),包括半跗線蟎屬(Hemitarsonemus spp.),Phytonemus pallidus 及側多食跗線蟎(Polyphagotarsonemus latus ),狹跗線蟎屬(Stenotarsonemus spp.),Steneotarsonemus spinki ;細鬚蟎科(Tenuipalpidae),包括短鬚蟎屬(Brevipalpus spp.),諸如紫紅短鬚蟎(B. phoenicis );葉蟎科(Tetranychidae),包括始葉蟎屬(Eotetranychus spp.),真葉蟎屬(Eutetranychus spp.),小爪蟎屬(Oligonychus spp.),Petrobia latensTetranychus spp.,諸如朱砂葉蟎(T. cinnabarinus )、T. evansi 、神澤葉蟎(T. kanzawai )、太平洋葉蟎(T, pacificus )、T. phaseulus 、棉葉蟎(T. telarius )及二點葉蟎(T. urticae );苜蓿苔蟎(Bryobia praetiosa );全爪蟎屬(Panonychus spp.),諸如蘋果葉蟎(P. ulmi )、橘全爪蟎(P. citri );Metatetranychus spp.及小爪蟎屬(Oligonychus spp.),諸如草地小爪蟎(O. pratensis )、O. perseaeVasates lycopersiciRaoiella indica ,果蟎科(Carpoglyphidae),包括Carpoglyphus spp.;Penthaleidae spp.,諸如Halotydeus destructor ;蠕形蟎科(Demodicidae)屬種,諸如蠕形蟎屬(Demodex spp.);Trombicidea,包括恙蟎屬(Trombicula spp.);巨刺蟎科(Macronyssidae),包括Ornothonyssus spp.;蒲蟎科(Pyemotidae),包括Pyemotes triticiTyrophagus putrescentiae ;蟎科(Acaridae),包括Acarus siro ;蜘蛛目(Araneida),例如毒蜘蛛(Latrodectus mactans ),Tegenaria agrestisChiracanthium spLycosa sp Achaearanea tepidariorum 及褐絲蛛(Loxosceles reclusa ); 線蟲動物門(Phylum Nematoda)有害生物,例如植物寄生性線蟲,諸如根結線蟲,根結線蟲屬(Meloidogyne spp.),諸如北方根結線蟲(M. hapla )、南方根結線蟲(M. incognita )、爪哇根結線蟲(M. javanica );胞囊線蟲,球胞囊線蟲屬(Globodera spp.),諸如馬鈴薯金線蟲(G. rostochiensis );胞囊線蟲屬(Heterodera spp.),諸如禾穀胞囊線蟲(H. avenae )、大豆胞囊線蟲(H. glycines )、甜菜胞囊線蟲(H. schachtii )、三葉草胞囊線蟲(H. trifolii );種子腫癭線蟲,粒線蟲屬(Anguina spp.);莖葉線蟲,滑刃線蟲屬(Aphelenchoides spp.),諸如水稻幹尖線蟲(A. besseyi );刺線蟲,針刺線蟲屬(Belonolaimus spp.),諸如雜草刺線蟲(B. longicaudatus );松線蟲,傘滑刃線蟲屬(Bursaphelenchus spp.),諸如松材線蟲(B. lignicolus )、松材線蟲(B. xylophilus );環形線蟲,環紋線蟲屬(Criconema spp.),小環線蟲屬(Criconemella spp.),諸如C. xenoplaxC. ornata ,以及輪線蟲屬(Criconemoides spp.),諸如Criconemoides informis ,中環線蟲屬(Mesocriconema spp.);球莖線蟲,莖線蟲屬(Ditylenchus spp.),諸如腐爛莖線蟲(D. destructor )、甘薯莖線蟲(D. dipsaci );錐線蟲,錐線蟲屬(Dolichodorus spp.);螺旋形線蟲,多帶螺旋線蟲(Heliocotylenchus multicinctus );鞘線蟲和鞘形線蟲,鞘線蟲屬(Hemicycliophora spp.)及擬鞘線蟲屬(Hemicriconemoides spp.);Hirshmanniella spp.;冠線蟲,紐帶線蟲屬(Hoploaimus spp.);假根結線蟲,真珠線蟲屬(Nacobbus spp.);針線蟲,長針線蟲屬(Longidorus spp.),諸如伸展長針線蟲(L. elongatus );根腐線蟲,短體線蟲屬(Pratylenchus spp.),諸如最短尾短體線蟲(P. brachyurus )、疏忽短體線蟲(P. neglectus )、穿刺短體線蟲(P. penetrans )、P. curvitatus 、古迪短體線蟲(P. goodeyi );穿孔線蟲,穿孔線蟲屬(Radopholus spp.),諸如香蕉穿孔線蟲(R. similis );Rhadopholus spp.;Rhodopholus spp.;腎形線蟲,腎狀線蟲屬(Rotylenchus spp.),諸如盤旋線蟲(R. robustus )、腎形腎臟線蟲(R. reniformis );盾線蟲屬(Scutellonema spp.);殘根線蟲,毛刺線蟲屬(Trichodorus spp.),諸如T. obtusus 、原始毛刺線蟲(T. primitivus );類毛刺屬(Paratrichodorus spp.),諸如P. minor ;阻長線蟲,矮化線蟲屬(Tylenchorhynchus spp.),諸如克萊頓矮化線蟲(T. claytoni )、不定矮化線蟲(T. dubius );柑桔線蟲,小墊刃線蟲屬(Tylenchulus spp.),諸如柑桔半穿刺線蟲(T. semipenetrans );劍線蟲,劍線蟲屬(Xiphinema spp.);以及其他植物寄生性線蟲種屬; 等翅目(Isoptera)昆蟲,例如黃頸木白蟻(Calotermes flavicollis ),Coptotermes spp.,諸如臺灣乳白蟻(C. formosanus )、C. gestroiC.acinaciformisCornitermes cumulansCryptotermes spp.,諸如C. brevisC. cavifronsGlobitermes sulfureus ,異白蟻屬(Heterotermes spp.),諸如金黃異白蟻(H. aureus )、長頭異白蟻(H. longiceps )、甘蔗白蟻(H. tenuis );Leucotermes flavipes ,土白蟻屬(Odontotermes spp. ),Incisitermes spp.,諸如I. minorI. SnyderMarginitermes hubbardiMastotermes spp.,諸如M. darwiniensisNeocapritermes spp.,諸如N. opacusN. parvusNeotermes spp.,Procornitermes spp.,Zootermopsis spp.,諸如Z. angusticollisZ. nevadensis ,散白蟻屬(Reticulitermes spp.),諸如R. hesperusR. tibialis 、黃胸散白蟻(R. speratus )、黃肢散白蟻(R. flavipes )、R. grassei 、歐洲散白蟻(R. lucifugus )、R. santonensis 、美小黑散白蟻(R. virginicus );Termes natalensis , 蜚蠊目(Blattaria)昆蟲,例如Blatta spp.,諸如東方蜚蠊(B. orientalis )、B. LateralisBlattella spp.,諸如亞洲姬蠊(B. asahinae )、德國小蠊(B. germanica );馬德拉蜚蠊(Leucophaea maderae );Panchlora niveaPeriplaneta spp.,諸如美洲大蠊(P. americana )、澳洲蜚蠊(P. australasiae )、棕色蜚蠊(P. brunnea )、黑胸大蠊(P. fuligginosa )、日本大蠊(P. japonica );Supella longipalpa ;Parcoblatta pennsylvanica;Eurycotis floridana;Pycnoscelus surinamensis , 蚤目(Siphonoptera)昆蟲,例如Cediopsylla simples 、角葉蚤屬(Ceratophyllus spp.)、Ctenocephalides spp.,諸如貓櫛頭蚤(C. felis )、犬櫛頭蚤(C. canis )、印鼠客蚤(Xenopsylla cheopis )、致癢蚤(Pulex irritans )、Trichodectes canis 、穿皮潛蚤(Tunga penetrans )及具帶病蚤(Nosopsyllus fasciatus ), 纓尾目(Thysanura)昆蟲,例如西洋衣魚(Lepisma saccharina )、Ctenolepisma urbana 及斑衣魚(Thermobia domestica ), 唇足綱(Chilopoda)有害生物,例如地蜈蚣屬(Geophilus spp.);蚰蜒屬(Scutigera spp.),諸如Scutigera coleoptrata , 倍足綱(Diplopoda)有害生物,例如Blaniulus guttulatusJulus spp.、Narceus spp., 綜合綱(Symphyla)有害生物,例如Scutigerella immaculata , 革翅目(Dermaptera)昆蟲,例如歐洲球螋(Forficula auricularia ), 彈尾目(Collembola)昆蟲,例如棘跳蟲屬(Onychiurus ssp.),諸如武裝棘跳蟲(Onychiurus armatus ), 等足目(Isopoda)有害生物,例如鼠婦(Armadillidium vulgare )、櫛水蝨(Oniscus asellus )、球鼠婦(Porcellio scaber ), 毛虱目(Phthiraptera)昆蟲,例如畜虱屬(Damalinia spp.);人虱屬(Pediculus spp.),諸如人頭蝨(Pediculus humanus capitis )、人體虱(Pediculus humanus corporis )、Pediculus humanus humanus ;陰虱(Pthirus pubis );血虱屬(Haematopinus spp.),諸如牛血虱(Haematopinus eurysternus )、豬血虱(Haematopinus suis );顎虱屬(Linognathus spp.),諸如犢顎虱(Linognathus vituli );牛虱(Bovicola bovis )、雞虱(Menopon gallinae )、大雞虱(Menacanthus stramineus )及水牛盲虱(Solenopotes capillatus ),嚼虱屬(Trichodectes spp.)。Pests The compounds of the present invention are especially useful against animal pests such as arthropods, gastropods and nematodes, including but not limited to: Lepidoptera, such as the small wax moth ( Achroia grisella ); spp.), such as A. fimbriana , A. gloverana , A. variana , A. variana ; Acrolepiopsis assectella ); Acronicta major ( Acronicta major ); Adoxophyes spp ( Adoxophyes spp), such as A. cyrtosema , A. orana ; Aedia leucomelas ); cutcuts ( Agrotis spp.), such as police cutcut ( A. exclamationis ), Yanqing cutcut ( A. fucosa ), lesser cutcut ( A. ipsilon ), western gray cutworm ( A. orthogoma ), yellow cutworm ( A. segetum ), and grain-skinned cutworm ( A. subterranea ); cotton leaf moth ( Alabama argillacea ); spiral whitefly ( Aleurodicus dispersus ); Pauline inchworm ( Alsophila pometaria ); Horn moth ( Ampelophaga rubiginosa ); Navel orange borer ( Amyelois transitella ); White shoulder moth ( Anacampsis sarcitella ); Mediterranean mealy moth ( Anagasta kuehniella ); ; Antheraea pernyi ; Anticarsia (=Thermesia) spp., such as A. gemmatalis ; Apamea spp. ; Aproaerema modicella ; ; Archips spp., such as A. argyrospila , A. fuscocupreanus , A. rosana , A. xyloseanus Argyrestia conjugella ( Argyresthia conjugella ); Argyroploce spp.; Argyrotaenia spp, such as A. velutinana ; Athetis mindara ; Cotton leafhopper ( Austroasca viridigrisea ); Autographa gamma ; Autographa nigrisigna ; Cabbage armyworm ( Barathra brassicae ); Leafminer ( Bedelia spp. ); Borer ( Bonagota salubricola ); Indica butterfly ( Borbo cinnara ); Cotton leaf piercer ( Bucculatrix thurberiella ); Pine looper ( Bupalus piniarius ); Brown moth ( Busseola spp.); Leaf tortrix ( Cacoecia spp. ), such as C. murinana, C. podana ; Cactoblastis cactorum; Cadra cautella ; Calingo braziliensis ; tea Caloptilis theivora ; Capua reticulana ; Carposina spp., such as C. niponensis , C. sasakii ; Cephus spp. .) ; Chaetocnema aridula ; Cheimatobia brumata ; Chilo spp, such as C. Indicus , C. suppressalis , Grass moth ( C. partellus ); Apple moth ( Choreutis pariana ); Choristoneura spp., such as willow moth ( C. conflictana ), spruce moth ( C. fumiferana ), apple moth Leaf tortrix ( C. longicellana ), European spruce leaf tortrix ( C. murinana ), western spruce tortrix ( C. occidentalis ), rose tortrix ( C. rosaceana ) ; Pseu-doplusia) spp.), such as C. eriosoma , C. includens ; Cirphis unipuncta ; Clysia ambiguella ; Clysia ambiguella ; Cnaphalocerus spp.); Cnaphalocerus medinalis ; Cnephasia spp.; Cochylis hospes ; Coleophora spp.; Colias eurytheme ; Conopomorpha spp.; Conotrachelus spp.; Copitarsia spp.; Corcyra cephalonica ; Crambus caliginosellus ; Crambus teterrellus ); bean rootworm ( Crocidosema (=Epinotia) aporema ) ; boxwood moth ( Cydalima ( =Diaphania) perspectivelis ); , Nut leaf tortrix ( C. latiferreana ); Dalaca noctuides ; Walnut with chip boat moth ( Datana integerrima ); pine poison moth ( Dasychira pinicola ); pine caterpillar ( Dendrolimus spp.), such as European pine caterpillar ( D. pini ), Red pine caterpillar ( D. spectabilis ), larch caterpillar ( D. sibiricus ); grape leaf roller ( Desmia funeralis ); silk borer ( Diaphania spp.), such as cucumber silk borer ( D. nitidalis ), melon silkworm D. hyalinata ; Diatraea grandiosella ; Diatraea saccharalis ; Diphthera festiva ; Earias spp . E. insulana ), E. vittella ; citrus fruit borer ( Ecdytolopha aurantianu ); citrus groundworm ( Egira (=Xylomyges) curialis ); South American corn seedling borer ( Elasmopalpus lignosellus ); sugarcane borer ( Eldana saccharina ); grape borer ( Endopiza viteana ); elm autumn yellow-foot moth ( Ennomos subsignaria ); Mexican rice borer ( Eoreuma loftini ); E. elutella , E. kuehniella ; Epinotia aporema ; Epiphyas postvittana ; Erannis tiliaria ; Erionota thrax ); Etiella spp.; Eulia spp.; Eupoecilia ambiguella ; Euproctis chrysorrhoea ; Euxoa spp.; Evetria bouliana ; Faronta albilinea , Feltia spp., such as F. Subterranean ; Galleria mellonella , Gracillaria spp. ), Grapholita spp., such as Li small borer ( G.funebrana ), pear small borer ( G.molesta ), apple small borer ( G.inopinata ); Halysidota spp., Harrisina americana , Hedylepta spp., bell Helicoverpa spp., such as H. armigera ( = Heliothis armigera) ), H. zea ( = Heliothis zea ) ; Heliothis spp., such as tobacco Hellula spp. , such as H.undalis and H.rogatalis ; Helocoverpa gelotopoeon , Silkworm moth ( Hemileuca oliviae ), Rice leaf-cutting borer ( Herpetogramma licarsisalis ), Hibernia defoliaria , Brown weaver moth ( Hofmannophila pseudospretella ), Sunflower spot borer ( Homoeosoma electellum ), Tea tumbler moth ( Homona magnanima ), Green spider moth ( Hypena scabra ), American white moth ( Hyphantria cunea ), cherry nest moth ( Hyponomeuta padella ), apple nest moth ( Hyponomeuta malellus ), kaki pedicle moth ( Kakivoria flavofasciata ), tomato moth ( Keiferia lycopersicella ), hemlock looper moth ( Lambdina fiscelaria fiscellaria ), western hemlock looper moth ( Lambdina fiscellaria lugubrosa ), bean leaf roller ( Lamprosema indicata ), silverfish borer ( Laspeyresia molesta ), soybean borer ( Leguminivora glycinivorella ), rice leaf roller ( Lerodea eufala ), nightshade Leucinodes orbonalis , Leucoma salicis , Leucoptera spp. such as L. coffeella , L. scitella ; Leumivora lycinivorella , apple-spotted Leaf miner ( Lithocolletis blancardella ), green fruit winter armyworm ( Lithophane antennata ), soybean armyworm ( Llattia octo ( = Amyna axis ) ), grape berry tortillaria ( Lobesia botrana ), Lophocampa spp., bean white longcut Rootworm ( Loxagrotis albicosta ), Loxostege spp., such as L. sticticalis , L. cereralis ; Lymantria spp., such as L. dispar , L. .monacha ); Lyonetia clerkella , Lyonetia prunifoliella , Malacosoma spp., such as M.americanum , M.californicum ), forest canopy caterpillar ( M.constrictum ), tawny canopy caterpillar ( M.neustria ); noctuid genus ( Mamestra spp.), such as cabbage moth ( M.brassicae ), scalloped moth ( M.configurata ); Mamstra brassicae , Manduca spp., such as tomato hornworm ( M.quinquemaculata ), tobacco hornworm ( M.sexta ); brush beetle moth ( Marasmia spp), Marmara spp., bean pod borer ( Maruca testulalis ), Megalopyge lanata , Melanchra picta , Melanitis leda , Mocis spp., such as M.lapites , M.repanda ; Mocis latipes , Monochroa fragariae , Mythimna separata , Nemapogon cloacella , Neoleucinodes elegantalis , Nepytia spp., Nymphula spp., Oiketicus spp., Omiodes indicata , Omphisa spp. anastomosalis ), winter looper moth ( Operophtera brumata ), Douglas moth ( Orgyia pseudotsugata ), Oria spp., thick beetle moth ( Orthaga thyrisalis ), stalk moth ( Ostrinia spp.), such as the European corn borer ( O. nubilalis ); rice leaf beetle ( Oulema oryzae ), spring inchworm ( Paleacrita vernata ), winter armyworm ( Panolis flammea ), rice beetle ( Parnara spp. ), stem borer ( Papaipema nebris ), great swallowtail butterfly ( Papilio cresphontes ), navel orange borer moth ( Paramyelois transitella ), grape piercing moth ( Paranthrene regalis ), palmless butterfly moth ( Paysandisia archon ), pink bollworm ( Pectinophora spp.), such as red bollworm ( P. gossypiella ); Peridroma saucia , Perileucoptera spp., such as P. coffeeella ; Phalera bucephala , Phryganidia californica , Phthorimaea spp. , such as potato tuber moth ( P.operculella ); citrus miner ( Phyllocnistis citrella ), small miner ( Phyllonorycter spp.), such as spotted leafminer ( P.blancardella ), hawthorn leafminer ( P. crataegella ), P.issikii , P. ringoniella ; Pieris spp., such as P.brassicae , P.rapae , P.napi ); Pilocrocis tripunctata , Plathypena scabra , Platynota spp., such as P.flavedana , P.idaeusalis , P. moth ( P.stultana ); carnation moth ( Platyptilia carduidactyla ), bean ash butterfly ( Plebejus argus ), Indian meal moth ( Plodia interpunctella ), silver leaf moth ( Plusia spp), diamondback moth ( Plutella maculipennis ), Plutella xylostella , Pontia protodica , Prays spp., Prodenia spp., Proxenus lepigone , Pseudaletia spp., such as Moth ( P.sequax ), one-star armyworm ( P.unipuncta ); corn borer ( Pyrausta nubilalis ), mint gray armyworm ( Rachiplusia nu ), Richia albicosta , dark ladybug ( Rhizobius ventralis ), American pine moth ( Rhyacionia frustrana ), diseased inchworm ( Sabulodes aegrotata ), red mountain back boat moth ( Schizura concinna ), rice brown edge moth ( Schoenobius spp.), Schreckensteinia festaliella , white grass moth ( Scirpophaga spp.), such as rice stem borer (S.incertulas), S.innotata ; yellow cutworm ( Scotia segetum ), Sesamia spp., such as rice borer ( S.inferens ), grape tiger moth ( Seudyra subflava ), wheat moth ( Sitotroga cerealella ), Sparganothis pilleriana , Spilonota lechriaspis, S.ocellana , Spodoptera ( = Lamphygma) spp.), such as S.cosmoides , subtropical armyworm ( S.eridania ), beet armyworm ( S.exigua ), grass armyworm ( S.frugiperda ), S.latisfascia , sea gray wingworm ( S.littoralis ), litura ( S.litura ), S.omithogalli ; Stigmella spp., Stomopteryx subsecivella , Strymon bazochii , Syepta derogata , Pteroptera ( Synanthedon spp.), such as the small peach winged moth ( S.exitiosa ), Andean potato tuber moth ( Tecia solanivora ), Telehin licus , Thaumatopoea pityocampa , apple shaped small tumbler moth ( Thaumatotibia (=Cryptophlebia) leucotreta ), pine different boat moth ( Thaumetopoea pityocampa ), Thecla spp., Theresimima ampelophaga , Thyrinteina spp, Tildenia inconspicuella , Tinea spp., T. Cloacella , T. spp. ( T. Pellionella ); clothes moth ( Tineola bisselliella ), leaf tortrix ( Tortrix spp.), such as oak green tortrix ( T. Viridana ); felt clothes moth ( Trichophaga tapetzella ), trichoplusia spp. .), such as T. ni ; Tuta (=Scrobipal-pula) absoluta , Udea spp., such as U. rubigalis , Greenhouse netting borer ( U. rubigalis ); gray butterfly genus ( Viracola spp.), apple nest moth ( Yponomeuta padella ) and spruce liner moth ( Zeiraphera canadensis ); Coleoptera insects such as the striped cucumber beetle ( Acalymma vittatum ), Acanthoscehdes obtectus , Adoretus spp., Agelastica alni , Agrilus spp., such as A. anxius , A. Planipennis , A. sinuatus ; Agriotes spp., such as A. fuscicollis , A. lineatus , A. obscurus ; Alphitobius diaperinus , Amphimallus solstitialis , Anisandrus dispar , Anisoplia austriaca , Anobium punctatum , Aeruginosa beetle ( Anomala corpulenta ), red copper beetle ( Anomala rufocuprea ), star beetle ( Anoplophora spp.), such as glabripennis ( A. glabripennis ); flower elephant ( Anthonomus spp.), such as pepper flower elephant ( A. eugenii ) , cotton boll weevil ( A. grandis ), apple flower elephant ( A. pomorum ); genus Anthrenus spp., Aphthona euphoridae , genus Apion spp., genus Apogonia spp. ), Athous haemorrhoidalis , Atomaria spp., such as A. linearis ; Attagenus spp., Aulacophora femoralis , A. Blastophagus piniperda ), Blitophaga undata , Bruchidius obtectus ( Bruchidius obtectus ), Bruchus spp., such as B. lentis , B. pisorum , B. rufimanus ); pear leafroll weevil ( Byctiscus betulae ), red-winged beetle beetle ( Callidiellum rufipenne ), Callopistria floridensis , mung bean weevil ( Callosobruchus chinensis ), European horse chestnut leafminer ( Cameraria ohridella ), sugar beet giant tortoise beetle ( Cassida nebulosa ), bean leaf Cerotoma trifurcata , Cetonia aurata , Ceuthorhynchus spp., such as C.assimilis , C.napi ; Chaetocnema tibialis ), Cleonus mendicus , Conoderus spp., such as C. vespertinus ; Conotrachelus nenuphar , Cosmopolites spp., brown New Zealand rib Costelytra zealandica, Crioceris asparagi , Cryptolestes ferrugineus , Cryptorhynchus lapathi , Ctenicera spp., such as C. destructor ; Curculio spp., Cylindrocopturus spp., Cyclocephala spp., Dactylispa balyi , Dectes texanus , Dermestes spp.), root leaf beetle ( Diabrotica spp.), such as cucumber eleven-star leaf beetle ( D.undecimpunctata ), South American leaf beetle ( D.speciosa ), long-horned leaf beetle ( D.longicornis ), D.semipunctata , Corn root leaf beetle ( D.virgifera ); citrus weevil ( Diaprepes abbreviates ), surname wild borer ( Dichocrocis spp.), rice iron beetle ( Dicladispa armigera ), Argentine roundworm ( Diloboderus abderus ), coconut flower two spots Elephant ( Diocalandra frumenti ( Diocalandra stigmaticollis ) ), oak beetle ( Enaphalodes rufulus ), plant-eating ladybug ( Epilachna spp.), such as Mexican bean ladybug ( E.varivestis ), potato ladybug ( E.vigintioctomaculata ); Epitrix spp., such as E. hirtipennis , E. similaris ; Eutheola humilis , Eutinobothrus brasiliensis , Faustinus cubae , naked spider beetle ( Gibbium psylloides ), Gnathocerus cornutus , Hellula undalis , Heteronychus arator , Hylamorpha elegans , Hylobius abietis , Hylotrupes bajulus , leaf Hypera spp., such as H. brunneipennis , H. postica ; Hypomeces squamosus , Hypothenemus spp., spruce Ips typographus , Lachnosterna consanguinea , Lasioderma serricorne , Latheticus oryzae , Lathridius spp., Lathridius spp. ( Lema spp.), such as tobacco beetle ( L. bilineata ), black horned mud beetle ( L. melanopus ); Leptinotarsa spp., such as potato beetle ( L.decemlineata ); Leptispa pygmaea , Limonius californicus , Lissorhoptrus oryzophilus , Lixus spp., Luperodes spp., Lyctus spp., such as the brown beetle ( L.bruneus ); Falk beetle ( Liogenys fuscus ), Macrodactylus spp., such as rose thorn beetle ( M. subspinosus ); Maladera matrida , Megaplatypus mutates , Megascelis spp., Melanotus communis , Meligethes spp., such as rapeseed beetle ( M.aeneus ); gill beetle ( Melolontha spp.), such as chestnut beetle ( M. hippocastani ), western May beetle ( M. melolontha ); West Indian sugarcane borer ( Metamasius hemipterus ), Microtheca spp., Migdolus spp., such as M.fryanus , Monochamus spp., such as M. alternatus ; South American fruit tree weevil ( Naupactus xanthographus ), yellow spider beetle ( Niptus hololeucus ), Oberia brevis , Oemona hirta , coconut rhinoceros beetle ( Oryctes rhinoceros ), saw chest mealworm ( Oryzaephilus surinamensis ), Oryzaphagus oryzae , black grape-eared elephant ( Otiorrhynchus sulcatus ), strawberries Root weevil ( Otiorrhynchus ovatus ), black grape ear weevil ( Otiorrhynchus sulcatus ), black-horned mud worm ( Oulema melanopus ), rice mud worm ( Oulema oryzae ), small blue-and-white beetle ( Oxycetonia jucunda ), ape leaf beetle ( Phaedon spp.), such as P. brassicae , P. cochleariae ; Phoracantha recurva , Phyllobius pyri , Phyllopertha horticola , Phyllophaga spp., such as P. helleri ; Phyllotreta spp., such as P. chrysocephala , P. nemorum , yellow-curled beetle ( P.striolata ), yellow striped flea beetle ( P.vittula ); garden beetle ( Phyllopertha horticola ), Japanese beetle ( Popillia japonica ), small weevil ( Premnotrypes spp. ), yellow star beetle ( Psacothea hilaris ) , Psylliodes chrysocephala , Prostephanus truncates , Psylliodes spp., Ptinus spp., Pulga saltona , Rhizopertha dominica , Cryptorhiza ( Rhynchophorus spp.), such as R.billineatus , red palm weevil ( R.ferrugineus ), palm weevil ( R.palmarum ), purple palm weevil ( R.phoenicis ), subpalm weevil ( R.vulneratus ); Apple wedge beetle ( Saperda candida ), navel beetle ( Scolytus schevyrewi ), sisal weevil ( Scyphophorus acupunctatus ), pea root nodule ( Sitona lineatus ), weevil ( Sitophilus spp.), such as grain weevil ( S. granaria ), rice elephant ( S.oryzae ), corn elephant ( S.zeamais ); Sphenophorus spp., such as S.levis ; Stegobium panicum , stem elephant ( Sternechus spp. ), such as soybean stem elephant ( S.subsignatus ); Strophomorphus ctenotus , Symphyletes spp., Tanymecus spp., Tenebrio molitor, Tenebrioides mauretanicus ; ( Tribolium spp.), such as T. castaneum; Trogoderma spp., Tychius spp., Xylotrechus spp., such as grape tiger Beetles ( X.pyrrhoderus ); and Zabrus spp., such as Z. Tenebrioides ; Diptera insects, such as Aedes spp., such as Egypt Aedes mosquito ( A. aegypti ), Aedes albopictus ( A. albopictus ), Aedes mosquito ( A. vexans ); Mexican fruit fly ( Anastrepha ludens ); Anopheles spp., such as Anopheles albopedes ( A.albimanus ), Anopheles disaster ( A.crucians ), Anopheles fischii ( A.freeborni ), Anopheles gambiae ( A.gambiae ), Anopheles white ankle ( A.leucosphyrus ), Anopheles five spots ( A. .maculipennis ), A.minimus , A.quadrimaculatus , A.sinensis ; Bactrocera invadens , Bibio hortulanus , green-headed Calliphora erythrocephala , Calliphora vicina , Ceratitis capitata , Chrysomyia spp., such as C.bezziana , C.hominivorax , C. macellaria ); Atlantic fly ( Chrysops atlanticus ), deer fly ( Chrysops discalis ), quiet spot fly ( Chrysops silacea ), cone fly ( Cochliomyia spp. ), such as screw fly ( C. hominivorax ); spp.), such as C. sorghicola; Cordylobia anthropophaga , Culex spp., such as C. nigripalpus , C. pipiens ) , Culicoides furens , Culiseta inornata , Culiseta melanura , Cuterebra spp., Dacus cucurbitae , Dacus oleae , Dasineura brassicae , Dasineura oxycoccana , Dasineura oxycoccana ( Delia spp.), such as onion fly ( D.antique ), corn fly ( D.coarctata ), gray field fly ( D.platura ), cabbage fly ( D.radicum ); human skin fly ( Dermatobia hominis ), Drosophila spp . , such as Drosophila spp. ( D. suzukii ), Fannia spp., such as F. canicularis ); ), such as G. intestinalis ; Geomyza tipunctata , Glossina spp., such as G. fuscipes , G. morsitans , G. palpalis , G. tachinoides , Haematobia irritans , Haplodiplosis equestris , Hippelates spp., Hylemyia spp., such as peanut field fly ( H.platura ); Hypoderma spp., such as H. lineata ; Hyppobosca spp., Hydrellia philippina , Leptoconops torrens , Liriomyza spp., such as L. sativae , L. trifolii ; Lucilia spp., such as L. caprina , Lucilia copper fly ( L. .cuprina ), Lucilia sericata ( L.sericata ); Lycoria pectoralis , Mansonia titillanus , Mayetiola spp., such as M.destructor ; Musca spp., such as Qiujia M.autumnalis , M.domestica ; Muscina stabulans ; Oestrus spp., such as O.ovis ; Opomyza florum , Oscinella spp.), such as Swedish straw fly ( O. frit ); rice gall midge ( Orseolia oryzae ), hysocyami spring fly ( Pegomya hysocyami ), silver-footed sandfly ( Phlebotomus argentipes ), Phorbia spp. , such as P.antiqua , P.brassicae , P.coarctata ; Phytomyza gymnostoma , Prosimulium mixtum , Psila rosae , Colombia Psorophora columbiae , Psorophora discolor , Rhagoletis spp., such as R. cerasi , R. cingulate , western cherry fruit fly ( R. indifferentens ), blue fruit fly ( R. .mendax ), apple fruit fly ( R. pomonella ); Rivellia quadrifasciata , Sarcophaga spp., such as red-tailed fly ( S. haemorrhoidalis ); gnat ( Simulium vittatum ), wheat red midge ( Sitodiplosis mosellana ), biting fly Stomoxys spp., such as S. calcitrans ; Tabanus spp., such as T. atratus , T. bovinus , T. lineola , T.similis ; Tannia spp., Thecodiplosis japonensis , Tipula oleracea , Tipula paludosa , and Wohlfahrtia spp.; Thysanoptera insects, such as Rice thrips ( Baliothrips biformis ), orchid thrips ( Dichromothrips corbetti ), Dichromothrips ssp., American spiny thrips ( Echinothrips americanus ), Enneothrips flavens , flower thrips ( Frankliniella spp.), such as brown thrips ( F. fusca ), F. occidentalis , F. tritici ; Heliothrips spp., Hercinothrips femoralis , Kakothrips spp. , Microcephalothrips abdominalis , Neohydatothrips samayunkur , Pezothrips kellyanus , Rhipiphorothrips cruentatus , Scirtothrips spp. , such as orange hard thrips ( S.citri ), small yellow thrips ( S.dorsalis ), avocado thrips ( S.perseae ); straight mane thrips ( Stenchaetothrips spp), Taeniothrips cardamoni , pear band thrips ( Taeniothrips inconsequens ); Thrips spp., such as T. imagines , T. hawaiiensis , T. oryzae , T. palmi ), T. parvispinus , T. tabaci ; Hemiptera insects such as Acizzia jamatonica , Acrosternum spp. such as A. hilare Acyrthosipon spp. such as A. onobrychis , A. pisum ; Adelges laricis , Adelges tsugae , Adelphocoris spp .), such as A. rapidus , A. superbus ; Aeneolamia spp., Agonoscena spp., Aulacorthum solani , Aleurocanthus woglumi , Aleurodes spp., Aleurodicus disperses , Aleurolobus barodensis , Aleurothrixus spp., Amrasca spp., Squash edge Stinkbugs ( Anasa tristis ), Antestiopsis spp. , Anuraphis cardui , Aonidiella spp. , Aphanostigma piri , Aphidula nasturtii , Aphids ( Aphis spp.), such as alfalfa aphid ( A. craccivora ), sugar beet aphid ( A. fabae ), strawberry root aphid ( A. forbesi ), cotton aphid ( A. gossypii ), North American tea currant aphid ( A. grossulariae ) , corn root aphid ( A. maidradicis ), apple aphid ( A. pomi ), elderberry aphid ( A. sambuci ), schneideri ( A. schneideri ), leaf roller aphid ( A. spiraecola ); grape leafhopper ( Arboridia apicalis ), Arilus critatus , Aspidiella spp., Aspidiotus spp., Atanus spp., Aulacaspis yasumatsui , Solanum Aulacorthum solani , Bactericera cockerelli (Patrioza cockerelli) , whitefly ( Bemisia spp.), such as silverleaf whitefly ( B. argentifolii ), tabaci ( B. tabaci (Aleurodes tabaci) ); Blissus spp., such as B. leucopterus ; Brachycaudus spp., such as B. cardui , B. helichrysi , Peach aphid ( B. persicae ), B. prunicola ; Brachycolus spp., Brachycorynella asparagi , cabbage aphid ( Brevicoryne brassicae ), Cacopsylla spp., such as C. fulguralis , pear psyllid C. pyricola (Psylla piri) ; small brown rice lice ( Caligypona marginata ), genus Calocoris spp., campylomma livida , Capitophorus horni , Carneocephala fulgida , Cavelerius spp., Ceraplastes spp., Ceratovacuna lanigera , Ceroplastes ceriferus , Cerosipha gossypii , Chaetosiphon fragaefolii , Chionaspis tegalensis , Chlorita onukii , Chromaphis juglandicola , Chrysomphalus ficus , Cicadulina mbila , Cimex spp. , such as tropical bed bugs ( C. hemipterus ), temperate bed bugs ( C. lectularius ); Coccomytilus halli , Coccus spp., such as C. hesperidum , C. pseudognoliarum ; Corythucha arcuata , Creontiades dilutus , Cryptomyzus ribis , Chrysomphalus aonidum , Cryptom yzus ribis ), Ctenarytaina spatulata , Cyrtopeltis notatus , Dalbulus spp., Dasynus piperis , Dialeurodes spp. such as D. citrifolii ; Dalbulus maidis , Diaphorina spp.), such as D. citri ; Diaspis spp., such as D. bromeliae ; Dichelops furcatus , Diconocoris hewetti , Doralis spp., Dreyfusia nordmannianae ), Dreyfusia piceae , Drosicha spp.; Dysaphis spp., such as Dreyfusia picea , Dreyfusia spp . . pyri ), D. radicola ; Dysaulacorthum pseudosolani ; Dysdercus spp., such as D. cingulatus , D. intermedius ; Dysmicoccus spp. ), Edessa spp., Geocoris spp., Empoasca spp., such as broad bean leafhopper ( E. fabae ), Solana small green leaf butterfly ( E. solana ); Epidiaspis leperii , cotton aphid ( Eriosoma spp.), such as E. lanigerum , E. pyricola ; Leafhopper ( Erythroneura spp.); Eurygaster spp., such as wheat flat shield bug ( E. integriceps ); Blunt nose leafhopper ( Euscelis bilobatus ), Euschistus spp., such as soybean brown stink bug ( E. heroos ), tobacco bug ( E. impictiventris ), brown stinkbug ( E. servus ); Fiorinia theae , coffee ground mealybug ( Geococcus coffeae ), Glycaspis brimblecombei ; Halyomorpha spp., such as H. halys; Heliopeltis spp., Homalodisca vitripennis (=H. coagulata) ), Horcias nobilellus , Hyalopterus pruni , Hyperomyzus lactucae , Icerya spp., such as I. purchase ; Idiocerus spp., flat beak Idioscopus spp., Laodelphax striatellus , Lecanium spp., Lecanoideus floccissimus , Lepidosaphes spp., such as L. ulmi ; spp.), cotton red boll beak ( Leptoglossus phyllopus ), radish aphid ( Lipaphis erysimi ), Lygus spp., such as Lygus ( L. hesperus ), American pasture Lygus ( L. lineolaris ), L. pratensis ; Maconellicocus hirsutus , Marchalina hellenica , Macropes excavatus , Macrosiphum spp., such as M. rosae , wheat tube Aphid ( M. avenae ), Euphorbiae ( M. euphorbiae ); Macrosteles quadrilineatus , Mahanarva fimbriolata , Megacopta cribraria , Megoura viciae , Melanaphis pyrarius , sorghum aphid ( Melanaphis sacchari ); Melanocallis (=Tinocallis) caryaefoliae , Metcafiella spp., Metopolophium dirhodum , Monellia costalis , Monelliopsis pecanis ; Myzocallis coryli , Murgantia spp., Myzus spp. .), such as M. ascalonicus , M. cerasi, M. nicotianae , M. persicae , M. variants ; Aphids ( Nasonovia ribis-nigri ), Neotoxoptera formosana , Neomegalotomus spp , Nephotettix spp., such as N. malayanus , N. nigropictus , Leafhopper ( N. parvus ), Leafhopper ( N. virescens ) ; Nezara spp., such as N. viridula ; Brown rice lice ( Nilaparvata lugens ) , Nysius huttoni , Oebalus spp., such as O. pugnax ; Oncometopia spp., Orthezia praelonga , Oxycaraenus hyalinipennis , Parabemisia myricae , Parlatoria spp. , Parthenolecanium spp., such as P. corni , P. persicae ; Pemphigus spp., such as P. bursarius , P. populivenae ; Lice ( Perkinsiella saccharicida ), Phenacoccus spp., such as P. aceris , P. gossypii ; Phloeomyzus passerinii , Phorodon humuli , Phylloxera spp .), such as P. devastatrix ; Piesma quadrata , Piezodorus spp., such as P. guildinii ; Pinnaspis aspidistrae, Planococcus spp .), such as P. citri , P. ficus ; Prosapia bicincta , Protopulvinaria pyriformis, Psallus seriatus , Pseudacysta persea , Pseudaulacaspis pentagona , mealybug ( Pseudococcus spp.), such as P. comstocki ; Psylla spp., such as P. mali ; Pteromalus spp., Pulvinaria amygdali , Pyrilla spp ., Quadraspidiotus spp., such as Q. perniciosus ; Quesada gigas , Rastrococcus spp., Reduvius senilis , Rhizoecus americanus , Rhodnius spp., shallots Rhopalomyzus ascalonicus ; Rhopalosiphum spp., such as R. pseudobrassicas , R. inserttum , R. maidis , corn aphids Aphids ( R. padi ); Sagatodes spp., Cocoa brown Lygus ( Sahlbergella singularis ), Black Helmets ( Saissetia spp.), Sappaphis mala , Sappaphis mali , Scaptocoris spp . , grape leafhopper ( Scaphoides titanus ), wheat Schizaphis graminum , Schizoneura lanuginosa , Scotinophora spp., Selenaspidus articulatus , Sitobion avenae , Sogata spp., White-backed planthopper ( Sogatella furcifera ), Solubea insulatingis , Spissistilus festinus (=Stictocephala festina) , pear crown bug ( Stephanitis nashi ), Stephanitis pyrioides , Stephanitis takeyai , Tenalaphara malayensis , Tetraleurodes perseae , Therioaph is maculate , Thyanta spp., such as T . accerra , T. perditor ; Tibraca spp., Tomaspis spp., Toxoptera spp., such as T. aurantii ; Whitefly ( Trialeurodes spp.) , such as T. abutilonea , T. ricini , whitefly ( T. vaporariorum ); triatoma spp., trioza spp., small leafhopper (Typhlocyba spp . ), sharp shield scale Genus ( Unaspis spp.), such as U. citri , U. yanonensis ; and phylloxera ( Viteus vitifolii ); insects of the order Hymenoptera , such as Acanthomyops interjectus , Athalia rosae , Atta spp., such as A. capiguara , A. cephalotes, A. cephalotes , A. laevigata , A. robusta , A. sexdens , A. texana , Bombus spp. ), Brachymyrmex spp., Camponotus spp., such as C. floridanus , C. pennsylvanicus , C. modoc ; Cardiocondyla nuda , Chalibion sp . Crematogaster spp., Dasymutilla occidentalis , Diprion spp., Dolichovespula maculata , Dorymyrmex spp., Dryocosmus kuriphilus , Formica spp., Hoplocampa spp., Such as H. minuta , H. testudinea ; Iridomyrmex humilis , Lasius spp., such as L. niger , Linepithema humile , Liometopum spp., Leptocybe invasa , Monomorium spp., such as M. pharaonis , Monomorium , Nylandria fulva , Pachycondyla chinensis , Paratrechina longicornis , Paravespula spp., such as P. germanica , P. pennsylvanica , P. vulgaris ; Pheidole spp., such as brown ants ( P. megacephala ); Pogonomyrmex spp., such as red ants ( P. barbatus ), harvester ants ( P. californicus ), wasps ( Polistes rubiginosa ), Prenolepis impairs , Pseudomyrmex gracilis , Schelipron spp., Sirex cyaneus , Solenopsis spp., such as tropical fire ants ( S. geminata ), red fire ants ( S. invicta ), S. molesta , black fire ants ( S. richteri ), southern fire ants ( S. xyloni ); Sphecius speciosus , Sphex spp., Tapinoma spp., such as T. melanocephalum , T. sessile ; Tetramorium spp., such as T. caespitum , T. bicarinatum , Vespa spp., such as yellow-edged Wasps ( V. crabro ); Vespula spp., such as the hornet ( V. squamosal ); Wasmannia auropunctata , Xylocopa sp; Insects of the order Orthoptera, such as the house cricket ( Acheta domesticus ), Italian locust ( Calliptamus italicus ) , Chortoicetes terminifera , Ceuthophilus spp., Diastrammena asymamora , Dociostaurus maroccanus , Gryllotalpa spp., such as African mole cricket ( G. africana ), mole cricket ( G. gryllotalpa ); Gryllus spp., African sugarcane locust ( Hieroglyphus daganensis ), Indian yellow sandalwood locust ( Kraussaria angulifera ), migratory locust ( Locusta spp.), such as migratory locust ( L. migratoria ), brown locust ( L. pardalina ); black locust ( Melanoplus spp.), such as Two-striped black locust ( M. bivittatus ), red-footed black locust ( M. femurrubrum ), Mexican black locust ( M. mexicanus ), migratory black locust ( M. sanguinipes ), stone-dwelling black locust ( M. spretus ); stripes Red locust ( Nomadacris septemfasciata ), Senegalus senegalensis ( Oedaleus senegalensis ), Scapteriscus spp., Schistocerca spp., such as American desert locust ( S. americana ), desert locust ( S. gregaria ), Stemopelmatus spp. ., Tachycines aynamorus and Zonozerus variegatus ; Arachnida pests, such as Acari, such as Argasidae, Ixodidae and Sarcoptidae ), such as Amblyomma spp. (eg A. americanum , A. variegatum , A. maculatum ), Argas spp. .), such as A. persicu , Boophilus spp., such as B. annulatus , B. decoloratus , B. microplus ), Dermacentor spp., such as Dermacentor spp., such as D. silvarum, D. andersoni , D. variabilis , Hyalomma spp., such as Eye ticks ( H. truncatum ), Ixodes spp., such as I. ricinus , I. rubicundus , I. scapularis , Ixodes spp. Ixodes ( I. holocyclus ), Ixodes pacificus ( I. pacificus ), Rhipicephalus sanguineus , Ornithodorus spp., such as O. moubata , O. hermsi ), recurrent heat tick ( O. turicata ), Ornithonyssus bacoti , ear tick ( Otobius megnini ), chicken skin thorn mite ( Dermanyssus gallinae ), itchy mite ( Psoroptes spp.), such as sheep scabies ( P. ovis ), Rhipicephalus spp., such as R. sanguineus , R. appendiculatus , Rhipicephalus evertsi , root mite Rhizoglyphus spp., Sarcoptes spp., such as S. Scabiei ; and Eriophyidae, including Aceria spp., such as A. sheldoni , A. anthocoptes , Acallitus spp ., Aculops spp., such as A. lycopersici , A. pelekassi ; Aculus spp., such as A. schlechtendali ; Colomerus vitis , Jujube leaf rust mite ( Epitrimerus pyri ), orange wrinkled leaf gall mite ( Phyllocoptruta oleivora ); Eriophytes ribis and gall mite ( Eriophyes spp.), such as citrus gall mite ( Eriophyes sheldoni ); tarsonemidae (Tarsonemidae), Including Hemitarsonemus spp., Phytonemus pallidus and Polyphagotarsonemus latus , Stenotarsonemus spp., Steneotarsonemus spinki ; Tenuipalpidae, including short Brevipalpus spp., such as B. phoenicis ; Tetranychidae, including Eotetranychus spp., Eutetranychus spp., small-clawed Mites ( Oligonychus spp.), Petrobia latens , Tetranychus spp., such as cinnabar spider mite ( T. cinnabarinus ), T. evansi , Shenze spider mite ( T. kanzawai ), Pacific spider mite ( T, pacificus ), T. phaseulus , T. telarius and T. urticae ; Bryobia praetiosa ; Panonychus spp., such as P. ulmi , P. citri ; Metatetranychus spp. and Oligonychus spp., such as O. pratensis , O. perseae , Vasates lycopersici ; Raoiella indica , Carpoglyphidae , including Carpoglyphus spp.; Penthaleidae spp., such as Halotydeus destructor ; Demodicidae (Democidae) genus species, such as Demodex spp. ( Demodex spp.); Trombicidea, including chigger genus ( Trombicula spp.); Family Macronyssidae, including Ornothonyssus spp.; Pyemotidae, including Pyemotes tritici ; Tyrophagus putrescentiae ; Acaridae, including Acarus siro ; Araneida, such as Latrodectus mactans , Tegenaria agrestis , Chiracanthium sp , Lycosa sp Achaearanea tepidariorum and brown silk spider ( Loxosceles reclusa ); pests of the Phylum Nematoda, for example plant parasitic nematodes such as root-knot nematodes, Meloidogyne spp., such as northern Root-knot nematode ( M. hapla ), southern root-knot nematode ( M. incognita ), Javan root-knot nematode ( M. javanica ); cyst nematodes, Globodera spp., such as potato golden nematode ( G . rostochiensis ); Cyst nematodes ( Heterodera spp.), such as cereal cyst nematodes ( H. avenae ), soybean cyst nematodes ( H. glycines ), sugar beet cyst nematodes ( H. schachtii ), clover cyst nematodes ( H. trifolii ); seed gall nematodes, Anguina spp.; stem and leaf nematodes, Aphelenchoides spp., such as rice stem-point nematodes ( A. besseyi ); stinging nematodes, needle-stinging nematodes Nematodes of the genus Belonolaimus spp., such as B. longicaudatus ; pine nematodes, Bursaphelenchus spp., such as B. lignicolus , B. xylophilus ); Ringworms, Criconemella spp., Criconemella spp., such as C. xenoplax and C. ornata , and Criconemoides spp., such as Criconemoides informis , Criconemella spp. Genus ( Mesocriconema spp.); Bulb nematodes, Ditylenchus spp., such as D. destructor , D. dipsaci ; Trypanosoma, Dolichodorus spp.; Helicoidal nematodes, Heliocotylenchus multicinctus ; Heliocotylenchus multicinctus ; Sheath nematodes and sheath nematodes, Hemiccliophora spp. and Hemicriconemoides spp.; Hirshmanniella spp.; Hoploaimus spp.); pseudoroot-knot nematodes, Nacobbus spp.; needle nematodes, Longidorus spp., such as L. elongatus ; root-rot nematodes, Brachyphytes ( Pratylenchus spp.), such as P. brachyurus , P. neglectus , P. penetrans , P. curvitatus , P. goodeyi ); Perforator nematode, perforator nematode genus ( Radopholus spp .), such as banana perforator nematode ( R. similis ); Rhadopholus spp.; Rhodopholus spp.; R. robustus ), R. reniformis ; Scutellonema spp.; Root stump nematodes, Trichodorus spp. such as T. obtusus , T. primitivus ; Paratrichodorus spp., such as P. minor ; Stagnant nematodes, dwarf nematodes ( Tylenchorhynchus spp.), such as Clayton dwarf nematodes ( T. claytoni ), adventitious dwarf nematodes ( T. dubius ); citrus nematodes, Tylenchulus spp., such as T. semipenetrans ; sword nematodes, Xiphinema spp.; and other plant-parasitic nematode species; Isoptera (Isoptera) insects, for example yellow-necked wood termites ( Calotermes flavicollis ), Coptotermes spp., such as Taiwan milk termites ( C. formosanus ), C. gestroi , C. acinaciformis ; Cornitermes cumulans , Cryptotermes spp., such as C. brevis , C. cavifrons ; Globitermes sulfurus , Heterotermes spp., such as H. aureus , H. longiceps , H. tenuis ; Leucotermes flavipes , soil Termites ( Odontotermes spp. ), Incisitermes spp., such as I. minor , I. Snyder ; Marginitermes hubbardi , Mastotermes spp., such as M. darwiniensis , Neocapritermes spp., such as N. opacus , N. parvus ; Neotermes spp., Procornitermes spp., Zootermopsis spp., such as Z. angusticollis , Z. nevadensis , Reticulitermes spp., such as R. hesperus , R. tibialis , R. speratus , R. speratus ( R. flavipes ), R. grassei , European termite ( R. lucifugus ), R. santonensis , American small black termite ( R. virginicus ); Termes natalensis , Blattaria (Blattaria) insects, such as Blatta spp., such as B. orientalis, B. Lateralis ; Blattella spp., such as B. asahinae , B. germanica; Leucophaea maderae ; Panchlora nivea ; Periplaneta spp., such as American cockroach ( P. americana ), Australian cockroach ( P. australasiae ), brown cockroach ( P. brunnea ), black-breasted cockroach ( P. fuligginosa ), Japanese cockroach ( P. japonica ); Supella longipalpa ; Parcoblatta pennsylvanica; Eurycotis floridana; Pycnoscelus surinamensis , insects of the order Siphonoptera, such as Cediopsylla simples , Ceratophyllus spp., Ctenocephalides spp., such as C. felis , Ctenocephalides spp. C. canis , Xenopsylla cheopis , Pulex irritans, Trichodectes canis , Tunga penetrans and Nosopsyllus fasciatus , Thysanura ) Insects, such as Western silverfish ( Lepisma saccharina ), Ctenolepisma urbana and spotted fish ( Thermobia domestica ), Chilopoda (Chilopoda) pests, such as ground centipede ( Geophilus spp.); Scutigera (Scutigera spp.), Such as Scutigera coleoptrata , Diplopoda pests, such as Blaniulus guttulatus , Julus spp., Narceus spp., Symphyla pests, such as Scutigerella immaculata , Dermaptera insects, such as European ball fly ( Forficula auricularia ), insects of the order Collembola, for example Onychiurus ssp., such as Onychiurus armatus , pests of the order Isopoda, for example Armadillidium vulgare , Water lice ( Oniscus asellus ), Porcellio scaber , insects of the order Phthiraptera, for example Damalinia spp.; Pediculus spp., such as Pediculus humanus capitis , human lice ( Pediculus humanus corporis ), Pediculus humanus humanus ; pubic lice ( Pthirus pubis ); blood lice ( Haematopinus spp.), such as bovine blood lice ( Haematopinus eurysternus ), pig blood lice ( Haematopinus suis ); Linognathus spp.), such as Linognathus vituli ; Bovicola bovis , Menopon gallinae , Menacanthus stramineus and Solenopotes capillatus , Trichodectes spp .).

可由式(I)化合物控制的其他有害生物物種之實例包括軟體動物門(Phylum Mollusca),雙殼綱(Bivalvia),例如飾貝屬(Dreissena spp.);腹足綱(Gastropoda),例如阿勇蛞蝓屬(Arion spp.)、雙臍螺屬(Biomphalaria spp.)、小泡螺屬(Bulinus spp.)、Deroceras spp.、土蝸屬(Galba spp.)、椎實螺屬(Lymnaeas spp.)、釘螺屬(Oncomelania spp.)、福壽螺(Pomacea canaliclata )、琥珀螺屬(Succinea spp.);蠕蟲綱(helminths),例如十二指腸鉤口線蟲(Ancylostoma duodenale )、斯里蘭卡鉤口線蟲(Ancylostoma ceylanicum )、巴西鉤口線蟲(Acylostoma braziliensis )、鉤口線蟲屬(Ancylostoma spp.)、似引蛔線蟲(Ascaris lubricoides )、蛔蟲屬(Ascaris spp. )、馬來布魯線蟲(Brugia malayi )、帝汶布魯線蟲(Brugia timori )、仰口線蟲屬(Bunostomum spp.)、夏伯特線蟲屬(Chabertia spp.)、枝睾吸蟲屬(Clonorchis spp.)、古柏線蟲屬(Cooperia spp.)、雙腔吸蟲屬(Dicrocoelium spp.)、絲狀網尾線蟲(Dictyocaulus filaria )、闊葉裂頭絛蟲(Diphyllobothrium latum )、麥地那龍線蟲(Dracunculus medinensis )、細粒棘球絛蟲(Echinococcus granulosus )、多房棘球絛蟲(Echinococcus multilocularis )、蠕形住腸蟯蟲(Enterobius vermicularis )、片吸蟲屬(Faciola spp.)、血矛線蟲屬(Haemonchus spp.)諸如撚轉血矛線蟲(Haemonchus contortus );異刺線蟲屬(Heterakis spp.)、矮小嚙殼絛蟲(Hymenolepis nana )、豬圓線蟲屬(Hyostrongulus spp.)、羅阿羅阿線蟲(Loa Loa )、細頸線蟲屬(Nematodirus spp.)、結節線蟲屬(Oesophagostomum spp.)、後睾吸蟲屬(Opisthorchis spp.)、旋盤尾絲蟲(Onchocerca volvulus )、奧斯脫線蟲屬(Ostertagia spp.)、並殖吸蟲屬(Paragonimus spp.)、血吸蟲屬(Schistosomen spp.)、富氏類圓線蟲(Strongyloides fuelleborni )、糞類圓線蟲(Strongyloides stercoralis )、糞圓線蟲屬(Stronyloides spp.)、牛帶絛蟲(Taenia saginata )、豬帶絛蟲(Taenia solium )、旋毛形線蟲(Trichinella spiralis )、本地毛形線蟲(Trichinella nativa )、株布氏旋毛蟲(Trichinella britovi )、南方旋毛蟲(Trichinella nelsoni )、偽方定毛形線蟲(Trichinella pseudopsiralis )、毛圓線蟲屬(Trichostrongulus spp.)、毛首鞭形線蟲(Trichuris trichuria )、班氏吳策線蟲(Wuchereria bancrofti )。Examples of other pest species that can be controlled by compounds of formula (I) include Phylum Mollusca, Bivalvia, e.g. Dreissena spp.; Gastropoda, e.g. Arion spp., Biomphalaria spp., Bulinus spp., Deroceras spp., Galba spp., Lymnaeas spp. , Oncomelania spp., Pomacea canaliclata , Succinea spp.; Helminths, such as Ancylostoma duodenale , Ancylostoma ceylanicum , Acylostoma braziliensis, Ancylostoma spp., Ascaris lubricoides , Ascaris spp. , Brugia malayi , Timor blue Brugia timori , Bunostomum spp ., Chabertia spp., Clonorchis spp ., Cooperia spp., Dicoela Dicrocoelium spp., Dictyocaulus filaria , Diphyllobothrium latum , Dracunculus medinensis , Echinococcus granulosus , Echinococcus multilocularis , Enterobius vermicularis , Faciola spp., Haemonchus spp. such as Haemonchus contortus ; Heterakis spp., Hymenolepis nana , Hyostrongulus spp., Loa Loa , Nematodirus spp., Nodules Oesophagostomum spp., Opisthorchis spp., Onchocerca volvulus , Ostertagia spp., Paragonimus spp., Schistosomen spp., Strongyloides fueleborni, Strongyloides stercoralis , Stronyloides spp., Taenia saginata , Taenia saginata solium ), Trichinella spiralis , Trichinella nativa , Trichinella britovi , Trichinella nelsoni , Trichinella pseudopsiralis , Trichinella pseudopsiralis Trichostrongulus spp., Trichuris trichuria , Wuchereria bancrofti .

在本發明之一個實施例中,有害生物來自半翅目、鱗翅目、鞘翅目或纓翅目,較佳選自白粉虱屬、黑尾葉蟬屬、綠蝽屬、蚜屬、蠶豆修尾蚜、瘤蚜屬、實夜蛾屬、禾草螟屬、白禾螟屬、花象甲屬或薊馬(蘭花薊馬),更佳為溫室白粉虱(溫室白粉虱)、青葉蟬(二點黑尾葉蟬(Nephotettix virescens ))、稻褐飛虱(褐稻虱)、豇豆蚜蟲(苜蓿蚜(Aphis craccivora ))、蠶豆修尾蚜(蠶豆修尾蚜)、桃蚜(桃蚜(Myzus persicae ))、菸草夜蛾(美洲菸葉蛾(Heliothis virescens ))、水稻螟蟲/條螟 - 二化螟(Chilo suppressalis )、三化螟 - 三化螟(Tryporyza (=Scirpophaga) incertulas ) 棉鈴象甲(棉鈴象甲(Anthonomus grandis ))或薊馬(蘭花薊馬)。In one embodiment of the present invention, the harmful organisms are from the order Hemiptera, Lepidoptera, Coleoptera or Thysanoptera, preferably selected from the genus Whitefly, Leafhopper, Green Stinkbug, Aphid, Vicia faba Aphids, Tuxaphis, Helicopteris, Grassias, Sinella, Flower Weevil or Thrips (Orchid Thrips), more preferably Greenhouse Whitefly (Greenhouse Whitefly), Green Leafhopper (Two Black-tailed leafhopper ( Nephotettix virescens ) ) , rice brown planthopper ( B. persicae )), tobacco armyworm ( Heliothis virescens ), rice borer/strip borer- Chilo suppressalis , rice stem borer- tryporyza (=Scirpophaga) incertulas ) , cotton boll weevil (Cotton boll weevil ( Anthonomus grandis )) or thrips (Orchid thrips).

在本發明之一個實施例中,本發明係關於控制水稻中之水稻有害無脊椎動物的方法,該方法包含向該等水稻有害無脊椎動物施用至少一種殺有害生物活性之非外消旋化合物(I)或其對映異構體或其混合物。In one embodiment of the present invention, the present invention relates to a method of controlling rice harmful invertebrates in rice, the method comprising applying to said rice harmful invertebrates at least one non-racemic compound with pesticidal activity ( I) or its enantiomers or mixtures thereof.

在本發明之一個實施例中,本發明係關於控制水稻中之水稻有害無脊椎動物的方法,該方法包含向該等水稻有害無脊椎動物施用至少一種具有對映異構體過量化合物I-R之式(I)之殺有害生物活性化合物或其混合物。In one embodiment of the present invention, the present invention relates to a method of controlling rice harmful invertebrates in rice, the method comprising administering to said rice harmful invertebrates at least one compound of formula I-R having enantiomeric excess (I) The pesticidally active compound or a mixture thereof.

在本發明之一個實施例中,本發明係關於控制水稻中之水稻有害無脊椎動物的方法,該方法包含向該等水稻有害無脊椎動物施用至少一種殺有害生物活性化合物I-R或其混合物。In one embodiment of the present invention, the present invention relates to a method of controlling rice harmful invertebrates in rice, the method comprising applying to said rice harmful invertebrates at least one pesticidally active compound I-R or a mixture thereof.

水稻有害生物: 在本發明之上下文中,水稻有害無脊椎動物為在水稻中出現的動物有害生物。水稻有害無脊椎動物包括昆蟲、蟎蟲及線蟲,較佳昆蟲。水稻中熟知的水稻有害無脊椎動物包括但不限於以下物種: 半翅目: 褐飛虱 - 褐稻虱 灰飛虱 - 斑飛虱 白背飛虱 - 白背飛虱 白葉蟬 - 白翅褐脈葉蟬(Cofana spectra ) 青葉蟬 - 二點黑尾葉蟬、黑條黑尾葉蟬(N. nigriceps )、黑尾葉蟬(N. cincticeps )、馬來亞黑尾葉蟬 電光葉蟬 - 電光葉蟬(Recilia dorsalis ) 玉米橙葉蟬 - 二星葉蟬(Cicadulina bipunctata ) 紫莞葉蟬 -紫菀點葉蟬(Macrosteles fascifrons ) 稻穗蝽,大稻緣蝽(Leptocorisa oratorius ),稻蛛緣蝽(L. acuta ) 稻褐蝽 - 稻綠蝽(Nezara viridula )、異曼蝽(Pygomenida varipennis )、二星蝽屬(Eysarcoris )、Tibraca limbatriventris 、廣二星蝽(Eysarcoris ventralis ) 小臭蟲 - 雜色稻椿(Oebalus poecilus )、美洲稻蝽 緣蝽- 二星蝽屬 長蝽 -麥長蝽(Blissus leucopterus leucopterus ) 水稻粉蚧,水稻粉紅粉蚧(Brevennia rehi ),亞蔗粉蚧(Pseudococcus saccharicola ) 稻蚜,紅腹縊管蚜(Rhopalosiphum rufiabdominalis ),麥長管蚜(Macrosiphum avenae ),無肘詠蚜(Hysteroneura setariae ),黑腹四脈綿蚜(Tetraneuro nigriabdominalis ) 菜豆根蚜 - 棉根蚜(Smynthurodes betae ) 鱗翅目: 稻苞蟲 - 直紋稻弄蝶(Parnara guttata )、暮眼蝶(Melanitis Ieda ismene ) 水稻螟蟲 / 條螟 - 二化螟、黑頭條紋螟(Chilo polychrusus )、斑禾草螟(Chilo partellus )、七星稻螟(Chilo plejadellus ) 稻稈螟 - 稻多麗螟(Chilotraea polychrysa ) 大螟 - 大螟(Sesamia inferens ) 三化螟 - 三化螟 稻白螟 - 稻白螟(Tryporyza innotata ) 稻縱卷葉螟/卷葉蟲 - 稻縱卷葉野螟 寬紋刷鬚野螟(Marasmia patnalis )、稻顯紋刷鬚野螟(M. exigua ) 剃枝蟲/行軍蟲- 東方黏蟲(Pseudaletia separata ) 綠毛蟲 - 犁紋黃夜蛾(Xanthodes transversa ) 稻綠毛蟲 - 稻螟蛉(Narnaga aenescens ) 綠角毛蟲- 暮眼蝶、眉眼蝶屬(Mycalesis sp ) 草地黏蟲 - 草地貪夜蛾(Spodoptera frugiperda ) 切根蟲 - 黏蟲 稻殼蟲- 稻三點螟(Nymphula depunctalis ) 黑毛毛蟲,鹿蛾屬(Amata sp .) 長毛毛蟲-實毛脛裳蛾(Mocis frugalis ) 黃毛蟲,鉤茸毒蛾(Psalis pennatula ) 水稻半褐尺蠖,實毛脛裳蛾 水稻擬尺蠖,金色雙斑蛾(Chrysodeixis chalcites ) 草螟 - 水稻切葉野螟 蔗螟 - 小蔗螟 玉米稈螟 - 南美玉米苗斑螟 條紋草尺蠖 - 南美毛脛夜蛾 歐洲玉米螟 - 玉米螟(Ostrinia nubilalis ) 墨西哥稻螟 - 墨西哥水稻螟 鞘翅目: 水稻象鼻蟲 - 稻水象甲(Lissorhopterus oryzophilus ) 稻象鼻蟲 - 稻象甲(Echinocnemus squamous ) 米象 - 水稻負泥蟲(Oryzophagus oryzae ) 水稻鐵甲蟲 - 水稻鐵甲(Diclodispa armigera ) 水稻葉甲 - 稻葉甲 稻黑蝽 - 稻黑蝽(Scotinophora vermidulateS. vermidulateS. lurida )、寬翅黑蝽(S. latiuscula ) 水稻跳甲- 黑凹脛跳甲(Chaetocnima basalis ) 蛆 - 白鱗鰓金龜(Leucopholis irrorata )、白鱗鰓金龜、鰓角金龜屬、異爪犀金龜屬(Heteronychus sp ) 金龜子 (bicho torito) - 阿根廷兜蟲 象鼻蟲 - 尖隱喙象屬 葡萄肖葉甲 -葡萄鞘葉甲(Colaspis brunnea )、路易斯安那葉甲(C. louisianae ) 水稻花粉甲蟲,花金龜(Chilolaba acuta ) 雙翅目: 稈蠅 - 稻稈潛蠅(Chlorops oryzae ) 潛蠅 - 日本稻潛蠅(Agromyza oryzae ) 稻水蠅/稻稈蠅 - 稻莖毛眼水蠅(Hydrellia sasakii ) 稻水蠅/ 稻小潛蠅 - 稻潛葉蠅(Hydrellia griseola ) 稻癭蚊 - 稻癭蚊(Orseolia (=Pachydiplosis) oryzae ) 秧苗蠅- 稻芒蠅(Atherigona oryzae ) 稻搖蚊 -Chironomus cavazzai 、搖蚊屬(Chironomus spp )、環足搖蚊屬(Cricotopus spp ) 纓翅目: 稻薊馬- 稻薊馬(Chloethrips oryzae )、稻直鬃薊馬(Stenochaetothrips biformis )、裸薊馬屬(Perrisothrips sp. )、器管薊馬屬(Hoplothrips sp. ), 直翅目: 稻蝗、等岐蔗蝗(Hieroglyphus banian )、高粱蔗蝗(Hieroglyphus nigrorepletus )、紅褐斑腿蝗(Catantops pinguis )、紡梭負蝗(Attractomorpha burri )、短翅負蝗(A. crenulate )、柳枝負蝗(A. psittacina psittacina )、尖頭負蝗(A. Bedeli )、無齒稻蝗(Oxya adenttata )、Oxya ebneri 、小稻蝗(Oxya hyla intricata )、長頭蝗(Acrida turricata ) 蝗蟲 -東亞飛蝗(Locusta migratoria manilensis ) 螻蛄,非洲螻蛄(Grylotalpa africana ) 蟋蟀:雙斑蟋(Gryllus bimaculatus )、烏頭眉紋蟋蟀(Teleogryllus occipitalis )、靈巧纖蟋(Euscyrtus concinus ) 螽斯 - 長翅草螽(Conocephalus longipennis ) 等翅目: 白蟻 - 暗黃大白蟻(Macrotermes gilvus )、Syntermes molestans 膜翅目: 螞蟻 - 熱帶火蟻(Solenopsis geminata ) 稻幹尖線蟲 - 葉芽線蟲(Aphelenchoides besseyi ) 蜱蟎亞綱: 稻穗蟎 - 稻細蟎(Steotarsonemus pinki ) 甲殼綱: 鱟蟲 - 佳朋鱟蟲(Triops longicaudatus )、蟹形鱟蟲(T. cancriformis ) 水稻小龍蝦 - 克氏原螯蝦(Procambarus clarkii )、莫里斯綠螯蝦(Orconectes virilis )。Rice pests: In the context of the present invention, rice pest invertebrates are animal pests that occur in rice. Rice harmful invertebrates include insects, mites and nematodes, preferably insects. Known rice pest invertebrates in rice include, but are not limited to, the following species: Hemiptera: Brown planthopper - Brown rice hopper Sliverus striatellus - Spotted planthopper White-backed planthopper - White-backed planthopper Leafhopper - Leafhopper Leafhopper ( Cofana spectrum ) Green leafhopper - two-spotted black-tailed leafhopper, black-striped black-tailed leafhopper ( N. nigriceps ), black-tailed leafhopper ( N. cincticeps ), Malayan black-tailed leafhopper N. nigriceps Leafhopper ( Recilia dorsalis ) Corn Orange Leafhopper - Cicadulina bipunctata . acuta ) Rice brown bug - Nezara viridula , Pygomenida varipennis , Eysarcoris , Tibraca limbatriventris , Eysarcoris ventralis Small bug - Oebalus poecilus ), American rice bug ( Blissus leucopterus leucopterus ) rice mealybug, rice pink mealybug ( Brevennia rehi ), subcane mealybug ( Pseudococcus saccharicola ) rice aphid, red bellied tuber Aphids ( Rhopalosiphum rufiabdominalis ), wheat aphids ( Macrosiphum avenae ), armless aphids ( Hysteroneura setariae ), black-bellied four-veined aphids ( Tetraneuro nigriabdominalis ) bean root aphids - cotton root aphids ( Smynthurodes betae ) Lepidoptera: Rice bracts Insects - Parnara guttata , Melanitis Ieda ismene Rice borers/ Strip borers - Chilo borer, Chilo polychrusus , Chilo partellus , Chilo partellus ( Chilo plejadellus ) Rice stem borer - Chilotraea polychrysa Leaf insects- Rice leaf roller , Broad-grained wild borer ( Marasmia patnalis ), Rice striped wild-striped wild borer ( M. exigua ) Shaving insects/army insects- Oriental armyworm ( Pseudaletia separata ) Green caterpillars- Xanthodes transversa ( Xanthodes transversa ) Rice green caterpillar - Rice borer ( Narnaga aenescens ) Green horned caterpillar - Twilight butterfly, eyebrow eye butterfly ( Mycalesis sp ) Meadow armyworm - Spodoptera frugiperda Root cutter - Armyworm Rice Husk Worm - Nymphula depunctalis Black Caterpillar, Deer Moth ( Amata sp .) Long Hairy Caterpillar - Mocis frugalis Yellow Caterpillar, Psalis pennatula Rice Half Brown Inch moth, Pleurotus moth Pseudomonas oryzae, Golden double-spotted moth ( Chrysodeixis chalcites ) Grass moth - Rice leaf-cutting moth Cane borer - Small sugar cane borer Corn stalk borer - South American corn seedling borer Striped looper - South American hairy moth Europe Corn borer - corn borer ( Ostrinia nubilalis ) Mexican rice borer - Mexican rice borer Oryzophagus oryzae Rice iron beetle- Rice iron armor ( Diclodispa armigera ) Rice leaf beetle- Rice leaf beetle Rice black bug- Rice black bug ( Scotinophora vermidulate , S. vermidulate , S. lurida ), Broad-winged black bug ( S. latiuscula ) Rice flea beetle - Chaetocnima basalis maggot - Leucopholis irrorata, Leucopholis irrorata, Heteronychus sp , Bicho torito - Argentina Cyclopedia weevil - Cyclopsis genus Vitis brunnea - Colaspis brunnea, Louisiana beetle ( C. louisianae ) Rice pollen beetle, flower beetle ( Chilolaba acuta ) Diptera: stalks Flies - Chlorops oryzae ( Chlorops oryzae ) Liriomyza ( Agromyza oryzae ) Rice water fly / Rice straw fly - Hydrellia sasakii Rice water fly / Rice Liriomyzae - Rice water fly Leaf fly ( Hydrellia griseola ) Rice gall midge - Orseolia (= Pachydiplosis) oryzae Rice seedling fly - Rice awn fly ( Atherigona oryzae ) Rice midge - Chironomus cavazzai , Chironomus spp , Ring-footed midge Genus ( Cricotopus spp ) Thysanoptera: Rice thrips - rice thrips ( Chloethrips oryzae ), rice straight mane thrips ( Stenochaetothrips biformis ), naked thrips ( Perrisothrips sp. ), organ thrips ( Hoplothrips sp. ), Orthoptera: Rice Locust, Hieroglyphus banian , Hieroglyphus nigrorepletus , Catantops pinguis , Attractomorpha burri , Attractomorpha burri, A. crenulate ), willow grasshopper ( A. psittacina psittacina ), pointed grasshopper ( A. Bedeli ), toothless rice grasshopper ( Oxya adenttata ), Oxya ebneri , small rice grasshopper ( Oxya hyla intracata ), long-headed grasshopper ( Acrida turricata ) Locusts - Locusta migratoria manilensis mole crickets, African mole crickets ( Grylotalpa africana ) crickets: two-spotted crickets ( Gryllus bimaculatus ), black-headed brow crickets ( Teleogryllus occipitalis ), dexterous slender crickets ( Euscyrtus concinus ) katydids - Long-winged katydid ( Conocephalus longipennis ) Isoptera: Termites - Macrotermes gilvus , Syntermes molestans Hymenoptera: Ants - Tropical fire ants ( Solenopsis geminata ) Rice dry point nematodes - Leaf bud nematodes ( Aphelenchoides besseyi ) Ticks Acarid subclass: Rice ear mite - Steotarsonemus pinki ) Crustacea: Limulus - Triops longicaudatus , T. cancriformis Rice crayfish - Procambarus clarkii , Morris Green Crawfish ( Orconectes virilis ).

另外,水稻受一系列臭蟲(包括中華稻緣蝽(Leptocorisa chinensis )、稻褐蝽(Lagynotomus elongates )、稻綠蝽(Nerzara viridula )、尖角二星蝽(Eysacoris parvus )、大稻緣蝽、美洲稻蝽(Oebalus pugnax )、長肩棘緣蝽(Cletus trigonus ))以及各種蟎蟲、毛蟲、甲蟲、根蟲及蛆蟲侵襲。In addition, rice is affected by a series of bugs (including Leptocorisa chinensis , Lagynotomus elongates , Nerzara viridula , Eysacoris parvus , Oryza chinensis, Oryza americana Stinkbugs ( Oebalus pugnax ), Cletus trigonus ) and various mites, caterpillars, beetles, rootworms and maggots.

在一個實施例中,水稻有害無脊椎動物為噬咬/咀嚼昆蟲。In one embodiment, the rice harmful invertebrate is a biting/chewing insect.

在一個實施例中,水稻有害無脊椎動物為刺/吸昆蟲。In one embodiment, the rice harmful invertebrate is a stinging/sucking insect.

在一個實施例中,水稻有害無脊椎動物為銼式昆蟲。In one embodiment, the rice harmful invertebrate is a file insect.

在一個實施例中,水稻有害無脊椎動物為虹吸昆蟲。In one embodiment, the rice harmful invertebrate is a siphon insect.

在一個實施例中,水稻有害無脊椎動物為舔吸昆蟲。In one embodiment, the rice harmful invertebrate is a sucking insect.

在一個實施例中,水稻有害無脊椎動物係選自褐飛虱(褐稻虱)、灰飛虱(斑飛虱)、白背飛虱(白背飛虱)、水稻螟蟲/條螟(二化螟)、三化螟(三化螟)、稻縱卷葉螟/卷葉蟲(稻縱卷葉野螟)、水稻象鼻蟲(稻水象甲)。In one embodiment, the rice harmful invertebrates are selected from the group consisting of brown planthopper (BPH), brown planthopper (BPH), white-backed planthopper (White-backed planthopper), rice borer/strip borer (two Chilo borer), rice stem borer (Chilorrhizae three), rice leaf roller/leaf roller (rice leaf roller), rice weevil (rice water weevil).

在一個實施例中,水稻有害無脊椎動物來自半翅目或鱗翅目。In one embodiment, the rice harmful invertebrate is from the order Hemiptera or Lepidoptera.

在一個實施例中,水稻有害無脊椎動物來自半翅目。在另一個實施例中,水稻有害無脊椎動物為跳蟲,較佳選自褐飛虱(褐稻虱)、灰飛虱(斑飛虱)、白背飛虱(白背飛虱)、青葉蟬(二點黑尾葉蟬)。在另一個實施例中,水稻有害無脊椎動物係選自褐飛虱(褐稻虱)及青葉蟬(二點黑尾葉蟬),較佳為褐飛虱(褐稻虱)。In one embodiment, the rice harmful invertebrate is from the order Hemiptera. In another embodiment, the rice harmful invertebrate is a collembola, preferably selected from the group consisting of brown planthopper (BPH), brown planthopper (BPH), white-backed planthopper (white-backed planthopper), A. Cicada (Cicada bispots). In another embodiment, the harmful invertebrates for rice are selected from the group consisting of brown planthopper (BPH) and green leafhopper (Leafhopper bispott), preferably brown planthopper (BPH).

在一個實施例中,水稻有害無脊椎動物為褐飛虱(褐稻虱)。In one embodiment, the rice harmful invertebrate is the brown rice planthopper (BPH).

在一個實施例中,水稻有害無脊椎動物為青葉蟬(二點黑尾葉蟬)。In one embodiment, the harmful invertebrate to rice is Leafhopper (Cicada bispott).

在另一個實施例中,水稻有害無脊椎動物為臭蟲,較佳選自稻褐蝽(稻綠蝽、異曼蝽、二星蝽屬、Tibraca limbatriventris 、廣二星蝽)或小臭蟲(雜色稻椿、美洲稻蝽)。In another embodiment, the harmful invertebrates of rice are bedbugs, preferably selected from the group consisting of rice brown stinkbugs ( Oryza spp. , American rice bug).

在一個實施例中,水稻有害無脊椎動物來自鱗翅目。在另一個實施例中,水稻有害無脊椎動物為螟蟲,較佳為莖螟蟲,較佳為水稻螟蟲(二化螟)或三化螟(三化螟)。In one embodiment, the rice harmful invertebrate is from the order Lepidoptera. In another embodiment, the rice harmful invertebrate is a stem borer, preferably a stem borer, preferably a rice borer (Chilobarer) or a rice stem borer (Chilobarer).

在另一個實施例中,水稻有害無脊椎動物為稻縱卷葉螟/卷葉蟲(稻縱卷葉野螟、寬紋刷鬚野螟、稻顯紋刷鬚野螟)。In another embodiment, the harmful invertebrates of rice are rice leaf rollers/leaf rollers (rice leaf rollers, rice borers, and rice borers).

在一個實施例中,水稻有害無脊椎動物來自鞘翅目。在另一個實施例中,水稻有害無脊椎動物為水稻象鼻蟲(稻水象甲)。在另一個實施例中,水稻有害無脊椎動物為米象(水稻負泥蟲)。In one embodiment, the rice harmful invertebrate is from the order Coleoptera. In another embodiment, the rice harmful invertebrate is the rice weevil (Rice weevil). In another embodiment, the rice harmful invertebrate is the rice weevil (oryza sativa).

在一個實施例中,水稻有害無脊椎動物來自白蟻科(等翅目)。In one embodiment, the rice harmful invertebrate is from the family Termitidae (Isoptera).

動物健康 本發明之化合物及混合物適用於處理或保護動物抵抗寄生蟲侵染或感染。因此,本發明亦關於本發明化合物用於製造供處理或保護動物抵抗寄生蟲侵染或感染用之藥物的用途。此外,本發明係關於一種處理或保護動物抵抗寄生蟲侵染及感染之方法,其包含向動物經口、局部或非經腸投與或施用殺寄生蟲有效量之本發明化合物。animal health The compounds and mixtures according to the invention are suitable for the treatment or protection of animals against parasitic infestation or infection. Accordingly, the present invention also relates to the use of the compounds according to the invention for the manufacture of a medicament for the treatment or protection of animals against parasitic infestation or infection. Furthermore, the invention relates to a method of treating or protecting animals against parasitic infestation and infection, which comprises administering or administering to the animal a parasiticidally effective amount of a compound of the invention orally, topically or parenterally.

本發明亦關於本發明之化合物及混合物用於處理或保護動物抵抗寄生蟲侵染及感染的非治療性用途。此外,本發明係關於處理或保護動物抵抗寄生蟲侵染及感染的非治療性方法,其包含向所在地施用殺寄生蟲有效量之本發明化合物。The invention also relates to the non-therapeutic use of the compounds and mixtures of the invention for the treatment or protection of animals against parasitic infestation and infection. Furthermore, the invention relates to a non-therapeutic method of treating or protecting animals against parasitic infestation and infection, which comprises applying to the locus a parasiticidally effective amount of a compound of the invention.

本發明之化合物及混合物另外適用於對抗或控制動物體內及體表之寄生蟲。此外,本發明係關於一種對抗或控制動物體內及體表之寄生蟲的方法,其包含使寄生蟲與殺寄生蟲有效量之本發明化合物接觸。The compounds and mixtures according to the invention are additionally suitable for combating or controlling parasites in and on animals. Furthermore, the invention relates to a method of combating or controlling parasites in and on animals, which comprises contacting the parasites with a parasiticidally effective amount of a compound of the invention.

本發明亦關於本發明之化合物及混合物用於控制或對抗寄生蟲之非治療性用途。此外,本發明係關於對抗或控制寄生蟲之非治療性方法,其包含向所在地施用殺寄生蟲有效量之本發明化合物。The invention also relates to the non-therapeutic use of the compounds and mixtures according to the invention for controlling or combating parasites. Furthermore, the invention relates to a non-therapeutic method of combating or controlling parasites, which comprises applying to the locus a parasiticidally effective amount of a compound of the invention.

本發明之化合物及混合物可經由接觸(經由土壤、玻璃、牆壁、蚊帳、地毯、覆層或動物部分)及攝取(例如誘餌)而有效。此外,本發明之化合物及混合物可施用於任何及所有發育階段。The compounds and mixtures of the invention can be effective by contact (via soil, glass, walls, mosquito nets, carpets, coverings or animal parts) and ingestion (eg baits). Furthermore, the compounds and mixtures of the invention can be administered at any and all stages of development.

本發明之化合物及混合物可以原樣或以包含本發明之化合物及混合物的組合物形式施用。The compounds and mixtures of the invention can be applied as such or in the form of compositions comprising the compounds and mixtures of the invention.

本發明之化合物及混合物亦可與針對致病性寄生蟲起作用之混合搭配物,例如與合成球蟲病化合物;聚醚類抗生素,諸如安普羅利(Amprolium)、羅貝胍(Robenidin)、托曲珠利(Toltrazuril)、莫能菌素(Monensin)、鹽黴素(Salinomycin)、馬杜黴素(Maduramicin)、拉沙里菌素(Lasalocid)、那拉黴素(Narasin)或賽杜黴素(Semduramicin);或與如上文所定義之其他混合搭配物一起施用,或以包含該等混合物之組合物形式施用。Compounds and mixtures of the present invention can also be mixed with compounds that act against pathogenic parasites, such as synthetic coccidiosis compounds; polyether antibiotics, such as Amprolium, Robenidin, Toltrazuril, Monensin, Salinomycin, Maduramicin, Lasalocid, Narasin, or Sedumycin Semduramicin; or with other mixed partners as defined above, or in the form of a composition comprising such mixtures.

本發明之化合物及混合物以及包含其之組合物可經口、非經腸或局部(例如經皮)施用。本發明之化合物及混合物可為全身性或非全身性有效的。The compounds and mixtures of the invention and compositions comprising them can be administered orally, parenterally or topically (eg transdermally). The compounds and mixtures of the present invention may be systemically or nonsystemically effective.

可預防性、治療性或非治療性地進行施用。此外,可預防性地進行施用至預期出現寄生蟲的地方。Administration can be performed prophylactically, therapeutically, or nontherapeutically. Furthermore, the application can be carried out prophylactically where the occurrence of parasites is expected.

如本文所用,術語「接觸」包括直接接觸(將化合物/組合物直接施用於寄生蟲,包括直接施用於動物或不包括直接施用於動物,例如後者施用於其所在地)及間接接觸(將化合物/組合物施用於寄生蟲之所在地)。經由施用於其所在地來接觸寄生蟲為本發明之化合物及混合物之非治療性用途的實例。As used herein, the term "contacting" includes direct contact (administering the compound/composition directly to the parasite, including or excluding direct application to the animal, such as the latter at its locus) and indirect contact (applying the compound/composition directly to the parasite) The composition is applied to the locus of the parasite). Contacting parasites by application to their locus is an example of a non-therapeutic use of the compounds and mixtures of the invention.

術語「所在地」意謂寄生蟲生長或可在動物體外生長之棲息地、食物供應地、繁殖地、區域、材料或環境。The term "locus" means the habitat, food supply, breeding ground, area, material or environment in which the parasite grows or can grow outside the body of an animal.

如本文所用,術語「寄生蟲」包括內寄生蟲及外寄生蟲。在本發明之一些實施例中,內部寄生蟲可為較佳的。在其他實施例中,外寄生物可為較佳的。溫血動物及魚類之感染包括但不限於虱、咬虱、蜱、鼻蠅、綿羊蜱、螫蠅、實蠅、蒼蠅、蠅蛆病蠅幼蟲、恙蟲、蚋、蚊子及跳蚤。As used herein, the term "parasite" includes both endoparasites and ectoparasites. In some embodiments of the invention, internal parasites may be preferred. In other embodiments, ectoparasites may be preferred. Infections of warm-blooded animals and fish include but are not limited to lice, biting lice, ticks, nose flies, sheep ticks, biting flies, fruit flies, flies, myiasis larvae, chiggers, gnats, mosquitoes and fleas.

本發明之化合物及混合物尤其可用於分別對抗以下目及種之寄生蟲: 蚤(蚤目),例如貓櫛頭蚤、犬櫛頭蚤、印鼠客蚤、致癢蚤、穿皮潛蚤及具帶病蚤;蜚蠊(蜚蠊目),例如德國小蠊、亞洲姬蠊、美洲大蠊、日本大蠊、棕色蜚蠊、黑胸大蠊、澳洲蜚蠊及東方蜚蠊;蒼蠅、蚊子(雙翅目),例如埃及伊蚊、白紋伊蚊、剌擾伊蚊、墨西哥果蠅、五斑按蚊、災難按蚊、白足按蚊、岡比亞按蚊、費氏按蚊、白踝按蚊、微小按蚊、四斑按蚊、紅頭麗蠅、蛆症金蠅、Chrysomya hominivorax 、腐敗金蠅、鹿蠅、靜斑虻、大西洋虻、螺旋蠅、嗜人瘤蠅蛆、狂怒庫蠓、尖音庫蚊、斑蚊、致倦庫蚊、媒斑蚊、無飾脈毛蚊、黑尾脈毛蚊、人膚皮蠅、小毛廁蠅、馬蠅、刺舌蠅、鬚舌蠅、梭毒舌蠅、膠舌蠅、擾血蠅、Haplodiplosis equestris 、潛蠅屬、紋皮蠅、托氏細蠓、Lucilia caprina 、銅綠蠅、絲光綠蠅、Lycoria pectoralis 、曼蚊屬、家蠅、廄腐蠅、羊鼻蠅、銀足白蛉、哥倫比亞鱗蚊、Psorophora discolorProsimulium mixtum 、赤尾麻蠅、麻蠅屬、帶蚋、廄螫蠅、牛虻、北美黑虻、紅色原虻及二毛蟲;虱(毛虱目),例如人頭蝨、人體虱、陰虱、牛血虱、豬血虱、犢顎虱、牛虱、雞虱、大雞虱及水牛盲虱;蜱及寄生蟎(寄蟎目):蜱(硬蜱科),例如黑腳硬蜱、全環硬蜱、太平洋硬蜱、血紅扇頭蜱、安氏革蜱、美洲大革蜱、長星形蜱、斑點鈍眼蜱、赫氏鈍緣蜱、回歸熱蜱及寄生蟎(中氣門亞目),例如柏氏禽刺蟎及雞皮刺蟎;輻蟎亞目(前氣門亞目)及粉蟎亞目(無氣門亞目),例如蜂盾蟎屬(Acarapis spp. )、姬螯蟎屬(Cheyletiella spp. )、禽螯蟎屬(Ornithocheyletia spp. )、肉蟎屬(Myobia spp. )、瘡蟎屬(Psorergates spp. )、蠕形蟎屬、恙蟎屬、囊凸犛蟎屬(Listrophorus spp. )、粉蟎屬(Acarus spp. )、腐食蟎屬(Tyrophagus spp. )、嗜木蟎屬(Caloglyphus spp. )、Hypodectes spp. 、翅蟎屬(Pterolichus spp. )、癢蟎屬、足癢蟎屬(Chorioptes spp. )、耳癢蟎屬(Otodectes spp. )、疥蟎屬、背肛蟎屬(Notoedres spp. )、膝蟎屬(Knemidocoptes spp. )、胞蟎屬(Cytodites spp. )及雞雛蟎屬(Laminosioptes spp );臭蟲(異翅亞目):溫帶臭蟲、熱帶臭蟲、Reduvius senilis 、錐獵蝽屬、紅獵蝽屬、錐蝽屬(Panstrongylus ssp )及輪背獵蝽;虱目,例如血虱屬、顎虱屬、人虱屬、Phtirus spp. 及管虱屬(Solenopotes spp. );食毛目(Arnblycerina及Ischnocerina亞目),例如毛羽虱屬(Trimenopon spp. )、禽虱屬(Menopon spp. )、鴨虱屬(Trinoton spp. )、牛羽虱屬(Bovicola spp. )、Werneckiella spp.Lepikentron spp. 、嚼虱屬及貓羽虱屬(Felicola spp. );蛔蟲線蟲綱:鞭蟲及旋毛蟲病(毛管目),例如毛形科( 毛形屬(Trichinella spp. ))( 鞭蟲科) 鞭蟲屬(Trichuris spp. )、毛細線蟲屬(Capillaria spp. );桿形目,例如小桿線蟲屬(Rhabditis spp. )、類圓線蟲屬(Strongyloides spp. )、頭葉屬(Helicephalobus spp. );圓線蟲目,例如圓線蟲屬(Strongylus spp. )、鉤口線蟲屬、美洲板口線蟲(Necator americanus )、仰口線蟲屬( 鉤蟲 ) 、毛圓線蟲屬(Trichostrongylus spp. )、撚轉血矛線蟲、奧斯脫線蟲屬、古柏線蟲屬、細頸線蟲屬、網尾線蟲屬(Dictyocaulus spp. )、杯口線蟲屬(Cyathostoma spp. )、結節線蟲屬、牙冠線蟲(Stephanurus dentatus )、沃魯線蟲屬(Ollulanus spp. )、夏伯特線蟲屬、牙冠線蟲、氣管比翼線蟲、鉤口線蟲屬、彎口線蟲屬(Uncinaria spp. )、球首屬(Globocephalus spp. )、板口線蟲屬(Necator spp. )、後圓線蟲屬(Metastrongylus spp. )、毛細苗氏線蟲(Muellerius capillaris )、原圓線蟲屬(Protostrongylus spp. )、血管圓線蟲屬(Angiostrongylus spp. )、擬馬鹿圓線蟲屬(Parelaphostrongylus spp. )、Aleurostrongylus abstrusus 及腎膨結線蟲(Dioctophyma renale );腸蛔蟲(蛔目),例如似蚓蛔線蟲(Ascaris lumbricoides )、豬蛔蟲(Ascaris suum )、雞蛔蟲(Ascaridia galli )、馬副蛔蟲(Parascaris equorum )、蠕形住腸線蟲(Enterobius vermicularis )( 蟯蟲) 、犬弓蛔蟲(Toxocara canis )、獅弓蛔蟲(Toxascaris leonine )、斯氏蟲屬(Skrjabinema spp. )及馬尖尾線蟲(Oxyuris equi );駝形目,例如麥地那龍線蟲(幾內亞龍線蟲);旋尾目,例如吸吮線蟲屬(Thelazia spp. )、吳策線蟲屬(Wuchereria spp. )、布魯線蟲屬(Brugia spp. )、盤尾絲蟲屬(Onchocerca spp. )、Dirofilari spp.a, 雙瓣絲蟲屬(Dipetalonema spp. )、狗尾草屬(Setaria spp. )、絲絨蟲屬(Elaeophora spp. )、狼尾旋線蟲(Spirocerca lupi )及柔線屬(Habronema spp. )、多刺有頭蠕蟲(棘頭動物門),例如棘頭蟲屬(Acanthocephalus spp. )、豬巨吻棘頭蟲(Macracanthorhynchus hirudinaceus )及鉤棘頭蟲屬(Oncicola spp. ),真渦蟲(扁形動物門):吸蟲(吸蟲綱),例如Faciola spp. 、大擬片吸蟲(Fascioloides magna )、並殖屬(Paragonimus spp. )、雙腔屬(Dicrocoelium spp. )、布氏薑片吸蟲(Fasciolopsis buski )、華支睾吸蟲(Clonorchis sinensis )、裂體屬(Schistosoma spp. )、毛畢屬(Trichobilharzia spp. )、有翼翼形吸蟲(Alaria alata )、肺吸蟲屬(Paragonimus spp. )及Nanocyetes spp. ;Cercomeromorpha,尤其絛蟲類(絛蟲),例如裂頭屬(Diphyllobothrium spp. )、條蟲屬(Tenia spp. )、棘球緣蟲屬(Echinococcus spp. )、犬複殖孔絛蟲(Dipylidium caninum )、多頭絛蟲屬(Multiceps spp. )、膜殼屬(Hymenolepis spp. )、中殖孔絛蟲屬(Mesocestoides spp. )、蝙蝠皮絛蟲屬(Vampirolepis spp. )、莫尼茨屬(Moniezia spp. )、棵頭屬(Anoplocephala spp. )、Sirometra spp. 、棵頭屬及膜殼屬(Hymenolepis spp. )。The compounds and mixtures of the present invention are especially useful against parasites of the following orders and species, respectively: Fleas (Flea orders), such as Ctenocephalus felis, Ctenocephalus canis, Ctenophora spp. Carnivorous fleas; cockroaches (Clattata), such as German cockroaches, Asian cockroaches, American cockroaches, Japanese cockroaches, brown cockroaches, black-breasted cockroaches, Australian cockroaches and oriental cockroaches; flies, mosquitoes (Diptera), such as Aedes aegypti, Aedes albopictus, Aedes harasser, Drosophila mexicani, Anopheles quinquefalis, Anopheles catastrophe, Anopheles albopedia, Anopheles gambiae, Anopheles fischeri, Anopheles albicans Anopheles, Anopheles minimus, Anopheles tetrapipes, Blowfly, Chrysomya hominivorax, Chrysomya hominivorax , Chrysomya hominivorax, Deerfly, Mothfly, Atlantic fly, Screwworm, Anthropophagus, Culicoides furious , Culex acutus, Aedes mosquito, Culex fatigue, Aedes vegetative, Veinless, Vein black, Human skin fly, Small hairy toilet fly, Horsefly, Glossia stinging fly, Glossina palpitations, Tsetse fly, Glue fly, Blood fly, Haplodiplosis equestris , Liriomyza, Dermatophagoides, Toddler midge, Lucilia caprina , Lucilia copper fly, Lucila sericata, Lycoria pectoralis , Mannia, Musca domestica, rot Fly, Sheep-nosed fly, Silver-footed sandfly, Columbian scaled mosquito, Psorophora discolor , Prosimulium mixtum , Red-tailed scorpion fly, Sarcophagus, band gnat, sting fly, Gadfly, North American black fly, Red horsefly and Dichaetes; lice (hair lice order), such as human head lice, human body lice, pubic lice, bovine blood lice, pig blood lice, calf lice, cattle lice, chicken lice, large chicken lice and buffalo blind lice; ticks and parasitic mites (Paramatites): Ticks (Ixodidae) such as Ixodes blacklegs, Ixodes pannata, Ixodes pacificus, Rhizocephalus sanguineus, Derma ticks, Derma ticks, Longstar ticks, Amblyomma maculata, Amblyomma herstii Marginal ticks, relapsing fever ticks and parasitic mites (Mesostigmata), e.g. Poultryalis spp. Acarapis spp. , Cheyletiella spp. , Ornithocheyletia spp. , Myobia spp. , Psorergates spp. , Demodex Genus, Chigger, Listrophorus spp. , Acarus spp. , Tyrophagus spp. , Caloglyphus spp. , Hypodectes spp. , Wing Pterolichus spp. , Itch mite, Chorioptes spp. , Otodectes spp . , Scabies, Notoedres spp. , Knee mite ( Knemidocoptes spp. ), Cytodites spp. and Laminosioptes spp ; bed bugs (Heteroptera): temperate bed bugs, tropical bed bugs, Reduvius senilis , triatomine bugs, red bugs genus, triatomine Stinkbugs ( Panstrongylus ssp ) and stinkbugs; lice orders, for example, Haemophilus spp., Glycerus spp., Phtirus spp. and Solenopotes spp.; Trichophagia (Arnblycerina and Ischnocerina suborders ), such as Trimenopon spp. , Menopon spp. , Trinoton spp. , Bovicola spp. , Werneckiella spp. , Lepikentron spp. , chewing lice Genus and Felicola spp.; Ascaris nematodes: whipworms and trichinellosis (Trichinella spp.), such as Trichinella ( Trichinella spp. ) , ( Trichidae ) Trichinella spp. ( Trichuris spp. ), Capillaria spp. ; Rod-shaped ones, such as Rhabditis spp. , Strongyloides spp. , Heliphalobus spp. ; From the order of the Nematodes, for example Strongylus spp. , Ancylostoma, Necator americanus , Upostomum ( hookworm ) , Trichostrongylus spp. , Haemonchus contortus , Oustia spp., Coopera spp., Leptocaulus spp., Dictyocaulus spp., Cyathostoma spp . , Nodularia spp., Stephanurus dentatus Ollulanus spp. , Chabertalus, crown nematodes, tracheal nematodes, Anticostomum spp., Uncinaria spp., Globocephalus spp. Necator spp. , Metastrongylus spp. , Muellerius capillaris , Protostrongylus spp. , Angiostrongylus spp. , Strongylus spp. Parelaphosstrongylus spp. , Aleurostrongylus abstrusus and Dioctophyma renale; Intestinal roundworms (Ascaris), such as Ascaris lumbricoides, Ascaris suum , Ascaridia galli , Parascaris equirum, Enterobius vermicularis ( pinworm ) , Toxocara canis , Toxascaris leonine , Skrjabinema spp. Oxyuris equi ; Cameliformes, such as Guinea worms (Guinea worms); Spirocerans, such as Thelazia spp. , Wuchereria spp. , Brugeria spp. ( Brugia spp. ), Onchocerca spp. , Dirofilari spp.a, Dipetalonema spp. , Setaria spp. , Elaeophora spp. , Spirocerca lupi and Habronema spp. , spiny-headed worms (Acanthocephala) such as Acanthocephalus spp. , Macracanthorhynchus hirudinaceus ) and Oncicola spp. , planarians (Platezoa): flukes (Trematodes), such as Faciola spp. , Fascioloides magna , Conglomerate ( Paragonimus spp. ), Dicrocoelium spp. , Fasciolopsis buski , Clonorchis sinensis , Schistosoma spp. , Trichobilharzia spp . ), winged flukes ( Alaria alata ), lung flukes ( Paragonimus spp. ) and Nanocyetes spp. ; Cercomeromorpha, especially tapeworms (tapeworms), such as Diphyllobothrium spp . Tenia spp. ), Echinococcus spp. , Dipylidium caninum , Multiceps spp. , Hymenolepis spp. Mesocestoides spp. ), Vampirolepis spp. , Moniezia spp. , Anoplocephala spp. , Sirometra spp. , Hymenolepis spp. .

如本文所用,術語「動物」包括溫血動物(包括人類)及魚類。較佳為哺乳動物,諸如牛、綿羊、豬、駱駝、鹿、馬、豬、家禽、兔子、山羊、狗及貓、水牛、驢、黃鹿及馴鹿,以及毛皮動物,諸如貂、絨鼠及浣熊;鳥類,諸如母雞、鵝、火雞及鴨;魚類,諸如淡水及鹹水魚類,諸如鱒魚、鯉魚及鰻魚。尤其較佳為家畜,諸如狗或貓。As used herein, the term "animal" includes warm-blooded animals (including humans) and fish. Preferred are mammals such as cattle, sheep, pigs, camels, deer, horses, pigs, poultry, rabbits, goats, dogs and cats, buffaloes, donkeys, yellow deer and reindeer, and fur animals such as mink, chinchilla and Raccoons; birds such as hens, geese, turkeys and ducks; fish such as freshwater and saltwater fish such as trout, carp and eels. Especially preferred are domestic animals such as dogs or cats.

一般而言,「殺寄生蟲有效量」意謂實現對生長可觀察到的效應,包括壞死、死亡、阻滯、預防及移除、破壞或以其他方式減少目標生物體出現及活動的效應所需的活性成分之量。對於本發明中所用之各種化合物/組合物,殺寄生蟲有效量可變化。殺寄生蟲有效量之組合物亦將根據主要條件而變化,諸如所需殺寄生蟲效應及持續時間、目標物種、施用模式及其類似物。In general, "parasiticidally effective amount" means the amount required to achieve an observable effect on growth, including necrosis, death, arrest, prevention and removal, destruction or otherwise reducing the presence and activity of the target organism. required amount of active ingredient. The parasiticidally effective amount will vary for the various compounds/compositions used in the present invention. The parasiticidally effective amount of the composition will also vary depending on prevailing conditions, such as the desired parasiticidal effect and duration, target species, mode of application, and the like.

一般而言,有利的為以每天0.5 mg/kg至100 mg/kg、較佳每天1 mg/kg至50 mg/kg之總量施用本發明之化合物及混合物。In general, it is advantageous to administer the compounds and mixtures according to the invention in a total amount of 0.5 mg/kg to 100 mg/kg per day, preferably 1 mg/kg to 50 mg/kg per day.

對於溫血動物之經口投與,根據本發明之化合物及混合物可調配為動物飼料、動物飼料預混物、動物飼料濃縮物、丸劑、溶液、糊劑、懸浮液、浸液、凝膠、錠劑、大丸劑及膠囊。另外,根據本發明之化合物及混合物可在其飲用水中投與動物。對於經口投與,所選劑型應為動物提供每天0.01 mg/kg至100 mg/kg動物體重的組分I化合物,較佳每天0.5 mg/kg至100 mg/kg動物體重。For oral administration to warm-blooded animals, the compounds and mixtures according to the invention may be formulated as animal feed, animal feed premixes, animal feed concentrates, pills, solutions, pastes, suspensions, dips, gels, Tablets, boluses and capsules. In addition, the compounds and mixtures according to the invention can be administered to animals in their drinking water. For oral administration, the selected dosage form should provide the animal with 0.01 mg/kg to 100 mg/kg of the animal's body weight per day, preferably 0.5 mg/kg to 100 mg/kg of the animal's body weight per day.

或者,根據本發明之化合物(組分I)及混合物可非經腸投與動物,例如藉由瘤胃內、肌肉內、靜脈內或皮下注射。根據本發明之化合物(組分I)及混合物可分散或溶解於生理學上可接受之載劑中用於皮下注射。或者,根據本發明之化合物(組分I)及混合物可調配成用於皮下投與之植入物。另外,組分I化合物可經皮投與動物。對於非經腸投與,所選劑型應為動物提供每天0.01 mg/kg至100 mg/kg動物體重之組分I化合物。Alternatively, the compounds (component I) and mixtures according to the invention can be administered to animals parenterally, for example by intrarumen, intramuscular, intravenous or subcutaneous injection. The compounds (component I) and mixtures according to the invention can be dispersed or dissolved in a physiologically acceptable carrier for subcutaneous injection. Alternatively, the compounds (component I) and mixtures according to the invention may be formulated as implants for subcutaneous administration. Alternatively, the Component I compounds may be administered to animals transdermally. For parenteral administration, the dosage form selected should provide the animal with 0.01 mg/kg to 100 mg/kg of the animal's body weight per day of the Component I compound.

根據本發明之化合物(組分I)及混合物亦可以浸漬液、粉劑(dusts)、粉劑(powders)、套環、裝飾物(medallions)、噴霧劑、洗髮劑、點滴及澆潑調配物以及軟膏或水包油或油包水乳液形式局部施用於動物。對於局部施用,浸漬液及噴霧劑通常含有0.5 ppm至5,000 ppm且較佳1 ppm至3,000 ppm 組分I。另外,根據本發明之化合物(組分I)及混合物可調配為動物,特別是四足動物,諸如牛及綿羊之耳標。The compounds (component I) and mixtures according to the invention can also be dipping solutions, dusts, powders, collars, medallions, sprays, shampoos, drip and pour-on formulations and Ointments or oil-in-water or water-in-oil emulsions are administered topically to animals. For topical application, dips and sprays generally contain 0.5 ppm to 5,000 ppm and preferably 1 ppm to 3,000 ppm component I. In addition, the compounds (component I) and mixtures according to the invention can be formulated as ear tags for animals, especially quadrupeds, such as cattle and sheep.

適合之製劑為: - 溶液,諸如口服溶液、稀釋後用於經口投與之濃縮物、用於皮膚或體腔之溶液、澆潑調配物、凝膠; - 用於經口或皮膚投與之乳液及懸浮液;半固體製劑; - 活性組分I或II或混合物在軟膏基質或水包油或油包水乳液基質中加工之調配物; - 固體製劑,諸如粉劑、預混物或濃縮物、顆粒劑、丸劑、錠劑、大丸劑、膠囊;氣溶膠及吸入劑,及含有活性化合物之成形物品。Suitable formulations are: - solutions, such as oral solutions, concentrates diluted for oral administration, solutions for skin or body cavities, pour-on formulations, gels; - Emulsions and suspensions for oral or dermal administration; semisolid preparations; - formulations in which the active ingredient I or II or mixtures are processed in an ointment base or an oil-in-water or water-in-oil emulsion base; - solid preparations such as powders, premixes or concentrates, granules, pills, lozenges, boluses, capsules; aerosols and inhalants, and shaped articles containing the active compounds.

適於注射之組合物係藉由將活性成分溶解於適合之溶劑中且視情況添加其他助劑諸如酸、鹼、緩衝鹽、防腐劑及增溶劑來製備。適用於注射溶液之助劑為此項技術中已知的。過濾溶液且無菌填充。Compositions suitable for injection are prepared by dissolving the active ingredient in a suitable solvent and optionally adding other auxiliaries such as acids, bases, buffer salts, preservatives and solubilizers. Auxiliaries suitable for injection solutions are known in the art. The solution is filtered and filled aseptically.

口服溶液係直接投與。濃縮物係在預先稀釋至使用濃度後經口投與。口服溶液及濃縮物係根據目前先進技術且如上文關於注射溶液所述製備,無需無菌程序。Oral solutions are administered directly. Concentrates are administered orally after pre-diluted to the concentration to be used. Oral solutions and concentrates are prepared according to the state of the art and as described above for injectable solutions, without requiring sterile procedures.

用於皮膚之溶液係經滴入、塗敷、塗抹、噴灑或噴塗。用於皮膚之溶液係根據目前先進技術及根據上文關於注射溶液所述來製備,無需無菌程序。Solutions for skin application are dripped, applied, smeared, sprayed or sprayed on. Solutions for application to the skin are prepared according to the state of the art and as described above for injection solutions without the need for sterile procedures.

將凝膠施用或塗敷於皮膚或引入體腔。凝膠係藉由用足夠的增稠劑處理已如注射溶液之情況中所述製備之溶液來製備,從而產生具有軟膏狀稠度之透明材料。適合之增稠劑為此項技術中已知的。The gel is applied or spread on the skin or introduced into a body cavity. Gels are prepared by treating solutions, which have been prepared as described for injection solutions, with sufficient thickening agent to yield a clear material with an ointment-like consistency. Suitable thickeners are known in the art.

將澆潑調配物傾倒或噴灑於皮膚之有限區域,活性化合物I或混合物滲透皮膚且全身作用。澆潑調配物係藉由將活性組分I或II或混合物溶解、懸浮或乳化於適合之皮膚相容性溶劑或溶劑混合物中來製備。若適宜,添加其他助劑,諸如著色劑、生物吸收促進物質、抗氧化劑、光穩定劑、黏合劑。適合之此類助劑為此項技術中已知的。The pour-on formulation is poured or sprayed on a limited area of the skin, the active compound I or mixture penetrates the skin and acts systemically. Pour-on formulations are prepared by dissolving, suspending or emulsifying the active ingredient I or II or a mixture in a suitable skin compatible solvent or solvent mixture. If appropriate, further auxiliaries are added, such as colorants, bioabsorption-promoting substances, antioxidants, light stabilizers, binders. Suitable such auxiliaries are known in the art.

乳液可經口、經皮或以注射液形式投與。乳液為油包水型或水包油型。其係藉由將活性組分I或混合物溶解於疏水相或親水相中並藉助於適合之乳化劑及(若適宜)其他助劑使其與另一相之溶劑均質化來製備,該等其他助劑諸如著色劑、吸收促進物質、防腐劑、抗氧化劑、光穩定劑、增黏物質。適合之疏水相(油)、適合之親水相、適合之乳化劑及適用於乳液之其他助劑為此項技術中已知的。Emulsions can be administered orally, transdermally, or as injections. Emulsions are either water-in-oil or oil-in-water. It is prepared by dissolving the active ingredient I or the mixture in the hydrophobic or hydrophilic phase and homogenizing it with the solvent of the other phase by means of suitable emulsifiers and, if appropriate, other auxiliaries, which Auxiliaries such as colorants, absorption-promoting substances, preservatives, antioxidants, light stabilizers, viscosity-increasing substances. Suitable hydrophobic phases (oils), suitable hydrophilic phases, suitable emulsifiers and further auxiliaries suitable for emulsions are known in the art.

懸浮液可經口或局部/經皮投與。其係藉由將活性組分I或II或混合物懸浮於懸浮劑中,若適宜,添加其他助劑來製備,該等其他助劑諸如濕潤劑、著色劑、生物吸收促進物質、防腐劑、抗氧化劑、光穩定劑。適合之懸浮劑及適用於懸浮液之其他助劑(包括濕潤劑)為此項技術中已知的。Suspensions can be administered orally or topically/transdermally. They are prepared by suspending the active ingredient I or II or the mixture in a suspending agent, adding, if appropriate, other auxiliaries, such as wetting agents, colorants, bioabsorption-promoting substances, preservatives, anti-oxidants, etc. Oxidizing agent, light stabilizer. Suitable suspending agents and other auxiliaries suitable for suspensions, including wetting agents, are known in the art.

半固體製劑可經口或局部/經皮投與。其與上述懸浮液及乳液之不同之處僅在於其黏度較高。Semisolid formulations can be administered orally or topically/transdermally. It differs from the aforementioned suspensions and emulsions only in its higher viscosity.

為製備固體製劑,將活性組分I或II或混合物與適合之賦形劑混合,若適宜,添加助劑且使其變為所需形式。適用於此目的之助劑為此項技術中已知的。For the preparation of solid preparations, the active ingredient I or II or mixtures are admixed with suitable excipients, if appropriate with auxiliaries, and brought into the desired form. Adjuvants suitable for this purpose are known in the art.

可用於本發明之組合物可一般包含約0.001至95%之本發明組分I。Compositions useful in the present invention may generally comprise from about 0.001 to 95% of Component I of the present invention.

即用製劑含有針對寄生蟲、較佳外寄生蟲起作用之化合物,其濃度為10 ppm至80重量%,較佳0.1至65重量%,更佳1至50重量%,最佳5至40重量%。The ready-to-use preparation contains a compound acting against parasites, preferably ectoparasites, in a concentration of 10 ppm to 80% by weight, preferably 0.1 to 65% by weight, more preferably 1 to 50% by weight, most preferably 5 to 40% by weight %.

在使用前稀釋之製劑含有針對外寄生蟲起作用之化合物,其濃度為0.5至90重量%,較佳1至50重量%。The preparation diluted before use contains the compound acting against ectoparasites in a concentration of 0.5 to 90% by weight, preferably 1 to 50% by weight.

此外,製劑包含針對內寄生蟲之組分I,其濃度為10 ppm至2重量%,較佳0.05至0.9重量%,極其較佳0.005至0.25重量%。In addition, the preparations contain a component I directed against endoparasites in a concentration of 10 ppm to 2% by weight, preferably 0.05 to 0.9% by weight, very preferably 0.005 to 0.25% by weight.

局部施用可用含有化合物之成形物品進行,諸如套環、裝飾物、耳標、用於固定在身體部分之條帶、黏合帶及箔。Topical application may be carried out with shaped articles containing the compound, such as loops, ornaments, ear tags, strips for fastening to body parts, adhesive tapes and foils.

通常有利的是施用固體調配物,其在三週過程中釋放總量為10 mg/kg至300 mg/kg、較佳20 mg/kg至200 mg/kg、最佳25 mg/kg至160mg/kg經處理動物體重之本發明之化合物(組分I)及混合物。It is generally advantageous to administer a solid formulation that releases a total of 10 mg/kg to 300 mg/kg, preferably 20 mg/kg to 200 mg/kg, optimally 25 mg/kg to 160 mg/kg over the course of three weeks. Compounds of the invention (component I) and mixtures in kg body weight of treated animals.

實例 合成實例:3-(2-氯噻唑-5-基)-8-甲基-7-側氧基-6-苯基-2,3-二氫噻唑并[3,2-a]嘧啶-8-鎓-5-醇鹽(對應於化合物I-1)example Synthetic example: 3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[3,2-a]pyrimidine-8 -onium-5-alkoxide (corresponding to compound I-1)

步驟1:2-氯-N-甲氧基-N-甲基-乙醯胺 將N-甲氧基甲胺鹽酸鹽(345 g)及水(1.5 L)冷卻至0℃。向此反應混合物中分批添加K2 CO3 (1466 g),隨後在0℃下添加甲基第三丁基醚(1000 mL)。將反應混合物冷卻至-5℃。在-5℃至0℃下逐滴添加含氯乙醯氯(400 g)之甲基第三丁基醚(500 ml),且在0℃下攪拌2小時。使反應混合物達到20-25℃。自有機層獲得呈白色固體狀之所需產物(438 g,90%產率;98.45% HPLC純度)。Step 1: 2-Chloro-N-methoxy-N-methyl-acetamide N-methoxymethylamine hydrochloride (345 g) and water (1.5 L) were cooled to 0°C. To this reaction mixture was added K2CO3 (1466 g) in portions, followed by methyl tert-butyl ether (1000 mL) at 0 ° C . The reaction mixture was cooled to -5 °C. Chloroacetyl chloride (400 g) in methyl tert-butyl ether (500 ml) was added dropwise at -5°C to 0°C, and stirred at 0°C for 2 hours. The reaction mixture was brought to 20-25°C. The desired product was obtained from the organic layer as a white solid (438 g, 90% yield; 98.45% HPLC purity).

步驟2:2-氯-1-(2-氯噻唑-5-基)乙酮 在氮氣氛圍下,將含2-氯噻唑(187 ml)之750 ml四氫呋喃冷卻至-20℃。逐滴添加氯化異丙基鎂x LiCl (1684 ml,1.3莫耳於四氫呋喃中)且在-20℃下攪拌60分鐘。在-20℃至-25℃下逐滴添加2-氯-N-甲氧基-N-甲基-乙醯胺(250 g)於四氫呋喃中之溶液。將反應混合物在-20℃下攪拌90分鐘。在-20℃下添加飽和氯化銨水溶液,隨後使反應混合物達到20-25℃。分離兩相且用乙酸乙酯萃取水相。自合併之有機層獲得呈深棕色油狀之所需粗產物,將其用含活性炭及二氧化矽之甲基第三丁基醚處理,得到呈淺棕色油狀之粗產物(335 g),直接用於下一步驟。Step 2: 2-Chloro-1-(2-chlorothiazol-5-yl)ethanone Under nitrogen atmosphere, 2-chlorothiazole (187 ml) in 750 ml tetrahydrofuran was cooled to -20°C. Isopropylmagnesium chloride x LiCl (1684 ml, 1.3 mol in THF) was added dropwise and stirred at -20°C for 60 minutes. A solution of 2-chloro-N-methoxy-N-methyl-acetamide (250 g) in tetrahydrofuran was added dropwise at -20°C to -25°C. The reaction mixture was stirred at -20°C for 90 minutes. Saturated aqueous ammonium chloride solution was added at -20°C, then the reaction mixture was brought to 20-25°C. The two phases were separated and the aqueous phase was extracted with ethyl acetate. The desired crude product was obtained as a dark brown oil from the combined organic layers, which was treated with methyl tert-butyl ether containing charcoal and silica to give the crude product as a light brown oil (335 g), used directly in the next step.

步驟3:N-[2-氯-1-(2-氯噻唑-5-基)亞乙基]-2-甲基-丙烷-2-亞磺醯胺 在20-25℃下,在氮氣氛圍下,向含粗物質2-氯-1-(2-氯噻唑-5-基)乙酮(335 g)之四氫呋喃中添加第三丁基亞磺醯胺(206 g)及Ti(OEt)4 (396 ml)。將混合物加熱至50℃且攪拌2小時,隨後冷卻至20-25℃且用乙酸乙酯稀釋。在添加水之後,將混合物攪拌30分鐘,隨後過濾。蒸發有機相,獲得呈棕色油狀之所需粗產物。在用含活性炭及二氧化矽之甲基第三丁基醚處理之後,獲得呈淺棕色油狀之粗產物(365 g),直接用於下一步驟。Step 3: N-[2-chloro-1-(2-chlorothiazol-5-yl)ethylidene]-2-methyl-propane-2-sulfinamide at 20-25°C under nitrogen atmosphere Next, to the crude material 2-chloro-1-(2-chlorothiazol-5-yl)ethanone (335 g) in THF was added tert-butylsulfinamide (206 g) and Ti(OEt) 4 (396ml). The mixture was heated to 50°C and stirred for 2 hours, then cooled to 20-25°C and diluted with ethyl acetate. After adding water, the mixture was stirred for 30 minutes, then filtered. The organic phase was evaporated to obtain the desired crude product as a brown oil. After treatment with methyl tert-butyl ether containing activated charcoal and silica, the crude product (365 g) was obtained as a light brown oil which was used directly in the next step.

步驟4:N-[2-氯-1-(2-氯噻唑-5-基)乙基]-2-甲基-丙烷-2-亞磺醯胺 在-5℃下,向含N-[2-氯-1-(2-氯噻唑-5-基)亞乙基]-2-甲基-丙烷-2-亞磺醯胺(365 g)之四氫呋喃及甲醇中逐批添加NaBH4 (23 g)且攪拌30分鐘。在0℃下添加飽和氯化銨水溶液。在用乙酸乙酯萃取後,有機層產生呈棕色油狀之所需粗產物(310 g)。Step 4: N-[2-Chloro-1-(2-chlorothiazol-5-yl)ethyl]-2-methyl-propane-2-sulfinamide was added to N-[ Add NaBH 4 (23 g) and stirred for 30 minutes. A saturated aqueous ammonium chloride solution was added at 0 °C. The organic layer yielded the desired crude product (310 g) as a brown oil after extraction with ethyl acetate.

步驟5:2-氯-1-(2-氯噻唑-5-基)乙胺鹽酸鹽 在20-25℃下,將N-[2-氯-1-(2-氯噻唑-5-基)乙基]-2-甲基-丙烷-2-亞磺醯胺與含HCl之甲醇(1 mol,620 mL)一起攪拌12小時。在真空下移除甲醇,產生淺黃色黏性固體(244 g),其用甲基第三丁基醚且隨後用乙酸乙酯洗滌,得到淺黃色固體(78 g,經步驟2至5之26%產率,>98%純度)。Step 5: 2-Chloro-1-(2-chlorothiazol-5-yl)ethanamine hydrochloride At 20-25°C, mix N-[2-chloro-1-(2-chlorothiazol-5-yl)ethyl]-2-methyl-propane-2-sulfinamide with methanol containing HCl ( 1 mol, 620 mL) were stirred together for 12 hours. Methanol was removed under vacuum to give a light yellow sticky solid (244 g), which was washed with methyl tert-butyl ether and then ethyl acetate to give a light yellow solid (78 g, 26 % yield, >98% purity).

步驟6:4-(2-氯噻唑-5-基)-N-甲基-噻唑啶-2-亞胺 在23℃下,將含2-氯-1-(2-氯噻唑-5-基)乙胺鹽酸鹽(285 g)之甲基第三丁基醚及2莫耳NaOH水溶液(1060 mL)攪拌20分鐘。有機層產生呈淺棕色油狀之游離胺(230 g)。Step 6: 4-(2-Chlorothiazol-5-yl)-N-methyl-thiazolidine-2-imine At 23°C, 2-chloro-1-(2-chlorothiazol-5-yl)ethylamine hydrochloride (285 g) in methyl tert-butyl ether and 2 molar NaOH aqueous solution (1060 mL) Stir for 20 minutes. The organic layer yielded the free amine (230 g) as a light brown oil.

含胺(230 g)之乙醇與三乙胺NEt3 (351 ml)及Me-NCS (143.2 g)在22至25℃下反應18小時。濃縮反應物料,獲得棕色殘餘物,向其中添加NaOH水溶液(114 g於920 mL水中)。將所得混合物加熱至100℃持續2小時,隨後冷卻至20-25℃且用水稀釋。在用乙酸乙酯萃取後,有機層產生呈棕色固體狀之粗物質4-(2-氯噻唑-5-基)-N-甲基-噻唑啶-2-亞胺(256 g),其與含20%乙酸乙酯之庚烷(300 mL)一起攪拌30分鐘。在過濾後,獲得呈棕色固體狀之產物(245 g,85%產率)。The amine (230 g) in ethanol was reacted with triethylamine NEt3 (351 ml) and Me-NCS (143.2 g) at 22 to 25°C for 18 hours. The reaction mass was concentrated to obtain a brown residue, to which aqueous NaOH (114 g in 920 mL of water) was added. The resulting mixture was heated to 100°C for 2 hours, then cooled to 20-25°C and diluted with water. After extraction with ethyl acetate, the organic layer yielded crude 4-(2-chlorothiazol-5-yl)-N-methyl-thiazolidine-2-imine (256 g) as a brown solid, which was mixed with 20% ethyl acetate in heptane (300 mL) was stirred together for 30 minutes. After filtration, the product was obtained as a brown solid (245 g, 85% yield).

步驟7:3-(2-氯噻唑-5-基)-8-甲基-7-側氧基-6-苯基-2,3-二氫噻唑并[3,2-a]嘧啶-8-鎓-5-醇鹽(I-1) 在110至115℃下攪拌含4-(2-氯噻唑-5-基)-N-甲基-噻唑啶-2-亞胺(110 g)之甲苯。在添加2-苯基丙二酸雙(4-氯苯基)酯(226 g)後,將反應混合物在此溫度下攪拌2小時,隨後冷卻至40至45℃。在真空下移除甲苯後,獲得棕色固體,將其用甲基第三丁基醚濕磨,獲得黃色固體。Step 7: 3-(2-Chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[3,2-a]pyrimidine-8 -Onium-5-alkoxide (I-1) 4-(2-Chlorothiazol-5-yl)-N-methyl-thiazolidine-2-imine (110 g) in toluene was stirred at 110 to 115°C. After addition of bis(4-chlorophenyl)-2-phenylmalonate (226 g), the reaction mixture was stirred at this temperature for 2 hours and then cooled to 40 to 45°C. After removing the toluene under vacuum, a brown solid was obtained which was triturated with methyl tert-butyl ether to obtain a yellow solid.

在22至25℃下在甲基第三丁基醚(1 L)中攪拌14小時,產生淺黃色固體(160 g)。藉由溶解於二氯甲烷中且用甲基第三丁基醚沈澱進一步純化,產生呈淺黃色細粉狀之所需產物(129 g,80%產率)。 *:HPLC方法:滯留時間(分鐘);質荷比m/z HPLC方法A: MSD4/5: Shimadzu Nexera UHPLC + Shimadzu LCMS 20-20, ESI 管柱:Phenomenex Kinetex 1.7µm XB-C18 100A, 50 × 2.1mm 移動相:A:水+ 0.1%三氟乙酸;B:乙腈,溫度:60℃ 梯度:在1.50min內5% B至100% B;100% B 0,25min 流速:在1.51 min內0.8 ml/min至1.0 ml/min MS方法:ESI陽性,質量範圍(m/z):100-700 HPLC方法B: MSD4/5: Shimadzu Nexera UHPLC + Shimadzu LCMS 20-20, ESI 管柱:Agilent Eclipse Plus C18, 50mm × 4.6mm × 3 移動相:A=10 mM甲酸銨(0.1%甲酸),B=乙腈(0.1%甲酸),流速= 1.2 ml/min。管柱烘箱:30℃ 梯度:= 10% B至100% B - 1.5min,保持1min,2.51min - 10% B;運行時間= 3.50 min HPLC方法C: 與方法A相同,但MS方法:ESI陽性,質量範圍(m/z):100-1400Stirring in methyl tert-butyl ether (1 L) at 22 to 25 °C for 14 hours yielded a pale yellow solid (160 g). Further purification by dissolution in dichloromethane and precipitation with methyl tert-butyl ether gave the desired product (129 g, 80% yield) as a fine light yellow powder. *: HPLC method: retention time (minutes); mass-to-charge ratio m/z HPLC Method A: MSD4/5: Shimadzu Nexera UHPLC + Shimadzu LCMS 20-20, ESI Column: Phenomenex Kinetex 1.7µm XB-C18 100A, 50 × 2.1mm Mobile phase: A: water + 0.1% trifluoroacetic acid; B: acetonitrile, temperature: 60°C Gradient: 5% B to 100% B in 1.50min; 100% B 0,25min Flow rate: 0.8 ml/min to 1.0 ml/min in 1.51 min MS method: ESI positive, mass range (m/z): 100-700 HPLC Method B: MSD4/5: Shimadzu Nexera UHPLC + Shimadzu LCMS 20-20, ESI Column: Agilent Eclipse Plus C18, 50mm × 4.6mm × 3 Mobile phase: A = 10 mM ammonium formate (0.1% formic acid), B = acetonitrile (0.1% formic acid), flow rate = 1.2 ml/min. Column oven: 30°C Gradient: = 10% B to 100% B - 1.5min, hold 1min, 2.51min - 10% B; run time = 3.50 min HPLC Method C: Same as method A, but MS method: ESI positive, mass range (m/z): 100-1400

實例-分離對映異構體: R-3-(2-氯噻唑-5-基)-8-甲基-7-側氧基-6-苯基-2,3-二氫噻唑并[3,2-a] 嘧啶-8-鎓-5-醇鹽及 S-3-(2-氯噻唑-5-基)-8-甲基-7-側氧基-6-苯基-2,3-二氫噻唑并[3,2-a] 嘧啶-8-鎓-5-醇鹽Example - separation of enantiomers: R-3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[3,2-a]pyrimidine-8- Onium-5-alkoxide and S-3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[3,2-a]pyrimidine-8- Onium-5-alkoxide

實例1之3-(2-氯噻唑-5-基)-8-甲基-7-側氧基-6-苯基-2,3-二氫噻唑并[3,2-a]嘧啶-8-鎓-5-醇鹽之對映異構體可藉由製備型對掌性超臨界流體層析分離。分離126 g rac-3-(2-氯噻唑-5-基)-8-甲基-7-側氧基-6-苯基-2,3-二氫噻唑并[3,2-a]嘧啶-8-鎓-5-醇鹽。此舉在滯留時間1.94 min產生53.4 g R-3-(2-氯噻唑-5-基)-8-甲基-7-側氧基-6-苯基-2,3-二氫噻唑并[3,2-a]嘧啶-8-鎓-5-醇鹽及在滯留時間1.41 min產生57.7 g S-3-(2-氯噻唑-5-基)-8-甲基-7-側氧基-6-苯基-2,3-二氫噻唑并[3,2-a]嘧啶-8-鎓-5-醇鹽。此等滯留時間參考下文列舉之分析方法。藉由X射線分析來確定對掌性中心之組態。3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[3,2-a]pyrimidine-8 of Example 1 The enantiomers of the -onium-5-alkoxides can be separated by preparative chiral supercritical fluid chromatography. 126 g of rac-3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[3,2-a]pyrimidine were isolated -8-ium-5-alkoxide. This resulted in 53.4 g of R-3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[ 3,2-a]pyrimidin-8-ium-5-alkoxide and 57.7 g of S-3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo at a retention time of 1.41 min -6-Phenyl-2,3-dihydrothiazolo[3,2-a]pyrimidin-8-ium-5-olate. For these residence times, refer to the analysis methods listed below. The configuration of the chiral centers was determined by X-ray analysis.

分析型分離方法: 儀器:Thar分析型SFC 管柱:Chiralpak AS-H, 150×4.6 mm i.d., 5 u 移動相:A為CO2 且B為MeOH,梯度:B%=40% 流動速率:4.0 mL/min,背壓:100巴,管柱溫度:35℃ 波長:220 nmAnalytical Separation Method: Instrument: Thar Analytical SFC Column: Chiralpak AS-H, 150×4.6 mm id, 5 u Mobile Phase: A is CO 2 and B is MeOH, Gradient: B%=40% Flow Rate: 4.0 mL/min, back pressure: 100 bar, column temperature: 35°C wavelength: 220 nm

製備型分離方法: 儀器:Thar 80製備型SFC 管柱:Chiralcel OJ-H, 250×30 mm I.D. 5 u 移動相:A為CO2 且B為CH3 CN,梯度:B% = 50% 流動速率:80 g/min,背壓:100巴,管柱溫度:40℃ 波長:220 nm 循環時間:6.5 min 樣品製備:將外消旋物質溶解於MeOH-CH3 CN-DCM (1:1:0.5)之混合溶液中至20 mg/mL,且經由孔徑為0.45 um之膜過濾。 注射:每次注射4 mL。Preparative Separation Method: Instrument: Thar 80 Preparative SFC Column: Chiralcel OJ-H, 250×30 mm ID 5 u Mobile Phase: A is CO 2 and B is CH 3 CN, Gradient: B% = 50% Flow Rate : 80 g/min, Back pressure: 100 bar, Column temperature: 40°C Wavelength: 220 nm Cycle time: 6.5 min Sample preparation: Dissolve racemic substance in MeOH-CH 3 CN-DCM (1:1:0.5 ) to 20 mg/mL, and filtered through a membrane with a pore size of 0.45 um. Injection: 4 mL per injection.

在分離後,將溶離份經由旋轉蒸發器在浴溫35℃下乾燥,得到兩種對映異構體。After separation, the fractions were dried via a rotary evaporator at a bath temperature of 35°C to yield the two enantiomers.

製備具有對映異構體過量之式I化合物: 表徵可藉由耦聯的高效液相層析/質譜分析(HPLC/MS)、氣相層析(GC)、藉由NMR或藉由其熔點來進行。 HPLC方法:Agilent Eclipse Plus C18, 150mm×4.6mm ID×5um 梯度A=0.1% TFA/水,B= 0.1% TFA/乙腈。 流速= 1.4 ml/min.,管柱烘箱溫度= 30℃ 梯度程式= 10% B - 100% B - 5min,保持2min,3min - 10% B。 運行時間 = 10 min LCMS方法1:C18管柱(50 mm×3.0 mm× 3µ) 梯度A= 10 Mm甲酸銨/水,B= 0.1%甲酸/乙腈 流速= 1.2 ml/min.,管柱烘箱溫度= 40℃ 梯度程式= 在1.5 min內10% B至100% B,保持1 min 100% B,1 min - 10% B 運行時間:3.75 min 對掌性HPLC方法1:ChiralPak IA管柱,150 mm×4.6 mm× 5µ 移動相A=庚烷,B=異丙醇, 流速= 1.0 ml/min,管柱烘箱溫度= 40℃ 梯度程式= 10% B等度;運行時間:20 min 對掌性HPLC方法3:ChiralPak IA管柱,150 mm×4.6 mm× 5µ 移動相A=庚烷,B=異丙醇, 流速= 1.0 ml/min,管柱烘箱溫度= 40℃ 梯度程式= 40% B等度;運行時間:20 min1 H-NMR:信號係藉由相對於四甲基矽烷之化學位移(ppm)、其多重性及其積分(給定的相對氫原子數)表徵。以下縮寫用於表徵信號之多重性:m = 多重峰,q = 四重峰,t = 三重峰,d = 二重峰且s = 單峰。Preparation of compounds of formula I with enantiomeric excess: Characterization can be by coupled high performance liquid chromatography/mass spectrometry (HPLC/MS), gas chromatography (GC), by NMR or by their melting point to proceed. HPLC method: Agilent Eclipse Plus C18, 150mm×4.6mm ID×5um gradient A=0.1% TFA/water, B=0.1% TFA/acetonitrile. Flow rate = 1.4 ml/min., Column oven temperature = 30°C Gradient program = 10% B - 100% B - 5min, hold 2min, 3min - 10% B. Run time = 10 min LCMS method 1: C18 column (50 mm × 3.0 mm × 3µ) Gradient A = 10 Mm ammonium formate/water, B = 0.1% formic acid/acetonitrile Flow rate = 1.2 ml/min., column oven temperature = 40°C Gradient program = 10% B to 100% B in 1.5 min, hold 1 min 100% B, 1 min - 10% B Run time: 3.75 min Chiral HPLC method 1: ChiralPak IA column, 150 mm ×4.6 mm× 5µ Mobile phase A=heptane, B=isopropanol, flow rate=1.0 ml/min, column oven temperature=40℃, gradient program=10% B isocratic; running time: 20 min for chiral HPLC Method 3: ChiralPak IA column, 150 mm×4.6 mm×5µ mobile phase A=heptane, B=isopropanol, flow rate=1.0 ml/min, column oven temperature=40℃, gradient program=40% B isocratic ; run time: 20 min 1 H-NMR: signal is characterized by chemical shift (ppm) relative to tetramethylsilane, its multiplicity and its integral (given relative number of hydrogen atoms). The following abbreviations are used to characterize the multiplicity of signals: m = multiplet, q = quartet, t = triplet, d = doublet and s = singlet.

使用的縮寫為:h表示小時,min表示分鐘,rt表示滯留時間且環境溫度錶示20-25℃。The abbreviations used are: h for hours, min for minutes, rt for residence time and ambient temperature for 20-25°C.

實例1:製備具有對映異構體過量化合物I-R-1((3R )-3-(2-氯噻唑-5-基)-8-甲基-7-側氧基-6-苯基-2,3-二氫噻唑并[3,2-a]嘧啶-4-鎓-5-醇鹽)之式I-1化合物: 步驟1:製備2-氯-N-甲氧基-N-甲基-乙醯胺:Example 1: Preparation of compound IR-1 with enantiomeric excess ((3 R )-3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl- 2,3-Dihydrothiazolo[3,2-a]pyrimidin-4-ium-5-alkoxide) compound of formula I-1: Step 1: Preparation of 2-chloro-N-methoxy-N-methoxy Base-Acetamide:

向配備有鐵氟龍(Teflon)葉片攪拌器、回流冷凝器及熱袋之3 L四頸燒瓶中饋入N-甲氧基甲胺鹽酸鹽(345 g)、水(1.6公升),且將所得反應混合物冷卻至0至-5℃。隨後將碳酸鉀(1466 g)分批添加至上述反應混合物中,隨後添加甲基第三丁基醚(1.4公升)。將氯乙醯氯(400 g)溶解於第三丁基甲基醚(0.2公升)中且在-5℃至0℃下逐滴添加至上述保持的反應混合物中,並將反應混合物在0℃下攪拌2小時。使反應混合物達到環境溫度且分離兩相。將有機層經硫酸鈉乾燥,過濾且蒸發,得到呈白色固體狀之2-氯-N-甲氧基-N-甲基-乙醯胺(440 g,90%產率,HPLC純度為98.0面積%)。N-methoxymethylamine hydrochloride (345 g), water (1.6 liters), and The resulting reaction mixture was cooled to 0 to -5°C. Potassium carbonate (1466 g) was then added portionwise to the above reaction mixture followed by methyl tert-butyl ether (1.4 L). Chloroacetyl chloride (400 g) was dissolved in tert-butyl methyl ether (0.2 L) and added dropwise to the above kept reaction mixture at -5°C to 0°C, and the reaction mixture was stirred at 0°C 2 hours. The reaction mixture was allowed to reach ambient temperature and the two phases were separated. The organic layer was dried over sodium sulfate, filtered and evaporated to give 2-chloro-N-methoxy-N-methyl-acetamide as a white solid (440 g, 90% yield, HPLC purity 98.0 area %).

步驟2:製備2-氯-1-(2-氯噻唑-5-基)乙烯酮: 向配備有鐵氟龍葉片攪拌器、回流冷凝器及熱袋之5 L四頸燒瓶中饋入2-氯噻唑(250 g)、THF (0.75 L),且將所得反應混合物冷卻至0至-5℃。隨後在0至-5℃下經0.5小時將異丙基氯化鎂氯化鋰(1.929 L,1.3 M THF溶液)添加至上述保持的反應混合物中。隨後將反應混合物加熱至40℃且在40℃下繼續反應2小時。藉由用碘淬滅反應混合物之少量等分試樣且藉由GC分析監測2-氯-5-碘-噻唑之形成(藉由GC分析觀察到96%轉化率)來確認氯-(2-氯噻唑-5-基)鎂物種的形成。將反應混合物冷卻至0至-5℃,且逐滴添加2-氯-N-甲氧基-N-甲基-乙醯胺(343 g)於THF (0.25 L)中之溶液。在-5至0℃下繼續反應1小時,且藉由HPLC監測反應進程。將反應混合物在-5至0℃下用1.5 N HCl水溶液(1 L)淬滅且隨後升溫至環境溫度。分離兩相且用甲基第三丁基醚(2 × 300 mL)萃取水相。合併之有機層經硫酸鈉乾燥,過濾且蒸發,獲得粗殘餘物。在環境溫度下將粗產物溶解於甲基第三丁基醚(0.7 L)中,且添加活性炭(4 g)及二氧化矽(80 g,60-120目)。將漿液攪拌0.5小時,經由布赫納漏斗(Buchner funnel)過濾且用甲基第三丁基醚(0.3 L)洗滌。蒸發濾液,獲得呈淺棕色油狀之2-氯-1-(2-氯噻唑-5-基)乙酮(409 g,HPLC純度為46面積%)。Step 2: Preparation of 2-chloro-1-(2-chlorothiazol-5-yl)ketene: Into a 5 L four-necked flask equipped with a Teflon blade stirrer, reflux condenser, and heat pack was fed 2-chlorothiazole (250 g), THF (0.75 L), and the resulting reaction mixture was cooled to 0 to - 5°C. Isopropylmagnesium chloride lithium chloride (1.929 L, 1.3 M solution in THF) was then added to the above held reaction mixture at 0 to -5 °C over 0.5 h. The reaction mixture was then heated to 40°C and the reaction was continued at 40°C for 2 hours. Chloro-(2-chloro-(2- Formation of chlorothiazol-5-yl)magnesium species. The reaction mixture was cooled to 0 to -5 °C, and a solution of 2-chloro-N-methoxy-N-methyl-acetamide (343 g) in THF (0.25 L) was added dropwise. The reaction was continued for 1 hour at -5 to 0°C, and the progress of the reaction was monitored by HPLC. The reaction mixture was quenched with 1.5 N aqueous HCl (1 L) at -5 to 0 °C and then warmed to ambient temperature. The two phases were separated and the aqueous phase was extracted with methyl tert-butyl ether (2 x 300 mL). The combined organic layers were dried over sodium sulfate, filtered and evaporated to give a crude residue. The crude product was dissolved in methyl tert-butyl ether (0.7 L) at ambient temperature, and activated carbon (4 g) and silica (80 g, 60-120 mesh) were added. The slurry was stirred for 0.5 h, filtered through a Buchner funnel and washed with methyl tert-butyl ether (0.3 L). The filtrate was evaporated to obtain 2-chloro-1-(2-chlorothiazol-5-yl)ethanone (409 g, HPLC purity 46 area %) as a light brown oil.

步驟3:製備乙酸[2-(2-氯噻唑-5-基)-2-側氧基-乙基]酯: 在環境溫度下,向配備有鐵氟龍葉片攪拌器、回流冷凝器及熱袋之0.25 L三頸燒瓶中饋入2 - - 1 -( 2 - 氯噻唑 - 5 - ) 乙酮 (15 g,HPLC純度為46面積%)及二甲基甲醯胺(45 mL)。隨後將乙酸鈉(12.55 g)分數份添加且在環境溫度下繼續反應4小時。藉由HPLC監測反應進程(藉由HPLC確定轉化率>95%)。將反應物用水(50 mL)淬滅且用甲基第三丁基醚(3×100 mL)萃取。分離兩相,合併之有機相經硫酸鈉乾燥,過濾且蒸發,獲得粗殘餘物(17 g)。藉由矽膠管柱層析純化粗產物,獲得呈黃色固體狀之乙酸 [ 2 -( 2 - 氯噻唑 - 5 - )- 2 - 側氧基 - 乙基 ] (7.5 g)。Step 3: Preparation of [2-(2-chlorothiazol-5-yl)-2-oxo-ethyl] acetate: At ambient temperature, the 2 - Chloro - 1- ( 2 - chlorothiazol - 5 - yl ) ethanone (15 g, HPLC purity 46 area%) and dimethylformamide (45 mL) were fed into a 0.25 L three-necked flask . Sodium acetate (12.55 g) was then added in portions and the reaction was continued for 4 hours at ambient temperature. The progress of the reaction was monitored by HPLC (conversion >95% by HPLC). The reaction was quenched with water (50 mL) and extracted with methyl tert-butyl ether (3 x 100 mL). The two phases were separated and the combined organic phases were dried over sodium sulfate, filtered and evaporated to give a crude residue (17 g). The crude product was purified by silica gel column chromatography to obtain [ 2- ( 2 - chlorothiazol - 5 - yl ) -2 - oxo - ethyl ] acetate (7.5 g) as a yellow solid .

步驟4:製備1-(2-氯噻唑-5-基)-2-羥基-乙酮: 向配備有磁性攪拌器、回流冷凝器及熱袋之250 mL三頸燒瓶中饋入乙酸 [ 2 -( 2 - 氯噻唑 - 5 - )- 2 - 側氧基 - 乙基 ] (7.5 g)及含1 N HCl之MeOH (50 mL)。將所得溶液攪拌5小時且藉由TLC監測反應進程。真空蒸餾反應混合物中之甲醇,且藉由管柱層析純化所得粗殘餘物,獲得呈淺黃色固體狀之1 -( 2 - 氯噻唑 - 5 - )- 2 - 羥基 - 乙酮 (2.8 g,HPLC純度為84面積%)。Step 4: Preparation of 1-(2-chlorothiazol-5-yl)-2-hydroxy-ethanone: Into a 250 mL three-necked flask equipped with a magnetic stirrer, reflux condenser and thermal pack was fed acetic acid [ 2 − ( 2 - Chlorothiazol - 5 - yl ) -2 - oxo - ethyl ] ester (7.5 g) and 1 N HCl in MeOH (50 mL). The resulting solution was stirred for 5 hours and the progress of the reaction was monitored by TLC. The methanol in the reaction mixture was distilled in vacuo, and the resulting crude residue was purified by column chromatography to obtain 1- ( 2 - chlorothiazol - 5 - yl ) -2 - hydroxy - ethanone (2.8 g , HPLC purity of 84 area%).

步驟5:製備4-(2-氯噻唑-5-基)-5H-噁噻唑2,2-二氧化物 向配備有磁性攪拌器、回流冷凝器及熱袋之100 mL三頸燒瓶中饋入1 -( 2 - 氯噻唑 - 5 - )- 2 - 羥基 - 乙酮 (1 g)、甲苯(20 mL)、氯磺醯胺(0.975 g)及對甲苯磺酸(0.214 g)。將所得溶液加熱至100℃且攪拌1小時。藉由HPLC監測反應進程(>95%轉化率)。反應混合物用水淬滅且用MTBE (15 mL × 2)萃取。分離兩相,蒸發有機相且藉由管柱層析來純化4 -( 2 - 氯噻唑 - 5 - )- 5H - 噁噻唑 2 , 2 - 二氧化物 (0.42 g)。Step 5: Preparation of 4-(2-chlorothiazol-5-yl)-5H-oxathiazole 2,2-dioxide Feed into a 100 mL three-necked flask equipped with a magnetic stirrer, reflux condenser and heat pack 1- ( 2 - chlorothiazol - 5 - yl ) -2 - hydroxy - ethanone (1 g), toluene (20 mL), chlorosulfamide (0.975 g) and p-toluenesulfonic acid (0.214 g). The resulting solution was heated to 100°C and stirred for 1 hour. Reaction progress (>95% conversion) was monitored by HPLC. The reaction mixture was quenched with water and extracted with MTBE (15 mL x 2). The two phases were separated, the organic phase was evaporated and 4- ( 2 - chlorothiazol - 5 - yl ) -5H - oxathiazole 2,2 - dioxide (0.42 g) was purified by column chromatography .

步驟6:製備(4R)-4-(2-氯噻唑-5-基)氧雜噻唑啶2,2-二氧化物a) 製備銠催化劑 - RhCl[(R,R)-TsDPEN]Cp*:Step 6: Preparation of (4R)-4-(2-chlorothiazol-5-yl)oxathiazolidine 2,2-dioxide a) Preparation of rhodium catalyst - RhCl[(R,R)-TsDPEN]Cp*:

在氮氣氛圍下,向配備有鐵氟龍葉片攪拌器、氮氣入口及熱袋之250 mL三頸燒瓶中饋入[RhCl2 Cp*]2 (2.0 g)、(1R, 2R)-N-對甲苯磺醯基-1,2-二苯基乙二胺(2.38 g)、二氯甲烷(68 mL)及三乙胺(1.72 ml)。將所得漿液在22-27℃下攪拌0.5小時,且添加蒸餾水(40 mL)。分離兩相,有機相用水(40 mL)洗滌。有機相經硫酸鈉乾燥,過濾且蒸發,得到棕色固體殘餘物。將棕色殘餘物用正庚烷(20 mL)濕磨,過濾且在氮氣氛圍下乾燥,得到呈紅色固體狀之RhCl [(R, R)-TsDPEN]Cp* (3.4 g)。Under a nitrogen atmosphere, [RhCl 2 Cp*] 2 (2.0 g), (1R, 2R)-N-pair Tosyl-1,2-diphenylethylenediamine (2.38 g), dichloromethane (68 mL) and triethylamine (1.72 ml). The resulting slurry was stirred at 22-27 °C for 0.5 h, and distilled water (40 mL) was added. The two phases were separated and the organic phase was washed with water (40 mL). The organic phase was dried over sodium sulfate, filtered and evaporated to give a brown solid residue. The brown residue was triturated with n-heptane (20 mL), filtered and dried under nitrogen to afford RhCl[(R,R)-TsDPEN]Cp* (3.4 g) as a red solid.

b) 製備HCOOH-NEt3 混合物: 在2公升3頸圓底燒瓶中添加甲酸(275 mL,>= 99% w/w)且冷卻至0℃。在0℃下,向其中緩慢添加三乙胺250 mL,>=99%w/w)且立即用於反應。 b) Preparation of HCOOH-NEt 3 mixture: In a 2 liter 3 neck round bottom flask was added formic acid (275 mL, >= 99% w/w) and cooled to 0 °C. At 0°C, triethylamine 250 mL, >=99% w/w) was slowly added thereto and used for the reaction immediately.

c) 製備(4R)-4-(2-氯噻唑-5-基)氧雜噻唑啶2,2-二氧化物: 向配備有磁性攪拌器、冷凝器及熱袋之100 ml二頸燒瓶中饋入4 -( 2 - 氯噻唑 - 5 - )- 5H - 噁噻唑 2 , 2 - 二氧化物 (0.5 g)及二甲基甲醯胺(15 mL,30 V),用氮氣脫氣10分鐘。隨後添加RhCl[(R , R )-TsDPEN]Cp* (27 mg),接著逐滴添加HCOOH-NEt3 (2.5 mL,比率為5:2)。將所得混合物攪拌2小時。HPLC顯示>97%轉化率。將反應混合物用水(15 ml)淬滅且用甲基第三丁基醚(3×50 mL)萃取。蒸發合併之有機相,獲得( 4R )- 4 -( 2 - 氯噻唑 - 5 - ) 氧雜噻唑啶 2 , 2 - 二氧化物 (500 mg;90面積% HPLC純度(rt= 3.645 min.),>99% ee,對掌性HPLC方法1)。 c) Preparation of (4R)-4-(2-chlorothiazol-5-yl)oxathiazolidine 2,2-dioxide: Into a 100 ml two-necked flask equipped with a magnetic stirrer, condenser and heat pack Feed in 4- ( 2 - chlorothiazol - 5 - yl ) -5H - oxthiazole 2,2 - dioxide (0.5 g) and dimethylformamide (15 mL, 30 V ) , degas with nitrogen for 10 minute. RhCl[( R , R )-TsDPEN]Cp* (27 mg) was then added followed by dropwise addition of HCOOH-NEt 3 (2.5 mL, ratio 5:2). The resulting mixture was stirred for 2 hours. HPLC showed >97% conversion. The reaction mixture was quenched with water (15 ml) and extracted with methyl tert-butyl ether (3 x 50 mL). The combined organic phases were evaporated to obtain ( 4R ) -4- ( 2 - chlorothiazol - 5 - yl ) oxathiazolidine 2,2 - dioxide ( 500 mg; 90 area% HPLC purity (rt=3.645 min.) , >99% ee, for chiral HPLC method 1).

步驟7:製備(4R)-4-(2-氯噻唑-5-基)-N-甲基-噻唑啶-2-亞胺 在環境溫度下,向配備有磁性攪拌器、回流冷凝器及熱袋之100 mL三頸燒瓶中饋入(4R)-4-(2-氯噻唑-5-基)氧雜噻唑啶2,2-二氧化物(0.5 g,99% ee)、乙醇(2 ml)、異硫氰酸甲酯(0.228 g)及三乙胺(0.56 ml)。將所得混合物在22-27℃下攪拌14小時。隨後真空移除有機揮發物,且將氫氧化鈉(0.2 g)及水(2 mL)添加至反應燒瓶中。將反應混合物加熱至100℃且攪拌2小時。將反應物用水(2 mL)稀釋且用甲基第三丁基醚(2 × 50 mL)萃取。有機相經硫酸鈉乾燥且真空蒸發,得到呈棕色油狀之(4R)-4-(2-氯噻唑-5 - )- N - 甲基 - 噻唑啶 - 2 - 亞胺 [0.34 g,m / z = 234 amu (M+H+ )]。Step 7: Preparation of (4R)-4-(2-Chlorothiazol-5-yl)-N-methyl-thiazolidine-2-imine (4R)-4-(2-chlorothiazol-5-yl)oxathiazolidine 2,2-dioxide (0.5 g, 99% ee), ethanol (2 ml ), methyl isothiocyanate (0.228 g) and triethylamine (0.56 ml). The resulting mixture was stirred at 22-27°C for 14 hours. Organic volatiles were then removed in vacuo, and sodium hydroxide (0.2 g) and water (2 mL) were added to the reaction flask. The reaction mixture was heated to 100 °C and stirred for 2 hours. The reaction was diluted with water (2 mL) and extracted with methyl tert-butyl ether (2 x 50 mL). The organic phase was dried over sodium sulfate and evaporated in vacuo to give (4R)-4-(2-chlorothiazol- 5 - yl ) -N - methyl - thiazolidine - 2 - imine as a brown oil [0.34 g, m / z = 234 amu (M+H + )].

步驟8:製備(3R)-3-(2-氯噻唑-5-基)-8-甲基-7-側氧基-6-苯基-2,3-二氫噻唑并[3,2-a]嘧啶-4-鎓-5-醇鹽: 在氮氣氛圍下,向配備有磁性攪拌器、回流冷凝器及熱袋之50 mL三頸燒瓶中饋入( E , 4R )- 4 -( 2 - 氯噻唑 - 5 - )- N - 甲基 - 噻唑啶 - 2 - 亞胺 (0.34 g)、甲苯(2 mL)且加熱至110℃。隨後將2 - 苯基丙二酸 ( 2 , 4 , 6 - 三氯苯基 ) (0.857 g)分批添加至保持在110℃下之反應物料中。在110℃下攪拌2小時後,HPLC顯示>99%轉化率。將反應物冷卻至50℃以下,經由燒結漏斗過濾沈澱的淺黃色固體,隨後用甲基第三丁基醚(4 mL)洗滌固體殘餘物且真空乾燥,得到( 3R )- 3 -( 2 - 氯噻唑 - 5 - )- 8 - 甲基 - 7 - 側氧基 - 6 - 苯基 - 2 , 3 - 二氫噻唑并 [ 3 , 2 - a ] 嘧啶 - 4 - - 5 - 醇鹽 (110 mg,m / z = 378 amu (M+H+ )及95.2%對映異構體過量,對掌性HPLC方法3)。1 H NMR (300 MHz, DMSO-d6): 3.42(s, 3H), 3.94(d, J= 12 Hz, 1H), 4.25-4.32(m, 1H), 6.48 (d, J=8.1 Hz, 1H), 7.06-7.11(m, 1H), 7.21-7.26(m, 2H), 7.6(d, J= 7.5 Hz, 1H), 7.96(s, 1H)。Step 8: Preparation of (3R)-3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[3,2- a] Pyrimidin-4-ium-5-alkoxide: Under nitrogen atmosphere, feed ( E , 4R ) -4- ( 2 -chlorothiazol - 5 - yl ) -N - methyl - thiazolidine - 2 - imine (0.34 g ), toluene (2 mL) and heated to 110 °C. Then bis ( 2,4,6 - trichlorophenyl ) -2 - phenylmalonate ( 0.857 g) was added in portions to the reaction mass kept at 110 ° C . After stirring at 110°C for 2 hours, HPLC showed >99% conversion. The reaction was cooled below 50 °C, the precipitated light yellow solid was filtered through a sintered funnel, and the solid residue was washed with methyl tert-butyl ether (4 mL) and dried in vacuo to give ( 3R )- 3 -( 2 - Chlorothiazol - 5 - yl ) -8 - methyl - 7 - oxo - 6 - phenyl - 2,3 - dihydrothiazolo [ 3,2 - a ] pyrimidin - 4 - ium - 5 - alkoxide ( _ _ _ 110 mg, m / z = 378 amu (M+H + ) and 95.2% enantiomeric excess, chiral HPLC method 3). 1 H NMR (300 MHz, DMSO-d6): 3.42(s, 3H), 3.94(d, J=12 Hz, 1H), 4.25-4.32(m, 1H), 6.48 (d, J=8.1 Hz, 1H ), 7.06-7.11(m, 1H), 7.21-7.26(m, 2H), 7.6(d, J= 7.5 Hz, 1H), 7.96(s, 1H).

生物實例 若未另外說明,則測試溶液製備如下:biological instance If not stated otherwise, the test solutions were prepared as follows:

將活性化合物以所需濃度溶解於1:1 (體積:體積)蒸餾水:丙酮之混合物中。測試溶液在使用當天製備。The active compound is dissolved at the desired concentration in a 1:1 (vol:vol) mixture of distilled water:acetone. Test solutions were prepared on the day of use.

除非另外規定,否則以下生物實例中使用之測試化合物I-R-1為95%對映異構體過量。Test compound I-R-1 used in the following biological examples was in 95% enantiomeric excess unless otherwise specified.

除非另外規定,否則以下生物實例中使用之測試化合物I-S-1為95%對映異構體過量。Test compound I-S-1 used in the following biological examples was in 95% enantiomeric excess unless otherwise specified.

B.1 稻青葉蟬(二點黑尾葉蟬): 在噴灑前24小時清潔及洗滌水稻秧苗。將活性化合物調配於50:50丙酮:水(體積:體積)中,且添加0.1%體積/體積界面活性劑(EL 620)。將盆栽的水稻秧苗用5 ml測試溶液進行噴灑,風乾,置於籠中且接種10隻成蟲。經處理之水稻植物保持在約28-29℃及約50-60%相對濕度下。72小時後記錄死亡率百分比。B.1 Rice green leafhopper (two-spotted leafhopper): Clean and wash the rice seedlings 24 hours before spraying. The active compounds were formulated in 50:50 acetone:water (v:v) with the addition of 0.1% v/v surfactant (EL 620). Potted rice seedlings were sprayed with 5 ml of the test solution, air-dried, placed in cages and inoculated with 10 adults. The treated rice plants are maintained at about 28-29°C and about 50-60% relative humidity. The percent mortality was recorded after 72 hours.

B.2 稻褐飛虱(褐稻虱): 在噴灑前24小時清潔及洗滌水稻秧苗。將活性化合物調配於50:50丙酮:水(體積:體積)中,且添加0.1%體積/體積界面活性劑(EL 620)。將盆栽的水稻秧苗用5 ml測試溶液進行噴灑,風乾,置於籠中且接種10隻成蟲。經處理之水稻植物保持在約28-29℃及約50-60%相對濕度下。72小時後記錄死亡率百分比。B.2 Rice brown planthopper (Rice brown planthopper): Clean and wash the rice seedlings 24 hours before spraying. The active compounds were formulated in 50:50 acetone:water (v:v) with the addition of 0.1% v/v surfactant (EL 620). Potted rice seedlings were sprayed with 5 ml of the test solution, air-dried, placed in cages and inoculated with 10 adults. The treated rice plants are maintained at about 28-29°C and about 50-60% relative humidity. The percent mortality was recorded after 72 hours.

B.3 豇豆蚜蟲(苜蓿蚜): 為經由接觸或全身方式評估對豇豆蚜蟲之控制,測試單元由含有蠶豆葉盤之24孔微量滴定盤組成。B.3 Cowpea aphid (Alfalfa aphid): To assess control of cowpea aphids via contact or systemic means, the test unit consisted of 24-well microtiter plates containing broad bean leaf discs.

使用含有75% v/v水及25% v/v DMSO之溶液調配化合物。使用定製的微霧化器將不同濃度的調配化合物以2.5 µl噴霧於葉盤上,重複兩次。Compounds were formulated using solutions containing 75% v/v water and 25% v/v DMSO. Different concentrations of formulated compounds were sprayed onto the leaf discs at 2.5 µl using a custom-made micro-atomizer in two replicates.

施用後,將葉盤風乾,並將5-8隻成蟲蚜蟲置於微量滴定盤孔內之葉盤上。隨後使蚜蟲吸吮經處理之葉盤,且在約23±1℃及約50±5%相對濕度下培育5天。隨後目測評定蚜蟲死亡率及繁殖力。After application, the leaf discs were air-dried and 5-8 adult aphids were placed on the leaf discs within the wells of the microtiter plate. Aphids were then allowed to suck the treated leaf discs and incubated for 5 days at about 23±1°C and about 50±5% relative humidity. Aphid mortality and fecundity were then assessed visually.

B.4 薊馬(蘭花薊馬): 用於生物分析之蘭花薊馬成蟲獲自在實驗室條件下連續維持之群體。出於測試目的,將測試化合物稀釋於丙酮:水(體積:體積)之1:1混合物中,加上0.01%體積/體積Alkamuls® EL 620界面活性劑。B.4 Thrips (Orchid Thrips): Adult orchid thrips for bioanalysis were obtained from colonies maintained continuously under laboratory conditions. For testing purposes, test compounds were diluted in a 1:1 mixture of acetone:water (v:v) plus 0.01% v/v Alkamuls ® EL 620 surfactant.

藉由使用花浸技術評估各化合物之薊馬效力。塑膠培養皿用作測試場地。將個別完整蘭花之所有花瓣浸入處理溶液中且使其乾燥。將經處理之花連同約20隻成蟲薊馬一起置於單獨的培養皿中。培養皿隨後用蓋子覆蓋。在分析期間,所有測試場地保持在連續光照及約28℃之溫度下。3天後,在每朵花上,沿著各培養皿之內壁計數活薊馬的數量。處理後72小時記錄死亡率百分比。The thrips efficacy of each compound was assessed by using the flower dip technique. Plastic Petri dishes were used as test sites. All petals of individual whole orchids were dipped in the treatment solution and allowed to dry. The treated flowers were placed in individual petri dishes along with approximately 20 adult thrips. The Petri dish is then covered with a lid. During the analysis period, all test sites were kept under continuous light and a temperature of about 28°C. After 3 days, on each flower, the number of live thrips was counted along the inner wall of each Petri dish. The percent mortality was recorded 72 hours after treatment.

下表A展示活動資料: A

Figure 107134558-A0304-0003
Table A below shows the event data: Table A :
Figure 107134558-A0304-0003

B.3. 水稻螟蟲 B.3a 小瓶生物分析B.3. Rice borers B.3a Vial Bioanalysis

用自來水洗滌田間收集的稻草且切割一定的長度。將稻草風乾,隨後單獨放入小瓶中(=重複,3次)。每一小瓶噴灑約125 μl測試溶液。將小瓶中經處理之稻草在實驗室通風櫥下風乾。在風乾後,用10隻新生(0日齡)的螟蟲幼蟲接種每根稻草。隨後蓋上小瓶。將裝置保持於維持在27℃及65% RH之保存室中三天。在接種後3天,手動解剖稻草以進行幼蟲死亡率評定。資料(表C)顯示針對兩種水稻螟蟲的活性。 表C:中離子化合物對水稻螟蟲之功效

Figure 107134558-A0304-0004
Straw collected in the field was washed with tap water and cut to a certain length. Straws were air-dried and then placed individually in vials (=repeated, 3 times). Approximately 125 μl of test solution was sprayed per vial. The treated straw in the vial was air-dried under a laboratory fume hood. After air-drying, each straw was inoculated with 10 newborn (0-day-old) borer larvae. The vial is then capped. Devices were kept in a storage room maintained at 27°C and 65% RH for three days. Three days after inoculation, straws were manually dissected for larval mortality assessment. The data (Table C) show activity against two rice stem borers. Table C: Efficacy of neutral ionic compounds against rice borer
Figure 107134558-A0304-0004

B.3b 葉面噴灑 每次處理的所有三盆(=重複)四至五週齡的盆栽水稻同時噴灑12 mL測試溶液。噴灑施用後,在接種前將植物在實驗室風乾。風乾後,使用5至6日齡的CHILSU卵塊進行接種。在接種後1天,將所有受螟蟲浸染的盆栽水稻植物轉移至篩選室內,直至最終評定。在處理及接種後10天進行評定。在切割基部之每個小丘之前評定整株植物的損傷以進行分蘖解剖。檢查各解剖之分蘗,尋找死亡(若可能)及存活的螟蟲幼蟲。B.3b Foliar spraying All three pots (=repeats) of four- to five-week-old potted rice per treatment were simultaneously sprayed with 12 mL of the test solution. After spray application, the plants were air-dried in the laboratory before inoculation. After air-drying, 5- to 6-day-old CHILSU egg masses were used for inoculation. One day after inoculation, all borer-infested potted rice plants were transferred to the screening chamber until final evaluation. Evaluations were performed 10 days after treatment and inoculation. Whole plant damage was assessed for tiller dissection prior to cutting each mound at the base. Each dissected tiller was inspected for dead (if possible) and surviving stem borer larvae.

結果表明,所測試之化合物在幼蟲死亡率及攝食抑制方面對水稻條螟具有極好的活性 表D:中離子化合物藉由葉面噴灑對水稻條螟之功效

Figure 107134558-A0304-0005
The results showed that the tested compounds had excellent activity against the rice stem borer in terms of larval mortality and feeding inhibition Table D: Efficacy of neutral ionic compounds against rice stem borer by foliar spraying
Figure 107134558-A0304-0005

B.3c 澆灌施用 將測試溶液倒入各盆栽水稻植物(=重複)之土壤上,每一盆五個分蘖。在澆灌施用後,將經處理之植物轉移至篩選室內三天,隨後在實驗室內進行螟蟲接種。在澆灌施用後三天,使用5至6日齡的CHILSU卵塊進行接種。在接種後1天,將所有受螟蟲浸染的盆栽水稻植物轉移至篩選室內,直至最終評定。在處理後12天(接種後9天)進行評定。在切割基部之每個小丘之前評定整株植物的損傷以進行分蘖解剖。檢查各解剖之分蘗,尋找死亡(若可能)及存活的螟蟲幼蟲。B.3c Water application The test solution was poured onto the soil of each potted rice plant (=repeat), five tillers per pot. After water application, the treated plants were transferred to the screening room for three days, followed by borer inoculation in the laboratory. Three days after the water application, 5- to 6-day-old CHILSU egg masses were used for inoculation. One day after inoculation, all borer-infested potted rice plants were transferred to the screening chamber until final evaluation. Evaluations were performed 12 days after treatment (9 days after inoculation). Whole plant damage was assessed for tiller dissection prior to cutting each mound at the base. Each dissected tiller was inspected for dead (if possible) and surviving stem borer larvae.

資料(表3)顯示,所有針對水稻條螟之測試化合物在幼蟲死亡率及攝食抑制方面經由澆灌施用獲得與葉面施用相比時類似的結果 表E:中離子化合物藉由澆灌施用對水稻條螟之功效

Figure 107134558-A0304-0006
The data (Table 3) show that all tested compounds against the rice stem borer obtained similar results in terms of larval mortality and feeding inhibition by water application compared to foliar application. Table E: Effect of neutral ionic compounds on rice strips by irrigation The effect of moth
Figure 107134558-A0304-0006

混合物之實例: 協同作用可描述為兩種或更多種化合物之組合效應大於每種化合物之單獨效應總和的相互作用。兩種混合搭配物(X及Y)之間在控制百分比方面存在協同效應可使用Colby方程計算(Colby, S. R., 1967, Calculating Synergistic and Antagonistic Responses in Herbicide Combinations,Weeds , 15, 20-22):

Figure 02_image051
Example of a mixture: Synergy can be described as an interaction in which the combined effect of two or more compounds is greater than the sum of the individual effects of each compound. The presence of synergy between two mixed partners (X and Y) in terms of percentage control can be calculated using the Colby equation (Colby, SR, 1967, Calculating Synergistic and Antagonistic Responses in Herbicide Combinations, Weeds , 15, 20-22):
Figure 02_image051

當觀察到的組合控制效應大於預期的組合控制效應(E)時,則組合效應為協同的。A combined effect is synergistic when the observed combined control effect is greater than the expected combined control effect (E).

以下測試證明本發明之化合物、混合物或組合物對特定有害生物的控制功效,其中除非另外規定,否則化合物I-R-1為95%對映異構體過量。然而,由該等化合物、混合物或組合物提供之有害生物控制保護不限於此等物種。在某些情況下,發現本發明化合物與其他無脊椎有害生物控制化合物或試劑之組合對某些重要的無脊椎有害生物表現出協同效應。The following tests demonstrate the control efficacy of the compounds, mixtures or compositions of the present invention against specified pests, where Compound I-R-1 is in 95% enantiomeric excess unless otherwise specified. However, the pest control protection provided by the compounds, mixtures or compositions is not limited to these species. In some cases, it was found that combinations of compounds of the present invention and other invertebrate pest control compounds or agents exhibit synergistic effects against certain important invertebrate pests.

使用Colby方程確定混合物或組合物之間的協同作用或拮抗作用的分析。Analysis using the Colby equation to determine synergy or antagonism between mixtures or compositions.

測試1 為經由接觸或全身方式評估對蠶豆修尾蚜之控制,測試單元由含有蠶豆葉盤之24孔微量滴定盤組成。test 1 To assess control of P. vicia fabae via contact or systemic means, the test unit consisted of 24-well microtiter plates containing leaf discs of vicia faba.

使用含有75%水及25% DMSO之溶液調配化合物或混合物。使用定製的微霧化器將各種濃度的調配化合物或混合物以2.5 µl噴霧於葉盤上,重複兩次。Compounds or mixtures were formulated using solutions containing 75% water and 25% DMSO. Various concentrations of formulated compounds or mixtures were sprayed onto leaf discs at 2.5 µl in two replicates using a custom-made micro-atomizer.

對於此等測試中之實驗混合物,分別將相同體積之兩種混合搭配物以所需濃度混合在一起。For the experimental mixtures in these tests, equal volumes of each of the two mixing partners were mixed together at the desired concentrations.

施用後,將葉盤風乾,並將5-8隻成蟲蚜蟲置於微量滴定盤孔內之葉盤上。隨後使蚜蟲吸吮經處理之葉盤,且在23±1℃、50±5% RH下培育5天。隨後目測評定蚜蟲死亡率及繁殖力。對於所測試之混合物,結果列於表1中。 表1:I-R-1及賜諾特.

Figure 107134558-A0304-0007
After application, the leaf discs were air-dried and 5-8 adult aphids were placed on the leaf discs within the wells of the microtiter plate. Aphids were then allowed to suck the treated leaf discs and incubated for 5 days at 23±1°C, 50±5% RH. Aphid mortality and fecundity were then assessed visually. The results are listed in Table 1 for the mixtures tested. Table 1: IR-1 and Cinot.
Figure 107134558-A0304-0007

測試2 為經由全身方式評估對桃蚜之控制,測試單元由在人造膜下含有液體人造飼料之96孔微量滴定盤組成。test 2 To assess control of green peach aphid via a systemic approach, the test unit consisted of a 96-well microtiter plate containing liquid artificial feed under an artificial membrane.

使用含有75%水及25% DMSO之溶液調配化合物或混合物。使用定製的移液器將各種濃度之調配化合物或混合物移液至蚜蟲飼料中,重複兩次。Compounds or mixtures were formulated using solutions containing 75% water and 25% DMSO. Various concentrations of formulated compounds or mixtures were pipetted into aphid feed in duplicate using custom-made pipettes.

對於此等測試中之實驗混合物,分別將相同體積之兩種混合搭配物以所需濃度混合在一起。For the experimental mixtures in these tests, equal volumes of each of the two mixing partners were mixed together at the desired concentrations.

施用後,將5-8隻成蟲蚜蟲置於微量滴定盤孔內的人造膜上。隨後使蚜蟲吸吮經處理之蚜蟲飼料,且在23±1℃、50±5% RH下培育3天。隨後目測評定蚜蟲死亡率及繁殖力。對於所測試之混合物,結果列於表2.1至2.6中。 表2.1:I-R-1及賜諾殺.

Figure 107134558-A0304-0008
表2.2:I-R-1及氟芬隆.
Figure 107134558-A0304-0009
表2.3:I-R-1及三氟苯嘧啶.
Figure 107134558-A0304-0010
表2.4:I-R-1及因得克.
Figure 107134558-A0304-0011
表2.5:I-R-1及氟啶蟲醯胺.
Figure 107134558-A0304-0012
表2.6:I-R-1及α-賽滅寧.
Figure 107134558-A0304-0013
After application, 5-8 adult aphids were placed on the artificial membrane in the wells of the microtiter plate. Aphids were then allowed to suck the treated aphid feed and incubated for 3 days at 23±1 °C, 50±5% RH. Aphid mortality and fecundity were then assessed visually. The results are listed in Tables 2.1 to 2.6 for the mixtures tested. Table 2.1: IR-1 and Spinosad.
Figure 107134558-A0304-0008
Table 2.2: IR-1 and Flufenoron.
Figure 107134558-A0304-0009
Table 2.3: IR-1 and trifluoropyrimidine.
Figure 107134558-A0304-0010
Table 2.4: IR-1 and Indec.
Figure 107134558-A0304-0011
Table 2.5: IR-1 and floxamid.
Figure 107134558-A0304-0012
Table 2.6: IR-1 and α-Saphenin.
Figure 107134558-A0304-0013

測試3 為評估對棉鈴象甲之控制,測試單元由含有昆蟲飼料及20-30個棉鈴象甲蟲卵之24孔微量滴定盤組成。test 3 To assess control of boll weevil, the test unit consisted of a 24-well microtiter plate containing insect diet and 20-30 boll weevil eggs.

使用含有75%水及25% DMSO之溶液調配化合物或混合物。使用定製的微霧化器將各種濃度之調配化合物或混合物以20 µl噴霧於昆蟲飼料上,重複兩次。Compounds or mixtures were formulated using solutions containing 75% water and 25% DMSO. 20 µl of various concentrations of formulated compounds or mixtures were sprayed onto insect diets using a custom-made micro-atomizer in duplicate.

對於此等測試中之實驗混合物,分別將相同體積之兩種混合搭配物以所需濃度混合在一起。For the experimental mixtures in these tests, equal volumes of each of the two mixing partners were mixed together at the desired concentrations.

施用後,將微量滴定盤在23±1℃、50±5% RH下培育5天。隨後目測評定蟲卵及幼蟲死亡率。對於所測試之混合物,結果列於表3.1至表3.3中。 表3.1:I-R-1及氟芬隆.

Figure 107134558-A0304-0014
表3.2:I-R-1及賜諾特.
Figure 107134558-A0304-0015
表3.3:I-R-1及氟唑醯胺.
Figure 107134558-A0304-0016
After application, the microtiter plates were incubated for 5 days at 23±1°C, 50±5% RH. Egg and larval mortality was then assessed visually. The results are listed in Tables 3.1 to 3.3 for the mixtures tested. Table 3.1: IR-1 and Flufenoron.
Figure 107134558-A0304-0014
Table 3.2: IR-1 and Cinot.
Figure 107134558-A0304-0015
Table 3.3: IR-1 and Fluazolamide.
Figure 107134558-A0304-0016

測試4 為評估對菸草夜蛾(美洲菸葉蛾)之控制,測試單元由含有昆蟲飼料及15-25個美洲菸葉蛾蟲卵之96孔微量滴定盤組成。test 4 To assess control of tobacco armyworm (N. tabaci moth), the test unit consisted of a 96-well microtiter plate containing an insect diet and 15-25 N. tabaci moth eggs.

使用含有75%水及25% DMSO之溶液調配化合物或混合物。使用定製的微霧化器將各種濃度之調配化合物或混合物以10 µl噴霧於昆蟲飼料上,重複兩次。Compounds or mixtures were formulated using solutions containing 75% water and 25% DMSO. 10 µl of various concentrations of formulated compounds or mixtures were sprayed onto insect diets using a custom-made micro-atomizer in duplicate.

對於此等測試中之實驗混合物,分別將相同體積之兩種混合搭配物以所需濃度混合在一起。For the experimental mixtures in these tests, equal volumes of each of the two mixing partners were mixed together at the desired concentrations.

施用後,將微量滴定盤在28±1℃、80±5% RH下培育5天。隨後目測評定蟲卵及幼蟲死亡率。對於所測試之混合物,結果列於表4.1及4.2中。 表4.1:I-R-1及派滅淨.

Figure 107134558-A0304-0017
表4.2:I-R-1及α-賽滅寧.
Figure 107134558-A0304-0018
After application, the microtiter plates were incubated for 5 days at 28±1°C, 80±5% RH. Egg and larval mortality was then assessed visually. The results are presented in Tables 4.1 and 4.2 for the mixtures tested. Table 4.1: IR-1 and Pemetrazine.
Figure 107134558-A0304-0017
Table 4.2: IR-1 and α-Saphenin.
Figure 107134558-A0304-0018

測試5 為評估對溫室白粉虱之控制,測試單元由含有具有白粉虱蟲卵之茄子葉盤的葉盤的96孔微量滴定盤組成。使用含有75%水及25% DMSO之溶液調配化合物或混合物。使用定製的微霧化器將各種濃度之調配化合物或混合物以2.5 µl噴霧於昆蟲飼料上,重複兩次。test 5 To evaluate control of whitefly in a greenhouse, the test unit consisted of a 96-well microtiter plate containing leaf discs of eggplant with whitefly eggs. Compounds or mixtures were formulated using solutions containing 75% water and 25% DMSO. Various concentrations of formulated compounds or mixtures were sprayed onto insect diets at 2.5 µl using a custom-made micro-atomizer in duplicate.

對於此等測試中之實驗混合物,分別將相同體積之兩種混合搭配物以所需濃度混合在一起。For the experimental mixtures in these tests, equal volumes of each of the two mixing partners were mixed together at the desired concentrations.

施用後,將微量滴定盤在23±1℃、65±5% RH下培育6天。隨後目測評定孵化爬蟲之死亡率。對於所測試之混合物,結果列於表5中。 表5:I-R-1及噁唑沙非.

Figure 107134558-A0304-0019
After application, the microtiter plates were incubated for 6 days at 23±1°C, 65±5% RH. Mortality of hatched reptiles was then assessed visually. The results are listed in Table 5 for the mixtures tested. Table 5: IR-1 and oxazoxafil.
Figure 107134558-A0304-0019

測試6: 用於藉由葉面噴霧法評估對褐飛虱(褐稻虱)之控制。恰當標記上部葉切割之清潔盆栽的水稻秧苗。在旋轉圓盤(270 mm)之頂部,每一處理濃度/組合放置三株盆栽水稻植物,且用12 mL噴霧溶液進行噴霧。使經處理之植物在實驗室中風乾約一小時。風乾後,覆蓋各經處理之水稻植物。使用抽吸真空使各經處理之植物受褐飛虱浸染。在保存室中將植物維持在27℃±1℃、50±5% RH及24小時光照條件下。在侵染後7天,藉由計數植物上及水上死亡及存活的褐飛虱來記錄死亡率百分比。所測試之化合物及混合物的7天後平均控制在表6.1至6.2中給出。 表6.1:I-R-1及派滅淨.

Figure 107134558-A0304-0020
表6.2:I-R-1及賜諾特.
Figure 107134558-A0304-0021
Test 6: For evaluating the control of the brown planthopper (BPH) by foliar spraying. Clean potted rice seedlings properly marked for upper leaf cutting. Three potted rice plants per treatment concentration/combination were placed on top of a rotating disc (270 mm) and sprayed with 12 mL of spray solution. The treated plants were allowed to air dry in the laboratory for about one hour. After air drying, each treated rice plant was covered. Each treated plant was infested with N. lugens using suction vacuum. Plants were maintained in a holding room at 27°C±1°C, 50±5% RH and 24 hours of light. Seven days after infestation, percent mortality was recorded by counting dead and surviving N. lugens on plants and in water. The average controls after 7 days for the compounds and mixtures tested are given in Tables 6.1 to 6.2. Table 6.1: IR-1 and Pemetrazine.
Figure 107134558-A0304-0020
Table 6.2: IR-1 and Cinot.
Figure 107134558-A0304-0021

測試7: 為經由接觸或全身方式評估對蠶豆修尾蚜之控制,測試單元由含有蠶豆葉盤之24孔微量滴定盤組成。Test 7: To assess control of P. vicia fabae via contact or systemic means, the test unit consisted of 24-well microtiter plates containing leaf discs of vicia faba.

使用含有75%水及25% DMSO之溶液調配化合物或混合物。使用定製的微霧化器將各種濃度的調配化合物或混合物以2.5 µl噴霧於葉盤上,重複兩次。Compounds or mixtures were formulated using solutions containing 75% water and 25% DMSO. Various concentrations of formulated compounds or mixtures were sprayed onto leaf discs at 2.5 µl in two replicates using a custom-made micro-atomizer.

對於此等測試中之實驗混合物,分別將相同體積之兩種混合搭配物以所需濃度混合在一起。For the experimental mixtures in these tests, equal volumes of each of the two mixing partners were mixed together at the desired concentrations.

施用後,將葉盤風乾,並將5-8隻成蟲蚜蟲置於微量滴定盤孔內之葉盤上。隨後使蚜蟲吸吮經處理之葉盤,且在23±1℃、50±5% RH下培育5天。隨後目測評定蚜蟲死亡率及繁殖力。對於所測試之混合物,結果列於表7.1及7.2中。 表7.1:

Figure 107134558-A0304-0022
表7.2:
Figure 107134558-A0304-0023
After application, the leaf discs were air-dried and 5-8 adult aphids were placed on the leaf discs within the wells of the microtiter plate. Aphids were then allowed to suck the treated leaf discs and incubated for 5 days at 23±1°C, 50±5% RH. Aphid mortality and fecundity were then assessed visually. The results are presented in Tables 7.1 and 7.2 for the mixtures tested. Table 7.1:
Figure 107134558-A0304-0022
Table 7.2:
Figure 107134558-A0304-0023

測試8: 為經由全身方式評估對桃蚜之控制,測試單元由在人造膜下含有液體人造飼料之96孔微量滴定盤組成。Test 8: To assess control of green peach aphid via a systemic approach, the test unit consisted of a 96-well microtiter plate containing liquid artificial feed under an artificial membrane.

使用含有75%水及25% DMSO之溶液調配化合物或混合物。使用定製的移液器將各種濃度之調配化合物或混合物移液至蚜蟲飼料中,重複兩次。Compounds or mixtures were formulated using solutions containing 75% water and 25% DMSO. Various concentrations of formulated compounds or mixtures were pipetted into aphid feed in duplicate using custom-made pipettes.

對於此等測試中之實驗混合物,分別將相同體積之兩種混合搭配物以所需濃度混合在一起。For the experimental mixtures in these tests, equal volumes of each of the two mixing partners were mixed together at the desired concentrations.

施用後,將5-8隻成蟲蚜蟲置於微量滴定盤孔內的人造膜上。隨後使蚜蟲吸吮經處理之蚜蟲飼料,且在23±1℃、50±5% RH下培育3天。隨後目測評定蚜蟲死亡率及繁殖力。對於所測試之混合物,結果列於表8.1及8.2中。 表8.1:

Figure 107134558-A0304-0024
表8.2:
Figure 107134558-A0304-0025
After application, 5-8 adult aphids were placed on the artificial membrane in the wells of the microtiter plate. Aphids were then allowed to suck the treated aphid feed and incubated for 3 days at 23±1 °C, 50±5% RH. Aphid mortality and fecundity were then assessed visually. The results are presented in Tables 8.1 and 8.2 for the mixtures tested. Table 8.1:
Figure 107134558-A0304-0024
Table 8.2:
Figure 107134558-A0304-0025

測試9: 為評估對棉鈴象甲之控制,測試單元由含有昆蟲飼料及20-30個棉鈴象甲蟲卵之24孔微量滴定盤組成。Test 9: To assess control of boll weevil, the test unit consisted of a 24-well microtiter plate containing insect diet and 20-30 boll weevil eggs.

使用含有75%水及25% DMSO之溶液調配化合物或混合物。使用定製的微霧化器將各種濃度之調配化合物或混合物以20 µl噴霧於昆蟲飼料上,重複兩次。Compounds or mixtures were formulated using solutions containing 75% water and 25% DMSO. 20 µl of various concentrations of formulated compounds or mixtures were sprayed onto insect diets using a custom-made micro-atomizer in duplicate.

對於此等測試中之實驗混合物,分別將相同體積之兩種混合搭配物以所需濃度混合在一起。For the experimental mixtures in these tests, equal volumes of each of the two mixing partners were mixed together at the desired concentrations.

施用後,將微量滴定盤在23±1℃、50±5% RH下培育5天。隨後目測評定蟲卵及幼蟲死亡率。對於所測試之混合物,結果列於表9.1及9.2中。 表9.1:

Figure 107134558-A0304-0026
表9.2:
Figure 107134558-A0304-0027
After application, the microtiter plates were incubated for 5 days at 23±1°C, 50±5% RH. Egg and larval mortality was then assessed visually. The results are presented in Tables 9.1 and 9.2 for the mixtures tested. Table 9.1:
Figure 107134558-A0304-0026
Table 9.2:
Figure 107134558-A0304-0027

測試10: 為評估對菸草夜蛾(美洲菸葉蛾)之控制,測試單元由含有昆蟲飼料及15-25個美洲菸葉蛾蟲卵之96孔微量滴定盤組成。Test 10: To assess control of tobacco armyworm (N. tabaci moth), the test unit consisted of a 96-well microtiter plate containing an insect diet and 15-25 N. tabaci moth eggs.

使用含有75%水及25% DMSO之溶液調配化合物或混合物。使用定製的微霧化器將不同濃度之調配化合物或混合物以10 µl噴霧於昆蟲飼料上,重複兩次。Compounds or mixtures were formulated using solutions containing 75% water and 25% DMSO. Different concentrations of formulated compounds or mixtures were sprayed onto the insect feed at 10 µl using a custom-made micro-atomizer in duplicate.

對於此等測試中之實驗混合物,分別將相同體積之兩種混合搭配物以所需濃度混合在一起。For the experimental mixtures in these tests, equal volumes of each of the two mixing partners were mixed together at the desired concentrations.

施用後,將微量滴定盤在28±1℃、80±5% RH下培育5天。隨後目測評定蟲卵及幼蟲死亡率。對於所測試之混合物,結果列於表10.1及10.2中。 表10.1:

Figure 107134558-A0304-0028
表10.2:
Figure 107134558-A0304-0029
After application, the microtiter plates were incubated for 5 days at 28±1°C, 80±5% RH. Egg and larval mortality was then assessed visually. The results are presented in Tables 10.1 and 10.2 for the mixtures tested. Table 10.1:
Figure 107134558-A0304-0028
Table 10.2:
Figure 107134558-A0304-0029

測試11: 為評估對溫室白粉虱之控制,測試單元由含有具有白粉虱蟲卵之茄子葉盤的葉盤的96孔微量滴定盤組成。使用含有75%水及25% DMSO之溶液調配化合物或混合物。使用定製的微霧化器將不同濃度之調配化合物或混合物以2.5 µl噴霧於昆蟲飼料上,重複兩次。Test 11: To evaluate control of whitefly in a greenhouse, the test unit consisted of a 96-well microtiter plate containing leaf discs of eggplant with whitefly eggs. Compounds or mixtures were formulated using solutions containing 75% water and 25% DMSO. Different concentrations of formulated compounds or mixtures were sprayed onto the insect feed at 2.5 µl using a custom-made micro-atomizer in duplicate.

對於此等測試中之實驗混合物,分別將相同體積之兩種混合搭配物以所需濃度混合在一起。For the experimental mixtures in these tests, equal volumes of each of the two mixing partners were mixed together at the desired concentrations.

施用後,將微量滴定盤在23±1℃、65±5% RH下培育6天。隨後目測評定孵化爬蟲之死亡率。對於所測試之混合物,結果列於表11.1及11.2中。 表11.1:

Figure 107134558-A0304-0030
表11.2:
Figure 107134558-A0304-0031
After application, the microtiter plates were incubated for 6 days at 23±1°C, 65±5% RH. Mortality of hatched reptiles was then assessed visually. The results are presented in Tables 11.1 and 11.2 for the mixtures tested. Table 11.1:
Figure 107134558-A0304-0030
Table 11.2:
Figure 107134558-A0304-0031

測試12: 為評估對黃熱病蚊(埃及伊蚊)之控制,測試單元由每孔含有200 µl自來水及5-15個新孵出之埃及伊蚊幼蟲的96孔微量滴定盤組成。Test 12: To assess control of the yellow fever mosquito (Aedes aegypti), the test unit consisted of a 96-well microtiter plate containing 200 µl of tap water and 5-15 newly hatched Aedes aegypti larvae per well.

使用含有75%水及25% DMSO之溶液調配化合物或混合物。使用定製的微霧化器將不同濃度之調配化合物或混合物以2.5 µl噴霧於昆蟲飼料上,重複兩次。Compounds or mixtures were formulated using solutions containing 75% water and 25% DMSO. Different concentrations of formulated compounds or mixtures were sprayed onto the insect feed at 2.5 µl using a custom-made micro-atomizer in duplicate.

對於此等測試中之實驗混合物,分別將相同體積之兩種混合搭配物以所需濃度混合在一起。For the experimental mixtures in these tests, equal volumes of each of the two mixing partners were mixed together at the desired concentrations.

施用後,將微量滴定盤在28±1℃、80±5% RH下培育2天。隨後目測評定幼蟲死亡率。對於所測試之混合物,結果列於表12中。 表12:

Figure 107134558-A0304-0032
After application, the microtiter plates were incubated at 28±1°C, 80±5% RH for 2 days. Larval mortality was then assessed visually. The results are listed in Table 12 for the mixtures tested. Table 12:
Figure 107134558-A0304-0032

Figure 107134558-A0101-11-0001-1
Figure 107134558-A0101-11-0001-1

Claims (11)

一種式I-R-1之化合物或其鹽,
Figure 107134558-A0305-02-0168-1
A compound of formula IR-1 or a salt thereof,
Figure 107134558-A0305-02-0168-1
一種殺有害生物混合物,其包含(1)如請求項1所定義之式I-R-1化合物或其鹽,及(2)至少一種化合物II,其選自以下之群:M.1乙醯膽鹼酯酶(AChE)抑制劑:M.1A胺基甲酸酯類;或M.1B有機磷酸酯類;M.2.GABA閘控氯離子通道拮抗劑:M.2A環二烯有機氯化合物;或M.2B苯基吡唑類(fiproles)(苯基吡唑);M.3 M.3A擬除蟲菊酯類之鈉通道調節劑;或M.3B鈉通道調節劑;M.4菸鹼乙醯膽鹼受體促效劑(nAChR):M.4A新菸鹼類似物(neonicotinoids);或化合物M.4A.1 4,5-二氫-N-硝基-1-(2-環氧乙烷基甲基)-1H-咪唑-2-胺,M.4A.2:(2E-)-1-[(6-氯吡啶-3-基)甲基]-N'-硝基-2-亞戊肼甲脒,或M4.A.3:1-[(6-氯吡啶-3-基)甲基]-7-甲基-8-硝基-5-丙氧基-1,2,3,5,6,7-六氫咪唑并[1,2-a]吡啶;或M.4B菸鹼;M.4C氟啶蟲胺腈(sulfoxaflor);M.4D氟吡呋喃酮(flupyradifurone);M.4E三氟苯嘧啶 (triflumezopyrim);M.5菸鹼乙醯膽鹼受體異位活化劑:多殺黴素類(spinosyns);M.6阿維菌素類(avermectins)及米爾倍黴素類(milbemycins)之氯離子通道活化劑;M.7保幼激素模擬物;M.8各種非特異性(多位點)抑制劑;M.9弦音器TRPV通道調節劑;M.10蟎生長抑制劑;M.12粒線體ATP合成酶抑制劑;M.13經由破壞質子梯度之氧化磷酸化去偶合劑;M.14菸鹼乙醯膽鹼受體(nAChR)通道阻斷劑;M.15甲殼素生物合成類型0之抑制劑;M.16甲殼素生物合成類型1之抑制劑;M.17雙翅目昆蟲蛻皮干擾劑;M.18蛻皮素受體促效劑;M.19章魚胺受體促效劑;M.20粒線體複合物III電子傳遞抑制劑;M.21粒線體複合物I電子傳遞抑制劑;M.22電壓依賴性鈉通道阻斷劑;M.23乙醯CoA羧化酶之抑制劑;M.24粒線體複合物IV電子傳遞抑制劑;M.25粒線體複合物II電子傳遞抑制劑;M.28二醯胺類之利阿諾定(Ryanodine)受體調節劑,M.28.1:(R)-3- 氯-N1-{2-甲基-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基}-N2-(1-甲基-2-甲基磺醯基乙基)鄰苯二甲醯胺,M.28.2:(S)-3-氯-N1-{2-甲基-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基}-N2-(1-甲基-2-甲基磺醯基乙基)鄰苯二甲醯胺,M.28.3:環溴蟲醯胺(cyclaniliprole)或M.28.4:甲基-2-[3,5-二溴-2-({[3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基]羰基}胺基)苯甲醯基]-1,2-二甲肼甲酸酯;或M.28.5a)N-[4,6-二氯-2-[(二乙基-λ-4-亞硫基)胺甲醯基]-苯基]-2-(3-氯-2-吡啶基)-5-(三氟甲基)吡唑-3-甲醯胺;M.28.5b)N-[4-氯-2-[(二乙基-λ-4-亞硫基)胺甲醯基]-6-甲基-苯基]-2-(3-氯-2-吡啶基)-5-(三氟甲基)吡唑-3-甲醯胺;M.28.5c)N-[4-氯-2-[(二-2-丙基-λ-4-亞硫基)胺甲醯基]-6-甲基-苯基]-2-(3-氯-2-吡啶基)-5-(三氟甲基)吡唑-3-甲醯胺;M.28.5d)N-[4,6-二氯-2-[(二-2-丙基-λ-4-亞硫基)胺甲醯基]-苯基]-2-(3-氯-2-吡啶基)-5-(三氟甲基)吡唑-3-甲醯胺;M.28.5h)N-[4,6-二溴-2-[(二乙基-λ-4-亞硫基)胺甲醯基]-苯基]-2-(3-氯-2-吡啶基)-5-(三氟甲基)吡唑-3-甲醯胺;M.28.5i)N-[2-(5-胺基-1,3,4-噻二唑-2-基)-4-氯-6-甲基苯基]-3-溴-1-(3-氯-2-吡啶基)-1H-吡唑-5-甲醯胺;M.28.5j)3-氯-1-(3-氯-2-吡啶基)-N-[2,4-二氯-6-[[(1-氰基-1-甲基乙基)胺基]羰基]苯基]-1H-吡唑-5-甲醯胺;M.28.5k)3-溴-N-[2,4-二氯-6-(甲基胺甲醯基)苯基]-1-(3,5-二氯-2-吡啶基)-1H-吡唑-5-甲醯胺;M.28.5l)N-[4-氯-2-[[(1,1-二甲基乙基)胺基]羰基]-6-甲基苯基]-1-(3-氯-2-吡啶基)-3-(氟甲氧基)-1H-吡唑-5-甲醯胺;或M.28.6:氯氟氰蟲醯胺(cyhalodiamide);或M.29:弦音器調節劑-不確定的靶位點;M.UN.作用模式未知或不明確之殺昆蟲活性化合物; M.UN.3:11-(4-氯-2,6-二甲基苯基)-12-羥基-1,4-二氧雜-9-氮雜二螺[4.2.4.2]-十四-11-烯-10-酮;M.UN.4:3-(4'-氟-2,4-二甲基聯苯-3-基)-4-羥基-8-氧雜-1-氮雜螺[4.5]癸-3-烯-2-酮,M.UN.5:1-[2-氟-4-甲基-5-[(2,2,2-三氟乙基)亞磺醯基]苯基]-3-(三氟甲基)-1H-1,2,4-三唑-5-胺,或基於強固芽胞桿菌(bacillus firmus)(Votivo,I-1582)之活性劑;M.UN.6:氟吡嘧(flupyrimin);M.UN.8:三氟咪啶醯胺(fluazaindolizine);M.UN.9.a):4-[5-(3,5-二氯苯基)-5-(三氟甲基)-4H-異噁唑-3-基]-2-甲基-N-(1-側氧基硫雜環丁烷-3-基)苯甲醯胺;M.UN.9.b):氟唑醯胺(fluxametamide);M.UN.10:5-[3-[2,6-二氯-4-(3,3-二氯烯丙氧基)苯氧基]丙氧基]-1H-吡唑;M.UN.11.b)3-(苯甲醯基甲胺基)-N-[2-溴-4-[1,2,2,3,3,3-六氟-1-(三氟甲基)丙基]-6-(三氟甲基)苯基]-2-氟-苯甲醯胺;M.UN.11.c)3-(苯甲醯基甲胺基)-2-氟-N-[2-碘-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]-苯甲醯胺;M.UN.11.d)N-[3-[[[2-碘-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]胺基]羰基]苯基]-N-甲基-苯甲醯胺;M.UN.11.e)N-[3-[[[2-溴-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]胺基]羰基]-2-氟-苯基]-4-氟-N-甲基-苯甲醯胺;M.UN.11.f)4-氟-N-[2-氟-3-[[[2-碘-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]胺基]羰基]苯基]-N-甲基-苯甲醯胺;M.UN.11.g)3-氟-N-[2-氟-3-[[[2-碘-4-[1,2,2,2- 四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]胺基]羰基]苯基]-N-甲基-苯甲醯胺;M.UN.11.h)2-氯-N-[3-[[[2-碘-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]胺基]羰基]苯基]-3-吡啶甲醯胺;M.UN.11.i)4-氰基-N-[2-氰基-5-[[2,6-二溴-4-[1,2,2,3,3,3-六氟-1-(三氟甲基)丙基]苯基]胺甲醯基]苯基]-2-甲基-苯甲醯胺;M.UN.11.j)4-氰基-3-[(4-氰基-2-甲基-苯甲醯基)胺基]-N-[2,6-二氯-4-[1,2,2,3,3,3-六氟-1-(三氟甲基)丙基]苯基]-2-氟-苯甲醯胺;M.UN.11.k)N-[5-[[2-氯-6-氰基-4-[1,2,2,3,3,3-六氟-1-(三氟甲基)丙基]苯基]胺甲醯基]-2-氰基-苯基]-4-氰基-2-甲基-苯甲醯胺;M.UN.11.l)N-[5-[[2-溴-6-氯-4-[2,2,2-三氟-1-羥基-1-(三氟甲基)乙基]苯基]胺甲醯基]-2-氰基-苯基]-4-氰基-2-甲基-苯甲醯胺;M.UN.11.m)N-[5-[[2-溴-6-氯-4-[1,2,2,3,3,3-六氟-1-(三氟甲基)丙基]苯基]胺甲醯基]-2-氰基-苯基]-4-氰基-2-甲基-苯甲醯胺;M.UN.11.n)4-氰基-N-[2-氰基-5-[[2,6-二氯-4-[1,2,2,3,3,3-六氟-1-(三氟甲基)丙基]苯基]胺甲醯基]苯基]-2-甲基-苯甲醯胺;M.UN.11.o)4-氰基-N-[2-氰基-5-[[2,6-二氯-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基]胺甲醯基]苯基]-2-甲基-苯甲醯胺;M.UN.11.p)N-[5-[[2-溴-6-氯-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基]胺甲醯基]-2-氰基-苯基]-4-氰基-2-甲基-苯甲醯胺;或M.UN.12.a)2-(1,3-二氧雜環己烷-2-基)-6-[2-(3-吡啶基)-5-噻唑基]-吡啶;M.UN.12.b)2-[6-[2-(5-氟-3-吡啶基)-5-噻唑基]-2-吡啶基]-嘧啶;M.UN.12.c)2-[6-[2-(3-吡啶基)-5-噻唑基]-2-吡啶基]-嘧啶;M.UN.12.d)N-甲基磺醯基-6-[2-(3-吡啶基)噻唑-5-基]吡啶-2-甲醯胺;M.UN.12.e)N-甲基磺醯基-6-[2-(3-吡啶基)噻唑-5-基]吡啶-2-甲醯胺;M.UN.12.f)N-乙基-N-[4-甲基-2-(3-吡啶基)噻唑-5-基]-3-甲硫基-丙醯胺;M.UN.12.g)N- 甲基-N-[4-甲基-2-(3-吡啶基)噻唑-5-基]-3-甲硫基-丙醯胺;M.UN.12.h)N,2-二甲基-N-[4-甲基-2-(3-吡啶基)噻唑-5-基]-3-甲硫基-丙醯胺;M.UN.12.i)N-乙基-2-甲基-N-[4-甲基-2-(3-吡啶基)噻唑-5-基]-3-甲硫基-丙醯胺;M.UN.12.j)N-[4-氯-2-(3-吡啶基)噻唑-5-基]-N-乙基-2-甲基-3-甲硫基-丙醯胺;M.UN.12.k)N-[4-氯-2-(3-吡啶基)噻唑-5-基]-N,2-二甲基-3-甲硫基-丙醯胺;M.UN.12.l)N-[4-氯-2-(3-吡啶基)噻唑-5-基]-N-甲基-3-甲硫基-丙醯胺;M.UN.12.m)N-[4-氯-2-(3-吡啶基)噻唑-5-基]-N-乙基-3-甲硫基-丙醯胺;M.UN.14a)1-[(6-氯-3-吡啶基)甲基]-1,2,3,5,6,7-六氫-5-甲氧基-7-甲基-8-硝基-咪唑并[1,2-a]吡啶;或M.UN.14b)1-[(6-氯吡啶-3-基)甲基]-7-甲基-8-硝基-1,2,3,5,6,7-六氫咪唑并[1,2-a]吡啶-5-醇;M.UN.16a)1-異丙基-N,5-二甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;或M.UN.16b)1-(1,2-二甲基丙基)-N-乙基-5-甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;M.UN.16c)N,5-二甲基-N-嗒嗪-4-基-1-(2,2,2-三氟-1-甲基-乙基)吡唑-4-甲醯胺;M.UN.16d)1-[1-(1-氰基環丙基)乙基]-N-乙基-5-甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;M.UN.16e)N-乙基-1-(2-氟-1-甲基-丙基)-5-甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;M.UN.16f)1-(1,2-二甲基丙基)-N,5-二甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;M.UN.16g)1-[1-(1-氰基環丙基)乙基]-N,5-二甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;M.UN.16h)N-甲基-1-(2-氟-1-甲基-丙基]-5-甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;M.UN.16i)1-(4,4-二氟環己基)-N-乙基-5-甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺;或M.UN.16j)1-(4,4-二氟環己基)-N,5-二甲基-N-嗒嗪-4-基-吡唑-4-甲醯胺,M.UN.17a)N-(1-甲基乙基)-2-(3-吡啶基)-2H-吲唑-4-甲醯胺; M.UN.17b)N-環丙基-2-(3-吡啶基)-2H-吲唑-4-甲醯胺;M.UN.17c)N-環己基-2-(3-吡啶基)-2H-吲唑-4-甲醯胺;M.UN.17d)2-(3-吡啶基)-N-(2,2,2-三氟乙基)-2H-吲唑-4-甲醯胺;M.UN.17e)2-(3-吡啶基)-N-[(四氫-2-呋喃基)甲基]-2H-吲唑-5-甲醯胺;M.UN.17f)2-[[2-(3-吡啶基)-2H-吲唑-5-基]羰基]肼甲酸甲酯;M.UN.17g)N-[(2,2-二氟環丙基)甲基]-2-(3-吡啶基)-2H-吲唑-5-甲醯胺;M.UN.17h)N-(2,2-二氟丙基)-2-(3-吡啶基)-2H-吲唑-5-甲醯胺;M.UN.17i)2-(3-吡啶基)-N-(2-嘧啶基甲基)-2H-吲唑-5-甲醯胺;M.UN.17j)N-[(5-甲基-2-吡嗪基)甲基]-2-(3-吡啶基)-2H-吲唑-5-甲醯胺,M.UN.18a)N-[3-氯-1-(3-吡啶基)吡唑-4-基]-N-乙基-3-(3,3,3-三氟丙基硫基)丙醯胺;M.UN.18b)N-[3-氯-1-(3-吡啶基)吡唑-4-基]-N-乙基-3-(3,3,3-三氟丙基亞磺醯基)丙醯胺;M.UN.18c)N-[3-氯-1-(3-吡啶基)吡唑-4-基]-3-[(2,2-二氟環丙基)甲基硫基]-N-乙基-丙醯胺;M.UN.18d)N-[3-氯-1-(3-吡啶基)吡唑-4-基]-3-[(2,2-二氟環丙基)甲基亞磺醯基]-N-乙基-丙醯胺;M.UN.19薩洛拉納(sarolaner);M.UN.20洛替拉納(lotilaner);M.UN.21 N-[4-氯-3-[[(苯基甲基)胺基]羰基]苯基]-1-甲基-3-(1,1,2,2,2-五氟乙基)-4-(三氟甲基)-1H-吡唑-5-甲醯胺;M.UN.22a 2-(3-乙基磺醯基-2-吡啶基)-3-甲基-6-(三氟甲基)咪唑并[4,5-b]吡啶,或M.UN.22b 2-[3-乙基磺醯基-5-(三氟甲基)-2-吡啶基]-3-甲基-6-(三氟甲基)咪唑并[4,5-b]吡啶;M.UN.23a 4-[5-(3,5-二氯苯基)-5-(三氟甲基)-4H-異噁唑-3-基]-N- [(4R)-2-乙基-3-側氧基異噁唑啶-4-基]-2-甲基-苯甲醯胺,或M.UN.23b 4-[5-(3,5-二氯-4-氟-苯基)-5-(三氟甲基)-4H-異噁唑-3-基]-N-[(4R)-2-乙基-3-側氧基-異噁唑啶-4-基]-2-甲基-苯甲醯胺;M.UN.24a)N-[4-氯-3-(環丙基胺甲醯基)苯基]-2-甲基-5-(1,1,2,2,2-五氟乙基)-4-(三氟甲基)吡唑-3-甲醯胺或M.UN.24b)N-[4-氯-3-[(1-氰基環丙基)胺甲醯基]苯基]-2-甲基-5-(1,1,2,2,2-五氟乙基)-4-(三氟甲基)吡唑-3-甲醯胺;M.UN.25艾諾派瑞(acynonapyr);M.UN.26苯吡莫安(benzpyrimoxan);M.UN.27 2-氯-N-(1-氰基環丙基)-5-[1-[2-甲基-5-(1,1,2,2,2-五氟乙基)-4-(三氟甲基)吡唑-3-基]吡唑-4-基]苯甲醯胺;M.29.28噁唑沙非(oxazosulfyl);A)呼吸抑制劑Qo位點之複合物III的抑制劑:亞托敏(azoxystrobin)(A.1.1),甲香菌酯(coumethoxystrobin)(A.1.2),丁香菌酯(coumoxystrobin)(A.1.3),地莫菌胺(dimoxystrobin)(A.1.4),烯肟菌酯(enestroburin)(A.1.5),烯肟菌胺(fenaminstrobin)(A.1.6),菌蟎酯(fenoxystrobin)/氟菌蟎酯(flufenoxystrobin)(A.1.7),氟嘧菌酯(fluoxastrobin)(A.1.8),克收欣(kresoxim-methyl)(A.1.9),曼德托冰(mandestrobin)(A.1.10),苯氧菌胺(metominostrobin)(A.1.11),肟醚菌胺(orysastrobin)(A.1.12),啶氧菌酯(picoxystrobin)(A.1.13),百克敏(pyraclostrobin)(A.1.14),唑胺菌酯(pyrametostrobin)(A.1.15),唑菌酯(pyraoxystrobin)(A.1.16),三氟敏(trifloxystrobin)(A.1.17),2(2-(3-(2,6-二氯苯基)-1-甲基-亞烯丙基胺氧 基甲基)-苯基)-2甲氧亞胺基-N甲基-乙醯胺(A.1.18),吡菌苯威(pyribencarb)(A.1.19),三環吡菌威(triclopyricarb)/氯啶菌酯(chlorodincarb)(A.1.20),凡殺同(famoxadone)(A.1.21),咪唑菌酮(fenamidone)(A.1.21),甲基-N-[2-[(1,4-二甲基-5苯基-吡唑-3-基)氧基甲基]苯基]-N-甲氧基-胺基甲酸酯(A.1.22),1-[3-氯-2[[1(4-氯苯基)-1H-吡唑-3-基]氧基甲基]苯基]-4-甲基-四唑-5-酮(A.1.23),1-[3-溴-2-[[1-(4-氯苯基)吡唑-3-基]氧基甲基]苯基]-4-甲基-四唑-5-酮(A.1.24),1-[2-[[1-(4-氯苯基)吡唑-3-基]氧基甲基]-3-甲基-苯基]-4-甲基-四唑-5-酮(A.1.25),1-[2-[[1-(4-氯苯基)吡唑-3-基]氧基甲基]-3-氟-苯基]-4-甲基-四唑-5-酮(A.1.26),1-[2-[[1-(2,4-二氯苯基)吡唑-3-基]氧基甲基]-3-氟-苯基]-4-甲基-四唑-5-酮(A.1.27),1-[3-環丙基-2-[[2-甲基-4(1甲基吡唑-3-基)苯氧基]甲基]苯基]-4甲基-四唑-5-酮(A.1.30),1[3(二氟甲氧基)-2-[[2-甲基-4-(1甲基吡唑-3基)苯氧基]甲基]苯基]-4甲基-四唑-5-酮(A.1.31),1-甲基-4-[3-甲基-2[[2甲基-4-(1-甲基吡唑-3基)苯氧基]甲基]苯基]四唑-5-酮(A.1.32),(Z,2E)-5-[1-(2,4-二氯苯基)吡唑-3-基]-氧基-2-甲氧亞胺基-N,3-二甲基-戊-3-烯醯胺(A.1.34),(Z,2E)5[1(4-氯苯基)吡唑-3-基]氧基-2-甲氧亞胺基-N,3-二甲基-戊-3-烯醯胺(A.1.35),嘧蟎胺(pyriminostrobin)(A.1.36),吡氟菌酯(bifujunzhi)(A.1.37),2-(鄰-((2,5-二甲基苯基-氧基-亞甲基)苯基)-3-甲氧基-丙烯酸甲酯(A.1.38);Qi位點之複合物III的抑制劑:賽座滅(cyazofamid)(A.2.1),吲唑磺菌胺(amisulbrom)(A.2.2),[(6S,7R,8R)2-甲基丙酸8苯甲基-3-[(3-羥基-4-甲氧基-吡啶-2-羰基)胺基]-6-甲基-4,9-二側氧基-1,5-二側氧基壬-7-基]酯(A.2.3),芬吡醯胺(fenpicoxamid)(A.2.4); 複合物II之抑制劑:麥鏽靈(benodanil)(A.3.1),苯丙烯氟菌唑(benzovindiflupyr)(A.3.2),必殺吩(bixafen)(A.3.3),白可列(boscalid)(A.3.4),萎鏽靈(carboxin)(A.3.5),甲呋醯胺(fenfuram)(A.3.6),氟吡菌醯胺(fluopyram)(A.3.7),福多寧(flutolanil)(A.3.8),氟唑菌醯胺(fluxapyroxad)(A.3.9),福拉比(furametpyr)(A.3.10),艾索非他米(isofetamid)(A.3.11),吡唑萘菌胺(isopyrazam)(A.3.12),滅普寧(mepronil)(A.3.13),嘉保信(oxycarboxin)(A.3.14),噴福芬(penflufen)(A.3.15),吡噻菌胺(penthiopyrad)(A.3.16),吡二氟甲多芬(pydiflumetofen)(A.3.17),吡瑞氟密得(pyraziflumid)(A.3.18),氟唑環菌胺(sedaxane)(A.3.19),克枯爛(tecloftalam)(A.3.20),賽氟滅(thifluzamide)(A.3.21),3(二氟甲基)-1-甲基-N-(1,1,3-三甲基茚滿-4-基)吡唑-4甲醯胺(A.3.22),3(三氟甲基)-1-甲基-N-(1,1,3-三甲基茚滿-4-基)吡唑-4甲醯胺(A.3.23),1,3-二甲基-N-(1,1,3-三甲基茚滿-4-基)吡唑-4-甲醯胺(A.3.24),3-(三氟甲基)-1,5二甲基-N-(1,1,3-三甲基茚滿-4-基)吡唑-4-甲醯胺(A.3.25),1,3,5-三甲基-N-(1,1,3-三甲基茚滿-4-基)吡唑-4-甲醯胺(A.3.26),3-(二氟甲基)-1,5二甲基-N-(1,1,3-三甲基茚滿-4-基)吡唑-4-甲醯胺(A.3.27),3-(二氟甲基)-N(7氟-1,1,3-三甲基-茚滿-4-基)-1-甲基-吡唑-4-甲醯胺(A.3.28),N-[(5-氯-2-異丙基-苯基)甲基]-N-環丙基-5-氟-1,3-二甲基-吡唑-4-甲醯胺(A.3.29),(E)-2-[2-[(5-氰基-2-甲基-苯氧基)甲基]苯基]-3-甲氧基-丙-2烯酸甲酯(A.3.30),N-[(5-氯-2-異丙基-苯基)甲基]-N-環丙基-3-(二氟甲基)-5氟-1-甲基-吡唑-4-甲醯胺(A.3.31),2-(二氟甲基)-N-(1,1,3-三甲基-茚滿-4-基)吡啶-3-甲醯胺(A.3.32),2-(二氟甲基)-N-[(3R)-1,1,3-三甲基茚滿-4-基]吡啶-3-甲醯胺(A.3.33),2-(二氟甲基)- N-(3-乙基-1,1-二甲基-茚滿-4-基)吡啶-3-甲醯胺(A.3.34),2-(二氟甲基)-N-[(3R)-3-乙基-1,1-二甲基-茚滿-4-基]吡啶-3-甲醯胺(A.3.35),2-(二氟甲基)-N-(1,1-二甲基-3-丙基-茚滿-4-基)吡啶-3-甲醯胺(A.3.36),2-(二氟甲基)-N-[(3R)-1,1-二甲基-3-丙基-茚滿-4-基]吡啶-3-甲醯胺(A.3.37),2-(二氟甲基)-N-(3-異丁基-1,1-二甲基-茚滿-4-基)吡啶-3-甲醯胺(A.3.38),2-(二氟甲基)-N-[(3R)-3-異丁基-1,1-二甲基-茚滿-4基]吡啶-3-甲醯胺(A.3.39);其他呼吸抑制劑:二氟林(diflumetorim)(A.4.1);硝苯基衍生物:百蟎克(binapacryl)(A.4.2),大脫蟎(dinobuton)(A.4.3),白粉克(dinocap)(A.4.4),扶吉胺(fluazinam)(A.4.5),敵蟎普(meptyldinocap)(A.4.6),富米綜(ferimzone)(A.4.7);有機金屬化合物:薯瘟錫鹽(fentin salts);辛唑嘧菌胺(ametoctradin)(A.4.11);矽硫芬(silthiofam)(A.4.12);B)固醇生物合成抑制劑(SBI殺真菌劑)C14去甲基酶抑制劑:三唑類:氧環唑(azaconazole)(B.1.1)、比多農(bitertanol)(B.1.2)、糠菌唑(bromu-conazole)(B.1.3)、環克座(cyproconazole)(B.1.4)、待克利(difenoconazole)(B.1.5)、達克利(diniconazole)(B.1.6)、高效達克利(diniconazole-M)(B.1.7)、依普座(epoxiconazole)(B.1.8)、芬克座(fenbuconazole)(B.1.9)、氟喹唑(fluquinconazole)(B.1.10)、護矽得(flusilazole)(B.1.11)、護汰芬(flutriafol)(B.1.12)、菲克利(hexaconazole)(B.1.13)、亞胺唑(imibenconazole)(B.1.14)、種菌唑(ipconazole)(B.1.15)、滅特座(metconazole)(B.1.17)、邁克尼(myclobutanil)(B.1.18)、噁咪唑 (oxpoconazole)(B.1.19)、多效唑(paclobutrazole)(B.1.20)、平克座(penconazole)(B.1.21)、普克利(propiconazole)(B.1.22)、丙硫菌唑(prothioconazole)(B.1.23)、矽氟唑(simeconazole)(B.1.24)、得克利(tebuconazole)(B.1.25)、四克利(tetraconazole)(B.1.26)、三泰芬(triadimefon)(B.1.27)、三泰隆(triadimenol)(B.1.28)、滅菌唑(triticonazole)(B.1.29)、烯效唑(uniconazole)(B.1.30)、伊分三康唑(ipfentrifluconazole)(B.1.37)、甲分三康唑(mefentrifluconazole)(B.1.38)、2-(氯甲基)-2-甲基-5-(對甲苯基甲基)-1(1,2,4-三唑-1-基甲基)環戊醇(B.1.43);咪唑類:依滅列(imazalil)(B.1.44)、披扶座(pefurazoate)(B.1.45)、咪醯胺(prochloraz)(B.1.46)、賽福座(triflumizol)(B.1.47);嘧啶類、吡啶類及哌嗪類:芬瑞莫(fenarimol)(B.1.49)、比芬諾(pyrifenox)(B.1.50)、賽福寧(triforine)(B.1.51)、[3-(4-氯-2-氟-苯基)-5-(2,4-二氟苯基)異噁唑-4-基]-(3-吡啶基)甲醇(B.1.52);δ14-還原酶抑制劑:阿迪嗎啉(aldimorph)(B.2.1)、嗎菌靈(dodemorph)(B.2.2)、嗎菌靈乙酸鹽(dodemorph-acetate)(B.2.3)、芬普福(fenpropimorph)(B.2.4)、三得芬(tridemorph)(B.2.5)、苯鏽啶(fenpropidin)(B.2.6)、粉病靈(piperalin)(B.2.7)、螺環菌胺(spiroxamine)(B.2.8);3-酮基還原酶之抑制劑:環醯菌胺(fenhexamid)(B.3.1);其他固醇生物合成抑制劑:氯苯肟唑(chlorphenomizole)(B.4.1);C)核酸合成抑制劑苯基醯胺或醯基胺基酸殺真菌劑:苯霜靈(benalaxyl)(C.1.1)、甲霜 靈苯霜靈(benalaxyl-M)(C.1.2)、精苯霜靈(kiralaxyl)(C.1.3)、甲霜靈(metalaxyl)(C.1.4)、高效甲霜靈(metalaxyl-M)(C.1.5)、呋醯胺(ofurace)(C.1.6)、歐殺斯(oxadixyl)(C.1.7);其他核酸合成抑制劑:殺紋寧(hymexazole)(C.2.1)、辛噻酮(octhilinone)(C.2.2)、歐索林酸(oxolinic acid)(C.2.3)、布瑞莫(bupirimate)(C.2.4)、5-氟胞嘧啶(C.2.5)、5-氟-2-(對甲苯基甲氧基)嘧啶-4胺(C.2.6)、5-氟-2-(4-氟苯基甲氧基)嘧啶-4胺(C.2.7)、5-氟-2(4氯苯基甲氧基)嘧啶-4胺(C.2.8);D)細胞分裂及細胞骨架抑制劑微管蛋白抑制劑:免賴得(benomyl)(D.1.1),貝芬替(carbendazim)(D.1.2),麥穗靈(fuberidazole)(D1.3),腐絕(thiabendazole)(D.1.4),甲基托布津(thiophanate-methyl)(D.1.5),3-氯-4-(2,6-二氟苯基)-6-甲基-5-苯基-嗒嗪(D.1.6),3-氯-6-甲基-5-苯基-4-(2,4,6-三氟苯基)嗒嗪(D.1.7),N乙基-2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]丁醯胺(D.1.8),N-乙基-2-[(3-乙炔基-8甲基-6喹啉基)氧基]-2-甲基硫基-乙醯胺(D.1.9),2-[(3-乙炔基-8-甲基-6-喹啉-基)氧基]-N(2-氟乙基)丁醯胺(D.1.10),2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]-N-(2-氟乙基)-2-甲氧基-乙醯胺(D.1.11),2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]-N-丙基-丁醯胺(D.1.12),2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]-2-甲氧基-N-丙基-乙醯胺(D.1.13),2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]-2-甲基硫基-N-丙基-乙醯胺(D.1.14),2[(3乙炔基-8-甲基-6-喹啉基)氧基]-N-(2-氟乙基)-2-甲基硫基-乙醯胺(D.1.15),4-(2-溴-4-氟-苯基)-N-(2-氯-6-氟-苯基)-2,5-二甲基-吡唑-3胺(D.1.16);其他細胞分裂抑制劑:乙黴威(diethofencarb)(D.2.1)、噻唑菌胺 (ethaboxam)(D.2.2)、賓克隆(pencycuron)(D.2.3)、氟吡菌胺(fluopicolide)(D.2.4)、座賽胺(zoxamide)(D.2.5)、滅芬農(metrafenone)(D.2.6)、吡芬酮(pyriofenone)(D.2.7);E)胺基酸及蛋白質合成抑制劑甲硫胺酸合成抑制劑:嘧菌環胺(cyprodinil)(E.1.1)、嘧菌胺(mepanipyrim)(E.1.2)、嘧黴胺(pyrimethanil)(E.1.3);蛋白質合成抑制劑:殺稻瘟菌素-S(blasticidin-S)(E.2.1)、春日黴素(kasugamycin)(E.2.2)、春日黴素鹽酸鹽水合物(E.2.3)、米多黴素(mildiomycin)(E.2.4)、鏈黴素(streptomycin)(E.2.5)、土黴素(oxytetracyclin)(E.2.6);F)信號轉導抑制劑MAP/組胺酸激酶抑制劑:氟菌安(fluoroimid)(F.1.1)、依普同(iprodione)(F.1.2)、撲滅寧(procymidone)(F.1.3)、免克寧(vinclozolin)(F.1.4)、護汰寧(fludioxonil)(F.1.5);G蛋白抑制劑:快諾芬(quinoxyfen)(F.2.1);G)脂質及膜合成抑制劑磷脂生物合成抑制劑:護粒松(edifenphos)(G.1.1)、丙基喜樂松(iprobenfos)(G.1.2)、白粉松(pyrazophos)(G.1.3)、稻瘟靈(isoprothiolane)(G.1.4);脂質過氧化:氯硝胺(dicloran)(G.2.1)、五氯硝基苯(quintozene)(G.2.2)、四氯硝基苯(tecnazene)(G.2.3)、脫克松(tolclofos-methyl)(G.2.4)、聯苯(G.2.5)、地茂散(chloroneb)(G.2.6)、依得利(etridiazole)(G.2.7); 磷脂生物合成及細胞壁沈積:達滅芬(dimethomorph)(G.3.1)、氟嗎啉(flumorph)(G.3.2)、雙炔醯菌胺(mandipropamid)(G.3.3)、丁吡嗎啉(pyrimorph)(G.3.4)、苯噻菌胺(benthiavalicarb)(G.3.5)、纈黴威(iprovalicarb)(G.3.6)、威利芬那雷特(valifenalate)(G.3.7);影響細胞膜滲透性及脂肪酸之化合物:霜黴威(propamocarb)(G.4.1);氧化固醇結合蛋白之抑制劑:奧賽普林(oxathiapiprolin)(G.5.1),甲磺酸2-{3-[2-(1-{[3,5-雙(二氟甲基-1H-吡唑-1-基]乙醯基}哌啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2噁唑-5-基}苯酯(G.5.2),甲磺酸2-{3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}哌啶-4-基)1,3-噻唑-4-基]-4,5-二氫-1,2-噁唑-5基}-3-氯苯酯(G.5.3),4-[1-[2-[3-(二氟甲基)-5-甲基-吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.4),4-[1-[2-[3,5-雙(二氟甲基)吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.5),4-[1-[2-[3-(二氟甲基)-5-(三氟甲基)吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.6),4-[1-[2-[5-環丙基-3-(二氟甲基)吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.7),4-[1-[2-[5-甲基-3-(三氟甲基)吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.8),4-[1-[2-[5-(二氟甲基)-3-(三氟甲基)吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.9),4-[1-[2-[3,5-雙(三氟甲基)吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.10),(4-[1-[2-[5-環丙基-3-(三氟甲基)吡唑-1-基]乙醯基]-4-哌啶基]-N-萘滿-1-基-吡啶-2-甲醯胺(G.5.11);H)具有多位點作用之抑制劑 無機活性物質:波爾多液(Bordeaux mixture)(H.1.1)、銅(H.1.2)、乙酸銅(H.1.3)、氫氧化銅(H.1.4)、氯氧化銅(H.1.5)、鹼式硫酸銅(H.1.6)、硫(H.1.7);硫代及二硫代胺基甲酸鹽:福美鐵(ferbam)(H.2.1)、鋅錳乃浦(mancozeb)(H.2.2)、錳乃浦(maneb)(H.2.3)、威百畝(metam)(H.2.4)、免得爛(metiram)(H.2.5)、甲基鋅乃浦(propineb)(H.2.6)、得恩地(thiram)(H.2.7)、鋅乃浦(zineb)(H.2.8)、益穗(ziram)(H.2.9);有機氯化合物:敵菌靈(anilazine)(H.3.1)、四氯異苯腈(chlorothalonil)(H.3.2)、四氯丹(captafol)(H.3.3)、蓋普丹(captan)(H.3.4)、福爾培(folpet)(H.3.5)、益發靈(dichlofluanid)(H.3.6)、二氯酚(dichlorophen)(H.3.7)、六氯苯(H.3.8)、五氯酚(H.3.9)及其鹽、苯酞(phthalide)(H.3.10)、甲基益發靈(tolylfluanid)(H.3.11);胍類及其他:胍(H.4.1)、多寧(dodine)(H.4.2)、多寧游離鹼(H.4.3)、雙胍鹽(guazatine)(H.4.4)、雙胍鹽乙酸鹽(H.4.5)、克熱淨(iminoctadine)(H.4.6)、克熱淨三乙酸鹽(H.4.7)、克熱淨參(烷苯磺酸鹽)(H.4.8)、腈硫醌(dithianon)(H.4.9)、2,6-二甲基-1H,5H-[1,4]二噻
Figure 107134558-A0305-02-0183-2
并[2,3-c:5,6-c']二吡咯-1,3,5,7(2H,6H)-四酮(H.4.10);I)細胞壁合成抑制劑葡聚糖合成抑制劑:維利微素(validamycin)(I.1.1)、保粒黴素B(polyoxin B)(I.1.2);黑色素合成抑制劑:百快隆(pyroquilon)(I.2.1)、三賽唑(tricyclazole)(I.2.2)、加普胺(carpropamid)(I.2.3)、雙氯氰菌胺(dicyclomet)(I.2.4)、氰菌胺(fenoxanil)(I.2.5); J)植物防護誘導劑酸化苯并噻二唑-S-甲酯(acibenzolar-S-methyl)(J.1.1)、撲殺熱(probenazole)(J.1.2)、異噻菌胺(isotianil)(J.1.3)、汰敵寧(tiadinil)(J.1.4)、調環酸鈣(prohexadione-calcium)(J.1.5);膦酸鹽:福賽得(fosetyl)(J.1.6)、乙磷鋁(fosetyl-aluminum)(J.1.7)、亞磷酸及其鹽(J.1.8)、膦酸鈣(J.1.11)、膦酸鉀(J.1.12)、碳酸氫鉀或碳酸氫鈉(J.1.9)、4環丙基-N-(2,4-二甲氧基苯基)噻二唑-5-甲醯胺(J.1.10);K)作用模式未知溴硝醇(bronopol)(K.1.1),蟎離丹(chinomethionat)(K.1.2),環氟菌胺(cyflufenamid)(K.1.3),克絕(cymoxanil)(K.1.4),邁隆(dazomet)(K.1.5),咪菌威(debacarb)(K.1.6),二氯西莫(diclocymet)(K.1.7),達滅淨(diclomezine)(K.1.8),野燕枯(difenzoquat)(K.1.9),野燕枯甲基硫酸鹽(K.1.10),二苯胺(diphenylamin)(K.1.11),種衣酯(fenitropan)(K.1.12),胺苯吡菌酮(fenpyrazamine)(K.1.13),氟醯菌胺(flumetover)(K.1.14),氟硫滅(flusulfamide)(K.1.15),氟替尼(flutianil)(K.1.16),超敏蛋白(harpin)(K.1.17),磺菌威(metha-sulfocarb)(K.1.18),氯啶(nitrapyrin)(K.1.19),異丙消(nitrothal-isopropyl)(K.1.20),托普洛卡(tolprocarb)(K.1.21),快得寧(oxin-copper)(K.1.22),丙氧喹啉(proquinazid)(K.1.23),特普弗洛奎(tebufloquin)(K.1.24),克枯爛(tecloftalam)(K.1.25),咪唑嗪(triazoxide)(K.1.26),N'-(4-(4-氯-3-三氟甲基-苯氧基)-2,5-二甲基-苯基)-N-乙基-N甲基甲脒(K.1.27),N'(4-(4-氟-3-三氟甲基-苯氧基)-2,5-二甲基-苯基)-N-乙基-N-甲基甲脒(K.1.28),N'-[4-[[3-[(4-氯苯基)甲基]-1,2,4-噻二唑-5-基]氧基]-2,5-二甲基-苯基]-N- 乙基-N-甲基-甲脒(K.1.29),N'-(5-溴-6-茚滿-2-基氧基-2-甲基-3-吡啶基)-N-乙基-N-甲基-甲脒(K.1.30),N'-[5-溴-6-[1-(3,5-二氟苯基)乙氧基]-2-甲基-3-吡啶基]-N-乙基-N-甲基-甲脒(K.1.31),N'-[5-溴-6-(4-異丙基環己氧基)-2-甲基-3-吡啶基]-N-乙基-N-甲基-甲脒(K.1.32),N'[5溴-2-甲基-6-(1-苯基乙氧基)-3-吡啶基]-N-乙基-N-甲基-甲脒(K.1.33),N'-(2-甲基-5-三氟甲基-4-(3-三甲基矽烷基-丙氧基)-苯基)-N-乙基-N-甲基甲脒(K.1.34),N'-(5-二氟甲基-2甲基-4-(3-三甲基矽烷基-丙氧基)-苯基)-N-乙基-N-甲基甲脒(K.1.35),2-(4-氯-苯基)-N-[4-(3,4-二甲氧基-苯基)-異噁唑-5基]-2-丙-2-炔氧基-乙醯胺(K.1.36),3[5-(4-氯-苯基)-2,3-二甲基-異噁唑啶-3-基]-吡啶(啶菌噁唑(pyrisoxazole))(K.1.37),3-[5-(4-甲基苯基)-2,3-二甲基-異噁唑啶-3基]-吡啶(K.1.38),5-氯-1(4,6-二甲氧基-嘧啶-2-基)-2-甲基-1H-苯并咪唑(K.1.39),(Z)3胺基-2-氰基-3-苯基-丙-2-烯酸乙酯(K.1.40),皮卡布西(picarbutrazox)(K.1.41),N-[6-[[(Z)-[(1-甲基四唑-5-基)-苯基-亞甲基]胺基]氧基甲基]-2-吡啶基]胺基甲酸戊酯(K.1.42),N-[6-[[(Z)-[(1-甲基四唑-5-基)-苯基-亞甲基]胺基]氧基甲基]-2-吡啶基]胺基甲酸丁-3-炔基酯(K.1.43),2-[2-[(7,8-二氟-2-甲基-3-喹啉基)氧基]-6-氟-苯基]丙-2-醇(K.1.44),2-[2-氟-6-[(8-氟-2-甲基-3-喹啉基)氧基]苯基]丙-2-醇(K.1.45),喹氟美林(quinofumelin)(K.1.47),9-氟-2,2-二甲基-5-(3-喹啉基)-3H 1,4苯并噁氮呯(K.1.49),2-(6-苯甲基-2-吡啶基)喹唑啉(K.1.50),2-[6-(3-氟-4甲氧基-苯基)-5-甲基-2-吡啶基]喹唑啉(K.1.51),二氯苯噻(dichlobentiazox)(K.1.52),N'-(2,5-二甲基-4-苯氧基-苯基)-N-乙基-N-甲基-甲脒(K.1.53)。
A pesticidal mixture comprising (1) a compound of formula IR-1 or a salt thereof as defined in claim 1, and (2) at least one compound II selected from the following group: M.1 acetylcholine Esterase (AChE) inhibitors: M.1A carbamates; or M.1B organophosphates; M.2. GABA-gated chloride channel antagonists: M.2A cyclodiene organochlorine compounds; or M.2B Phenylpyrazoles (fiproles) (phenylpyrazoles); M.3 M.3A Sodium channel modulators of pyrethroids; or M.3B Sodium channel modulators; M.4 Nicotine Acetylcholine receptor agonist (nAChR): M.4A neonicotinoids; or compound M.4A.1 4,5-dihydro-N-nitro-1-(2-cyclo Oxyethylmethyl)-1H-imidazol-2-amine, M.4A.2: (2E-)-1-[(6-chloropyridin-3-yl)methyl]-N'-nitro- 2-Pentylidene carboxamidine, or M4.A.3: 1-[(6-chloropyridin-3-yl)methyl]-7-methyl-8-nitro-5-propoxy-1, 2,3,5,6,7-hexahydroimidazo[1,2-a]pyridine; or M.4B Nicotine; M.4C Sulfoxaflor; M.4D Fluoropyrfuranone ( flupyradifurone); M.4E triflumezopyrim; M.5 nicotinic acetylcholine receptor ectopic activators: spinosyns; M.6 avermectins Chloride channel activators of milbemycins; M.7 juvenile hormone mimics; M.8 various non-specific (multi-site) inhibitors; M.9 TRPV channel modulators of stringed instruments; M.10 Mite growth inhibitor; M.12 Mitochondrial ATP synthase inhibitor; M.13 Oxidative phosphorylation decoupler via disruption of proton gradient; M.14 Nicotinic acetylcholine receptor (nAChR) channel Blocker; M.15 Inhibitor of chitin biosynthesis type 0; M.16 Inhibitor of chitin biosynthesis type 1; M.17 Diptera insect molting disruptor; M.18 Ecdysone receptor stimulator M.19 Octopamine receptor agonists; M.20 Mitochondrial complex III electron transport inhibitors; M.21 Mitochondrial complex I electron transport inhibitors; M.22 Voltage-dependent sodium channel inhibitors M.23 Inhibitor of Acetyl CoA Carboxylase; M.24 Mitochondrial Complex IV Electron Transport Inhibitor; M.25 Mitochondrial Complex II Electron Transport Inhibitor; M.28 Diamide Similar to ryanodine receptor modulators, M.28.1: (R)-3-chloro-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1- (Trifluoromethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamide, M.28.2: (S)-3-chloro- N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonium Acylethyl)phthalamide, M.28.3: Cyclaniliprole or M.28.4: Methyl-2-[3,5-dibromo-2-({[3-bromo -1-(3-Chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-dimethylcarbazinate; or M.28.5a )N-[4,6-dichloro-2-[(diethyl-λ-4-sulfenyl)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)- 5-(Trifluoromethyl)pyrazole-3-carboxamide; M.28.5b) N-[4-chloro-2-[(diethyl-λ-4-sulfide)aminoformyl] -6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; M.28.5c)N-[4- Chloro-2-[(di-2-propyl-λ-4-sulfide)aminoformyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5 -(trifluoromethyl)pyrazole-3-carboxamide; M.28.5d) N-[4,6-dichloro-2-[(di-2-propyl-λ-4-sulfide) Carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; M.28.5h)N-[4, 6-Dibromo-2-[(diethyl-λ-4-sulfide)aminoformyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoroform Base) pyrazole-3-carboxamide; M.28.5i) N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methyl Phenyl]-3-bromo-1-(3-chloro-2-pyridyl)-1H-pyrazole-5-carboxamide; M.28.5j) 3-chloro-1-(3-chloro-2- Pyridyl)-N-[2,4-dichloro-6-[[(1-cyano-1-methylethyl)amino]carbonyl]phenyl]-1H-pyrazole-5-carboxamide ; M.28.5k) 3-bromo-N-[2,4-dichloro-6-(methylaminoformyl)phenyl]-1-(3,5-dichloro-2-pyridyl)- 1H-pyrazole-5-carboxamide; M.28.5l) N-[4-chloro-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl ]-1-(3-chloro-2-pyridyl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide; or M.28.6: cyhalodiamide; or M.29: Chord modulators - undefined target site; M.UN. Insecticidally active compounds with unknown or unclear mode of action; M.UN.3: 11-(4-chloro-2,6- Dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one; M.UN.4:3- (4'-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one, M. UN.5: 1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H -1,2,4-Triazol-5-amine, or an active agent based on bacillus firmus (Votivo, I-1582); M.UN.6: Flupyrimin; M.UN .8: Fluazaindolizine; M.UN.9.a): 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-iso Oxazol-3-yl]-2-methyl-N-(1-oxothietane-3-yl)benzamide; M.UN.9.b): Fluazolamide ( fluxametamide); M.UN.10: 5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]-1H-pyrazole; M.UN.11.b) 3-(Benzoylmethylamino)-N-[2-bromo-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoro Methyl)propyl]-6-(trifluoromethyl)phenyl]-2-fluoro-benzamide; M.UN.11.c) 3-(benzoylmethylamino)-2- Fluoro-N-[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]-benzoyl Amine; M.UN.11.d) N-[3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6- (Trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; M.UN.11.e)N-[3-[[[2-bromo-4- [1,2,2,2-Tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]-2-fluoro-phenyl]-4 -Fluoro-N-methyl-benzamide; M.UN.11.f) 4-fluoro-N-[2-fluoro-3-[[[2-iodo-4-[1,2,2, 2-Tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; M.UN .11.g) 3-fluoro-N-[2-fluoro-3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl] -6-(Trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; M.UN.11.h) 2-Chloro-N-[3-[[ [2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl] -3-Pyridinecarboxamide; M.UN.11.i) 4-cyano-N-[2-cyano-5-[[2,6-dibromo-4-[1,2,2,3 ,3,3-Hexafluoro-1-(trifluoromethyl)propyl]phenyl]aminoformyl]phenyl]-2-methyl-benzamide; M.UN.11.j)4 -cyano-3-[(4-cyano-2-methyl-benzoyl)amino]-N-[2,6-dichloro-4-[1,2,2,3,3, 3-Hexafluoro-1-(trifluoromethyl)propyl]phenyl]-2-fluoro-benzamide; M.UN.11.k) N-[5-[[2-chloro-6- Cyano-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]aminoformyl]-2-cyano-phenyl]- 4-cyano-2-methyl-benzamide; M.UN.11.l) N-[5-[[2-bromo-6-chloro-4-[2,2,2-trifluoro- 1-Hydroxy-1-(trifluoromethyl)ethyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; M. UN.11.m) N-[5-[[2-bromo-6-chloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl] phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; M.UN.11.n) 4-cyano-N-[2 -Cyano-5-[[2,6-dichloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl base]phenyl]-2-methyl-benzamide; M.UN.11.o) 4-cyano-N-[2-cyano-5-[[2,6-dichloro-4- [1,2,2,2-Tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]aminoformyl]phenyl]-2-methyl-benzamide; M.UN.11 .p) N-[5-[[2-bromo-6-chloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]carbamoyl ]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; or M.UN.12.a) 2-(1,3-dioxane-2 -yl)-6-[2-(3-pyridyl)-5-thiazolyl]-pyridine; M.UN.12.b) 2-[6-[2-(5-fluoro-3-pyridyl) -5-thiazolyl]-2-pyridyl]-pyrimidine; M.UN.12.c) 2-[6-[2-(3-pyridyl)-5-thiazolyl]-2-pyridyl]- Pyrimidine; M.UN.12.d) N-Methylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide; M.UN.12.e ) N-methylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide; M.UN.12.f) N-ethyl-N-[ 4-Methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propionamide; M.UN.12.g) N-methyl-N-[4-methyl -2-(3-Pyridyl)thiazol-5-yl]-3-methylthio-propionamide; M.UN.12.h)N,2-Dimethyl-N-[4-methyl- 2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propionamide; M.UN.12.i) N-ethyl-2-methyl-N-[4-methyl -2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propionamide; M.UN.12.j) N-[4-chloro-2-(3-pyridyl)thiazole -5-yl]-N-ethyl-2-methyl-3-methylthio-propionamide; M.UN.12.k) N-[4-chloro-2-(3-pyridyl)thiazole -5-yl]-N,2-dimethyl-3-methylthio-propionamide; M.UN.12.l) N-[4-chloro-2-(3-pyridyl)thiazole-5 -yl]-N-methyl-3-methylthio-propionamide; M.UN.12.m) N-[4-chloro-2-(3-pyridyl)thiazol-5-yl]-N -Ethyl-3-methylthio-propionamide; M.UN.14a) 1-[(6-chloro-3-pyridyl)methyl]-1,2,3,5,6,7-hexa Hydrogen-5-methoxy-7-methyl-8-nitro-imidazo[1,2-a]pyridine; or M.UN.14b) 1-[(6-chloropyridin-3-yl)methyl Base]-7-methyl-8-nitro-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridin-5-ol; M.UN.16a)1- Isopropyl-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; or M.UN.16b) 1-(1,2-dimethylpropyl) -N-ethyl-5-methyl-N-pyridazine-4-yl-pyrazole-4-carboxamide; M.UN.16c) N,5-dimethyl-N-pyridazine-4- Base-1-(2,2,2-trifluoro-1-methyl-ethyl)pyrazole-4-carboxamide; M.UN.16d)1-[1-(1-cyanocyclopropyl ) ethyl]-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-formamide; M.UN.16e) N-ethyl-1-(2-fluoro -1-methyl-propyl)-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; M.UN.16f) 1-(1,2-dimethylpropane Base) -N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; M.UN.16g) 1-[1-(1-cyanocyclopropyl) ethyl Base]-N,5-Dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; M.UN.16h) N-methyl-1-(2-fluoro-1-methyl M.UN.16i) 1-(4,4-difluorocyclohexyl)-N- Ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; or M.UN.16j) 1-(4,4-difluorocyclohexyl)-N,5- Dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide, M.UN.17a) N-(1-methylethyl)-2-(3-pyridyl)-2H- Indazole-4-carboxamide; M.UN.17b) N-cyclopropyl-2-(3-pyridyl)-2H-indazole-4-carboxamide; M.UN.17c) N-ring Hexyl-2-(3-pyridyl)-2H-indazole-4-carboxamide; M.UN.17d) 2-(3-pyridyl)-N-(2,2,2-trifluoroethyl )-2H-indazole-4-carboxamide; M.UN.17e) 2-(3-pyridyl)-N-[(tetrahydro-2-furyl)methyl]-2H-indazole-5 -Formamide; M.UN.17f) methyl 2-[[2-(3-pyridyl)-2H-indazol-5-yl]carbonyl]hydrazine carboxylate; M.UN.17g)N-[( 2,2-difluorocyclopropyl)methyl]-2-(3-pyridyl)-2H-indazole-5-carboxamide; M.UN.17h)N-(2,2-difluoropropane Base)-2-(3-pyridyl)-2H-indazole-5-carboxamide; M.UN.17i) 2-(3-pyridyl)-N-(2-pyrimidinylmethyl)-2H -Indazole-5-carboxamide; M.UN.17j) N-[(5-methyl-2-pyrazinyl)methyl]-2-(3-pyridyl)-2H-indazole-5 -Formamide, M.UN.18a) N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3-trifluoro Propylthio)acrylamide; M.UN.18b) N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3, 3-trifluoropropylsulfinyl)propionamide; M.UN.18c)N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-3-[(2, 2-Difluorocyclopropyl)methylthio]-N-ethyl-acrylamide; M.UN.18d)N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl ]-3-[(2,2-difluorocyclopropyl)methylsulfinyl]-N-ethyl-acrylamide; M.UN.19 Salolaner (sarolaner); M.UN. 20 Lotilaner (lotilaner); M.UN.21 N-[4-chloro-3-[[(phenylmethyl)amino]carbonyl]phenyl]-1-methyl-3-(1, 1,2,2,2-Pentafluoroethyl)-4-(trifluoromethyl)-1H-pyrazole-5-carboxamide; M.UN.22a 2-(3-Ethylsulfonyl- 2-pyridyl)-3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridine, or M.UN.22b 2-[3-ethylsulfonyl-5-( Trifluoromethyl)-2-pyridyl]-3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridine; M.UN.23a 4-[5-(3,5 -Dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-N-[(4R)-2-ethyl-3-oxazolidine-4 -yl]-2-methyl-benzamide, or M.UN.23b 4-[5-(3,5-dichloro-4-fluoro-phenyl)-5-(trifluoromethyl)- 4H-isoxazol-3-yl]-N-[(4R)-2-ethyl-3-oxo-isoxazolidine-4-yl]-2-methyl-benzamide; M .UN.24a) N-[4-chloro-3-(cyclopropylaminoformyl)phenyl]-2-methyl-5-(1,1,2,2,2-pentafluoroethyl) -4-(trifluoromethyl)pyrazole-3-formamide or M.UN.24b) N-[4-chloro-3-[(1-cyanocyclopropyl)aminoformyl]phenyl ]-2-Methyl-5-(1,1,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3-carboxamide; M.UN.25 Ainopa Rui (acynonapyr); M.UN.26 benzpyrimoxan (benzpyrimoxan); M.UN.27 2-chloro-N-(1-cyanocyclopropyl)-5-[1-[2-methyl- 5-(1,1,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yl]pyrazol-4-yl]benzamide; M.29.28 Oxa oxazosulfyl; A) Inhibitors of complex III of the respiratory inhibitor Qo site: azoxystrobin (A.1.1), coumethoxystrobin (A.1.2), syringae coumoxystrobin (A.1.3), dimoxystrobin (dimoxystrobin) (A.1.4), enestroburin (enestroburin) (A.1.5), fenaminstrobin (A.1.6), bacteria Fenoxystrobin/flufenoxystrobin (A.1.7), fluoxastrobin (A.1.8), kresoxim-methyl (A.1.9), Mandalorian ice (mandestrobin) (A.1.10), metominostrobin (A.1.11), orysastrobin (A.1.12), picoxystrobin (A.1.13), becclomin (pyraclostrobin) (A.1.14), pyraclostrobin (pyrametostrobin) (A.1.15), pyraoxystrobin (pyraoxystrobin) (A.1.16), trifluorosensitive (trifluoxystrobin) (A.1.17), 2(2- (3-(2,6-dichlorophenyl)-1-methyl-allylaminooxymethyl)-phenyl)-2methoxyimino-N methyl-acetamide (A .1.18), pyribencarb (A.1.19), triclopyricarb/chlorodincarb (A.1.20), famoxadone (A.1.21) , Fenamidone (A.1.21), methyl-N-[2-[(1,4-dimethyl-5phenyl-pyrazol-3-yl)oxymethyl]phenyl] -N-methoxy-carbamate (A.1.22), 1-[3-chloro-2[[1(4-chlorophenyl)-1H-pyrazol-3-yl]oxymethyl ]phenyl]-4-methyl-tetrazol-5-one (A.1.23), 1-[3-bromo-2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxygen Base methyl] phenyl] -4-methyl-tetrazol-5-one (A.1.24), 1-[2-[[1-(4-chlorophenyl) pyrazol-3-yl] oxy Methyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one (A.1.25), 1-[2-[[1-(4-chlorophenyl)pyrazole-3 -yl]oxymethyl]-3-fluoro-phenyl]-4-methyl-tetrazol-5-one (A.1.26), 1-[2-[[1-(2,4-dichloro Phenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl]-4-methyl-tetrazol-5-one (A.1.27), 1-[3-cyclopropyl- 2-[[2-Methyl-4(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4methyl-tetrazol-5-one (A.1.30), 1[ 3(Difluoromethoxy)-2-[[2-methyl-4-(1methylpyrazol-3yl)phenoxy]methyl]phenyl]-4methyl-tetrazole-5- Ketone (A.1.31), 1-methyl-4-[3-methyl-2[[2methyl-4-(1-methylpyrazol-3yl)phenoxy]methyl]phenyl] Tetrazol-5-one (A.1.32), (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-oxyl-2-methoxyimine Base-N,3-dimethyl-pent-3-enamide (A.1.34), (Z,2E)5[1(4-chlorophenyl)pyrazol-3-yl]oxy-2- Methoxyimino-N,3-dimethyl-pent-3-enamide (A.1.35), pyriminostrobin (A.1.36), pyrflustrobin (bifujunzhi) (A.1.37 ), 2-(o-((2,5-dimethylphenyl-oxy-methylene)phenyl)-3-methoxy-methyl acrylate (A.1.38); complexation of Qi sites Inhibitors of substance III: cyazofamid (A.2.1), amisulbrom (A.2.2), [(6S,7R,8R) 2-methylpropionic acid 8 benzyl -3-[(3-Hydroxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxononyl-7 -yl] esters (A.2.3), fenpicoxamid (A.2.4); complex II inhibitors: benodanil (A.3.1), benzovindiflupyr (A.3.2), bixafen (A.3.3), boscalid (A.3.4), carboxin (A.3.5), fenfuram (A. .3.6), fluopyram (A.3.7), fudolanil (A.3.8), fluxapyroxad (A.3.9), furametpyr (A.3.10), isofetamid (A.3.11), isopyrazam (A.3.12), mepronil (A.3.13), oxycarboxin (A.3.14), Penflufen (A.3.15), Penthiopyrad (A.3.16), Pydiflumetofen (A.3.17), Pyreflumide Pyraziflumid (A.3.18), sedaxane (A.3.19), tecloftalam (A.3.20), thifluzamide (A.3.21), 3 ( Difluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4 carboxamide (A.3.22), 3(trifluoromethyl) -1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4 formamide (A.3.23), 1,3-dimethyl-N-(1 , 1,3-trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.24), 3-(trifluoromethyl)-1,5 dimethyl-N-(1, 1,3-trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.25), 1,3,5-trimethyl-N-(1,1,3-trimethyl Indan-4-yl)pyrazole-4-carboxamide (A.3.26), 3-(difluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindene Full-4-yl)pyrazole-4-carboxamide (A.3.27), 3-(difluoromethyl)-N(7 fluoro-1,1,3-trimethyl-indan-4-yl )-1-methyl-pyrazole-4-carboxamide (A.3.28), N-[(5-chloro-2-isopropyl-phenyl)methyl]-N-cyclopropyl-5- Fluoro-1,3-dimethyl-pyrazole-4-carboxamide (A.3.29), (E)-2-[2-[(5-cyano-2-methyl-phenoxy)methanol Base] phenyl] -3-methoxy-prop-2-enoic acid methyl ester (A.3.30), N-[(5-chloro-2-isopropyl-phenyl)methyl]-N-cyclopropane Base-3-(difluoromethyl)-5 fluoro-1-methyl-pyrazole-4-carboxamide (A.3.31), 2-(difluoromethyl)-N-(1,1,3 -Trimethyl-indan-4-yl)pyridine-3-formamide (A.3.32), 2-(difluoromethyl)-N-[(3R)-1,1,3-trimethyl Indan-4-yl]pyridine-3-carboxamide (A.3.33), 2-(difluoromethyl)-N-(3-ethyl-1,1-dimethyl-indan-4- Base) pyridine-3-carboxamide (A.3.34), 2-(difluoromethyl)-N-[(3R)-3-ethyl-1,1-dimethyl-indan-4-yl ] Pyridine-3-carboxamide (A.3.35), 2-(difluoromethyl)-N-(1,1-dimethyl-3-propyl-indan-4-yl)pyridine-3- Formamide (A.3.36), 2-(difluoromethyl)-N-[(3R)-1,1-dimethyl-3-propyl-indan-4-yl]pyridine-3-methyl Amide (A.3.37), 2-(difluoromethyl)-N-(3-isobutyl-1,1-dimethyl-indan-4-yl)pyridine-3-carboxamide (A .3.38), 2-(difluoromethyl)-N-[(3R)-3-isobutyl-1,1-dimethyl-indan-4 base]pyridine-3-carboxamide (A. 3.39); other respiratory inhibitors: diflumetorim (A.4.1); nitrophenyl derivatives: binapacryl (A.4.2), dinobuton (A.4.3), Dinocap (A.4.4), fluazinam (A.4.5), meptyldinocap (A.4.6), ferimzone (A.4.7); organometallic compounds : fentin salts; ametoctradin (A.4.11); silthiofam (A.4.12); B) sterol biosynthesis inhibitors (SBI fungicides) C14 demethylase inhibitors: triazoles: azaconazole (B.1.1), bitertanol (B.1.2), bromu-conazole (B.1.3), Cyproconazole (B.1.4), difenoconazole (B.1.5), diniconazole (B.1.6), diniconazole-M (B.1.7), Epsil Epoxiconazole (B.1.8), Fenbuconazole (B.1.9), Fluquinconazole (B.1.10), Flusilazole (B.1.11), and Fenbuconazole (B.1.11) flutriafol) (B.1.12), Fickley (hexaconazole) (B.1.13), imibenconazole (B.1.14), ipconazole (B.1.15), metconazole (B.1.15) .1.17), myclobutanil (B.1.18), oxpoconazole (B.1.19), paclobutrazole (B.1.20), penconazole (B.1.21), Pukeli (propiconazole) (B.1.22), prothioconazole (B.1.23), simeconazole (B.1.24), tebuconazole (B.1.25), tetraconazole (B.1.26), triadimefon (B.1.27), triadimenol (B.1.28), triticonazole (B.1.29), uniconazole (B.1.30 ), ipfentrifluconazole (B.1.37), mefentrifluconazole (B.1.38), 2-(chloromethyl)-2-methyl-5-(p-tolylmethyl) base)-1(1,2,4-triazol-1-ylmethyl)cyclopentanol (B.1.43); imidazoles: imazalil (B.1.44), pefurazoate (B.1.45), prochloraz (B.1.46), triflumizol (B.1.47); pyrimidines, pyridines and piperazines: fenarimol (B.1.49 ), bifenox (pyrifenox) (B.1.50), saifoning (triforine) (B.1.51), [3-(4-chloro-2-fluoro-phenyl)-5-(2,4-two Fluorophenyl)isoxazol-4-yl]-(3-pyridyl)methanol (B.1.52); δ14-reductase inhibitors: adimorph (aldimorph) (B.2.1), mobendazim (dodemorph ) (B.2.2), dodemorph-acetate (B.2.3), fenpropimorph (B.2.4), tridemorph (B.2.5), fenpropidin (fenpropidin) (B.2.6), piperalin (B.2.7), spiroxamine (B.2.8); 3-keto reductase inhibitors: fenhexamid ) (B.3.1); Other sterol biosynthesis inhibitors: chlorphenomizole (B.4.1); C) Nucleic acid synthesis inhibitors phenylamide or acyl amino acid fungicides: Benzox benalaxyl (C.1.1), metalaxyl benalaxyl (benalaxyl-M) (C.1.2), fine benalaxyl (kiralaxyl) (C.1.3), metalaxyl (metalaxyl) (C.1.4 ), high-efficiency metalaxyl (metalaxyl-M) (C.1.5), furamide (ofurace) (C.1.6), oxadixyl (C.1.7); other nucleic acid synthesis inhibitors: Shawenning (hymexazole) (C.2.1), octhilinone (octhilinone) (C.2.2), oxolinic acid (oxolinic acid) (C.2.3), bupirimate (C.2.4), 5-fluoro Cytosine (C.2.5), 5-fluoro-2-(p-tolylmethoxy)pyrimidine-4amine (C.2.6), 5-fluoro-2-(4-fluorophenylmethoxy)pyrimidine- 4 amine (C.2.7), 5-fluoro-2 (4 chlorophenylmethoxy) pyrimidine-4 amine (C.2.8); D) cell division and cytoskeleton inhibitors tubulin inhibitors: Mianlaide (benomyl) (D.1.1), carbendazim (D.1.2), fuberidazole (D1.3), thiabendazole (D.1.4), thiophanate methyl (thiophanate -methyl)(D.1.5), 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyridazine (D.1.6), 3-chloro-6- Methyl-5-phenyl-4-(2,4,6-trifluorophenyl)pyridazine (D.1.7), N-ethyl-2-[(3-ethynyl-8-methyl-6- Quinolinyl)oxy]butanamide (D.1.8), N-ethyl-2-[(3-ethynyl-8methyl-6quinolyl)oxy]-2-methylthio- Acetamide (D.1.9), 2-[(3-ethynyl-8-methyl-6-quinolin-yl)oxy]-N(2-fluoroethyl)butyramide (D.1.10) , 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-N-(2-fluoroethyl)-2-methoxy-acetamide (D.1.11), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-N-propyl-butyramide (D.1.12), 2-[(3-ethynyl-8-methyl Base-6-quinolyl)oxy]-2-methoxy-N-propyl-acetamide (D.1.13), 2-[(3-ethynyl-8-methyl-6-quinoline Base) oxy]-2-methylthio-N-propyl-acetamide (D.1.14), 2[(3 ethynyl-8-methyl-6-quinolyl)oxy]-N -(2-fluoroethyl)-2-methylsulfanyl-acetamide (D.1.15), 4-(2-bromo-4-fluoro-phenyl)-N-(2-chloro-6-fluoro -phenyl)-2,5-dimethyl-pyrazol-3amine (D.1.16); other cell division inhibitors: diethofencarb (D.2.1), ethaboxam (D. .2.2), pencycuron (D.2.3), fluopicolide (D.2.4), zoxamide (D.2.5), metrafenone (D.2.6 ), pyriofenone (D.2.7); E) amino acid and protein synthesis inhibitors methionine synthesis inhibitors: cyprodinil (E.1.1), mepanipyrim (mepanipyrim ) (E.1.2), pyrimethanil (pyrimethanil) (E.1.3); protein synthesis inhibitors: blasticidin-S (blasticidin-S) (E.2.1), kasugamycin (E. .2.2), kasugamycin hydrochloride hydrate (E.2.3), midiomycin (mildiomycin) (E.2.4), streptomycin (streptomycin) (E.2.5), oxytetracyclin (E.2.5) .2.6); F) signal transduction inhibitors MAP/histidine kinase inhibitors: fluoroimid (F.1.1), iprodione (F.1.2), procymidone ( F.1.3), vinclozolin (F.1.4), fludioxonil (F.1.5); G protein inhibitors: quinoxyfen (F.2.1); G) lipids and membranes Synthesis inhibitors Phospholipid biosynthesis inhibitors: edifenphos (G.1.1), iprobenfos (G.1.2), pyrazophos (G.1.3), isoprothiolane ) (G.1.4); lipid peroxidation: dicloran (G.2.1), quintozene (G.2.2), tecnazene (G.2.3) , tolclofos-methyl (G.2.4), biphenyl (G.2.5), chloroneb (G.2.6), etridiazole (G.2.7); phospholipid biosynthesis and cell wall deposition: dimethomorph (G.3.1), flumorph (flumorph) (G.3.2), mandipropamid (G.3.3), pyrimorph (pyrimorph) ( G.3.4), benthiavalicarb (G.3.5), iprovalicarb (G.3.6), valifenalate (G.3.7); affect cell membrane permeability and Compounds of fatty acids: propamocarb (G.4.1); inhibitors of oxidized sterol-binding proteins: oxathiapiprolin (G.5.1), methanesulfonic acid 2-{3-[2-(1 -{[3,5-bis(difluoromethyl-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5- Dihydro-1,2-oxazol-5-yl}phenyl ester (G.5.2), 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H) methanesulfonate -pyrazol-1-yl]acetyl}piperidin-4-yl)1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5yl}-3- Chlorophenyl ester (G.5.3), 4-[1-[2-[3-(difluoromethyl)-5-methyl-pyrazol-1-yl]acetyl]-4-piperidinyl] -N-tetralin-1-yl-pyridine-2-carboxamide (G.5.4), 4-[1-[2-[3,5-bis(difluoromethyl)pyrazol-1-yl] Acetyl]-4-piperidinyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.5), 4-[1-[2-[3-(difluoromethyl )-5-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-piperidinyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.6) , 4-[1-[2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetyl]-4-piperidinyl]-N-tetraline-1- Base-pyridine-2-carboxamide (G.5.7), 4-[1-[2-[5-methyl-3-(trifluoromethyl)pyrazol-1-yl]acetyl]-4 -Piperidinyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.8), 4-[1-[2-[5-(difluoromethyl)-3-(trifluoromethyl) Fluoromethyl)pyrazol-1-yl]acetyl]-4-piperidinyl]-N-tetral-1-yl-pyridine-2-carboxamide (G.5.9), 4-[1- [2-[3,5-bis(trifluoromethyl)pyrazol-1-yl]acetyl]-4-piperidinyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.10), (4-[1-[2-[5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-piperidinyl]-N - tetralin-1-yl-pyridine-2-carboxamide (G.5.11); H) Inhibitor inorganic active substances with multi-site action: Bordeaux mixture (Bordeaux mixture) (H.1.1), copper (H. .1.2), copper acetate (H.1.3), copper hydroxide (H.1.4), copper oxychloride (H.1.5), basic copper sulfate (H.1.6), sulfur (H.1.7); thio and Dithiocarbamates: ferbam (H.2.1), zinc manganese (mancozeb) (H.2.2), manganese (maneb) (H.2.3), metam ) (H.2.4), so as not to rot (metiram) (H.2.5), methyl zinc Naipu (propineb) (H.2.6), get grace (thiram) (H.2.7), zinc Naipu (zineb) ( H.2.8), Yisui (ziram) (H.2.9); organochlorine compounds: anilazine (H.3.1), tetrachloroisobenzonitrile (chlorothalonil) (H.3.2), tetrachlordane ( captafol) (H.3.3), captan (captan) (H.3.4), folpet (H.3.5), Yifaling (dichlorofluanid) (H.3.6), dichlorophen (dichlorophen) ( H.3.7), hexachlorobenzene (H.3.8), pentachlorophenol (H.3.9) and its salts, phthalide (H.3.10), methyl tolylfluanid (H.3.11); Guanidines and others: guanidine (H.4.1), dodine (H.4.2), dodine free base (H.4.3), biguanide salt (guazatine) (H.4.4), biguanide salt acetate (H. .4.5), Kerejing (iminoctadine) (H.4.6), Kerejing Triacetate (H.4.7), Kerejing Ginseng (Alkanebenzenesulfonate) (H.4.8), Nitrithioquinone (dithianon )(H.4.9), 2,6-dimethyl-1H,5H-[1,4]dithia
Figure 107134558-A0305-02-0183-2
And[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetraketone (H.4.10); I) Cell wall synthesis inhibitor Glucan synthesis inhibition Agents: validamycin (I.1.1), polyoxin B (I.1.2); melanin synthesis inhibitors: pyroquilon (I.2.1), trisethazole (tricyclazole) (I.2.2), carpropamid (I.2.3), dicyclomet (I.2.4), fenoxanil (I.2.5); J) plants Protection inducers Acibenzolar-S-methyl (acibenzolar-S-methyl) (J.1.1), probenazole (J.1.2), isotianil (J.1.3) , tiadinil (J.1.4), prohexadione-calcium (J.1.5); phosphonates: fosetyl (J.1.6), fosetyl-aluminum (fosetyl- aluminum) (J.1.7), phosphorous acid and its salts (J.1.8), calcium phosphonate (J.1.11), potassium phosphonate (J.1.12), potassium bicarbonate or sodium bicarbonate (J.1.9), 4 Cyclopropyl-N-(2,4-dimethoxyphenyl)thiadiazole-5-carboxamide (J.1.10); K) Unknown mode of action bronopol (K.1.1) , chinomethionat (K.1.2), cyflufenamid (K.1.3), cymoxanil (K.1.4), dazomet (K.1.5), michamycin Debacarb (K.1.6), diclocymet (K.1.7), diclomezine (K.1.8), difenzoquat (K.1.9), wild swallow Methylsulfate (K.1.10), diphenylamine (K.1.11), fenitropan (K.1.12), fenpyrazamine (K.1.13), fluorinated bacteria Amine (flumetover) (K.1.14), flusulfamide (flusulfamide) (K.1.15), flutinib (flutianil) (K.1.16), hypersensitive protein (harpin) (K.1.17), sulfacarb ( Metha-sulfocarb) (K.1.18), nitrapyrin (K.1.19), nitrothal-isopropyl (K.1.20), tolprocarb (K.1.21), fast Oxin-copper (K.1.22), proquinazid (K.1.23), tebufloquin (K.1.24), tecloftalam (K.1.25) , imidazosin (triazoxide) (K.1.26), N'-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl Base-N methylformamidine (K.1.27), N'(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl Base-N-methylformamidine (K.1.28), N'-[4-[[3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl] Oxy]-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine (K.1.29), N'-(5-bromo-6-indan-2-yl Oxygen-2-methyl-3-pyridyl)-N-ethyl-N-methyl-formamidine (K.1.30), N'-[5-bromo-6-[1-(3,5- Difluorophenyl)ethoxy]-2-methyl-3-pyridyl]-N-ethyl-N-methyl-formamidine (K.1.31), N'-[5-bromo-6-( 4-isopropylcyclohexyloxy)-2-methyl-3-pyridyl]-N-ethyl-N-methyl-formamidine (K.1.32), N'[5 bromo-2-methyl -6-(1-phenylethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine (K.1.33), N'-(2-methyl-5-trifluoro Methyl-4-(3-trimethylsilyl-propoxy)-phenyl)-N-ethyl-N-methylformamidine (K.1.34), N'-(5-difluoromethyl -2-methyl-4-(3-trimethylsilyl-propoxy)-phenyl)-N-ethyl-N-methylformamidine (K.1.35), 2-(4-chloro-benzene Base)-N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5 base]-2-prop-2-ynyloxy-acetamide (K.1.36), 3 [5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidine-3-yl]-pyridine (pyrisoxazole (pyrisoxazole)) (K.1.37), 3-[5 -(4-methylphenyl)-2,3-dimethyl-isoxazolidine-3 base]-pyridine (K.1.38), 5-chloro-1(4,6-dimethoxy-pyrimidine -2-yl)-2-methyl-1H-benzimidazole (K.1.39), (Z) 3 amino-2-cyano-3-phenyl-prop-2-enoic acid ethyl ester (K. 1.40), picarbutrazox (K.1.41), N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino] Oxymethyl]-2-pyridyl]amyl carbamate (K.1.42), N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl- Methylene]amino]oxymethyl]-2-pyridyl]but-3-ynyl carbamate (K.1.43), 2-[2-[(7,8-difluoro-2- Methyl-3-quinolinyl)oxy]-6-fluoro-phenyl]propan-2-ol (K.1.44), 2-[2-fluoro-6-[(8-fluoro-2-methyl -3-quinolyl)oxy]phenyl]propan-2-ol (K.1.45), quinofumelin (quinofumelin) (K.1.47), 9-fluoro-2,2-dimethyl-5 -(3-quinolinyl)-3H 1,4 benzoxazepine (K.1.49), 2-(6-benzyl-2-pyridyl)quinazoline (K.1.50), 2-[ 6-(3-fluoro-4methoxy-phenyl)-5-methyl-2-pyridyl]quinazoline (K.1.51), dichlorobentiazox (K.1.52), N' -(2,5-Dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine (K.1.53).
如請求項2之殺有害生物混合物,其中該化合物II係選自以下之群:M.2.GABA閘控氯離子通道拮抗劑,M.3鈉通道調節劑,M.4菸鹼乙醯膽鹼受體促效劑,M.5菸鹼乙醯膽鹼受體異位活化劑,M.6阿維菌素類(avermectins)及米爾倍黴素類(milbemycins)之氯離子通道活化劑,M.9弦音器TRPV通道調節劑,M.13經由破壞質子梯度之氧化磷酸化去偶合劑,M.15甲殼素生物合成類型0之抑制劑,M.16甲殼素生物合成類型1之抑制劑,M.22電壓依賴性鈉通道阻斷劑,M.23乙醯CoA羧化酶之抑制劑,M.28二醯胺類之利阿諾定(Ryanodine)受體調節劑,M.29:弦音器調節劑,M.UN.9.b):氟唑醯胺(fluxametamide),M.29.28噁唑沙非(oxazosulfyl),呼吸抑制劑:Qo位點之複合物III的抑制劑,Qi位點之複合物III的抑制劑,複合物II之抑制劑,固醇生物合成抑制劑,脂質及膜合成抑制劑,細胞壁合成抑制劑,植物防護誘導劑,二氯西莫(diclocymet)(K.1.7),托普洛卡(tolprocarb)(K.1.21)及皮卡布西(picarbutrazox)(K.1.41)。 Such as the pesticidal mixture of claim 2, wherein the compound II is selected from the following group: M.2. GABA-gated chloride channel antagonists, M.3 sodium channel modulators, M.4 nicotine acetylcholine Alkaline receptor agonist, M.5 Nicotinic acetylcholine receptor ectopic activator, M.6 Chloride channel activator of avermectins and milbemycins, M.9 Chitin TRPV channel modulator, M.13 Oxidative phosphorylation decoupler via disruption of proton gradient, M.15 Chitin biosynthesis type 0 inhibitor, M.16 Chitin biosynthesis type 1 inhibitor , M.22 Voltage-dependent sodium channel blockers, M.23 Inhibitors of acetyl CoA carboxylase, M.28 Rianodine receptor modulators of diamides, M.29: Chord regulator, M.UN.9.b): Fluxametamide, M.29.28 oxazosulfyl, Respiratory inhibitor: Inhibitor of complex III of Qo site, Qi site Inhibitors of complex III, inhibitors of complex II, sterol biosynthesis inhibitors, lipid and membrane synthesis inhibitors, cell wall synthesis inhibitors, plant protection inducers, diclocymet (K. 1.7), Tolprocarb (K.1.21) and picarbutrazox (K.1.41). 如請求項2或3之殺有害生物混合物,其中該式I-R-1之化合物或其鹽與該化合物II之比率在10000:1與1:10000之間。 The pesticidal mixture according to claim 2 or 3, wherein the ratio of the compound of formula I-R-1 or its salt to the compound II is between 10000:1 and 1:10000. 如請求項2或3之殺有害生物混合物,其中該式I-R-1之化合物或其鹽與該化合物II之比率在1000:1與1:1000之間。 The pesticidal mixture according to claim 2 or 3, wherein the ratio of the compound of formula I-R-1 or its salt to the compound II is between 1000:1 and 1:1000. 一種殺有害生物組合物,其包含液體或固體載劑及如請求項1中所定義之式I-R-1之化合物或其鹽或如請求項2至5中任一項所定義之殺有害生 物混合物。 A pesticidal composition comprising a liquid or solid carrier and a compound of formula I-R-1 as defined in Claim 1 or a salt thereof or a pesticidal pest as defined in any one of Claims 2 to 5 mixture of substances. 一種用於控制昆蟲、蟎蟲或線蟲之非治療方法,其包含使昆蟲、蟎蟲或線蟲或其食物供應地、棲息地、繁殖地或其所在地與殺有害生物有效量之如請求項1所定義之式I-R-1之化合物或其鹽或如請求項2至5中任一項所定義之殺有害生物混合物接觸。 A non-therapeutic method for controlling insects, acarids or nematodes, comprising exposing insects, acarids or nematodes or their food supply, habitat, breeding ground or their location with a pesticidally effective amount of A compound of formula I-R-1 or a salt thereof or a pesticidal mixture as defined in any one of claims 2 to 5 is contacted. 一種保護植物免受昆蟲、蟎蟲或線蟲侵襲或侵染之方法,其包含使該植物或該植物生長之土壤或水與殺有害生物有效量之如請求項1中所定義之式I-R-1之化合物或其鹽或如請求項2至5中任一項所定義之殺有害生物混合物接觸。 A method for protecting plants from attack or infestation by insects, acarids or nematodes, comprising making the plant or the soil or water in which the plant grows and a pesticidally effective amount of formula I-R-1 as defined in claim 1 Compounds or salts thereof or pesticidal mixtures as defined in any one of claims 2 to 5. 一種用於保護植物繁殖材料之方法,其包含使該植物繁殖材料與殺有害生物有效量之如請求項1所定義之式I-R-1之化合物或其鹽或如請求項2至5中任一項所定義之殺有害生物混合物接觸。 A method for protecting plant propagation material, which comprises making the plant propagation material and a pesticidally effective amount of the compound of formula I-R-1 as defined in claim 1 or a salt thereof or any one of claim 2 to 5 Exposure to pesticidal mixtures as defined in the subparagraph. 如請求項8或請求項9之方法,其中該植物為水稻植物且昆蟲係選自以下之群:半翅目:褐飛虱-褐稻虱(Nilaparvata lugens)灰飛虱-斑飛虱(Laodelphax striatellus)白背飛虱-白背飛虱(Sogatella furcifera)白葉蟬-白翅褐脈葉蟬(Cofana spectra) 青葉蟬-二點黑尾葉蟬(Nephotettix virescens)、黑條黑尾葉蟬(N.nigriceps)、黑尾葉蟬(N.cincticeps)、馬來亞黑尾葉蟬(N.malayanus)電光葉蟬-電光葉蟬(Recilia dorsalis)玉米橙葉蟬-二星葉蟬(Cicadulina bipunctata)紫莞葉蟬-紫菀點葉蟬(Macrosteles fascifrons)稻穗蝽,大稻緣蝽(Leptocorisa oratorius),稻蛛緣蝽(L.acuta)稻褐蝽-稻綠蝽(Nezara viridula)、異曼蝽(Pygomenida varipennis)、二星蝽屬(Eysarcoris)、Tibraca limbatriventris、廣二星蝽(Eysarcoris ventralis)小臭蟲-雜色稻椿(Oebalus poecilus)、美洲稻蝽(O.pugnax)緣蝽-二星蝽屬長蝽-麥長蝽(Blissus leucopterus leucopterus)水稻粉蚧,水稻粉紅粉蚧(Brevennia rehi),亞蔗粉蚧(Pseudococcus saccharicola)稻蚜,紅腹縊管蚜(Rhopalosiphum rufiabdominalis),麥長管蚜(Macrosiphum avenae),無肘詠蚜(Hysteroneura setariae),黑腹四脈綿蚜(Tetraneuro nigriabdominalis)菜豆根蚜-棉根蚜(Smynthurodes betae)鱗翅目:稻苞蟲-直紋稻弄蝶(Parnara guttata)、暮眼蝶(Melanitis Ieda ismene)水稻螟蟲/條螟-二化螟(Chilo suppressalis)、黑頭條紋螟(Chilo polychrusus)、斑禾草螟(Chilo partellus)、七星稻螟(Chilo plejadellus) 稻稈螟-稻多麗螟(Chilotraea polychrysa)大螟-大螟(Sesamia inferens)三化螟-三化螟(Tryporyza(=Scirpophaga)incertulas)稻白螟-稻白螟(Tryporyza innotata)稻縱卷葉螟/卷葉蟲-稻縱卷葉野螟(Cnaphalocrocis medinalis)、寬紋刷鬚野螟(Marasmia patnalis)、稻顯紋刷鬚野螟(M.exigua)剃枝蟲/行軍蟲-東方黏蟲(Pseudaletia separate)綠毛蟲-犁紋黃夜蛾(Xanthodes transversa)稻綠毛蟲-稻螟蛉(Narnaga aenescens)綠角毛蟲-暮眼蝶、眉眼蝶屬(Mycalesis sp)草地黏蟲-草地貪夜蛾(Spodoptera frugiperda)切根蟲-黏蟲(Mythimna separata)稻殼蟲-稻三點螟(Nymphula depunctalis)黑毛毛蟲,鹿蛾屬(Amata sp.)長毛毛蟲-實毛脛裳蛾(Mocis frugalis)黃毛蟲,鉤茸毒蛾(Psalis pennatula)水稻半褐尺蠖,實毛脛裳蛾水稻擬尺蠖,金色雙斑蛾(Chrysodeixis chalcites)草螟-水稻切葉野螟(Herpetogramma licarsisalis)蔗螟-小蔗螟(Diatraea saccharalis)玉米稈螟-南美玉米苗斑螟(Elasmopalpus lignosellus)條紋草尺蠖-南美毛脛夜蛾(Mocis latipes)歐洲玉米螟-玉米螟(Ostrinia nubilalis) 墨西哥稻螟-墨西哥水稻螟(Eoreuma loftini)鞘翅目:水稻象鼻蟲-稻水象甲(Lissorhopterus oryzophilus)稻象鼻蟲-稻象甲(Echinocnemus squamous)米象-水稻負泥蟲(Oryzophagus oryzae)水稻鐵甲蟲-水稻鐵甲(Diclodispa armigera)水稻葉甲-稻葉甲(Oulema oryzae)稻黑蝽-稻黑蝽(Scotinophora vermidulateS.vermidulateS.lurida)、寬翅黑蝽(S.latiuscula)水稻跳甲-黑凹脛跳甲(Chaetocnima basalis)蛆-白鱗鰓金龜(Leucopholis irrorata)、白鱗鰓金龜、鰓角金龜屬(Phyllophaga sp)、異爪犀金龜屬(Heteronychus sp)金龜子-阿根廷兜蟲(Diloboderus abderus)象鼻蟲-尖隱喙象屬(Sphenophorus spp)葡萄鞘葉甲-葡萄鞘葉甲(Colaspis brunnea)、路易斯安那葉甲(C.louisianae)水稻花粉甲蟲,花金龜(Chilolaba acuta)雙翅目:稈蠅-稻稈潛蠅(Chlorops oryzae)潛蠅-日本稻潛蠅(Agromyza oryzae)稻水蠅/稻稈蠅-稻莖毛眼水蠅(Hydrellia sasakii)稻水蠅/稻小潛蠅-稻潛葉蠅(Hydrellia griseola)稻癭蚊-稻癭蚊(Orseolia(=Pachydiplosis)oryzae) 秧苗蠅-稻芒蠅(Atherigona oryzae)稻搖蚊-Chironomus cavazzai、搖蚊屬(Chironomus spp)、環足搖蚊屬(Cricotopus spp)纓翅目:稻薊馬-稻薊馬(Chloethrips oryzae)、稻直鬃薊馬(Stenochaetothrips biformis)、裸薊馬屬(Perrisothrips sp.)、器管薊馬屬(Hoplothrips sp.),直翅目:稻蝗、等岐蔗蝗(Hieroglyphus banian)、高粱蔗蝗(Hieroglyphus nigrorepletus)、紅褐斑腿蝗(Catantops pinguis)、紡梭負蝗(Attractomorpha burri)、短翅負蝗(A.crenulate)、柳枝負蝗(A.psittacina psittacina)、尖頭負蝗(A.Bedeli)、無齒稻蝗(Oxya adenttata)、Oxya ebneri、小稻蝗(Oxya hyla intricata)、長頭蝗(Acrida turricata)蝗蟲-東亞飛蝗(Locusta migratoria manilensis)螻蛄,非洲螻蛄(Grylotalpa africana)蟋蟀:雙斑蟋(Gryllus bimaculatus)、烏頭眉紋蟋蟀(Teleogryllus occipitalis)、靈巧纖蟋(Euscyrtus concinus)螽斯-長翅草螽(Conocephalus longipennis)等翅目:白蟻-暗黃大白蟻(Macrotermes gilvus)、Syntermes molestans膜翅目:螞蟻-熱帶火蟻(Solenopsis geminata)稻幹尖線蟲-葉芽線蟲(Aphelenchotdes besseyi) 蜱蟎亞綱:稻穗蟎-稻細蟎(Steotarsonemus pinki)甲殼綱:鱟蟲-佳朋鱟蟲(Triops longicaudatus)、蟹形鱟蟲(T.cancriformis)水稻小龍蝦-克氏原螯蝦(Procambarus clarkii)、莫里斯綠螯蝦(Orconectes virilis)。 The method of claim 8 or claim 9, wherein the plant is a rice plant and the insect is selected from the following group: Hemiptera: brown planthopper-brown rice hopper ( Nilaparvata lugens ) brown planthopper-spotted planthopper ( Laodelphax striatellus ) white-backed planthopper - white-backed planthopper ( Sogatella furcifera ) white leafhopper - white-winged leafhopper ( Cofana spectrum ) green leafhopper - two-spotted black-tailed leafhopper ( Nephotettix virescens ), black-striped black-tailed leafhopper ( N .nigriceps ), black-tailed leafhopper ( N. cincticeps ), Malayan black-tailed leafhopper ( N. malayanus ) electric leafhopper - electric light leafhopper ( Recilia dorsalis ) corn orange leafhopper - two-star leafhopper ( Cicadulina bipunctata ) purple Leafhopper-Macrosteles fascifrons ( Macrosteles fascifrons ) Rice ear bug, Rice bug ( Leptocorisa oratorius ), Rice spider bug ( L.acuta ) Rice brown bug-Rice green bug ( Nezara viridula ) Pygomenida varipennis ), Eysarcoris ( Eysarcoris ), Tibraca limbatriventris , Eysarcoris ventralis small bedbugs- Oebalus poecilus , American rice bugs ( O.pugnax )- Rice bug ( Blissus leucopterus leucopterus ) rice mealybug, rice pink mealybug ( Brevennia rehi ), subcane mealybug ( Pseudococcus saccharicola ) rice aphid, red-bellied tube aphid ( Rhopalosiphum rufiabdominalis ), wheat long tube aphid ( Macrosiphum avenae ) , Hysteroneura setariae ( Hysteroneura setariae ), Tetraneuro nigriabdominalis ( Tetraneuro nigriabdominalis ) Bean root aphid - Cotton root aphid ( Smynthurodes betae ) Lepidoptera: Rice bract insect - straight grained rice butterfly ( Parnara guttata ), evening eye Butterfly ( Melanitis Ieda ismene ) rice borer/strip borer - Chilo suppressalis ( Chilo suppressalis ), black-headed stripe borer ( Chilo polychrusus ), spotted grass borer ( Chilo partellus ), seven-star rice borer ( Chilo plejadellus ) rice stem borer - rice multi Chilotraea polychrysa ( Chilotraea polychrysa ) large borer - large borer ( Sesamia inferens ) rice borer - rice borer ( Tryporyza ( = Scirpophaga) incertulas ) rice white borer - rice white borer ( Tryporyza innotata ) rice leaf roller / leaf roller -Cnaphalocrocis medinalis , Marasmia patnalis , M. exigua shaving worm/army insect-Oriental armyworm ( Pseudaletia separate ) green Caterpillar - Xanthodes transversa Rice green caterpillar - Rice borer ( Narnaga aenescens ) Green horned caterpillar - Twilight butterfly, Mycalesis sp ( Mycalesis sp ) Meadow armyworm - Spodoptera frugiperda Cut root Insects - armyworm ( Mythimna separata ) rice shell insect - rice three-spot borer ( Nymphula depunctalis ) black caterpillar, deer moth ( Amata sp. ) long caterpillar - real hairy shrub moth ( Mocis frugalis ) yellow caterpillar, hookworm ( Psalis pennatula ) rice semi-brown inchworm, Pseudomonas oryzae, Chrysodeixis chalcites grass moth-rice leaf-cutting wild borer ( Herpetogramma licarsisalis ) sugarcane borer-small sugarcane borer ( Diatraea saccharalis ) corn stem borer- South American Corn Borer ( Elasmopalpus lignosellus ) Striped Geometrid- South American Mocis latipes European Corn Borer- Corn Borer ( Ostrinia nubilalis ) Mexican Rice Borer- Mexican Rice Borer ( Eoreuma loftini ) Coleoptera: Rice Weevil- Rice water weevil ( Lissorhopterus oryzophilus ) rice weevil - rice weevil ( Echinocnemus squamous ) rice weevil - rice negative mud worm ( Oryzophagus oryzae ) rice iron beetle - rice iron armor ( Diclodispa armigera ) rice leaf beetle - rice leaf beetle ( Oulema oryzae ) rice black bug - rice black bug ( Scotinophora vermidulate , S.vermidulate , S.lurida ), wide-winged black bug ( S.latiuscula ) rice flea beetle - black concave shank flea beetle ( Chaetocnima basalis ) maggot - white scale beetle ( Leucopholis irrorata ), White-scaled Beetle, Phyllophaga sp , Heteronychus sp Scarab-Argentine Diloboderus abderus Weevil- Sphenophorus spp Grape Colaspis brunnea , C. louisianae rice pollen beetle, Chilolaba acuta Diptera: stalk fly - Chlorops oryzae - Japanese rice water fly ( Agromyza oryzae ) rice water fly / rice stalk fly - rice stem water fly ( Hydrellia sasakii ) rice water fly / rice small miner - rice leafminer ( Hydrellia griseola ) rice gall mosquito - rice gall Mosquitoes (Orseolia (= Pachydiplosis) oryzae ) Seedling flies - Atherigona oryzae Rice midges - Chironomus cavazzai , Chironomus spp , Cricotopus spp Thysanoptera: Rice thrips -Chloethrips oryzae , Stenochaetothrips biformis , Perrisothrips sp. , Hoplothrips sp. Orthoptera: Rice Grasshopper, Isocane Hieroglyphus banian , Hieroglyphus nigrorepletus , Catantops pinguis , Attractomorpha burri , A. crenulate , A. psittacina psittacina ), A. Bedeli , Oxya adenttata , Oxya ebneri , Oxya hyla intracata , Acrida turricata , Locusta migratoria manilensis ) mole crickets, African mole crickets ( Grylotalpa africana ) crickets: Gryllus bimaculatus , Teleogryllus occipitalis , Euscyrtus concinus katydid-long-winged katydids ( Conocephalus longipennis ) Isoptera: Termites - Macrotermes gilvus , Syntermes molestans Hymenoptera: Ants - Tropical Fire Ants ( Solenopsis geminata ) Rice Stem Apex Nematodes - Leaf Bud Nematodes ( Aphelenchotdes besseyi ) Steotarsonemus pinki ) Crustacea: Limulus-Jia Peng Limulus ( Triops longicaudatus ), Crab-shaped Limulus ( T.cancriformis ) Rice crayfish-Procambarus clarkii ( Procambarus clarkii ), Morris green crayfish ( Orconectes virilis ). 一種種子,其以每100kg種子0.1g至10kg之量包含如請求項1所定義之式I-R-1之化合物或其鹽或如請求項2至5中任一項所定義之殺有害生物混合物。 A seed comprising the compound of formula I-R-1 or a salt thereof as defined in claim 1 or the pesticidal mixture as defined in any one of claims 2 to 5 in an amount of 0.1 g to 10 kg per 100 kg of seeds.
TW107134558A 2018-09-28 2018-09-28 Pyrimidinium compounds and their mixtures for combating animal pests TWI804514B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW107134558A TWI804514B (en) 2018-09-28 2018-09-28 Pyrimidinium compounds and their mixtures for combating animal pests

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW107134558A TWI804514B (en) 2018-09-28 2018-09-28 Pyrimidinium compounds and their mixtures for combating animal pests

Publications (2)

Publication Number Publication Date
TW202012418A TW202012418A (en) 2020-04-01
TWI804514B true TWI804514B (en) 2023-06-11

Family

ID=71130411

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107134558A TWI804514B (en) 2018-09-28 2018-09-28 Pyrimidinium compounds and their mixtures for combating animal pests

Country Status (1)

Country Link
TW (1) TWI804514B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113252824B (en) * 2021-06-17 2022-04-19 湖南农业大学 Gas chromatography-electronic capture detector method for determining content of trifluoro-phenylpyrimidine in water body

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014167084A1 (en) * 2013-04-11 2014-10-16 Basf Se Substituted pyrimidinium compounds and derivatives for combating animal pests

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014167084A1 (en) * 2013-04-11 2014-10-16 Basf Se Substituted pyrimidinium compounds and derivatives for combating animal pests

Also Published As

Publication number Publication date
TW202012418A (en) 2020-04-01

Similar Documents

Publication Publication Date Title
RU2765370C2 (en) Pyrimidinium compounds and mixtures thereof for suppressing vermin
AU2017242539B2 (en) Bicyclic compounds
ES2754274T3 (en) Cyclic compounds replaced by a condensed ring system
JP2022505569A (en) Pesticide compounds
US20200077658A1 (en) Pesticidal Compounds
ES2733532T3 (en) Azoline compounds substituted by a condensed carbocyclic ring system
JP6854813B2 (en) An imino compound having a 2-chloropyrimidine-5-yl substituent as a pest control agent
US20190077809A1 (en) Spirocyclic Derivatives
TWI804514B (en) Pyrimidinium compounds and their mixtures for combating animal pests
BR112019025191B1 (en) SUBSTITUTED PYRIMIDINIUM COMPOUNDS, COMPOSITION, METHOD FOR PROTECTING CROPS, COATED SEED, USE OF THE COMPOUNDS AND USE OF A COMPOUND
US10106558B2 (en) Azolobenzazine compounds, compositions comprising these compounds and their use for controlling invertebrate pests
WO2019224092A1 (en) Pesticidally active c15-derivatives of ginkgolides
WO2018192793A1 (en) Substituted rhodanine derivatives
WO2018166855A1 (en) Heterobicyclic substituted dihydroisoxazoles
WO2018162312A1 (en) Spirocyclic derivatives